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A2780 human ovarian carcinoma cell line 
A2780 R cisplatin-resistant human ovarian carcinoma cell line 
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MC Metal-centered  
Me methyl 
MLCT Metal-to-ligand charge transfer 
NBD-PC 1-acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine 
NMR nuclear magnetic resonance 
PBS Phosphate-buffered saline 
PACT Photoactivated chemotherapy 
PDT photodynamic therapy 
PEG polyethylene glycol 
phen 1,10-phenanthroline 
Ph. red phenolsulfonphthalein 
ppb parts per billion 
ppm parts per million 
P/S penicillin/streptomycin 
pymi phenylpiridin-2-ylmethylene-imine 
rpm revolutions per minute  
r.t. room temperature 
[Ru]tot total bulk concentration of ruthenium complex  
Ru-DMPG ruthenium complex supported on DMPG liposome 
RuHmte ruthenium complex containing an Hmte ligand 
RuOH2 ruthenium complex containing an aqua ligand 
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RuSRR‘ ruthenium complex containing a sulfur-containing ligand  
s singlet (NMR) 
T temperature 
t triplet (NMR) or time  























In this chapter an overview is given concerning photosensitive polypyridyl ruthenium 
complexes. The photosubstitution reactions of these complexes and their applications as 
light-controlled molecular machines and light-activatable anticancer compounds are 
presented. Lipid bilayers are introduced as a link between these two research fields. Lipid 
bilayers can be used on the one hand as surfaces where the molecular motion of ruthenium 
complexes can occur, and on the other hand as molecular carriers for drug delivery of 




1.1. Photosensitive polypyridyl ruthenium(II) complexes  
1.1.1. Photoreactivity and photophysical properties 
Ruthenium(II) complexes with polypyridyl ligands have been extensively studied 
because they show a variety of interesting properties in the excited-state, such as 
photosubstitution, photoluminescence, photo-redox chemistry, and photoisomerization 
processes. The unique photophysical and photochemical properties of these complexes 





 is a d
6
 octahedral system; the polypyridine ligands usually have σ donor orbitals 
localized on the nitrogen atoms, and π donor and π* acceptor orbitals delocalized on 
the aromatic rings. Transition of an electron from a t2g metal-based orbital to a π*L 
ligand orbital typically results in a metal-to-ligand charge transfer (MLCT) excited 
states, whereas promotion of an electron from the t2g to the eg orbitals gives rise to a 
metal-centered (MC) excited state (Figure 1.1). The geometry of the metal center in a 
3
MC excited state is strongly modified with respect to the ground state geometry 
notably along the metal-ligand bonds. When the lowest excited state has 
3
MC 
character, it usually undergoes either fast, radiationless deactivation to the ground state, 
or ligand dissociation reactions (Figure 1.2a). Thus, the excited state lifetime is very 
short at room temperature and no radiative decay (luminescence) to the ground state is 
observed. On the other hand, since the ground state (GS) and MLCT states do not 
involve a change in eg orbital occupation, their corresponding potential wells are 
usually not significantly modified along the Ru–L coordinates. Consequently, when the 
lowest excited state is 
3
MLCT it does not undergo fast radiationless decay to the 
ground state and luminescence is usually observed (Figure 1.2b). In such a case, the 
lifetime of the 
3
MLCT excited state is typically temperature dependent, as it can be 
promoted to the 
3
MC state thermally, which leads to photosubstitution reaction or rapid 
non-radiative decays to the ground state.
[3-4]
 Overall, the photochemical behavior of 
ruthenium(II) complexes, i.e., either their excellent luminescence properties or their 
ability for photochemical ligand exchange, is strongly influenced by the relative energy 




MLCT excited states.  




MC states of the complex and get the desired behavior under light 
irradiation. One strategy is the adjustment of the electronic properties of the 
polypyridyl ligands, which affects the energy of the 
3





 The second strategy is to vary the steric properties of the ligand 





states. Thus, the relative energy levels of the various excited states, and thereby the 
nature of the lowest excited state, can be controlled by tuning the properties of the 




Figure 1.1. Schematic orbital diagram for the electronic ground state (GS) and the excited states for 
[Ru(bpy)3]
2+ complex. Adapted from reference [4]. 
 
Figure 1.2. Potential well diagrams showing the relative energies of the 3MC and 3MLCT for Ru(II) 
polypyridyl complexes. (a) The 3MC is the lowest excited state, and (b) the 3MLCT is the lowest 
excited state. Ru-L is a coordination bond, where L is a nitrogen- or sulfur-donor ligand. Adapted 






























 is one of the most investigated polypyridyl ruthenium(II) complexes (bpy 
= 2,2’-bipyridine).
[3, 7]
 This complex has D3 symmetry and its lowest excited state is of 
3
MLCT character with a long lifetime at room temperature (~1 µs). It thus undergoes 
relatively slow radiationless transitions and rather intense emission.
[3]
 By replacing one 
bpy ligand with a constrained bipyridyl ligand like 1,2-di(pyridin-3-yl)ethane, the 
ligand field splitting energy decreases due to the modification of the N-Ru-N bite 
angle. Distortion of the complex and lower ligand field splitting energy reduces the 
energy of 
3





observed and the 
3
MC becomes thermally accessible from the 
3
MLCT state, which 
facilitates non-radiative decay back to the ground state (GS). As a result at room 
temperature the emission intensity of the ruthenium complex with 1,2-di(pyridin-3-






Similarly, using rigid tridentate ligands such as 2,2′;6′,2′′-terpyridine (terpy) induces an 
even greater distortion from the ideal octahedral geometry compared to the Ru(II) 
complexes containing only bidentate ligands, since the N–Ru–N trans angles are 
significantly smaller than 180° with coordinated terpyridine ligands.
[9]
 As a result, the 
complex [Ru(terpy)2]
2+
 for example is only luminescent at 77 K, whereas at room 
temperature the 
3
MLCT excited state is quenched.
[10-11]
 In the extreme case, Ru[(6,6”-
dptpy)]
2+
 (dpterpy = 6,6”-dipheny1-2,2’;6’,2’’-terpyridine) does not show any 
luminescence even at 77 K. A possible explanation is the presence of inter-ligand steric 
repulsions, which may further weaken the ligand field splitting, and as a consequence 
lower the energy of the 
3
MC state below that of the 
3
MLCT state, to fully quench 
emission.
[10]
 Overall, more distortion in the coordination octahedron results in lower 
luminescence intensity for Ru(II) complexes. 
1.1.2. Photosubstitution reactions 
Photochemically labile ruthenium(II) complexes are capable of selectively  
photosubstituting a given ligand upon visible light irradiation.
[12-15]
 Decreasing the 
energy of the 
3
MC state, for example by introducing distortion in the coordination 
octahedron, not only renders non-radiative processes more efficient, but also allows for 
the thermal population of the 
3
MC state from the 
3
MLCT state. Such thermal 
population of 
3
MC states may lead to photocleavage of one ligand L of the 
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coordination sphere, followed more or less simultaneously by the coordination of an 
incoming ligand L’, typically a coordinating solvent molecule.
[16]
 
Ruthenium complexes of the [Ru(terpy)(N-N)(L)]
2+
 family, where N–N is a bidentate 
diimine ligand like 1,10-phenanthroline (phen) or 2,2’-bipyridine (bpy), and L is a 
neutral monodentate ligand, typically have enough distortion in their coordination 
sphere to selectively photosubstitute the monodentate ligand L.
[17]
 In a study by Collin 
et al., the photosubstitution of 2,6- -dimethoxybenzonitrile (MeOBN) by pyridine in a 
pyridine solution of [Ru(terpy*)(N-N)(L)]
2+
 was investigated, where terpy* is 4’-(3,5-
ditertiobutylphenyl)- 2,2’;6’,2’’-terpyridine and N-N is phen or 2,9-dimethyl-1,10-
phenanthroline (dmp). The study showed that using a sterically hindered dmp ligand, 
instead of the non-hindered ligand phen, resulted in an increase of the photosubstitution 
quantum yield by a factor 20 (Scheme 1.1). More steric interactions between dmp and 
MeOBN led to more efficient photoexpulsion of MeOBN from the octahedral 




Scheme 1.1. Increasing the photosubstitution quantum yield by distorting the coordination sphere of 
the ruthenium complex. φ represents the photosubstitution quantum yield. Adapted from reference 
[13]. 
The electronic properties of the ligands can also affect the rate and efficiency of 
photosubstitution processes. In a recent study by Turro et al.,
[18]





state in photosubstitution reactions was investigated by changing the electronic 
properties of the leaving ligands. In this study, the photosubstitution of ligand L in 
[Ru(bpy)2(L)]
2+
, where L is a bidentate sulfur-donor ligand like 3,6-dithiaoctane or a 
bidentate nitrogen-donor ligand like 1,2-diaminoethane, was investigated. Higher 
photosubstitution quantum yields were reported in the former case. Based on DFT 
calculation, it was shown that the elongation of the Ru-S bond in the 
3
MLCT triplet 
state is larger than that of a Ru-N bond, which means that the Ru-S bonds are weaker 
in the 
3
MLCT excited state than Ru-N bonds, and will lead more efficiently to 
photosubstitution. 
In the ruthenium(II) complexes of the [Ru(bpy)(X)(Y)]
2+
 family, the monodentate 
ligands X and Y can be efficiently photosubstituted by solvent molecules. Modifying 
the properties of these monodentate ligands helps promoting the photodissociation of 
one of them, while allowing the other one to be photochemically stable. Typically, 
weaker σ donor ligands like phosphites, thioethers, or triazoles, were reported to be 
photoreleased faster than stronger σ donors such as pyridines, amines, or phosphines. 
Etchenique and co-workers have investigated the properties of these complexes to 
apply them as phototriggered caged molecules.
[19]
  In complex [5]
2+
 (Scheme 1.2), 
PPh3 is a weaker σ-donor and stronger π-acceptor than the amino group of γ-
aminobutyric acid. Thus, upon irradiation with visible light the amine ligand is 
substituted by a water molecule to give [6]
2+
, but the phosphine ligand in [6]
2+
 remains 




Scheme 1.2. Amine vs. phosphine reactivity in the photosubstitution of a monodentate ligand in 
complex [5]2+ upon visible light irradiation[20]. 
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1.1.3. Ruthenium-based molecular machines 
A molecular machine can be defined as an assembly of different molecular 
components, i.e., a supramolecular structure, designed to perform a specific mechanical 
function in response to an appropriate external stimulus such as light, electricity, or 
chemical energy.
[21-22]
 The extension of the concept of machine from the macroscale to 
the molecular level is believed to be valuable for the development of nano-sized 
devices. Furthermore, it helps understanding the complex behavior of biological 
molecular machines such as ATPases or myosin, by mimicking their functions.
[23-25]
 
With such a concept in mind, the controlled unidirectional motion of single molecules 
is an ultimate goal that has been challenged mostly by organic chemists. For example, 
unidirectional motion in a mechanically interlocked assembly (molecular rotor)
[26]
 and 
‘walking’ of a two-legged molecular unit on a four-foothold molecular track (linear 
molecular machine),
[27]
 have been reported by Leigh and co-workers. 
Light irradiation, in particular, is a powerful tool to induce molecular motion. Several 
molecular machines have been reported that are powered by photonic stimuli.
[28-31]
 
Transition metal-containing catenanes and rotaxanes for example have been considered 
for building such systems, and among them multicomponent ruthenium(II) complexes, 
in which one part of the molecule can be set in motion photochemically with respect to 
the other part.
[32-35]
 These systems take advantage of the dissociative, metal-centered 
3
MC state described in Section 1.1.1 to perform the motion in one direction by 
photosubstitution of one ligand. The reverse motion usually occurs thermally, to reset 
the molecule into the initial, photosensitive state. In such systems, sterically hindered 
chelating ligands are necessary to distort the octahedral geometry of the ruthenium(II) 
complexes and allow thermal population of the 
3





 Complexes of the [Ru(diimine)2(N-N)]
2+
 family with 
hindered N-N ligands have been reported by the group of Sauvage and co-workers.
[37-
41]
 Two examples from this family are discussed below. 
A rotaxane-based ruthenium complex forms by threading a N-N-containing macrocycle 
onto a Ru(diimine)2-containing helical axis. Rigidity of the macrocycle is important for 
obtaining only the endo-coordinated isomer, where the helical axis passes through the 
macrocycle. As shown in Scheme 1.3, a Ru(phen)2-based complex ([8]
2+
) can act as an 
axis, and a 6,6’-diphenyl-2,2’-bipyridine-based (dpbpy) macrocycle is threaded 





Under visible light irradiation, de-coordination of the dpbpy-containing ring was 




Scheme 1.3. Photoinduced dissociation of the macrocycle from a pseudo-rotaxane [Ru(diimine)3]
2+ 
complex. Adapted from reference [40]. 
The second example consists of the catenane-based ruthenium complex [9]
2+
 
containing two interlocked rings. A macrocycle is usually used as a templating element 
in order to incorporate the [Ru(diimine)3]
2+
 core in the catenane (see Scheme 1.4).  
 
Scheme 1.4. The catenane-based ruthenium complex [9]2+ undergoes a thermally reversible and 
complete rearrangement upon visible light irradiation [17]. 
The [Ru(diimine)2] -containing fragment is a 63-membered ring incorporating two 
phen units, whereas the N-N-bidentate fragment is a 42-membered ring containing a 
6,6’-disubstituted bipyridine ligand. Light irradiation leads to the dissociation of the 





 was recovered by heating the system. The size of the macrocyclic ring has a 
strong influence on the photoreactivity of the ruthenium complex: a catenane with a 
smaller ring than in complex [9]
2+
 was reported to be less photoreactive.
[36]
 Recently, a 
biisoquinoline-based 39-membered macrocycle was shown to improve the shuttling 
kinetics in this kind of mechanically interlocked coordination compounds.
[42]
 
Another strategy reported by the same group
[43]
 is to build a macrocycle using the 
Ru(terpy)(phen) core instead of Ru(phen)2. In the sixth coordination position a 
monodentate ligand that can be photosubstituted should be included inside the 
macrocyclic cavity (Scheme 1.5).
[43]
 In complex [11]
2+
 a Ru(terpy)(phen) macrocyclic 
core was formed by connecting the terpy unit to the phen unit by a (CH2)18 linker and  
the monodentate pyridine ligand is included inside the ring. White light irradiation of 
this isomer induces the formation of a “photochemical” isomer [12]
2+
 where the phen 
moiety has rotated by an angle of 90° compared to the terpy chelate. Such rotation 
leads to a major rearrangement of the alkyl linker chain. The reverse rotation of the 
phen chelate was achieved by heating the photochemical isomer in dimethylsulfoxide 
to recover, after ligand exchange, the initial “thermal” isomer [11]
2+
. This is an 





Scheme 1.5. Re-organization of a flexible (CH2)18 chain by the photoinduced rotation of the phen 
chelate in [11]2+. The reverse motion is obtained by heating the complex in DMSO, followed by 
ligand exchange in pyridine [43]. 
In all of these examples the light-controlled motion of ruthenium-based molecules was 
performed in homogeneous solutions. Linear motion in homogeneous solution can be 
achieved for rotaxane-based transition-metal complexes when the ring moves from a 
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given position on the rotaxane axle to another position and vice versa.
[35]
 These type of 
linear motors have been developed in order to mimic natural linear molecular machines 
such as myosin or kinesin, which move along the linear track of actin filament or 
microtubules, respectively, using ATP as a fuel (Figure 1.3a).
[44]
 Ideal mimicking of 
the linear motion of natural molecular machines would be obtained by the development 
of molecules walking on a surface or on an artificial molecular track. 
 
Figure 1.3. a) Myosin V works as a dimer that transports intracellular cargos along actin filaments. 
Adapted from reference [44]. b) Schematic cartoon proposed for the molecular motion of a 
photosensitive ruthenium complex at the surface of a lipid bilayer. The ruthenium carrier is detached 
from the lipid bilayer surface upon visible light irradiation (forming an aqua ruthenium complex), 
while it binds to the membrane embedded ligand L in the dark. 
In the research reported in this thesis, such an artificial road was envisioned as being 
self-assembled at the surface of lipid bilayer membranes. Model membranes do not 
have the complexity of natural membranes, and their size, geometry, and composition 
can be optimized.
[45]
 In such a vision, photosensitive ruthenium polypyridyl complexes 
would be used as molecular carriers to move a load unidirectionally at the surface of an 
artificial membrane. As shown in Figure 1.3b, the surface of a lipid bilayer can be 
functionalized with monodentate ligands L that may coordinate to ruthenium 
complexes. The idea was to use visible light to substitute ligand L by an aqua ligand, 
thus detaching the ruthenium carrier from the surface of the lipid bilayer. The aqua 
ruthenium species would diffuse freely near the surface and bind back to the 
membrane-embedded ligand L under thermal conditions, i.e., in the absence of light.
[46]
 
By making the artificial road dissymmetric, the light-controlled motion of the 







the design of such a supramolecular system, understanding the reactivity of 
photosensitive ruthenium complexes must be deepened, and the dynamic interaction of 
the ruthenium complex with a model membrane should be fully understood. Thus, in 
Section 1.2 the dynamic interaction of metal cations and lipid bilayers will be 
discussed. 
1.2. Lipid bilayers  
1.2.1. Liposomes as model for cellular membranes 
The self-assembly of lipid molecules in aqueous solution usually results in the 
formation of amphiphilic bilayers. In such an assembly the hydrophilic polar heads 
orient towards the aqueous phase while the hydrophobic part of the lipids form the 
inner hydrophobic core of the bilayer. Closed, spherical bilayers form structures called 
vesicles. Artificially synthesized vesicles are usually named liposomes.
[47]
 Liposomes 
are dynamic systems with flexible surfaces; they have a great variety of topologies and 




Figure 1.4. Schematic presentation of liposome structures of bilayer membranes. 
Cell membranes play a crucial role in biological systems and many fundamental 
molecular processes are controlled by them. Membranes also act as a boundary 
between the extracellular and intracellular environments of a cell, and represent an 
essential functional unit for the transportation of materials, energy, and information. 
Liposomes formed of phospholipids or synthetic lipids have been widely used to mimic 
the functions and shape of biological membranes,
[49-50]
 and also to develop biomimetic 
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 or supramolecular catalysts.
[57]
 
Chemical recognition events on cellular membranes are the initial steps toward cellular 
signaling, and mimicking these functions is an important goal in the development of 
nano-scale molecular systems.
[58]
 Usually, synthetic receptors are incorporated into 
liposomes that can interact with guest molecules or metal ions, which mostly leads to 
vesicular aggregation or fusion.
[59]





 but also metal ion 
coordination.
[58-59]
 Metal ion coordination reactions in liposomal systems are more 
specifically discussed in the next section. 
1.2.2. Dynamic systems involving liposomes and metals 
In nature, important biological functions depend on metal ions interactions with 
cellular membranes. For example, it is known for a long time that calcium ions can 
bind to biological cell membranes containing phospholipids to induce liposome 
aggregation, and ultimately liposomal fusion.
[62]
 Artificial membranes (liposomes) can 
be equipped with membrane-embedded ligands to control interaction with metal ions or 
complexes, in particular those involving transition metals.
[63]
 Metal ion coordination to 
several membrane-embedded ligands can occur either on the same vesicle 
(intravesicular binding) or between two different vesicles (intervesicular binding). Only 
intervesicular binding induces aggregation, adhesion, or fusion of vesicles.
[64]
 
The interaction between metal ions and lipid vesicles depends on several factors such 
as the charge of the lipid bilayer, the nature of the metal ions, or the nature and number 
of coordination sites of the membrane-embedded ligand (monodentate, bidentate, etc.). 
In addition, the ligand conformation and orientation in the lipid bilayer, and the 
strength of the metal-ligand coordination, can have an effect on the metal-bilayer 
interaction. It is noteworthy to briefly discuss these factors as an introduction to 
Chapters 2, 4, and 5 of this thesis. 
Negatively charged phospholipids are known to aggregate or fuse in presence of metal 




, or lanthanoid ions.
[65]
 The nature of these interactions is 
believed to be mostly electrostatic and involves coordination of the phosphate head 
groups of the lipids to the metal ion. However, better selectivity and stronger metal-
lipid interactions can be obtained with membrane-embedded ligands. For example, 
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intervesicular interaction has been reported for vesicles functionalized with terpyridine 
ligands (terpy), which aggregated in the presence of Fe
2+
 ions. The aggregation process 
proved to be reversible, as the addition of the strongly chelating ligand Na2H2edta 
(disodium salt of ethylendiaminetetraacetic acid) recovered the initial situation of non-
aggregated vesicles (Figure1.5).
[66]
 Lehn and co-workers
[58]
 have reported similar 





 cations. The coordination reaction first induced vesicle aggregation, 
which was followed by vesicle fusion.  
 
Figure 1.5. Aggregation of terpyridine-modified liposomes upon addition of iron(II) cations. Adapted 
from reference [66]. 
Besides the nature and number of coordination sites of the embedded ligands, the 
strength of the coordination bond plays a role in driving metal-lipid interactions. In 
other words, different metal ions may interact differently with one given ligand 
receptor incorporated in liposomes. In a study reported in 2007,
[67]
 liposomes 
composed of amphiphilic cyclodextrins containing adamantyl-functionalized 
ethylenediamine ligands (L) were prepared. When Cu
2+
 was added to the liposome 
sample, intravesicular interactions resulted in the formation of [CuL2]
2+
 complexes at 
the membrane, and no sign of aggregation was observed (Figure 1.6a). In contrast, after 
addition of Ni
2+
 a mixture was formed comprising L, NiL and [NiL2]
2+
, and 
intervesicular interactions resulted in vesicle aggregation (Figure 1.6b). In fact, the 
stronger metal-ligand coordination bond in [CuL2]
2+ 
resulted in exclusively 
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intravesicular interaction, while the weaker metal-ligand coordination bond in [NiL2]
2+
 
resulted in  predominantly intervesicular interaction. 
 
Figure 1.6. Orthogonal multivalent interactions within one bilayer and between two different bilayers 
of amphiphilic cyclodextrin-based liposomes. (a) Vesicle surface saturated with [CuL2]
2+ 
(intravesicular interaction). (b) Two vesicles interacting via multiple coordination sites on Ni2+ and L 
(intervesicular interaction). Adapted from reference [67]. 
Conformational changes of ligands inserted in a membrane, in response to metal 
coordination and/or external stimuli, can be used to control the reactivity of liposomes 
towards metal ions. For example, light irradiation can induce photoisomerization of 
membrane-embedded ligands, which might influence ligand coordination to metal ions. 
Kikuchi and co-workers reported supramolecular systems that mimic information 
processing in biological signal transduction systems.
[49, 68]
 Molecular communication 
occurs between a molecular emitter and a molecular receiver (see Figure 1.7). A 
molecular switch based on an azobenzene-containing peptide lipid was embedded in a 
lipid bilayer. This molecular switch exhibited photoresponsive recognition behavior 
towards Zn
2+
, which allowed for controlling the binding of a small liposome to a giant 
liposomal receiver. Upon UV light irradiation, the azobenzene ligand embedded in the 
small and giant liposomes significantly changed their configuration through 
photoisomerization of the N=N double bond, from the trans form to the cis form. As 
the metal-binding affinity of the cis isomer is much higher than that of the trans 
isomer; after addition of Zn
2+
 the metal ion was stabilized by forming a complex with 
two ligands in the cis conformation only. Thus, the small liposome equipped with cis 
ligands bound to a receiver liposome that had the same molecular conformation. In 
contrast, visible light irradiation converted the cis isomer to the trans isomer, which 
has a lower metal-binding affinity. Thus, light-induced cis-trans isomerization of the 
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ligand modified the adhesion of the small liposomes to the receiver liposomes, i.e., the 





Figure 1.7. Photonic control of the binding of a molecular capsule (small liposome) to a molecular 
receiver (large liposome) by using a molecular switch. Adapted from reference [68]. 
Metal coordination can also influence ligand conformation, which can be used to 
regulate the association and dissociation of adhering liposomes. In a study by  Ravoo et 
al.
[64]
 a p-tert-butylbenzyl dimer with a flexible N,N’-bis(3-
aminopropyl)ethylenediamine spacer was used as a non-covalent linker between 
cyclodextrin-functionalized liposomes (Figure 1.8). This linker induces adhesion of the 
liposomes by the formation of hydrophobic cyclodextrin/
t
Bu-phenyl inclusion 
complexes in absence of metal ions. In the presence of Cu
2+
, the tetraamine linker 
molecule formed a stable coordination complex and switched its conformation from 
linear to bent, which led to the dissociation of the intervesicular complexes and to the 
dispersion of the vesicle clusters. This process was reversible, as in presence of a 




 ions were removed from the system 
and liposomal adhesion was re-established (Figure 1.8). Overall, ligand shape changes, 
lipid bilayers, and metal coordination influence each other, and such interactions would 
need to be understood and controlled when building a molecular machine at a bilayer 




Figure 1.8. Coordination of Cu2+ to a tetraamine ligand and a schematic representation of the metal 
ion responsive supramolecular system, in which vesicle adhesion or dispersion is controlled by the 
reversible conformational change of the spacer induced by metal ion coordination. Adapted from 
reference [64]. 
Metal binding to ligands embedded in neutral membranes can induce ligand dispersion 
and prevent ligand aggregation in the lipid bilayer membranes due to electrostatic 
repulsion between the cationic metals at the membrane surface. Arnold and co-workers 
in 1995 reported a liposomal sensor system that was able to detect Cu
2+
 ions based on 
this principle.
[69]
 The system relies on the excimer–monomer equilibrium of a pyrene 
dye. Neutral liposomes were functionalized with a lipid conjugate containing a pyrene 
moiety that was inserted into the lipophilic part of the membrane, and that was attached 
to a ligand facing the aqueous phase (Figure 1.9). The lipid conjugates with neutral 
head groups formed clusters in the liposomal bilayer in absence of Cu
2+
, which showed 
the typical pyrene excimers emission. After addition of Cu
2+
 ions and subsequent 
metal-ligand coordination the positively charged coordination complexes at the 
membrane repelled each other, which induced the dispersion of the membrane-
embedded ligands and disrupted the pyrene eximers. The pyrene monomer and its 
excimer show very distinguishable emission spectra, which was used to detect 




Figure 1.9. Metal ion sensor based on the switching of the monomer–excimer equilibrium of a pyrene 
moiety in a neutral liposome. The equilibrium is modified by the electrostatic repulsion between 
positive charges upon binding of Cu2+ at the membrane surface. Adapted from reference [63]. 
Coordination of metal cations to membrane-embedded ligands can also modify the 
membrane permeability for metal cations. For example a 2004 study
[65]
 showed that 
coordination of Eu
3+
 ions to membrane-embedded diketonate ligands promotes the 
transportation of the Eu
3+
 ions across the lipid bilayer surface. It was an artificial 
functional system mimicking the selective transport of metal ions by ionophores in 
biology. 
The last factor to take into account in the design of a metal-based molecular transporter 
at the surface of a lipid bilayer is the site of metal-ligand coordination, which may be 
either the bilayer-water interface of the lipid membrane, or its lipophilic region. The 
latter type of coordination has been used to create liposomal ion sensors that mimic ion 
transportation through biological membranes via ion channels.
[70]
 Webb and co-
workers
[71]
 have reported such kind of ion channels that can be gated “open” or 
“closed” by the addition or removal of palladium(II) ions. In the example shown in 
Figure 1.10 a pyridyl-cholate moiety was incorporated in unilamellar liposomes 
composed of neutral phospholipids. These liposomes also encapsulated a pH-sensitive 
dye (Figure 1-10a). Addition of PdCl2 led to the linkage of two pyridyl-cholate 
moieties via coordination of the pyridine subunits to Pd
2+
. The palladium(II) 
bis(pyridyl) motives created a channel through the membrane, which facilitated alkali 
metal ion transport. After addition of NaOH the transportation of the Na
+
 ion resulted 
in an increase in pH, which was detected by a fluorescence increase of the encapsulated 
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dye. Subsequent addition of a palladium(II)-chelating agent (hexathia-18-crown-6 
(18S6)) disconnected the channels, which stopped the flow of sodium ions and the 
evolution of fluorescence. 
 
Figure 1.10. a) Chemical structure of a pH-sensitive encapsulated dye and cholic acid, b) pyridyl-
cholate conjugate and coordination to a Pd2+ ion , c) a schematic representation showing the gating of 
an artificial ion channels; either opened by the addition of PdCl2, or closed by the addition of the 
hexathia-18-crown-6 ligand (18S6, bottom). Adapted from reference [71]. 
Overall, the examples detailed above illustrate the many options available when 
designing dynamic systems involving liposomes and metals. The dynamics of systems 
involving ligands, metal, and lipid bilayers, depend on a variety of factors that should 
be controlled in order to control molecular motion of the metal center at the membrane 
surface. In particular, intervesicular interactions like aggregation or fusion, ligand 
conformational changes, coordination in the lipophilic region of the membrane, or deep 
insertion of the ruthenium complex into the lipid bilayers, may reduce or impair the 
motion of ruthenium compounds at the membrane. In addition, neutral ligands may 
aggregate in the membrane and be dispersed upon coordination of the positively 
charged ruthenium complex, which would add another level in the complexity of the 
motion of the complexes. Finally, the ruthenium-ligand coordination bond should be 
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light-sensitive and stable in the dark if one wants to control the motion using light. For 
this PhD project, neutral monodentate thioether-cholesterol conjugates with flexible 
polyethyleneglycol linker were chosen, as there are flexible enough not to have one 
preferred conformation or configuration, do not significantly interact with protons in 
water, and may disperse homogeneously in the two dimensions of the membrane. 
Next to their potential as metal sensors or as surfaces where molecular motion could 
occur, liposomes are mostly known for their application in drug delivery, as they can 
notably improve drug targeting towards cancer cells. In the next section the advantages 
of liposomal drug carrier systems in medicinal chemistry are introduced, before 
discussing the potential of ruthenium complexes as anticancer drugs. 
1.3. Ruthenium-decorated liposomes as light-activatable prodrugs  
1.3.1. Liposomes as drug carriers in cancer therapy 
The major goal in drug delivery is to effectively deliver molecular drugs to their 
biological target in order to avoid toxic side effects for the patient. Three basic 
requirements for a successful drug delivery system in anticancer research are: (I) 
prolonged blood circulation of the drug, (II) sufficient accumulation of the drug in the 
tumor, and (III) controlled drug release and uptake by tumor cells.
[72]
 Nano-sized drug 
delivery systems like micelles, liposomes, and nanoparticles, can be modified to 
incorporate targeting moieties that allow for specific delivery of the drug to cancer 
cells expressing specific receptors at their surface. Gregoriadis et al. 
[73]
 in 1974 
proposed the first liposomal-based drug carrier in cancer chemotherapy, and since then 
the interest in liposomal drug carriers has increased significantly.
[72]
 One of the most 
acknowledged advantage of liposomes is their ability to deliver both hydrophobic and 
hydrophilic drugs, as well as mixtures of these. Water-soluble drugs can be 
encapsulated in the internal aqueous compartment of the liposome, whereas lipophilic 
drugs can be included within the hydrophobic part of the phospholipid bilayer.
[74]
 
Moreover, liposomes tend to accumulate at cancer tumor sites rather than at normal 
tissues. The structure of the microvasculature in tumors has large openings (up to 500 
nm), which allows liposomes diffusion inside the tumors.
[75]
 Beside their size, the 
surface charge of liposomes and their lipid composition play critical roles in their 
circulation lifetimes in the blood.
[76]
 It has been proven that “stealth” liposomes, i.e., 
liposomes coated with synthetic polyethyleneglycol polymers (PEG), have 
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significantly increased half-life in the blood compared to liposomes of the same 
composition but deprived of PEG chains. Such long circulation half-life times allow 
efficient delivery of this kind of liposomes to cancer cells via the so-called “Enhanced 
Permeability and Retention” (EPR) effect.
[77-78]
 
There are two main strategies for efficient targeting of liposomes to tumors and drug-
release: (I) site-specific delivery, which can be achieved by coating the liposomes with 
ligands or antibodies that target overexpressed receptors in the tumor tissue; (II) site-







release the encapsulated drug.
[72]
 Using light as a triggering signal, for example, is 
possible with photosensitive liposomes made of lipids that can either isomerize, 
fragment, or polymerize upon light irradiation.
[84]
 
Light-triggered drug activation is a basic concept used primarily in a treatment 
modality called “photodynamic therapy” (PDT). In PDT a photosensitizer is applied to 
the diseased tissue. This photosensitizer absorbs photons and transfers its energy to the 
triplet ground state of the dioxygen molecule, to form the excited state of O2 called 
singlet oxygen (
1
O2). The high oxidizing properties of 
1
O2 can then induce cell death 
by fast reactions with proteins, lipids, or nucleic acids.
[85-87]
 Most photosensitizers 
applied in clinical treatments are rather hydrophobic and tend to form aggregates in 
aqueous media, which reduces their photosensitizing efficacy as only monomeric 
species are usually photoactive. Liposomes have been used in PDT since they can 
significantly decrease photosensitizer aggregation. A variety of photosensitizer drugs, 
such as tetramethyl hematoporphyrin (TMHP), fullerene (C60/C70), and zinc 
phthalocyanine (ZnPc), have been used in combination with liposomes.
[87-89]
 In a recent 
study by Lissi et al.
[90]
 the photophysical and photochemical properties of ZnPc 
photosensitizers in THF was compared with those of ZnPc incorporated in 
phosphatidylcholine liposomes. The results showed that dye incorporation into 
liposomes decreases ZnPc aggregation and provide a better photodynamic activity on 
HeLa cancer cell line (cervical cancer cells). 
Despite the variety of liposomal drug delivery systems reported in the scientific 
literature, there are only few examples of liposomes used for encapsulating metal-based 
drugs. Hence, some of the few systems described so far will be briefly discussed here. 
Anticancer platinum compounds, in particular cisplatin (cis-
diamminedichloridoplatinum), are one of the few metal-based anticancer agents that 
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have been considered for liposomal drug delivery. The antitumor property of cisplatin 
is largely due to its binding to nuclear DNA. However, cisplatin tends to bind to blood 
plasma proteins as well, particularly those with thiol groups such as human serum 
albumin and other proteins with high cysteine content. Such binding mostly leads to 
deactivation of cisplatin, and it induces side effects during cisplatin chemotherapy. 
[91-
92]
 Liposomal drug delivery is believed to be able to solve or at least reduce these 
problems. In the literature, mostly poorly water-soluble platinum compounds such as 
cisplatin have been incorporated into the hydrophilic core of liposomes (Figure 
1.11a).
[93-94]
 However, in a recent study by Kaluderovic et al.
[95]
 a water-insoluble 
platinum drug was incorporated into the lipophilic part of lecithin liposomes (Figure 
1.11b) and the cytotoxicity of this formulation was tested on several tumor cell lines as 
well as normal cells. The results showed that a liposome-incorporated cisplatin drug 
had higher cytotoxicity and selectivity for some cancer cell lines such as human thyroid 
carcinoma cells SW1736, compared to non-encapsulated complex [14] or cisplatin 
[13]. 
 
Figure 1.11. a) Cisplatin loaded in the hydrophilic core of a liposome. b) Lipophilic cisplatin analog 
loaded in the lipid bilayer of a liposome. Adapted from reference [95]. 
Most drugs are toxic in high dosage, which restricts their clinical application in cancer 
therapy. In order to overcome the high dosage toxicity, the drug activity needs to be 
controlled, for example by encapsulation in liposomes. In 2006 Halloran et al. 
[96]
 
developed a liposomal system for encapsulating arsenic-based drugs. Arsenic trioxide 
(As2O3) is a promising agent for the treatment of blood and bone marrow cancers. 
However, clinical application of this drug to other cancers has been limited due to its 
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toxicity at higher doses. This problem was solved by encapsulation of high doses of 
As2O3 in phospholipid liposomes that were able to release the drug in a controlled 
fashion, i.e., upon pH variation. While the therapeutic agent remained in the liposome 
at physiological pH (7.4), it was released at lower pH (4.0), typical of the endocytic 
compartments involved in the cellular uptake of liposomes.  
The cellular uptake pathway can also be changed by encapsulation of metallodrugs in 
liposomes, which sometimes leads to better cellular uptake of a liposome formulation 
compared to the non-encapsulated drug. For example, gallium nitrilotriacetate is a 
therapeutic agent that has been proven to be effective for the treatment of several 
cancer types. Ga
3+
 ions are mostly taken up by cancer cells via a transferrin (TF) 
receptor pathway, and it competes with iron cellular uptake. The transferrin-
independent uptake mechanism is also possible, but this accounts for only 10% of the 
total Ga
3+
 uptake. In a study from 1993
[97]
 it was reported that encapsulation of gallium 
nitrilotriacetate in negatively charged liposomes provided a transferrin-independent 
route for the delivery of Ga
3+
 ions to cancer cells. 
 
Figure 1.12. Structural formula of complex AziRu [15]− and AziRu functional nucleolipids [16]−, 




Until recently no study has been reported for the liposomal drug delivery of ruthenium-
based anticancer compounds. In 2012 Paduana and co-workers
[98-99]
 reported the first 
systems of this kind. Ruthenium(III) complexes functionalized with different 
amphiphilic nucleosides (Figure 1.12) were incorporated in the lipophilic phase of 
neutral liposomes. The ruthenium complex [15]
−
 (named AziRu) was chemically 
linked to the nucleolipid (a hybrid molecule containing a nucleic acid unit and 
amphiphilic moieties) via an Ru-N coordination bond. The anticancer activity of these 
ruthenium-functionalized liposomes was investigated on several cancer cell lines and 
compared with free AziRu. 
[98-99]
  The results showed higher in vitro anti-proliferative 
activities for the ruthenium-containing liposomes than for free AziRu. It was reported 
that the liposomal formulation facilitated the internalization of the ruthenium complex 
and postponed its hydrolysis in physiological conditions. This work showed for the 
first time the capacity of ruthenium-decorated liposomes to be used in drug delivery. 
1.3.2. Ruthenium complexes as anticancer drugs 
1.3.2.1. Cytotoxicity of ruthenium complexes and mechanism of action 
Since the discovery of cisplatin, many transition metal complexes have been 
synthesized and tested for their anticancer activity. In recent years, ruthenium-based 
molecules have attracted much attention as promising antitumor agents. Ruthenium 
complexes have three properties that make them potentially suitable for medicinal use: 
I) slow ligand-exchange kinetics similar to those of Pt(II) complexes, II) multiple 
accessible oxidation states allowing prodrug activation strategies, and III) the ability to 
mimic iron binding to certain biologic molecules such as albumin and transferrin.
[100]
 
Since rapidly dividing cells, such as cancer cells, have a greater demand for iron 
compared to normal cells, transferrin receptors are over-expressed in tumors, which 
may allow for more effective delivery of ruthenium-based drugs to cancer cells.
[101-102]
 
Moreover, Ru(II) complexes have octahedral coordination spheres, in contrast to the 
square-planar geometry of Pt(II) compounds, which may allow for obtaining different 









 have entered human clinical trials 
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(Figure 1.13). Despite their structural and chemical similarities, these two Ru(III) 
complexes show different antitumor behavior. In pre-clinical studies, NAMI-A has 
shown inhibitory effects against the formation of metastases in a variety of animal 
tumor models, although it appeared to lack direct cytotoxicity towards human 
tumors.
[107]
 In contrast, KP1019 has proven to be cytotoxic against a wide range of 




Figure 1.13. Chemical structures of anticancer ruthenium complexes NAMI-A and KP1019. 
Most ruthenium complexes investigated for medicinal purposes, including NAMI-A 
and KP1019, undergo ligand exchange in biological media. Usually the metal complex 
is first hydrolyzed to give an aqua complex, which is often believed to interact with 
DNA through the formation of coordination bonds between the metal center and 
nitrogen ligands or DNA phosphate groups on the DNA bases,
[108]
 leading to metal-
DNA adduct formation and cell death (Scheme 1.6). This mechanism is quite often 
called “irreversible binding” because it involves the formation of a coordination 
bond.
[109]
 Binding of the ruthenium(II) center to DNA has been hypothesized for a 





 or complexes of the type 
[Ru(terpy)(N-N)(L)]
2+
, where N-N is a bidentate diimine ligand like bpy or phen.
[112]
 
However, in the case of substitutionally inert polypyridyl Ru(II) complexes of 
[Ru(diimine)3]
2+
 family , cytotoxic effects were also obtained via van der Waals 
interactions with DNA.
[113-115]
 All interactions with DNA not involving coordination to 
the metal center are usually called “reversible” binding, and are divided into four 
categories: I) electrostatic interaction, II) intercalation, III) groove binding (molecules 
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occupy the minor or major groove of DNA), and IV) binding to non-canonical DNA 
such as mismatch, G-quadruplex, or triplex DNA structures, which involves a 




Figure 1.14. Hydrolysis and coordination of a Ru(II) complex to the nucleophilic DNA binding sites. 
In recent years innovative studies have shown that other mechanisms such as 
topoisomerase enzymes inhibition,
[116]
 or mitochondria-mediated apoptosis,
[117-118]
  
may be responsible for the cytotoxicity of metallodrugs, in particular for saturated 
complexes unable to coordinate to DNA. In a study by Gazzer et al., the cytotoxicity 
mechanism of the coordinatively saturated Ru(II) complex [Ru(dppz)2(CppH)]
2+
 
(CppH =2-(2′-pyridyl)pyrimidine-4-carboxylic acid; dppz = dipyrido[3,2-a:2′,3′-
c]phenazine) was investigated in detail.
[119]
 It was proposed that this compound exerted 
its toxicity through a mitochondria-related pathway rather than via binding to nuclear 
DNA. Although the complex was shown to bind to calf thymus DNA by intercalation, 
this interaction is not involved in the toxicity mechanism in vitro.  
1.3.2.2. Photoactivated chemotherapy 
Photoactivated chemotherapy (PACT) consists in the light-controlled activation of a 
drug at the tumor site, which results in greater specificity for the action of a drug. The 
concept of an inactive precursor, or “prodrug”, is important in this field.
[120]
 The 
challenge is to develop compounds that are thermally stable, but can be triggered by 
low energy light irradiation to generate toxic species with anticancer properties similar 
to that of other chemotherapeutics.
[121]
 The activity of light-produced cytotoxic agents 
ideally depends on their ability to interact with biopolymers or bio-aggregates such as 
cell membranes, proteins, or DNA. Damage to DNA can occur by photoinduced 
electron transfer between the excited state of the photoactivated molecule and 
DNA.
[122]
 Another method is photodynamic therapy (PDT).
[85-86]
 Since in PDT the 
toxicity is oxygen-dependent and tumor cells are generally hypoxic, new approaches 
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based on photoinduced ligand substitution in transition metal complexes are interesting 
alternatives, where a coordinatively saturated metal complex would either bind to 
nucleic acids or proteins after photochemically losing a biologically inactive ligand 





Figure 1.15. Photochemotherapy using a photosensitive metal-based prodrug and two possible 
cytotoxicity mechanisms involving photosubstitution. M: metal complex, L: photosubstituted ligand, 
M-H2O: hydrolyzed metal complex. 
Ruthenium complexes are particularly attractive for photoactivated chemotherapy 
(PACT), as their photophysical properties can be tuned, they strongly absorb in the 
visible region (400-600 nm), and are kinetically inert.
[123]
 As mentioned in Section 
1.1.2. complexes with distorted octahedral geometry are prone to ligand dissociation 
under visible light irradiation. Thus, steric and electronic properties of the ligands can 
be tuned to obtain Ru(II) complexes suitable for PACT.
[124]
 For example, in a recent 
publication by Glazer and co-workers
[121]
 the light-induced cytotoxicity of three 
[Ru(bpy)2(N-N)]
2+
 complexes, where N-N is a sterically hindered bidentate diimine 
ligand, was investigated and compared with that of cisplatin. A high cytotoxicity was 




 (Figure 1.16), 
compared to the less strained complex [20]
2+
 and cisplatin. As both hindered 
complexes were inert in the dark and only became cytotoxic by visible light irradiation, 
the phototoxicity is believed to result from the photosubstitution of the hindered N-N 




Figure 1.16. Structures [Ru(bpy)2(N-N)]
2+ complexes with reported anticancer activity. [121] 
The photoinduced cytotoxicity of polypyridyl Ru(II) complexes also depends on the 
electronic properties of the spectator ligands. Nair and co-workers
[125]
 have recently 
investigated the cytotoxicity of a series of Ru(II) complexes of the type [Ru(Rterpy)(N-
N)Cl]
+
 (Figure 1.17). The Ru-Cl bond can be cleaved by light and Cl
−
 be 
photosubstituted by the nucleobase of a DNA fragment. It was shown that the 
electronic properties of the substituent X on the Xterpy ligand influence the ground 
state properties of its ruthenium complex, and thus the photolability of the Ru-Cl bond. 





 with an imidazole substituent on the Xterpy ligand were found to be more 






Figure 1.17. [Ru (Rterpy)(N-N)Cl]+ complexes with different light-induced cytotoxic properties. 
Adapted from reference [125]. 
Effective light absorption by the photoactive drug inside human tissues is another 
significant challenge in PACT. The penetration depth of light in human tissue is highly 
Chapter 1 
36  
wavelength dependent, and significant penetration only takes place in the range of 
600–850 nm, which is referred to as the “photodynamic window”.
[126-127]
 Many efforts 
have been dedicated to achieve photochemical activation of ruthenium complexes with 
low-energy photons. Changing the electronic properties of the polypyridyl ligands can 
extend the light activation of the ruthenium complexes towards longer wavelengths, as 
discussed in a recent review by Turro et al. 
[128]
 It was shown that in ruthenium 
complexes [Ru(N-N)2(L)2]
+
 (L=NH3, pyridine, or CH3CN, N-N=bpy or phen), if one of 
the N-N ligands is replaced by a cyclometallating ligand such as phpy
−
 (see Figure 
1.18) the negative charge of the carbon-based ligand induces an increase in the energy 
of the HOMO orbital of the complex, and thus reduces the energy needed to promote 
an electron to the π* orbital of the diimine ligand. As a result the MLCT absorption 
band is red-shifted to 690 nm. Compound [27]
+
 (Figure 1.18) showed very good 
phototoxicity on advanced ovarian epithelial cancer cells upon irradiation at 690 
nm.
[128]
 The cytotoxicity of this compound upon low-energy light irradiation enhanced 




Figure 1.18. Chemical formulae of [Ru(phen)(phpy)(CH3CN)2]
+ ([27]+) and 
[Ru(bpy)(phpy)(CH3CN)2]
+ ([28]+). 
In the development of light-activated ruthenium-based cytotoxic compounds, efficient 
targeting is also a great challenge. Mesoporous silica nanoparticles (MSNPs) have 
recently been reported by Sauvage and coworkers to be efficient nano-carriers for 
ruthenium dipyridophenazine (dppz) complexes.
[130]
 As shown in Figure 1.19. the 
ruthenium complexes were grafted on the surface of the nanoparticles via nitrile ligand 
29. The resulting supramolecular assembly showed fast cellular uptake, and while the 
ruthenium-modified nanoparticle was unreactive in the dark, upon visible light 
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irradiation the Ru-nitrile coordination bond was cleaved to release the ruthenium 
complex from the surface of the nanoparticles. The resulting cytotoxic aqua complex 
[30]
2+
 was able to form mono-adducts with DNA and induce cytotoxicity. As discussed 
in session 1.3.1. liposomes also have great potential to be used as metallodrug carriers 
that improve drug targeting to tumors. Liposomes functionalized with photosensitive 
ruthenium complexes have been proposed by our group as a support for the molecular 
motion of ruthenium-based molecular machines.
[46]
 However, they have not been used 
until now for the delivery of phototoxic ruthenium complexes to cancer cells, and no 
toxicity or phototoxicity data have been reported yet. Ideally, ruthenium-functionalized 
liposomes might be taken up by cancer cell, where light irradiation would release the 
ruthenium aqua complex (Figure 1.20). In Chapter 5 of this thesis the initial efforts in 
this direction are described. 
 
Figure 1.19. Structural formula of the nitrile ligand 29, ruthenium-aqua complex [30]2+, and 
ruthenium−dppz complex [31]2+. Ligand 29 is grafted onto the surface of nanoparticles (MSNP 1), 
followed by coordination of [30]2+ in the dark to form ruthenium-functionalized nanoparticle (MSNP 




Figure 1.20. Liposomes decorated with photosensitive ruthenium-based anticancer prodrugs. 
Cleavage of the Ru-L coordination bonds upon light irradiation leads to release of the potentially 
cytotoxic ruthenium-aqua complexes. 
1.4. Aim and scope of this thesis 
Polypyridyl ruthenium(II) complexes of the [Ru(terpy)(N-N)(L)]
2+ 
family, where N-N 
is a diimine ligand and L is a monodentate ligand, have been known for a long time. 
However, there are very few studies on liposomes functionalized with these complexes, 
and on the interaction of ruthenium complexes with lipid bilayers. The research 
described in this thesis focuses on the photoreactivity and coordination chemistry of 
[Ru(terpy)(N-N)(L)]
2+ 
complexes both in homogenous aqueous solutions and at the 
surface of lipid bilayers. Their potential application either for the building of light-
controlled molecular machines (chapters 2, 3, and 4), or as light-activatable anticancer 
prodrugs (chapters 5 and 6), is described. 
In Chapter 2 the coordination chemistry of [Ru(terpy)(dcbpy)(SRR’)]
2+
 complexes 
(dcbpy=6,6’-dichloro-2,2’-bipyridine and SRR’=thioether ligand), is reported in 
homogeneous aqueous media. The Ru-S coordination bond was found to form 
spontaneously in the dark and to be efficiently broken by light irradiation. The 
potential of this system in supramolecular chemistry is presented by describing the 
repeatable formation and breakage of the Ru-S bond at the surface of anionic lipid 
bilayers. 
In Chapter 3 an attempt to optimize the dynamics of the light-sensitive interconversion 
between [Ru(terpy)(N-N)(SRR’)]
2+
 (RuSRR’) and [Ru(terpy)(N-N)(H2O)]
2+
 (RuOH2) 
species in homogeneous aqueous media is reported. The effect of the steric hindrance 
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of the spectator diimine N-N ligand on the kinetics and thermodynamic of the Ru-S 
bond formation and hydrolysis is discussed, both in the dark and under light irradiation. 
In Chapter 4 the mechanism of the coordination of ruthenium polyryridyl complexes to 
sulfur ligands embedded in lipid bilayers is described. The kinetics of the coordination 
reaction at the membrane interface was found to be highly dependent on the charge of 
the lipid bilayer. This study highlights the differences between coordination chemistry 
at membranes and coordination chemistry in homogeneous conditions. 
In Chapter 5 the application of ruthenium-decorated liposomes in photochemotherapy 
is described. The photoreactivity of a series of photosensitive ruthenium complexes 
incorporated in liposomes with different surface charge (neutral or negative) is 
reported. The dark stability of the liposomes, their cellular uptake, and their 
cytotoxicity in the dark and under visible light irradiation are discussed. 
In Chapter 6 the functionalization of a [Ru(terpy)(N-N)(SRR’)]
2+ 
complex with a 
fluorescent rhodamine dye is reported. The dye-functionalized ruthenium complex was 
initially considered for monitoring the molecular motion of ruthenium complexes at the 
surface of a lipid bilayer. However, the emission of the dye appeared to be quenched 
by the nearby ruthenium complex, leading to the sensitization of ligand 
photosubstitution reactions with low-energy photons. This study demonstrates that 
efficient cleavage of the Ru-S bond can be obtained with yellow photons that, in 
theory, do not have enough energy. Our results provide thorough understanding of the 
effect of irradiation wavelength on ruthenium-based photosubstitution reactions. 
Parts of this thesis have been published,
[131-132]
 have been submitted,
[133-134]
 or are in 
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The new ruthenium complex [Ru(terpy)(dcbpy)(Hmte)](PF6)2 ([2](PF6)2) was synthesized, 
where dcbpy is 6,6’-dichloro-2,2’-bipyridine, terpy is 2,2’;6’,2”-terpyridine, and Hmte is 2-
(methylthio)ethanol. The X-ray structure shows that the Ru2+ ion is in a distorted octahedral 
geometry, revealing steric congestion between dcbpy and Hmte. In water, [2]2+ forms 
spontaneously by reacting Hmte and the aqua complex [Ru(terpy)(dcbpy)(H2O)]
2+ ([1]2+), 
with a second-order rate constant of 0.025 s−1·M−1 at 297 K. In the dark, the Ru-S bond of 
[2]2+ is thermally unstable and partially hydrolyzes; in fact, both complexes [1]2+ and [2]2+ 
are in equilibrium characterized by an equilibrium constant K of 151 M−1. By shining 
visible light at an aqueous solution containing [2]2+ the Ru-S bond is selectively broken to 
release [1]2+, i.e., the equilibrium is shifted by visible light irradiation. Such light-induced 
equilibrium shifts were repeated four times without signs of major degradation; the Ru-S 
coordination bond in [2]2+ can be described as a robust light-sensitive supramolecular bond 
in water. In order to demonstrate the potential of this system in supramolecular chemistry a 
new thioether-cholesterol conjugate (4) was synthesized that inserts into lipid bilayers via 
its cholesterol moiety, and coordinates to ruthenium via its sulfur atom. Anionic DMPG 
lipid vesicles (DMPG=dimyristoylphosphatidylglycerol sodium salt) functionalized with 
this thioether-conjugate were prepared, to which the aqua complex [1]2+ efficiently 
coordinates. Upon visible light irradiation on the Ru-decorated vesicles the Ru-S bond is 
selectively broken, thus releasing [1]2+ that stays at the water-bilayer interface. When light 
is switched off the metal complex spontaneously coordinates back to the membrane-
embedded thioether ligands without a need to heat the system. This process was repeated 
four times at 308 K, thus achieving the light-triggered hopping of the metal complex at the 















2.1. Introduction  
Shining light onto a chemical system is an attractive way to trigger molecular motion
[1-
5]
 or influence self-assembly,
[6-8]
 because it does not modify concentrations. In 
addition, some chromophores have a very specific absorption band, which makes their 
photoexcitation very selective and allows for precisely controlling the system. Several 
light-responsive processes have been used to trigger molecular or supramolecular 







 the closing/opening of diarylethenes,
[24-28]
 the cleavage of 
coordination bonds,
[29-34]
 or the linkage isomerization of transition metal complexes.
[35-
37]
 Over the years, light-responsive supramolecular interactions such as that between 
trans azobenzene and cyclodextrin, have led to a particularly large number of 
applications in nanotechnology, chemical biology, and drug delivery.
[38-58]
 
In this work, a new form of light-responsive supramolecular interaction based on 
coordination compounds is described. “Supramolecular” specifically means here that 
the two interacting molecular fragments are involved in a true thermodynamic 
equilibrium at room temperature, with kinetics occurring at the timescale of minutes to 
tens of minutes. This equilibrium involves a Ru-S coordination bond that 
spontaneously forms in aqueous solution and in the dark, but is selectively broken 
under visible light irradiation.  
 
Scheme 2.1. Equilibrium between [1]2+, Hmte, and [2]2+ in water. 
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2.2. Results  
2.2.1. Synthesis and X-ray crystal structure 
The orange Hmte complex [2](PF6)2 was prepared by heating [Ru(terpy)(dcbpy)Cl]Cl 
([3]Cl)
[59]
 and two equivalents of AgPF6 in Hmte. According to 
1
H NMR spectroscopy 
in acetone-d6 the protons of the Hmte ligand are high-field shifted in [2](PF6)2 
compared to the free ligand, which shows coordination of the ligand to the polypyridyl 
ruthenium complex. Single crystals suitable for X-ray structure determination were 
obtained by slow diffusion of diisopropyl ether in an Hmte solution of [2](PF6)2. As 
expected the Hmte ligand coordinates via its soft sulfur atom to ruthenium(II) (see 
Figure 2.1). The ruthenium center is in a distorted octahedral environment, typical for 
terpy-bound complexes. Noteworthy the dcbpy ligand is positioned out of the plane 
perpendicular to the terpyridine ligand, with Ru1-N4-C20-C21, Ru1-N5-C21-C20, 
Ru1-N4-C16-Cl1 and Ru1-N5-C25-Cl2 torsion angles larger than 20°. Such strong 
distortions, combined with a rather long Ru1-S1 bond distance (2.3819(6) Å), 
altogether suggest significant steric hindrance between the chloro substituents of dcbpy 




Figure 2.1. Displacement ellipsoid plot (given at 50% probability level) of complex [2](PF6)2. 
Hexafluoridophosphate counter ions and hydrogen atoms have been omitted for clarity. Selected bond 
length (Å): Ru-S1: 2.3819(6), Ru1-N1: 2.084(2), Ru1-N2: 1.962(1), Ru1-N3: 2.074(2), Ru1-N4: 
2.126(2), Ru1-N5: 2.115(2). Selected angles ():  Ru1-N4-C20-C21: 21.5(3), Ru1-N5-C21-C20: 
22.0(3), Ru1-N4-C16-Cl1: 23.9(3), Ru1-N5-C25-Cl2: −21.3(3), Ru1-N1-C5-C6: 2.4(3), Ru1-N3-
C11-C10: 7.6(3), Ru1-N2-C6-C5: 4.9(3), Ru1-N2-C10-C11: 0.7(3). 
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2.2.2. Thermodynamics and kinetics in homogeneous aqueous solution  
According to 
1
H NMR the Ru-S bond of [2]
2+
 is not stable in water and in the dark. 
Upon dissolution of [2](PF6)2 in D2O two A5 doublets (see Scheme 2.1 for proton 
notation) at 7.19 and 7.12 ppm reveal the presence of two different ruthenium species 
in solution (Figure 2.2a). The doublet at 7.19 ppm corresponds to the thioether-bound 
complex [2]
2+
, as it is the most intense signal in the initial spectrum, and as its intensity 
increases upon addition of free Hmte. The doublet at 7.12 ppm corresponds to the aqua 
complex [1]
2+
, which can be synthesized independently in the form of [1](PF6)2 (see 
Appendix II, section AII.1). Thus, at 297 K the Ru-S bond of [2]
2+
 slowly and partially 
hydrolyses to reach an equilibrium with [1]
2+
 and free Hmte. The equiliberium constant 
K was determined by dissolving the chloride complex [3]Cl and different amounts of 
Hmte in D2O (see section 2.4.3 and Figure 2.2a). The Ru-Cl bond of [3]
+
 is indeed 
quantitatively and rapidly hydrolyzed in D2O to give [1]
2+
, as shown by the unique A5 
doublet observed at 7.12 ppm upon dissolution of [3]Cl in D2O. In presence of 
different relative amounts of free Hmte and [3]Cl, and after equilibration in the dark at 
297 K the two expected A5 doublets at 7.19 and 7.12 ppm can be integrated to obtain 




, respectively. A plot of the ratio 
[RuHmte]/[RuOH2] vs. [Hmte] was drawn, where [RuHmte], [RuOH2], and [Hmte], 




, and Hmte, respectively (see Figure 2.2b). A 
straight line was found, which shows that indeed the reaction shown is Scheme 2.1 is a 
thermodynamic equilibrium. The slope of this line numerically corresponds to the 
equilibrium constant K; a value of 151(8) M
−1
 was found at 297 K and in the dark. 
The kinetics for the coordination of Hmte to [1]
2+
 were investigated by UV-vis 
spectroscopy. Upon adding a large excess of Hmte to an aqueous solution of [1]
2+
, the 
UV-vis spectrum of the solution gradually evolves within minutes in the dark to give a 
new absorption maximum at 467 nm (Figure AII.1). The clear isosbestic point at 465 
nm shows that the coordination of Hmte to ruthenium is selective. In such pseudo first-
order conditions the first-order rate constants k’1 were determined for different 
concentrations in Hmte (Figure AII.2a). It was found that the order of Hmte in the 





 was found for the second-order rate constant k1. Typically, half-reaction times 
at room temperature are ~3 min with Hmte concentrations of ~0.2 M. Such reaction 
rate is several orders of magnitude faster than for comparable systems with the 





 Knowing the equilibrium constant K and the rate constant k1 for 
the substitution of H2O by Hmte, the first-order rate constant k−1 for the thermal 




 at 297 K 
(see section 2.4.5). This corresponds to a half-time of 75 min for the spontaneous 
cleavage of the Ru-S bond of [2]
2+
 in pure water. Thus, the steric hindrance exerted by 
the dcbpy chelate on the coordination sphere of the complex not only has an effect on 
the structure of the Hmte complex [2]
2+
, as revealed by X-ray crystallography, but also 
on the rate of formation and cleavage of the Ru-S coordination bond in the dark. 
 
Figure 2.2. a) 1H NMR spectra (A5 region, 7.40-6.90 ppm in D2O) of equilibrated samples containing 
[2]2+, [1]2+ and free Hmte; Hmte concentrations are given at t=0 (before equilibration). b) Plot of the 
[RuHmte]/[RuOH2] ratio vs. [Hmte], at the equilibrium and in the dark. Conditions: T = 297 K, 
[Ru]tot=2.8 mM. 
2.2.3. Photochemistry in homogeneous aqueous solution  
Ruthenium polypyridyl complexes like [Ru(terpy)(bpy)(L)]
2+
 are known to selectively 
photosubstitute the monodentate ligand by a solvent molecule upon visible light 
irradiation.
[29, 62-64]
 The photoreactivity of this type of complexes is based on the 
thermal conversion of the photochemically generated 
3
MLCT state into a dissociative, 
metal-centered 
3
MC state. This process is more efficient when the ligand field strength 
is low, which can be achieved with sterically hindering ligands (see also Chapter 3).
[29, 
31, 60, 64]
 The Ru-S bond in [2]
2+
 was indeed found to be photochemically cleaved by 
visible light irradiation in water, to form [1]
2+
. When an aqueous solution of [2](PF6)2 
was irradiated at 465 nm a faster increase of the absorbance at 500 nm was observed 
compared to the dark reaction, with a clear isosbestic point at 452 nm (Figure AII-3). 
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The expression of the rate and of the pseudo first-order rate constant kφ of the purely 
photochemical substitution of Hmte by water is given in Equations 2.1 and 2.2 where 
nRuHmte is the number of moles of [2]
2+
 in the cuvette,  is the photon flux,  the 
photochemical quantum yield of the reaction, Ae the absorbance of the solution at the 
irradiation wavelength λe, and nRu(tot) the total number of moles of ruthenium in the 
sample. In this system measuring  was challenging because of the a priori comparable 
values of k’1, k−1, and k at room temperature (see Chapter 3 for more details). To do 
so, the solution was irradiated from the top of the UV-Vis cuvette, while absorption 
spectra were taken from the side, i.e., along the optical axis of the UV-Vis spectrometer 
(see Figure AI.1). In our experimental conditions a value of 0.097(9) was obtained for 
the photosubstitution quantum yield   at 297 K, which is one order of magnitude 
higher than for comparable unhindered bpy complexes.
[61]
 Such a high efficiency is 
consistent with previous studies in pyridine,
[60]
 which had shown that steric hindrance 
on the spectator diimine chelates increased the photosubstitution quantum yield of 
Ru(II) polypyridyl complexes. Although the Ru-S bond of [2]
2+
 is thermally not stable 
in water the photochemical cleavage of the Ru-S bond is typically one order of 
magnitude faster than the thermal reaction (see Chapter 3, Table 3.4). 
The fast kinetics of the equilibrium shown in Scheme 2.1, coupled to the high 





 may be shifted by visible light irradiation in an aqueous 
solution containing an excess of free Hmte. White light irradiation was thus realized 
inside a 
1




, and Hmte in 
D2O, initially equilibrated at 297 K. Before irradiation, the 
1
H MAS NMR spectrum of 





, respectively. The slightly different values compared to standard 
solution NMR spectroscopy is due to different setup of the MAS NMR equipment. The 
[RuOH2]/[RuHmte] ratio at the equilibrium in the dark was ~0.24, i.e., the major 
ruthenium species was for [2]
2+
. Upon irradiation, the relative intensity of the doublet 
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at 7.08 ppm increased (Figure 2.3), showing the gradual enrichment of the system in 
[1]
2+
 due to the photochemical cleavage of the Ru-S bond. After 30 minutes of 
irradiation a steady state was obtained, characterized by a [RuOH2]/[RuHmte] ratio of 
3.4, i.e., a majority of [1]
2+
. In a second step the lamp was turned off, upon which the 
sample spontaneously returned to its original state ([RuOH2]/[RuHmte] ~ 0.24) within 





 can be perturbed by visible light, and that only these two species (as 
well as free Hmte, visible in the aliphatic region) are present during and after 
irradiation at room temperature. 
 
Figure 2.3. Light-induced changes of the equilibrium between [2]2+, [1]2+ , and Hmte in water at 298 
K, as shown by 1H MAS NMR during white-light irradiation in situ (lines 2 to 6) and after switching 
off the lamp (lines 7 to 13). Spectra taken every 5 minutes.  
2.2.4. Repeated shift of a bimolecular equilibrium using light  
In order to check whether shifting the equilibrium by light could be repeated several 
times, further experiments were performed using UV-Vis spectroscopy and 
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, and Hmte, was 
prepared and equilibrated at 297 K. In the experimental conditions chosen the 
composition of the solution was measured to comprise 33% of [1]
2+
 and 67% of [2]
2+
 
by deconvolution of the UV-vis spectrum. Irradiation at 465 nm was performed 4 times 
during ~1 h, each time followed by ~2 h of equilibration in the dark. The UV-vis 
spectra were recorded both under irradiation and in the dark, at 5 minute intervals 
during 15 h at 297 K. Figure 2.4 shows the evolution of the percentage of the aqua 
complex [1]
2+
 vs. time. Similar photochemical steady states were obtained all four 
times, characterized by 75-80% of the aqua complex [1]
2+
. During each period in the 
dark an increase of the concentration of the thioether complex [2]
2+
 was observed, thus 





 ratio of 2:1. Thus, the combination of 
1
H NMR and UV-vis analysis shows 




, free Hmte, 
and water, which interconvert in a repeatable way upon switching on or off a source of 
visible light. To our knowledge, this is the first demonstration that light-induced ligand 
substitution reactions on ruthenium(II) can be controlled by light at one and the same 
temperature, and in a repetitive fashion. In homogeneous solution, the Ru-S bond of 
complex [2]
2+
 appears as a light-sensitive supramolecular bond that spontaneously 
forms in the dark, but is broken by visible light irradiation. 
 
Figure 2.4. Plot of the time evolution of the percentage of [1]2+ in an initially equilibrated 
homogeneous solution containing [2]2+ and Hmte upon switching ON or OFF several times a source 
of blue light. Conditions: λe = 465 nm, photon flux :3.910
−9 Einstein·s−1, sample temperature 297 K, 
concentration [Ru]tot = 1.410




Figure 2.5. a) Scheme showing the chemical structure of 4, the thermal binding of aqua complex [1]2+ 
to a lipid bilayer incorporating 4 to give [5]2+, and light-induced unbinding.  b) Time evolution of the 
UV-vis spectrum of a solution containing DMPG vesicles decorated with 25 mol% of ligand 4 after 
addition of [1](PF6)2 at t=0, in the dark and at room temperature. c) Time evolution of the absorbance 
at 500 nm of a solution containing DMPG vesicles functionalized with 25 or 35 mol% of ligand 4 
after addition of [1](PF6)2 at t=0, in the dark (OFF) and under blue light irradiation (λe=465 nm, ON). 
Condition: T = 297 K, [Ru]tot= 6.7 10
−2 mM, [4]=0.30 mM (25 mol%) or 0.42 (35 mol%), [lipid]tot = 
1.3 mM (as liposomes), photon flux 3.910−9 Einstein·s−1. 
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In our quest towards the light-controlled unidirectional motion of individual molecules 
we considered using this photosensitive Ru-S bond to achieve the light-induced 
hopping of Ru-based complexes at the surface of (large) unilamellar lipid bilayers. 
Liposomes represent an appealing system to define an interface where molecular 
motion can take place: they are easy to synthesize, transparent, and can be further 
deposited on glass surfaces. In addition, the water-bilayer interface can easily be 
functionalized using molecular building blocks covalently bound to cholesterol 
derivatives. Thus, we considered functionalizing liposomes with thioether ligands, and 
hopping ruthenium complexes at their surface by the repeated dark formation and light-
induced cleavage of the Ru-S bond (Figure 2.5a).
[61]
 The thioether-cholesterol 
conjugate 4 shown in Figure 2.5a was synthesized as described in Appendix II, section 
AII.1. Large unilamellar anionic DMPG vesicles including 25 mol% or 35 mol% of 
ligand 4 were prepared by standard extrusion methods; dynamic light scattering 
measured an average size distribution centered around 140 nm diameter, and cryo-
TEM pictures showed the corresponding well-defined, spherical assemblies typical of 
large unilamellar vesicles (Figure 2.6a). 
 
 
Figure 2.6. Cryo-TEM images of DMPG vesicles decorated with 25 mol% of ligand 4 (a) before and 
(b) after adding 5 mol% of complex [1](PF6)2. Images taken at 17000 (a) and 34000 (b) 
magnification; the size of the whole image is 1.51 μm for (a) and 0.724 μm for (b).  Conditions: 
[lipid]tot = 1.3 mM (as liposomes), vesicle average diameter= 140 nm. Total concentration [Ru]tot = 




It is shown previously that positively charged aqua ruthenium complexes similar to 
[1]
2+
 but containing an unhindered bpy chelate, strongly interact with negatively 
charged lipid bilayer membranes, and that coordination reaction at membrane-
embedded ligands can take place at high temperatures.
[61]
 Knowing that with hindered 
Ru complexes such as [1]
2+
 the coordination chemistry is much faster and occurs at 
room temperature, a solution of [1]
2+ 
was directly added to the thioether-decorated 
vesicles to observe whether coordination would take place at 297 K. In the dark, the 
initial absorption maximum of the solution, situated at 496 nm and characteristic of 
[1]
2+
 in presence of DMPG liposomes, gradually disappeared to give rise to a new band 
at 473 nm (Figure 2.5b). The clear isosbestic point at 480 nm shows that a single 





) at the lipid-water interface (see Figure 
2.5a and 2.5b). As [5]
2+
 is not thermodynamically stable it was not possible to measure 
its extinction coefficient in the environment of the bilayer as was done for [2]
2+
 in 
homogeneous solution. Thus, it was not possible to calculate the final conversion of the 
coordination reaction. However, from the absence of a shoulder around 500 nm in the 
last UV-Vis spectrum shown on Figure 2.5b it can be assumed that the conversion is 
almost complete. Half-reaction times of 165 and 87 min were found for bilayers 
containing 25 mol% and 35 mol% of ligand 4, respectively (Figure 2.5c). Thus, like for 
homogeneous solutions a higher concentration of thioether ligands at the DMPG 
membrane leads to shorter reaction times. Cryo-TEM images of the samples after 
adding [1]
2+
 and equilibration in the dark resembles that taken before addition of 
ruthenium (Figure 2.6b), showing that the morphology of the vesicles is not modified 
by the presence and coordination of the ruthenium complex.  
After reaching the thermal equilibrium at room temperature the sample was irradiated 
from the top with blue light (λe = 465 nm), and the evolution of the system was 
followed by UV-vis spectroscopy (Figure 2.5c). For both vesicle samples the 
absorbance at 500 nm gradually increased, indicating de-coordination of the sulfur 
ligand from the ruthenium complex and back-formation of the aqua complex [1]
2+
. 
Unlike in homogeneous conditions the photosubstitution of the thioether ligand by 
water was not complete for the sample containing 35 mol% of ligand 4, and the 
absorbance at 500 nm when the photochemical steady state was reached was lower 
than for the sample containing 25 mol% of ligand 4(see Figure 2.5c). In other words, 
although [1]
2+
 predominates in both cases at the photochemical steady state, thermal 




 to the membrane-embedded ligand may occur also during irradiation. 
Considering the kinetic results in homogeneous solution (see above), at higher 
concentration of 4 in the bilayer the rate of the thermal coordination should be higher, 
hence the [RuOH2]/[Ru]tot ratio and the absorbance of the solution at 500 nm at the 
photochemical steady state are expected to be lower. Finally, the photosubstitution 
quantum yield at the membrane was measured for the sample containing 25 mol% 
ligand 4 (see Figure AII.4), and a value of 0.065(6) was found, which is consistent with 
the value found in homogeneous solution. 
2.2.5. The coordination reactions occur at the surface of the bilayer  
As recently shown for unhindered ruthenium complexes,
[61]





 were expected to stay in proximity of the DMPG 
membrane, whether bound or not to the membrane-embedded thioether ligand. In order 
to prove this, complex [1]
2+
 was added to DMPG vesicles including 25 mol% of ligand 
4, and the sample was equilibrated at room temperature. In a second step, the large 
unilamellar vesicles (LUVs) were filtered using an Amicon centrifugal filter device, to 
yield an almost colorless filtrate and orange vesicles on the filter. This orange color 
indicates the presence of complex [5]
2+
 at the lipid vesicles, whereas according to ICP-
OES  (Inductively Coupled Plasma Optical Emission Spectroscopy) only 3% of the 
initially added ruthenium was found in the colorless filtrate. These 3% may correspond 
to the amount of non-coordinated aqua ruthenium complexes [1]
2+
 remaining when the 
equilibrium with [5]
2+
 is obtained, although it cannot be fully excluded that filtration 
slightly perturbs the chemical equilibrium at the vesicle surface. To check whether the 
Ru-DMPG interaction required the presence of the thioether ligand at the bilayer 
surface the same experiment was performed with DMPG vesicles functionalized with 
25 mol% of simple cholesterol, i.e., anionic membranes deprived of thioether ligand. 
After equilibration at room temperature and filtration with the Amicon device the 
filtrate showed 12% of the ruthenium initially present in the sample according to ICP-
OES, whereas the filter was stained with red-colored lipid vesicles. Thus, even in 
absence of coordinating thioether ligands a large fraction (88%) of the aqua complex 
interacts with the bilayer, i.e., the “free” aqua complex [1]
2+
 stays close to the bilayer 
surface. In a control experiment, zwitterionic 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) vesicles were prepared containing 25 mol% of ligand 4 or 
cholesterol. After adding [1]
2+
 and equilibration overnight both samples were filtered 
on the Amicon device, to leave a colorless residue in the filter and an intense red color 
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in the filtrate indicating the presence of [1]
2+
. According to ICP-OES the Ru 
concentration in the filtrate was found to be 96 and 90% of the initial Ru concentration 
in presence and in absence of coordinating thioether ligands, respectively. Thus, with 
neutral DMPC vesicles there is a negligible interaction between [1]
2+
 and the lipid 
bilayer, whether thioether ligands are embedded in the membrane or not. Overall, these 
results confirm that the interaction between polypyridyl Ru(II) complexes and DMPG 
membranes is based on electrostatic forces, and that the coordination chemistry 
between the aqua complex [1]
2+
 and the thioether ligands takes place at the negatively 
charged surface of the lipid bilayer (see Chapter 4). 
2.2.6. Hopping of a ruthenium complex at the surface of a lipid bilayer  
In order to check whether the results observed in homogeneous solution would stay 
valid for a supramolecular system the thermal binding and light-induced unbinding of 
Ru
2+
 at the surface of anionic DMPG lipid bilayers were repeated at 35 °C using a 
sample containing 35 mol% of ligand 4 and 5 mol% of complex [1]
2+
. The sample, 
initially equilibrated in the dark, was irradiated for 1 h at 465 nm and left in the dark 
for 2 h four consecutive times, while UV-vis spectra were recorded at 3-minute 
intervals. The time evolution of the absorbance at 500 nm is shown in Figure 2.7. 
Isosbestic points were obtained for each irradiation and each dark period, showing the 
selectivity of all reactions. A slow increase of the baseline was observed, which is 
attributed to water evaporation over long reaction times at 308 K. In the experimental 
setup indeed the UV-vis cell was left open to allow for irradiation from the top of the 
cuvette. A high absorbance at 500 nm was observed at the end of each irradiation 
period, showing the presence of a majority of [1]
2+
; reversely, a low absorbance at 500 
nm was found in the end of each dark period, showing the presence of a majority of 
[5]
2+
. According to all results above, the ruthenium complex [1]
2+
 hops from 
coordination site to coordination site at the water-bilayer interface. This motion is 
triggered by visible light. 
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Figure 2.7. Left: Time evolution of the absorbance at 500 nm of an equilibrated solution initially 
containing DMPG vesicles functionalized with 35 mol% of ligand 4 and 5 mol% of [1](PF6)2. At t=0 
the sample is alternatively irradiated with blue light (λe=465 nm, ON) or left in the dark (OFF). Right: 
representation of the light-induced hopping of a Ru complex on DMPG lipid bilayer. Conditions: T = 
308 K, [lipid]tot = 1.3 mM (as liposomes), vesicle average size= 140 nm, total concentration [Ru]tot = 
6.7  10−2 mM , spectra measured every 3 minutes, photon flux ~3.910−9 Einstein·s−1. Absorbance 
baseline due to light scattering at the vesicles was removed.  
 
2.3. Discussion and conclusion  
The effects of steric hindrance on the photo- and thermal reactivity of polypyridyl 





respectively. The photoreactivity of this type of complexes, based on the generation of 
a 
3
MC state with strong dissociative character,
[62-63]
 is efficient only if the ligand field 
strength is low enough, which can be achieved by using sterically hindered ligands. 
Very often however, steric hindrance also hinders thermal coordination of the 
photocleaved ligand back to the metal, and the system must be heated to recover its 
initial photoreactive state.
[1, 31, 61, 66]
 In this work, we show that in contrast to previous 
photoresponsive systems the steric hindrance of the dcbpy chelate destabilizes both the 
aqua- and the thioether-bound ruthenium complexes. Such destabilization leads to 
these two complexes being in thermal equilibrium at room temperature and in the dark. 
In these conditions the destabilization of the aqua complex [1]
2+
 is strong enough to 





water. Meanwhile, the photoreactivity of the thioether complexes is high enough to 




shifting the equilibrium towards a steady state where the ruthenium complex is in 
majority bound to water.
[67]
 Upon switching off the light, the equilibrium in favor of 
the thioether-bound complexes is re-established, typically within 30 to 120 minutes at 
room temperature, and whether the metal complex is in homogeneous solution or 
adsorbed at lipid bilayers. 
In the latter case, the unique combination of the cationic complex [1]
2+
, a negatively 
charged lipid bilayer, and a thioether-cholesterol ligand such as 4, results in the 
repeated hopping of the photosensitive metal complex at the water-membrane interface 
without a need to heating the system. Due to the excellent selectivity of both 
photochemical and thermal ligand substitution reactions, such hopping was repeated 
four times without alteration of the dark equilibrium state, or of the photochemical 
steady state. Thus, sterically hindered metal complexes such as [1]
2+
 might allow for 
controlling with light the motion of individual molecules. 
To conclude, this work shows that the Ru-S coordination bond between [1]
2+
 and 
thioether ligands in water is truly supramolecular, i.e., it involves a thermodynamical 
equilibrium that is established within minutes to hours at room temperature and in the 
dark. In addition, the sensitivity of this equilibrium to visible light irradiation is not 
accompanied by secondary degradation processes. To our knowledge only a small 
number of robust supramolecular interactions is sensitive to visible light and 
compatible with water; they are all based on the isomerization of covalent double 
bonds.
[6-7, 25]
 The present work adds a new member in the toolbox of self-assembly in 
water, which consists in a bimolecular equilibrium that can be shifted by visible light. 
2.4. Experimental section  
2.4.1. General 
1H and 13C NMR spectra were recorded using a Bruker DPX-300 spectrometer; chemical 
shifts are indicated in ppm relative to TMS. Electrospray mass spectra were recorded on a 
Finnigan TSQ-quantum instrument using an electrospray ionization technique (ESI-MS). 
UV-vis spectra were obtained on a Perkin-Elmer Lambda 900 spectrophotometer, or on a 
Cary Varian UV-visible spectrometer. Liposomes size distributions were determined by 
dynamic light scattering (DLS) in a Zetasizer (Malvern Instruments Ltd.,U.K.) operated at 
633 nm. 2-Dimyristoyl-sn-glycero-3-phosphoglycerol sodium salt (DMPG), 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were obtained from Avanti Polar Lipids 
Ruthenium complexes hopping at anionic lipid bilayers 
61 
and stored at −18 °C. 6,6’-dibromo-2,2’-bipyridine[68] and [Ru(terpy)Cl3]
[69] were 
synthesized using literature procedures. [3]Cl and [1](PF6)2 were synthesized by modified 
literature procedures (see Appendix II, Section AII.1).[70] 2-(Methylthio)-ethanol, PCl5, 
POCl3 and AgPF6 were purchased from Sigma-Aldrich and used as such. 
2.4.2. Synthesis 
[2](PF6)2: [3]Cl (50 mg, 79 μmol) and AgPF6 (75 mg, 300 μmol) were dissolved in Hmte (1 
mL). The purple solution was quickly heated to 100 °C. After 5 minutes, the orange 
solution was filtered to remove insoluble AgCl, after which Et2O was added to precipitate 
the compound. The orange/red solid was filtered and recrystalized from hot EtOH to yield 
[2](PF6)2 (60 mg, 78%). 
1H NMR (300 MHz, Acetone-d6, 298 K, see Scheme 2.1 for proton 
notation) δ 8.94 (d, J = 8.1 Hz, 1H, B3), 8.87 (d, J = 8.1 Hz, 2H, T3’5’), 8.77 (d, J = 8.1 
Hz, 2H, T33”), 8.67 (d, J = 8.1 Hz, 1H, A3), 8.59 – 8.47 (m, 4H, T66”+T4’+B4), 8.34 – 
8.23 (m, 3H, B5+T44”), 8.03 (t, J = 8.0 Hz, 1H, A4), 7.77 – 7.70 (m, 2H, T55”), 7.42 (d, J 
= 8.0 Hz, 1H, A5), 3.52 (t, J = 5.7 Hz, 2H, S-CH2-CH2), 1.76 (t, J = 5.8 Hz, 2H, S-CH2), 
1.18 (s, 3H, S-Me). 13C NMR was impossible due to slow decomposition of the product in 
acetone. UV-vis: λmax (ε in L·mol
−1·cm−1) in pure H2O: 467 nm (6640). ES MS m/z (calc): 
650.0 (650.6 [M – 2 PF6− H]
+), 590.0 (590.4 [M – 2 PF6 − Hmte + MeO]
+), 578.0 (577.43 
[M – 2 PF6 − Hmte + H2O]
+]), 558.1 (558.4 [M − 2 PF6 − Hmte −H]
+), 296.4 (295.7 [M – 2 
PF6 + MeOH]
2+). Anal. Calcd for C28H25Cl2F12N5OP2RuS: C, 35.72; H, 2.68; N, 7.44; S, 
3.41. Found: C, 34.57; H, 2.51; N, 7.21; S, 3.12. Crystal growing: Large single crystals of 
complex [2](PF6)2 suitable for X-ray structure determination were grown by vapor diffusion 
of diisopropylether into a solution of the compound in Hmte (~20 mg in 0.5 mL Hmte).  
Crystal structure data for [2](PF6)2: Fw = 941.50, dark orange lath, 0.45  0.20  0.05 
mm3, triclinic, P1 (no. 2), a = 8.28578(11), b = 10.46214(12), c = 19.7560(2) Å,  = 
87.3323(10),  = 88.7860(10),  = 84.6069(10), V = 1702.92(3) Å3, Z = 2, Dx = 1.836 g 
cm−3,  = 0.873 mm−1, abs. corr. range: 0.7640.959. 29119 Reflections were measured up 
to a resolution of (sin /)max = 0.59 Å
−1. 5991 Reflections were unique (Rint = 0.0559), of 
which 5377 were observed [I > 2(I)]. 531 Parameters were refined with 208 restraints. 
R1/wR2 [I > 2(I)]: 0.0293/0.0698. R1/wR2 [all refl.]: 0.0349/0.0716. S = 1.055. Residual 
electron density found between −0.43 and 0.57 eÅ−3. 
2.4.3. Determination of the equilibrium constant K  





        
              
 
 A stock solution of [1]2+ was prepared by dissolving complex [3]Cl in D2O (solution A, 10 
mg in 5 mL, 2.85 mM); a second stock solution of Hmte in D2O was prepared (solution B, 
15 μL Hmte in 1 mL, 163 mM). Five NMR tubes were prepared containing 0.5 mL of 
solution A (1.4 μmol [3]Cl). To each NMR tube was added 10 μL, 20 μL, 40 μL, 60 μL, or 
80 μL of solution B corresponding to initial Hmte concentrations of 3.2, 6.3, 12.0, 17.5 and 
22.5 mM, respectively. Each NMR tube was put in a water bath for 30 minutes at 50 °C and 
left to equilibrate overnight at room temperature. After this NMR spectra were measured at 
room temperature to determine the relative integral of the two species, and checked by 
another NMR spectrum to ensure the sample was at equilibrium. A plot of 
[RuOH2]/[RuHmte] as a function of the concentration in Hmte was made to determine the 
equilibrium constant K, where [RuHmte] represents the concentration in [2]2+ and [RuOH2] 
the concentration in [1]2+. 
2.4.4. Order in Hmte and determination of the second-order rate constant 
k1 for the thermal substitution of water by Hmte on complex [1]
2+
  
Stock solutions of complex [3]Cl (solution C, 7.53 mg in 50 mL H2O, 2.14×10
−4 M) and 
Hmte (solution D, 438.10 mg in 10 mL H2O, 4.75×10
−1 M) were prepared. For a typical 
experiment, 2 mL of solution C was added to a UV-vis cell, which was placed in a UV-vis 
spectrometer equipped with temperature control set to 297 K and stirring. To this solution 
was added x mL of H2O, and 1−x mL of solution D, where x was 0.2 mL, 0.4 mL, 0.6 mL 
or 0.8 mL. After the addition a UV-vis spectrum was taken every 30 seconds for a total of 6 
minutes. For each spectrum [RuHmte] and [RuOH2], i.e., the concentrations in [2]
2+ and 
[1]2+, respectively, were determined by deconvolution knowing the extinction coefficients 
of both species at 440 and 500 nm (ε = 5430 and 3609 L·mol−1·cm−1 for [2]2+, respectively, 
and 4680 and 7130 L·mol-1.cm-1 for [1]2+, respectively). The rate constants k’1 were 
determined by plotting ln([RuOH2]/[Ru]tot) vs. time. Values of 0.000861, 0.00168, 0.00241, 
and 0.00313 s−1 were found for k’1 for Hmte concentrations of 0.0317, 0.0634, 0.0951, and 
0.126 M, respectively. Plotting k’1 vs. [Hmte] afforded a straight line corresponding to a 
first order for Hmte (Figure AII.2). The slope of this line gives for the second-order rate 
constant k1 a value of 0.025 s
−1·M−1 (R2 = 0.995). 
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2.4.5. Rate constant for the thermal substitution of Hmte by water on 
complex [2]2+  
At the thermodynamic equilibrium between [1]2+, free Hmte, [2]2+, and water, the rates for 
the formation and hydrolysis of complex [2]2+ are equal: 
                                     
Thus the second order rate constant k−1 for the thermal substitution of Hmte by water is 




2.4.6. 1H MAS NMR under irradiation 
To determine the effect of light on the chemical equilibria, 1H NMR was performed on a 
Bruker 400 DMX equipped with a MAS probe (Bruker). A sample was prepared by adding 
to complex [3]Cl (3.2 mg, 4.56 μmol) 0.5 mL of a D2O solution of Hmte (6.7 mg, 72.7 
μmol in 2.5 mL). The sample was put in a water bath at 50 °C for 30 minutes and cooled 
down to room temperature overnight for equilibration. The solution was loaded into a 4 mm 
clear sapphire rotor and inserted into the MAS probe. 1H NMR spectra (64 scans) were 
taken every 5 minutes at 298 K with a spinning frequency of 2 kHz in the dark, or under 
white light irradiation. The light produced by a 1000 W xenon arc lamp equipped with a 
water filter and an infrared filter was brought perpendicularly to the rotation axis of the 
rotor through a fiber optic wire. The sample was irradiated during 30 minutes in total, and 
left in the dark during 60 minutes. [RuHmte] and [RuOH2], i.e., the relative concentration 
in [2]2+ and [1]2+, respectively, were determined by integration of the peaks at 7.16 ppm and 
7.08 ppm, respectively. We attribute the slight difference in chemical shift compared to 
7.19 and 7.12 ppm, respectively, to the MAS NMR experimental setup that is different 
from the standard setup used for solution NMR. 
2.4.7. Repeatedly shifting the equilibrium by blue light irradiation 
To a UV-vis cell containing 2 mL of a water solution of [3]Cl (0.214 mM) was added 1 mL 
of a water solution of Hmte (prepared with 27.15 mg Hmte in 10 mL H2O, thus [Hmte] = 
9.82 mM). The cell was mixed and kept closed in the dark overnight for equilibration at 
297 K. The cell was put in a UV-vis spectrophotometer equipped with stirring, and a LED 
light source was adapted that can irradiate the solution from the top (λe = 465 nm, Δ1/2 = 
25 nm, photon flux ~3.910−9 Einstein·s−1, optical path length 3 cm). The lamp was turned 
on for 1 hour at t = 0, 3, 6, and 9 hours, the rest of the time it stayed switched off. UV-vis 
spectra were taken at 5 min intervals, either under irradiation or in the dark, for a total of 15 
hours. For each spectrum [RuHmte] and [RuOH2], i.e., the concentrations in [2]
2+ and [1]2+, 
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respectively, were determined by deconvolution knowing the extinction coefficients of both 
species at 440 and 500 nm (ε = 5430 and 3609 L.mol−1·cm−1 for [2]2+, respectively, and 
4680 and 7130 L·mol−1·cm−1 for [1]2+, respectively). The ratio [RuOH2]/[RuHmte] was 
finally plotted as a function of time. 
2.4.8. Vesicle preparation 
DMPG or DMPC lipid and ligand 4 (25 or 35 mol%) were mixed from a chloroform: 
methanol (4:1)  stock solution and dried under a flow of argon for a few  hours. They were 
subsequently placed under vacuum to remove traces of organic solvents. Afterwards the 
lipid films were hydrated in a chloride-free buffer containing 10 mM of phosphates, and 40 
mM of K2SO4 (total ionic concentration 50 mM), at pH=7. The final concentration of the 
lipids was 2.5 mM. The lipid suspensions were freeze-thawed 10 times (from liquid N2 
temperature to +323 °C) and then extruded 11 times (at 323 °C) by using an Avanti mini-
extruder through polycarbonate membranes with 200  nm pore diameter. The size of the 
vesicles before and after adding [1]2+ were distributed between 130 and 150 nm as 
measured by DLS. The morphology of the vesicles before and after adding [1]2+ were 
determined by Cryo-transmission Electron microscopy. The samples were stored at 277 °C 
and used within 6 days. 
2.4.9. Vesicle filtration experiments 
1.6 mL samples containing either DMPG or DMPC vesicles functionalized with 25 mol% 
of either cholesterol or ligand 4, were prepared as above. Each sample was diluted with the 
buffer (1.0 mL) before complex [1]2+ was added (0.40 mL of a 5.010−4 M stock solution of 
[1](PF6)2, to reach a total volume of 3 mL, and final concentrations of 1.3 mM for the lipids 
and 6.710−5 M for Ru. The samples were stirred overnight at room temperature and in the 
dark. Absorbance maxima were measured at 500 nm for both DMPC samples and for the 
DMPG sample containing cholesterol, which corresponded to the presence of [1]2+. By 
contrast the absorbance maxima at 473 nm for the sample containing 4 corresponded to the 
formation of complex [5]2+. In a second step, each sample was centrifuged using a Milipore 
Ultra-4 centrifugal filter units, at 297 K and 4300 rpm during 90 minutes. The ruthenium 
concentration of each filtrate was determined by inductively coupled plasma atomic 
emission spectroscopy (ICP-OES) on a Varian VISTA-MPX spectrometer. The 
concentrations were found to be 275 ppb and 62 ppb for DMPG samples containing 
cholesterol and ligand 4, respectively, and 2.05 and 2.19 ppm for DMPC samples 
containing cholesterol and ligand 4, respectively.  These values correspond to 12% and 3% 
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of the initially added Ru for DMPG, and 90% and 96% for DMPC, as the value found for 
the reference sample was 2.28 ppm (100%). 
2.4.10. Irradiation and quantum yield measurement in vesicle samples  
1.6 mL of a vesicle sample containing DMPG and 25 mol% of ligand 4 (2.5 mM) was taken 
in a UV-vis cell. 1 mL of a buffer solution at pH=7 was added and the volume of the cell 
was completed by adding 0.4 mL of a 5  10−4 M stock solution of [1]2+ (ratio [1]2+ to 
ligand 4 was 1 to 5) . Final lipid concentration in the cell was 1.3 mM.  The absorbance of 
the sample at 500 nm was 0.46. In a second step the sample was stirred in the dark 
overnight while UV-vis spectra were measured every 3 minutes (Figure AII.4 left). At the 
thermal equilibrium the absorption maximum was 473 nm, which characterized the 
formation of complex [5]2+ at the water-bilayer interface, and the absorbance at 473 nm was 
0.40. In a third step the sample was irradiated for 90 minutes with a custom-made LED 
lamp (λe = 465 nm, Δλ1/2 = 25 nm) fitted to the top of the UV-vis cell. The absorbance of 
the solution was measured every 3 minutes during irradiation. Knowing the extinction 
coefficient and absorbance of [1]2+ at 500 nm (see Appendix I, section AI.1) the extinction 
coefficient of [5]2+ at 500 nm was calculated to determine the concentration of [5]2+ by 
deconvolution of each UV-vis spectrum during irradiation. By determining the slope of the 
plot ln([RuSRR’]/[Ru]tot) as a function of irradiation time (4.5(4)10
−3 s−1 for t<72 min, see 
Figure AII.4 right) and knowing  photon flux at the irradiation wavelength, a quantum yield 
of 0.065(5) was obtained for the photosubstitution of 4 by water at the bilayer-water 
interface (see Appendix I, section A.I.3  for quantum yield measurements). 
2.4.11. Cryo-electron transmission microscopy 
A few microliters of vesicle preparation were applied to glow-discharged lacey carbon EM 
grids. Excess medium was automatically blotted onto Whatman no. 4 filter paper for 1 to 2 
sec. in a controlled environment operated at room temperature and 100% humidity. 
Subsequently, the specimen was vitrified by plunging into liquid propane/ethane. Samples 
were stored in liquid nitrogen until use. Grids were mounted in a Gatan 626 cryo holder 
(Gatan, Pleasanton, U.S.A.) and images were recorded on a Tecnai 20 FEG (FEI Company) 
operated at 200 keV. Images were recorded at −8 micron under focus on a 2k × 2k camera 
mounted behind an energy filter (Gatan) operated at a slit width of 20 eV. 
2.4.12. Supporting Information 
Appendix I: General procedure for the determination of extinction coefficients; calculation 
the concentrations of reacting species from the UV-vis spectra, and quantum yield. 
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Appendix II: synthetic procedures for dcbpy, [3]Cl, [1](PF6)2, and for compound 4; X-ray 
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Spontaneous formation in the dark, and 
visible light-induced cleavage, of a Ru-S bond 















In this work the thermal and photochemical reactivity of a series of ruthenium complexes 
[Ru(terpy)(N-N)(L)](X)2 (terpy = 2,2’;6’,2”-terpyridine, L=2-(methylthio)ethanol (Hmte) 
or water, and X− is  Cl− or PF6
−) with four different bidentate chelates N-N=bpy (2,2’-
bipyridine), biq (2,2’-biquinoline), dcbpy (6,6’-dichloro-2,2’-bipyridine), or dmbpy (6,6’-
dimethyl-2,2’-bipyridine), is described. For each chelate N-N the thermodynamic constant 
of the dark equilibrium between the aqua and Hmte complexes, the Hmte photosubstitution 
quantum yield, and the rate constants of the thermal interconversion between the aqua and 
Hmte complexes, were measured at room temperature. By changing the steric hindrance 
and electronic properties of the spectator N-N ligand along the series bpy, biq, dcbpy, 
dmbpy the dark reactivity clearly shifts from a non-labile equilibrium with N-N=bpy, to a 
very labile thermal equilibrium with N-N=dmbpy. According to variable-temperature rate 
constant measurements in the dark near pH =7 the activation enthalpies for the thermal 
substitution of H2O by Hmte are comparable for all ruthenium complexes, whereas the 
activation entropies are negative for bpy and biq, and positive for dcbpy and dmbpy 
complexes. These data are indicative of a change in the substitution mechanism, being 
interchange associative with non-hindered or poorly hindered chelates (bpy, biq), and 
interchange dissociative for more bulky ligands (dcbpy, dmbpy). For the most labile dmbpy 
system, the thermal equilibrium is too fast to allow significant modification of the 
composition of the mixture using light, and for the non-hindered bpy complex the 
photosubstitution of Hmte by H2O is possible but thermal binding of Hmte to the aqua 
complex does not occur at room temperature. By contrast, with N-N = biq or dcbpy the 
thermodynamic and kinetic parameters describing the formation and breakage of the Ru-S 
bond lie in a range where the bond forms spontaneously in the dark, but is efficiently 
cleaved under light irradiation. Thus, the concentration between the aqua and Hmte 
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3.1. Introduction  
Visible light is an efficient tool to control molecular and supramolecular metal-based 
systems
[1-10]







 Among the vast family of photosensitive compounds ruthenium(II) 





type complexes are notorious for their luminescence,
[46-49]
 complexes bearing 
terpyridyl-like ligands, or sterically hindered chelating ligands, have emerged for their 
ability to selectively photosubstitute one of the ligands of the coordination sphere by 
solvent molecule(s).
[24, 48, 50-53]
 Such reactivity is based on low-lying, metal-centered 
(
3
MC) excited states with dissociative character that are thermally populated from the 
photochemically generated metal-to-ligand charge-transfer (
3
MLCT) excited states. In 
such systems, the photosubstitution reaction can be used to power a molecular machine 
[20, 22-23, 54-59]
 or trigger molecular switches.
[12-14, 60]
 More recently, visible light-induced 
photosubstitution reactions have been proposed as a new way to activate “caged” 
bioactive ruthenium complexes or ligands.
[28, 32, 35, 37, 42, 61]
 
It has been clearly demonstrated, notably by Sauvage et al, that in solution the steric 
properties of the spectator ligands influence dramatically the quantum efficiency of 
photosubstitution reactions.
[23, 62]
 This phenomenon is interpreted as a cause of the 
distortion of the coordination octahedron induced by steric bulkiness, which in turn 
lowers the ligand field splitting energy of the complex and brings the 
3
MC states closer 
in energy to the photogenerated 
3
MLCT states. However, the electronic and steric 
properties of the ligand set also influence the thermal reactivity of the metal complex. 
In principle, the thermal coordination of sterically hindered ligands requires more 
energy than that of unhindered ligands.
[23]
 Two decades ago however, Takeuchi et al. 
reported the reverse phenomenon in a family of complexes [Ru(terpy)(N-N)(L)]
2+
 
(terpy = 2,2’;6’,2”-terpyridine, L = H2O or CH3CN), where the rate of the thermal 
substitution of the aqua ligand by acetonitrile at room temperature increased with more 
sterically hindered spectator diimine ligands N-N.
[63]
 This work introduced a 
quantitative measure of the steric bulkiness of diimine chelates, but it remained elusive 
on the reasons for the higher lability of the aqua ligand observed with hindered 
spectator chelates. The reaction was studied at a single temperature, and based on 
earlier work
[64]
 a dissociative-interchange substitution mechanism was proposed 
without variable-temperature kinetic measurements.  
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Inspired by these results the substitution reaction of [Ru(terpy)(dcbpy)(H2O)]
2+ 
(dcbpy 
= 6,6’-dichloro-2,2’-bipyridine) with 2-methylthioethanol (hereafter, Hmte) in pure 
water has been studied in Chapter 2. At room temperature, binding of the thioether 
ligand to afford [Ru(terpy)(dcbpy)(Hmte)]
2+
 is a fast reaction. We realized that 
considering the high photosubstitution quantum yield of the Hmte complex (0.13 at 
465 nm) to afford the starting aqua complex [Ru(terpy)(dcbpy)(H2O)]
2+
, this system 
represents a very interesting tool in supramolecular chemistry, as the chemical 
equilibrium between the aqua and the Hmte ruthenium complexes can be shifted by 
visible light, while re-establishing itself in the dark. This work is expanded in this 
Chapter by studying in water the thermal coordination of Hmte to [Ru(terpy)(N-
N)(H2O)]
2+
 (hereafter, RuOH2) with a series of three other bidentate ligands having 
different steric demands, namely N-N = bpy (2,2’-bipyridine), biq (2,2’- biquinoline), 
and dmbpy (6,6’-dimethyl-2,2’-bipyridine, see Scheme 3.1).  
 
Scheme 3.1. The thermal equilibrium between [Ru(terpy)(N-N)(H2O)]
2+ and [Ru(terpy)(N-
N)(Hmte)]2+, and the photosubstitution of Hmte by an aqua ligand. ki are second-order rate constants 
for the thermal substitution of H2O by Hmte (unit: M
−1·s−1), k−i are first-order rate constants for the 
thermal substitution of Hmte by H2O (unit: s
−1), Ki the thermodynamic equilibrium constants (unit: 
M−1), and i are the quantum yields for the photosubstitution of Hmte by H2O (dimensionless). 
Indexes i refer to the complexes with N-N=bpy (i=1), N-N=biq (i=2), N-N=dcbpy (i=3), and N-
N=dmbpy (i=4). 
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The aim of the present work was double: first, achieving a thorough understanding of 
the effect of sterically hindering substituents on the bidentate ligand on the thermal and 
photochemical reactivity of Ru(II) complexes in water (Scheme 3.1). Secondly, 
unraveling the mechanism of the thermal coordination of Hmte to the aqua complex, 
and gain understanding of the counter-intuitive observation that ligand binding to more 
hindered complexes is faster.  
3.2. Results  
3.2.1. Synthesis and crystal structure 
The new complex [Ru(terpy)(bpy)(Hmte)](PF6)2 ([5](PF6)2) was synthesized by silver-
induced removal of the chloride ligand of [Ru(terpy)(bpy)Cl]Cl ([9]Cl) in presence of 





C NMR spectroscopy, electrospray mass spectrometry (ES-MS), elemental 
analysis, and electron absorption spectroscopy (UV-vis). 
1
H NMR spectroscopy in 
acetone-d6 showed that the protons of the Hmte ligand (3.55 ppm, 2.00 ppm, 1.53 ppm) 
are shielded in [5](PF6)2 compared to free Hmte (3.89 ppm, 2.58 ppm, 2.07 ppm) due 
to coordination to the ruthenium polypyridyl complex. Single crystals of [5](PF6)2 were 
obtained by slow vapor  diffusion of toluene into a solution of [5](PF6)2 in Hmte. The 
crystal structure of the complex was determined by single-crystal X-ray diffraction (see 
Figure 3.1). As expected, the Hmte ligand is coordinated to ruthenium(II) via its soft 
sulfur atom. The bpy ligand in [5](PF6)2  is positioned almost perpendicular to the 
terpy. The comparison of the crystal structure of [5](PF6)2 to that of the complex 
[Ru(terpy)(dcbpy)(Hmte)](PF6)2 ([7](PF6)2 see Chapter 2) shows that the torsion angles 
Ru1-N4-C20-C21 and Ru1-N5-C21-C20 for the bpy derivative are much smaller than 
those of the dcbpy derivative (see Table 3.1), which suggests that the coordination 
sphere is less distorted in [5](PF6)2. Moreover, the Ru1-S1 bond in [5](PF6)2  is slightly 
shorter (2.3690(5) Å) than that in [7](PF6)2 (2.3819(6) Å, see Table 3.1), also 
indicating less steric hindrance in [5](PF6)2. These results are similar to those reported 
for [Ru(terpy*)(phen)(dms)](PF6)2 and [Ru(terpy*)(dmp)(dms)](PF6)2 (terpy*=4′-(3,5-
di-t-butylphenyl)-2,2′;6′;2′′-terpyridine, phen=1,10-phenanthroline, dmp=2,9-dimethyl-






Scheme 3.2. Synthesis and numbering scheme of [Ru(terpy)(bpy)(Hmte)](PF6)2  ([5](PF6)2).  
 
Figure 3.1. Displacement ellipsoid plot (at 50% probability level) of complex [5](PF6)2. 
Hexafluoridophosphate counter ions and H atoms were omitted for clarity. 
Unlike [5](PF6)2 and [7](PF6)2, the RuHmte complexes [Ru(terpy)(biq)(Hmte)](PF6)2 
([6](PF6)2) and [Ru(terpy)(dmbpy)(Hmte)](PF6)2 ([8](PF6)2) could not be isolated in 
the solid state. Mixing [Ru(terpy)(biq)(Cl)]Cl ([10]Cl) or [Ru(terpy)(dmbpy)(Cl)]Cl 
([12]Cl), respectively, with AgPF6 and Hmte in water, was followed by precipitation, 
but the resulting salts [6](PF6)2 and [8](PF6)2 were always impure, even after 




in aqueous solution is straightforward, 
however, as they spontaneously and quantitatively form upon mixing [10]Cl or [12]Cl 
and an excess of Hmte in pure water – thus without addition of AgPF6. According to 
1




are the only ruthenium species present in 
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C NMR, ES-MS, and UV-vis spectroscopy (see section 3.5.1). 





Ru1-S1  2.3690(5) 2.3819(6) 
Ru1-N1  2.061(1) 2.084(2) 
Ru1-N2  1.961(1) 1.962(2) 
Ru1-N3  2.066(1) 2.074(2) 
Ru1-N4  2.092(1) 2.126(2) 
Ru1-N5  2.064(1) 2.115(2) 
Ru1-N4-C20-C21  2.3(2) 21.5(3) 
Ru1-N5-C21-C20  10.5(2) 22.0(3) 
Ru1-N1-C5-C6  1.8(2) 2.4(3) 
Ru1-N3-C11-C10  5.0(2) 7.6(3) 
Ru1-N2-C6-C5  2.7(2) 4.9(3) 
Ru1-N2-C10-C11  2.8(2) 0.7(3) 
a Taken from Chapter 2. 
Dissolution of the non-hindered bpy complex [9]Cl in water leads to a slow 
equilibrium between the chlorido complex [9]
+







 This equilibrium establishes only after hours at 
room temperature. By contrast, the chlorido complexes [10]Cl or [12]Cl are, within 






respectively. Indeed, according to 
1
H NMR adding increasing amounts of D2O to 
CD3OD solutions of [10]Cl or [12]Cl leads, within the time necessary for recording a 
1
H NMR spectrum, to the formation of a second species (see Figure AIII.3). In pure 
D2O, the 
1
H NMR spectrum of [10]Cl or [12]Cl shows a unique A8 or A5 doublet at 
6.75 ppm or 6.78 ppm (see Figures 3.2 and AIII.1), respectively. Aqua Ru(II) 





 were unknown; UV-vis titration led to values of 9.5 and 10.5, 
respectively (see Figure AIII.4), which is comparable to that of [1]
2+









 are not deprotonated in pure 
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, respectively. A similar observation is reported in Chapter 
2 for the dcbpy system. Thus, the hydrolysis of the Ru-Cl bond in water is fast at room 
temperature with hindered N-N ligands (biq, dmbpy, or dcbpy), and the hindered 




1H NMR of a solution of [2]Cl2 (top) and [6]Cl2 (down) in pure D2O near pH 7 (aromatic 
region 6.4-9.2 ppm), N-N=biq. See Figure AIII.1 for proton attributions. Conditions: [Ru]tot=12 mM, 
[Hmte]=0 (top) or 0.93 M (bottom), MilliQ water (pH ~ 7), 298 K. See Appendix III, Figure AIII.1 
for proton notation. 
As noted above, with hindered complexes (N-N=biq, dmbpy, or dcbpy) addition of an 
excess of Hmte to a solution of the chlorido precursor complex [Ru(terpy)(N-N)Cl]Cl 
(hereafter noted RuCl) in pure water leads, in the dark and at room temperature, to an 







, noted RuOH2) and the S-bonded Hmte ruthenium complexes [Ru(terpy)(N-








, noted RuHmte). Thioether ligands are not basic and, unlike 
for amine or pyridine ligands where a buffer is required, here the addition of even large 




 does not lead to 
significant deviations of the pH from 7. This was also observed upon adding Hmte to 
[1]
2+
, which can be introduced in solution in the form of [1](PF6)2. Typically, in 
presence of 0.1 M Hmte a 10
−4
 M solution of [1](PF6)2, [10]Cl, [11]Cl, or [12]Cl in 









not deprotonated. The substitution of the aqua ligand in [1]
2+
 by Hmte can be studied 
above 50 C, whereas for the hindered biq, dcbpy, and dmbpy system it was studied at 
room temperature and above (see below). The overall equilibria for the four systems 
are summarized in Scheme 3.1. 
3.2.2. Thermodynamic Study 
1
H NMR experiments were performed in D2O to measure the equilibrium constants K2 









 (N-N=dmbpy), respectively (see Scheme 1).  For each reaction, NMR samples 
containing the RuCl
 
precursor [10]Cl or [12]Cl and different initial amounts of free 
Hmte were prepared. After equilibration at 297 K in the dark, the 
1
H NMR spectrum of 
each sample was measured.  Integration of the two A8 doublets at 6.35 ([6]
2+
) and 6.75 
([2]
2+
) ppm for N-N=biq, or of the two A5 doublets at 6.86 ([8]
2+
) and 6.78 ([4]
2+
) ppm 
for N-N=dmbpy, allowed for calculating the relative amounts of RuHmte and RuOH2
 
present in solution (see Figures 3.3 and AIII.1).  A plot of the ratio [RuHmte]/[RuOH2] 
vs. [Hmte] is shown in Figure 3.4, where [RuHmte], [RuOH2], and [Hmte] represent 
the concentrations of the thioether complex, of the aqua complex, and of the free 
thioether ligand, respectively. For both reactions straight lines were obtained. 
According to Equation 3.1 the slope of each line corresponds to the thermodynamic 
equilibrium constant K2 (N-N=biq) and K4 (N-N=dmbpy); the values were found to be 
143(10) M
−1
 and 37(2) M
−1
, respectively, at 297 K, in pure water and in the dark. 
These values are both slightly lower than that of the dcbpy system (K3= 151(8) M
−1
 in 
the same conditions, see Chapter 2 and Table 3.2).  
          
         





Figure 3.3. Evolution of the 1H NMR spectra, at the equilibrium between RuOH2 and RuHmte, with 
different initial concentrations of Hmte for a) the equilibrium between [2]2+ and [6]2+ (N-N=biq); b) 
the equilibrium between [4]2+ and [8]2+ (N-N=dmbpy). Condition: a) [Ru]tot= 5.13 mM, b) [Ru]tot= 
12.7 mM, in D2O, pH ~ 7 (pure water), T=297 K, in the dark. The initial amounts of Hmte are 
indicated on each spectrum. 
 
Figure 3.4. Plots of the ratio [RuHmte]/[RuOH2] at the equilibrium at 297 K, as a function of the 
equilibrium concentration in free Hmte. [RuHmte] and [RuOH2] represents the concentrations (in 
mol·L–1) in [6]2+ and [2]2+, respectively (N-N=biq), or in [8]2+ and [4]2+, respectively (N-N=dmbpy). 
Knowing the equilibrium constant for each reaction and using ΔGi = –R·T·ln(Ki), the 











, and –9(1) kJ·mol
–1
, respectively, showing a lower 
thermodynamic driving force towards the formation of RuHmte for the most hindered 
dmbpy system, in water and at room temperature (see Table 3.3). The establishment of 
the thermodynamic equilibrium for the unhindered N-N=bpy system is too slow at 
room temperature to be measured, and the corresponding equilibrium constant K1 could 
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3.2.3. Kinetic Study 
Kinetic measurements were performed using UV-vis spectroscopy to compare the rate 






 by Hmte in pure 





UV-vis spectrum of each solution with absorption maximum at 549 or 486 nm, 
respectively, gradually evolved within minutes in the dark to give rise to a new 







respectively. Clear isosbestic points (see Figures 3.5b and 3.5c) indicated a 
selective reaction involving only RuOH2 and RuHmte. Remarkably, a solution of [1]
2+ 
containing large excess of the Hmte ligand is kinetically stable at room temperature, 
and coordination of the thioether ligand only takes place at temperatures above 323 K. 
At such high temperatures, the Hmte complex [5]
2+
 forms selectively, as shown by the 
clear isosbestic point at 455 nm and the final max at 450 nm, which is identical to that 
of the isolated complex (see Figure 3.5a). For the two systems N-N=bpy and biq the 
plots of ln([RuOH2]/[Ru]tot) vs. time were found linear at 323 and 297 K, respectively 




, and [Ru]tot is the 
total ruthenium concentration. The pseudo first-order rate constants k’i (i=1 or 2) were 
extracted from the slopes of these lines (see Figure 3.6), and a plot of k’i vs. [Hmte] 





 is first order in the ligand Hmte. 
For N-N=dmbpy the plot of ln([RuOH2]/[Ru]tot) vs. time at 297 K was not linear (see 
Figures 3.6d and AIII.6) because with such a sterically hindered chelate the thermal 
back-substitution of Hmte by water cannot be neglected, i.e., k–4 becomes comparable 
to k’4. Equation 3.2 and 3.3 give the general expression of the rate of the thermal 
formation of the RuHmte complex in pseudo first-order conditions. By integration 
Equation 3.4 was obtained, which was used to fit the plot ln([RuOH2]/[Ru]tot) vs. time 
and extract the values of kobs=k–4+k’4 (see Appendix III, section AIII.6). Finally, a plot 
of kobs vs. [Hmte] afforded a straight line, showing that also for N-N=dmbpy the 
coordination of Hmte to [4]
2+
 is first order in Hmte (see Figure AIII.7 and section 
AIII.7) for the full treatment). Overall, like for N-N=dcbpy (see Chapter 2) the rate 
laws for N-N=bpy, biq, and dmbpy were found to be first order in the Hmte ligand (see 
Figure AIII.7). The second-order rate constants ki and the half-reaction time t1/2(i) 
(calculated with [Hmte]= 0.2 M) are given in Table 3.2. At room temperature the N-
N=biq and N-N=dmbpy systems are slower and faster, respectively, compared to the 
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N-N=dcbpy system. With N-N=bpy Hmte does not coordinate to [1]
2+
 at 297 K, but k1 






 and 71 min, respectively, at 
[Hmte] = 0.2 M). Even at such high temperatures the rate of the coordination reaction 
was found to be 8 times slower than the rate of the N-N=biq system at 297 K (all other 
conditions being identical), which highlights the low lability of the non-hindered bpy 
system, compared to the sterically hindered ones. 
         
  
  
        
  
                        (Equation 3.2) 
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     )         (Equation 3.3) 
         
           
(       )
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     ) 
(       )
 (Equation 3.4) 
The pseudo first-order rate constants k–i, and half-reaction times t1/2(–i) for the thermal 
hydrolysis of the RuHmte complexes with N-N=biq, dcbpy, and dmbpy, in the dark 
and at 297 K, were determined from the knowledge of the thermodynamic equilibrium 
constants Ki, and the second-order rate constants ki (see Table 3.2). Equation 3.5, 
written at the equilibrium, indeed rearranges into Equation 3.6. 
                                    (Equation 3.5) 
    
  
  
  (Equation 3.6) 
For the N-N=bpy system measuring K1 was not possible at room temperature and k–1 
could not be calculated. However, k–1 could be obtained experimentally by heating an 
aqueous solution of [5](PF6)2 at high temperatures (>343 K), and monitoring by UV-
vis spectroscopy the thermal substitution of Hmte by water at different temperatures. 
Subsequently, the activation parameters for the thermal hydrolysis of [5]
2+
 were 
extracted via an Eyring plot (see Figure AIII.8 and Table III.3): values of 110(6) 
kJ·mol
–1








–1, respectively. By 
extrapolation of the values of k–1 at T>323 K, the value of ΔG
‡
–1 and k–1 at 297 K were 
calculated to be 117(10) kJ·mol
–1




, respectively. The equilibrium 




) was obtained using Equation 3.6 
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and the extrapolated value of k1 at 297 K (see below and Table 3.2). These extrapolated 
values for N-N=bpy are less precise than the direct measurements done for N-N=biq, 
dcbpy, and dmbpy considering the significant error on ΔS
‡
–1. However, they give 
qualitative information about how stable and inert the non-hindered complex [5]
2+
 is. 
Finally, comparing the kinetic data in Table 3.2 shows that the thermal lability of both 
species RuOH2 and RuHmte increases along the series bpy, biq, dcbpy, dmbpy, i.e., 
upon increasing the steric hindrance of the spectator N-N ligands. Such higher lability 
results in faster thermal coordination, but also faster hydrolysis of the Hmte ligand, 
while the thermodynamic driving force for Hmte binding to ruthenium is lowered. 
 
Figure 3.5. Time evolution of the UV-vis spectra of aqueous solutions initially containing (a) [1]2+, 
(b) [2]2+, and (c) [4]2+, and a large excess of Hmte in MilliQ water (pseudo-first order conditions). 
Conditions: (a) T=323 K, [Ru]tot=6.610
–5 M, [Hmte]=0.07 M, (b) T=297 K, [Ru]tot=6.610
–5 M, 
[Hmte]= 0.067 M, and (c) T=297 K, [Ru]tot = 2.110
–4 M, [Hmte] = 0.032 M. 
Table 3.2. Thermodynamic and kinetic data at 297 K for the interconversion between [Ru(terpy)(N-
N)(H2O)]
2+ and [Ru(terpy)(N-N)(Hmte)]2+ complexes, where N-N is bpy, biq, dcbpy, and dmbpy. 
Conditions: in the dark, pure water, pH ~ 7. 
* Data extrapolated at 297 K from the temperature-dependent kinetic measurements above 323 K (see 
text and Table 3.3). Uncertainties are high but the low rate constant obtained confirms the absence of 
measurable binding of Hmte to the unhindered aqua complex [1]2+ at room temperature.  † data taken 










































































































3.2.4. Activation parameters for the coordination of Hmte  
In order to obtain mechanistic information the rate of the thermal substitution of the 








, was studied at different temperatures 
using UV-vis spectroscopy. In pseudo first-order conditions the plot of 
ln([RuOH2]/[Ru]tot) vs. time at different temperatures afforded straight lines for N-
N=bpy, biq, and dcbpy complexes (Figure 3.6a-c), which allowed determining the 
second-order rate constants ki at different temperatures for all three reactions (Table 
AIII.2). For N-N=dmbpy the ln([RuOH2]/[Ru]tot) vs. time dataset was found non-linear 
as explained above (Figure 3.6d). It was modeled using Equation 3.4 and the values k4 
and k-4 could also be determined at five different temperatures (see Table AIII.1). The 
activation enthalpy ΔH
‡
i, activation entropy ΔS
‡
i, and activation Gibbs energy at 297 K, 
ΔG
‡
i, are defined, for each reaction, by the Eyring equation (Equation 3.7). In this 





), h is Plank’s constant (6.63  10
–34





). An Eyring plot of ln(ki/T) vs. 1/T for the four systems afforded 




i  could be 
extracted. The activation Gibbs energies, ΔG
‡





















    
 
 (Equation 3.7) 
Quite surprisingly the four activation enthalpies were found too similar to account for 
the clear differences in reactivity between the four N-N ligands. By contrast, 
unexpected differences in activation entropies were observed: the values for the less 
hindered N-N=bpy and N-N=biq bidentate ligands were found to be negative, whereas 
for the more hindering chelates N-N=dcbpy and N-N=dmbpy the values were found to 
be positive. When both contributions of enthalpy and entropy are taken into account, a 
clear trend was observed: the activation Gibbs energies ΔG
‡
i decreases along the series 
bpy, biq, dcbpy, dmbpy. Such acceleration of the coordination of Hmte to the aqua 
complex appears to be a consequence of a drastic increase of the activation entropy 
ΔS
‡
i, i.e., a change in the substitution mechanism, rather than a simple destabilization 
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Figure 3.6.  Plots of ln([RuOH2]/[Ru]tot) vs. time at different temperatures for the thermal 
coordination, in the dark and in pure water (pH ~ 7), of  Hmte to a) [1]2+, b) [2]2+, c) [3]2+ (see 
Chapter 2) and d) [4]2+. All the numerical values of k’i and ki are given in Tables AIII.1 and AIII.2. 
Conditions: (a) [Ru]tot=6.610
–5 M, [Hmte]=0.067 M, (b) [Ru]tot=6.610
–5 M, [Hmte]= 0.067 M, (c) 
[Ru]tot=1.410
–4 M, [Hmte]=0.16 M, and (d) [Ru]tot = 2.110
–4 M, [Hmte] = 0.032 M. 
 
Figure 3.7. Eyring plots for the thermal substitution of H2O by Hmte for [Ru(terpy)(N-N)(H2O)]
2+ in 
pure water, where N-N is a) bpy, b) biq, c) dcbpy, and d) dmbpy. The slope of the line is –ΔH‡i/R, and 
the y-intercept is ln(kB/h)+ΔS
‡



































































































Table 3.3. Activation parameters for the thermal coordination of Hmte to RuOH2 (i) and thermal 
hydrolysis of RuHmte (−i), where N-N is bpy (i=1), biq (i=2), dcbpy (i=3), or dmbpy (i=4). 



































bpy 83(1) –48(9) 97(5) 117(20) –20(2) 
biq 79(3) –20(8) 85(4) 97(6) –12(2) 
dcbpy 93(1) +38(4) 82(3) 94(4) –13(2) 
dmbpy 85(1) +20(2) 79(3) 88(4) –9(1) 
 
These variable-temperature measurements also allowed us obtaining the values of  
ΔG
‡

















i. Upon increasing 
the steric hindrance of the bidentate chelate, ΔG
‡
–i was found to decrease as well (see 
Table 3.3), i.e., the coordinated Hmte ligand becomes more and more labile in water. 
Overall, our data clearly indicate that increasing the bulkiness of the substituent on the 
bidentate chelate N-N increases the lability of both monodentate ligands (H2O and 
Hmte), whereas it decreases the thermodynamic driving force for the formation of the 
RuHmte species. 
3.2.5. Photochemistry  
3.2.5.1. Quantum yield determination 
Ruthenium polypyridyl complexes are known for their ability to photosubstitute a 
ligand of the coordination sphere by a solvent molecule upon visible light irradiation. 
[20-21, 24, 45, 50]








 can indeed be cleaved by 









, respectively (see Scheme 3.1). This photochemical process comes in 
addition to the thermal hydrolysis of the Hmte complex, the kinetics of which 
significantly varies depending on the steric hindrance of the bidentate chelate N-N (see 
above and Table 3.2). Different methods were used for measuring the photosubstitution 




 (see Appendix I, 
section AI.3 and Appendix III, section AIII.9). For [5]
2+
 full conversion to [1]
2+ 
is 
obtained after 30 minutes irradiation at 452 nm using a 1000 W Xe lamp fitted with a 
bandpath filter. The photochemical reaction can be followed by UV-vis spectroscopy 
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(Figure AIII.9), and a value of 0.022(6) was found for 1 at room temperature and at 
452 nm, which is consistent with previous work.
[32]
 







, respectively, was challenging because of the rapid equilibrium 
between RuHmte
 
and RuOH2 (see also Chapter 2). For these compounds standard 
measurements cannot be realized, so that another method was used consisting in the 
perturbation with light of the thermal equilibrium between RuOH2 and RuHmte (see 
Appendix III, section AIII.9). In short, the ratio [RuHmte]eq/[RuOH2]eq is measured by 
UV-vis spectroscopy at the equilibrium in the dark (eq), and compared to the ratio 
[RuHmte]ss/[RuOH2]ss at the steady state under visible light irradiation (ss). Both ratios 
can be expressed as a function of k’i, k−i, and kφi (Equation 3.8a and 3.8b), where kφi is 
a first-order rate constant for the photochemical substitution of Hmte by H2O (unit: s
−1
, 
see Equation 3.9 and Appendix III, section AIII.9).  
 )   
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   (Equation 3.8) 
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   )
   (   )
   (Equation 3.9) 
 
First the value of k−i was obtained in the dark from Equation 3.8a knowing the value of 
ki; Then the value of kφi can be obtained under irradiation using Equation 3.8b, and 
from the values of kφi the photosubstitution quantum yields i were calculated using 
Equation 3.9. Numerical values 2 = 0.12(4) (at 520 nm), 3 = 0.13(4) (at 465 nm), and 
4 = 0.30(10) (at 465 nm) were found for the biq, dcbpy, and dmbpy systems, 
respectively, at 297 K. These values are significantly higher than 1, as expected for 
sterically hindered complexes. The value of 3 found by this method was close to that 
obtained using a more direct method (0.097(9)) (see Chapter 2).  
Interestingly, comparing (Table 3.4) the pseudo first-order rate constant for the thermal 
substitution of H2O by Hmte, k’i, and the first-order rate constants k−i and kφi for the 
thermal and photochemical substitution of Hmte by H2O, respectively, highlights that 
with N-N=biq or N-N=dcbpy the values of kφi are one order of magnitude higher than 
that of k’i and k–i. By contrast, for N-N=dmbpy
 
kφ4 is one order of magnitude lower 
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than k–4 and k’4. Thus, by increasing too much the steric hindrance of the spectator 
diimine bidentate ligand (N-N=dmbpy), the thermal lability of Hmte increases to a 
point where the light-induced shifting of the thermal equilibrium between RuOH2 and 
RuHmte becomes difficult to realize. For such compounds shifting appreciably the 
equilibrium in favor of the aqua complex would require much higher light intensities. 
For N-N=biq and N-N=dcbpy low light intensities efficiently perturb the thermal 
equilibrium between RuOH2 and RuHmte. As shown in Figure AIII.10b and AIII.10c, 
during light irradiation the ratio [RuHmte]/[RuOH2] varies significantly: a steady state 
can be reached where Ru is mostly bound to H2O, whereas in the dark it is mostly 
bound to Hmte. Thus, moderately hindered compounds such as those with biq and 
dcbpy represent a better compromise between thermal and photochemical lability, and 
afford a light-sensitive Ru-S coordination bond in water. In contrast, the thermal 
reactivity of non-hindered (N-N=bpy) or too hindered (N-N=dmbpy) complexes is 
either too low, or too high, respectively. 
Table 3.4. Photochemical and thermal first-order rate constant values for a typical visible light 
irradiation experiment with interconversion between [Ru(terpy)(N-N)(H2O)]
2+ and [Ru(terpy)(N-
N)(Hmte)]2+ (N-N=biq, dcbpy, or dmbpy). Conditions: T= 297 K, solvent = MilliQ water (pH ~ 7). 
The photon flux  is indicated. 















































3.2.5.2. Reversibility of the light-induced equilibrium shift  
In Chapter 2 it was shown that the blue light-induced shifting of the equilibrium 
between RuOH2 and RuHmte in water for the N-N=dcbpy system could be repeated at 
least up to four cycles at room temperature.  Considering the similar kinetic properties 
of the N-N=biq system, these studies was repeated for [6]
2+
 using green light. The 




 in water was perturbed by light irradiation 
(λe=520 nm) for a period of 45 minutes, followed by a dark period of 90 minutes. This 
cycle was repeated four times, and the state of the system was monitored by UV-vis 
spectroscopy. The time evolution of the ratio [RuOH2]/[Ru]tot is shown in Figure 3.8. 
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, and no sign of degradation was observed after four 
cycles. The composition of the solution varies between 45% of [2]
2+
 in the dark and up 
to 85% of [2]
2+
 after irradiation in the steady state. These results show that the biq 





interconvert upon switching on and off a source of green light. Like for N-N=dcbpy, 
the Ru-S coordination bond forms spontaneously in the dark and is cleaved by visible 
light irradiation. 
 
Figure 3.8. Plot of the ratio [RuOH2]/[Ru]tot vs. time upon switching ON and OFF several times a 
source of green light (e=520 nm) in presence of [6]
2+ and [2]2+, and Hmte. Conditions:  T= 297 K, 
MilliQ water (pH ~ 7); photon flux Φ=9.8(5)10–9 Einstein.s−1; [Ru]tot =  8.610
–5 M , [Hmte] = 
0.011 M, spectra measured every 1 minute. 
3.3. Discussion 






 on the 
influence of steric hindrance on the photoreactivity of polypyridyl ruthenium(II) 
compounds it was realized in Chapter 2 that in the dark the Ru-S coordination bond of 
hindered complexes such as [Ru(terpy)(dcbpy)(Hmte)]
2+
 spontaneously forms at room 
temperature and in neutral aqueous solutions, while still keeping a very high sensitivity 
to visible light irradiation. As dark formation and photochemical breakage can both 
occur such systems open new possibilities for building supramolecular systems driven 
by visible light irradiation. However, the higher lability observed with the dcbpy 





, steric hindrance leads to efficient photosubstitution
[24]
 indeed, 
but also to a difficult thermal binding of the hindered chelate to the Ru center. The 
present study was undertaken to understand the relationship between thermal lability 
and steric hindrance for ruthenium complexes of the [Ru(terpy)(N-N)(Hmte)]
2+ 
 family, 
and to gather temperature-dependent kinetic data that had been overlooked in the past.  
First, it might be noticed that the substitutents in ortho position to the coordinated 
nitrogen atoms of N-N=biq, dcbpy, and dmbpy do not only increase the steric bulk of 
the coordination sphere around the metal, but they also exert on electronic effect on the 
metal center, which may in turn influence the rates of ligand substitutions. These 





, which lies at significant higher wavelength for N-N=biq (max=519 nm) 
than for N-N=bpy, dcbpy, or dmbpy (max=450, 467, and 463 nm, respectively). These 
electronic effects might play a role in fine-tuning the activation enthalpies and 
entropies of the thermal substitution reactions. However, one substituent of the 
bidentate chelate and the monodentate ligand coordinated to the metal center lie in very 
close spatial proximity, thus leading to significant distortion of the geometry in the 




 in Chapter 2 
and 3, respectively). Thus, in the following discussion the change in mechanism along 
the series bpy, biq, dcbpy, dmbpy is mostly interpreted as a consequence of the 
increasing steric demands of the spectator diimine chelate. 
Usually, the higher thermal lability for sterically hindered complexes is explained in 
terms of destabilization of the ground-state hexacoordinated species, compared to the 
transition state of the thermal substitution reaction. In such interpretation, the reaction 
always follows a dissociative interchange mechanism.
[63, 68-71]
 Applied to our system, 
this explanation should lead to enthalpy (ΔH
‡
i) being the main reason for the decreased 
activation Gibbs energies (ΔG
‡
i) when going from N-N=bpy to N-N=dmbpy. However, 
our data show that the increased lability of the hindered complexes in water is due to 
variations of the entropic term (ΔS
‡
i) in Eyring’s equation. Although ΔS
‡
i values are 
known to contain significant experimental errors and may be less accurate than, for 
example, activation volumes ΔV
‡
i, the similarities in ΔH
‡
i for the four systems and the 
clear differences in ΔS
‡
i, as seen in Figure 3.7, allow for drawing mechanistic 
conclusions.  Considering that for all four systems the rate law is first order in Hmte, it 
is concluded that there is a shift in the mechanism of the thermal substitution of H2O 
by Hmte, from interchange associative with N-N=bpy and biq, marked by ∆Si
‡
<0, to 
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shown in Scheme 3.3, H2O is still present in the coordination sphere when the Ru-S 
bond-making occurs, and in an interchange mechanism bond making occurs before the 
second coordination sphere has had time to relax. For less bulkier chelates (N-N=bpy, 
biq) the Ru-S bond-making is essentially synchronous with the Ru-O bond-breaking (Ia 
mechanism). Hydrogen bonding between Hmte and the aqua ligand may also 
contribute to stabilizing the hepta-coordinated transition state. Thus, a more compact 
transition state and more constraints for the unhindered chelates N-N=bpy and biq lead 
to negative values for the activation entropy, and thus to significantly (bpy) or slightly 
(biq) lower substitution rate constants. In contrast, for bulkier systems the Ru-S bond 
making only occurs when RuOH2 is already partially broken, but before H2O exits 
from the second coordination sphere (Id mechanism). Thus, there is no formation of a 
coordinatively unsaturated and potentially highly reactive pentacoordinated state, 
which would cancel the dependence of the substitution rate law in [Hmte]. The less 
compact transition state for N-N=dcbpy and dmbpy increases the degrees of freedom 
of both incoming and leaving monodentate ligands, thus resulting in positive activation 





Scheme 3.3.  The proposed transition states for the substitution of the aqua ligand in [Ru(terpy)(N-
N)(H2O)]
2+ by Hmte, where a) N-N=bpy, biq (more compact transition state with hydrogen-binding 
contributing to a loose hepta-coordinated transition state) and b) N-N=dcbpy,dmbpy (less compact 




The thermodynamic, kinetic, and photochemical properties of a series of polypyridyl 
ruthenium complexes [Ru(terpy)(N-N)(L)]
2+
 with N-N is bpy, biq, dcbpy, or dmbpy, 
and L is H2O or Hmte, have been determined in water near neutral pH. Our data 
provide a global understanding of the influence of the N-N chelate on the reactivity of 
these systems. Qualitatively, a global acceleration of all thermal and photochemical 
ligand exchange processes is observed when the steric hindrance of the spectator 
diimine chelate is increased. Variable-temperature kinetic data show that the increased 
lability of the monodentate ligand with hindered N-N chelates is due to entropy, and 
that the mechanism of the thermal ligand substitution reaction changes from 
interchange associative to interchange dissociative following the series N-N=bpy, biq, 
dcbpy, dmbpy. Analysis of the relative values of the rate constants for the thermal and 
photochemical ligand substitution reactions also shows that by increasing the steric 
hindrance too much (N-N = dmbpy) the lability in the dark becomes so high that no 
appreciable change of the composition of the solution can be obtained by light 
irradiation, unless exceptionally intense light would be used. With intermediate steric 
hindrance (N-N=biq or dcbpy) the Ru-S bond forms spontaneously in the dark at room 
temperature but it is efficiently cleaved under mild irradiation, which will allow using 
these systems in supramolecular chemistry. With the non-hindered ligand N-N=bpy, 
the photosensitivity of the Hmte complex is lower and the monodentate ligands (Hmte 
and H2O) are non-labile at room temperature. Overall, changing the N-N bidentate 




3.5. Experimental section  
3.5.1. Synthesis  
1H and 13C NMR spectra were recorded using a Bruker DPX-300 spectrometer; chemical 
shifts are indicated in ppm relative to TMS. Electrospray mass spectra were recorded on a 
Finnigan TSQ-quantum instrument using an electrospray ionization technique (ESI-MS). 
UV-vis spectra were obtained on a Perkin-Elmer Lambda 900 spectrophotometer or on a 
Varian Cary 50 UV-visible spectrometer. The classical routes for synthesizing 
[Ru(terpy)(biq)(Cl)]Cl ([10]Cl),[63] [Ru(terpy)(dmbpy)(Cl)]Cl ([12]Cl),[66] and 
[Ru(terpy)(dcbpy)(Cl)]Cl ([11]Cl),[66] were modified (see Appendix III, section AIII.1). 
[Ru(terpy)Cl3],
[87] 6,6’-dichloro-2,2’-bipyridine,[88] [Ru(terpy)(bpy)(Cl)]Cl ([9]Cl), 
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[Ru(terpy)(bpy)(H2O)](PF6)2 ([1](PF6)2), 
[32, 67] were synthesized following literature 
procedures. [Ru(terpy)(dcbpy)(Hmte)](PF6)2([7](PF6)2) was synthesized as explained in 
Chapter 2. 2,2';6',2"-terpyridine was purchased from ABCR GmbH & Co.KG. 2,2'-
bipyridine, 6,6’-dimethyl-2,2’-bipyridine, 2,2’-biquinoline, 2-(methylthio)-ethanol (Hmte), 
and AgPF6 were purchased from Sigma-Aldrich and used as such. 
 [Ru(terpy)(bpy)(Hmte)](PF6)2 ([5](PF6)2): [9]Cl (56 mg, 0.10 mmol) and AgPF6 (57 mg, 
0.22 mmol) were dissolved in 3:5 acetone/H2O mixture (16 mL). To this solution was 
added Hmte (90 μL, 1.0 mmol). The mixture was refluxed under argon for 8 hours in the 
absence of light, after which it was filtered hot over celite. Evaporation of the filtrate gave 
an orange solid, which was taken up in acetone and reprecipitated with Et2O. Filtration of 
the suspension yielded [5](PF6)2 as an orange powder (69 mg, 79%).
1H NMR (300 MHz, 
Acetone, 298 K) δ 9.95 (d, J = 5.6 Hz, 1H, A6), 9.03 – 8.87 (m, 3H, A3+T3’), 8.78 (d, J = 
8.1 Hz, 2H, T3), 8.72 (d, J = 8.2 Hz, 1H, B3), 8.59 – 8.42 (m, 2H, A4+T4’), 8.26 – 8.09 (m, 
3H, A5+T4), 8.09 – 7.94 (m, 3H, B4+T6), 7.63 – 7.47 (m, 3H, B6+T5), 7.31 (t, J = 6.6 Hz, 
B6, B5), 3.55 (t, J = 5.5 Hz, 2H, S-CH2-CH2), 2.03 – 1.97 (m, 2H, S-CH2), 1.53 (s, 3H, S-
Me). 13C NMR (75 MHz, Acetone, 297 K) δ 158.48+157.94+157.23+157.18 
(B2+A2+T2+T2’), 153.89 (T6), 152.61 (A6), 150.56 (B6), 139.34 (T4), 138.67+138.58 
(B4+A4), 137.42 (T4’), 129.03 (T5), 128.37 (A5), 127.71 (B5), 125.45 (T3), 125.16 (A3), 
124.76 (T3’), 124.30 (B4), 58.37 (S-CH2-CH2), 37.17 (S-CH2), 14.38 (S-Me). UV-vis: λmax 
(ε in L·mol-1·cm–1) in pure H2O: 450 nm (6600). ES MS m/z (calc): 728.0 (727.7 [M – 
PF6]
+), 582.1 (581.7 [M – 2 PF6 – H]
+), 261.5 (261.3 [M – 2PF6 – Hmte + MeOH]
2+). Anal. 
Calcd for C28H27F12N5OP2RuS: C, 38.54; H, 3.12; N, 8.03; S, 3.67. Found: C, 38.25; H, 
3.41; N, 7.94; S, 3.78. Crystal growing: Large single crystals of compound [5](PF6)2 were 
grown by vapor diffusion of toluene into a solution of [1](PF6)2 in Hmte (~10 mg in 0.5 mL 
mte). Crystal structure data: [C28H27N5ORuS](PF6)2; Fw = 872.62, red block, 0.45  0.25  
0.24 mm3, monoclinic, C2/c (no. 15), a = 24.06815(17), b = 10.86063(8), c = 24.69614(19) 
Å,  = 93.6407(7), V = 6442.43(8) Å3, Z = 8, Dx = 1.799 g cm
−3,  = 0.755 mm−1, abs. 
corr. range: 0.7690.867. 31610 Reflections were measured up to a resolution of (sin 
/)max = 0.65 Å
−1. 5673 Reflections were unique (Rint = 0.0367), of which 5375 were 
observed [I > 2(I)]. 511 Parameters were refined with 195 restraints. R1/wR2 [I > 2(I)]: 
0.0207/0.0517. R1/wR2 [all refl.]: 0.0226/0.0525. S = 1.051. Residual electron density 
found between −0.55 and 0.37 eÅ−3. 
[Ru(terpy)(biq)(Hmte)]Cl2 ([6]Cl2): [10]Cl (4.0 mg, 6.0 µmol) was dissolved in D2O (0.50 
mL). To this solution a large excess of Hmte (50 µL, 0.51 mmol) was added and stirred for 
5 minutes. The mixture was kept for 3 h at 80 C in a water bath. According to 1H NMR 
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and ES MS, [6]2+ is the only ruthenium species in solution. (For atom numbering see 
Figure AIII.1) 1H NMR (300 MHz, D2O, 298 K) δ 8.97 (dd, J = 19.4, 8.8 Hz, 2H, B3+B4), 
8.66 (d, J = 8.2 Hz, 4H, B8+T3’+A3), 8.47 (d, J = 8.0 Hz, 2H, T3), 8.43 – 8.33 (m, 3H, 
B5+A4+T4’), 8.14 – 7.92 (m, 6H, T4+B6+B7+T6), 7.85 (d, J = 7.4 Hz, 1H,A5), 7.55 – 
7.40 (m, 3H, T5+A6), 7.25 (t, J = 7.9 Hz, 1H,A7), 6.50 (d, J = 8.8 Hz, 1H,A8), 3.30 (t, J = 
7.1, 4.4 Hz, 2H,S-CH2-CH2), 1.54 (t, J = 5.8 Hz, 2H, S-CH2-CH2), 1.03 (s, 3H, CH3-S). 
13C 
NMR (75 MHz, D2O, 297 K) δ 159.83+159.80 (T2+T2’), 158.17+158.00 (A2+B2), 153.46 
(T6), 150.19+149.91 (A8a+B8a), 140.32+139.36 (B8+A8), 139.46 (T4), 137.94 (T4’), 
133.09 (B6+A6), 130.60+130.05 (A7+B7), 129.75+128.80 (B4a+ A4a), 129.64+129.04 
(A4+B4), 128.76 (T5), 126.92+123.06 (B5+A5), 125.03+124.34 (T3+T3’), 121.24+120.87 
(A3+B3), 57.32 (S-CH2-CH2), 46.78 (S-CH2-CH2), 8.48 (CH3-S). UV-vis: λmax (ε in L·mol
–
1·cm–1) in pure H2O: 519 nm (5600). ES MS m/z (calc): 682.0 (682.1 [M–2Cl–H]
+), 295.5 
(295.3 [M–2Cl–Hmte]2+).   
[Ru(terpy)(dmbpy)(Hmte)]Cl2 ([8]Cl2): [12]Cl (4.0 mg, 6.8 µmol) was dissolved in D2O 
(0.50 mL). To this solution a large excess of Hmte (24 µL, 0.28 mmol) was added. The 
mixture was stirred for 5 minutes. The compound was not isolated as it would react back to 
[12]Cl upon evaporation of water. According to 1H-NMR and MS [8]2+ is the the only 
ruthenium species present in solution. (For atom notations see Figure AIII.1) 1H NMR (300 
MHz, D2O, 298 K) δ 8.57 (d, J = 8.2 Hz, 2H, T3’), 8.45 (d, J = 8.0 Hz, 3H, B3+T3), 8.26 
(t, J = 8.1 Hz, 1H, T4’), 8.21 – 8.01 (m, 6H, B4+A3+T4+T6), 7.81 (d, J = 7.6 Hz, 1H, B5), 
7.61 (t, J = 7.9 Hz, 1H, A4), 7.55 – 7.46 (m, 2H, T5), 6.88 (d, J = 7.6 Hz, 1H, A5), 3.26 (t, 
J = 5.7 Hz, 2H, S-CH2-CH2), 3.09 (s, 3H, H7), 1.39 (t, J = 5.6 Hz, 2H, S-CH2), 1.27 (s, 3H, 
H7’), 0.87 (s, 3H, S-Me). 13C NMR (300 MHz, D2O) δ 165.61+164.45 (B6+A6), 
158.94+158.38 (T2+T2’), 158.12+158.06 (B2+A2), 153.82 (T6), 138.99 (T4), 138.33 (A4), 
138.15 (B4), 136.95 (T4’), 128.58 (T5), 127.76 (A5), 127.32 (B5), 124.61 (T3), 123.77 
(T3’), 121.80 (A3), 121.38 (B3), 56.46 (HO-CH2-), 34.71 (Me-S-CH2-), 26.86 (A7), 22.00 
(B7), 11.70 (Me-S). UV-vis: λmax (ε in L·mol
–1·cm–1) in pure H2O: 463 nm (5700). ES MS 
m/z (calc): 610.1 (609.8 [M – 2Cl – H]+), 305.6 (305.3 [M – 2 Cl]2+). 
General procedure for the hydrolysis in CD3OD of  [Ru(terpy)(N-N)(Cl)]Cl ([10]Cl, 
[11]Cl, or [12]Cl, N-N=biq, dcbpy, or dmbpy) : Three NMR samples of compound [10]Cl 
(2.2 mg, 3.310–3 mmol), [11]Cl (2.8 mg, 4.810–3 mmol), or [12]Cl (2.9 mg, 4.610–3 
mmol) were dissolved in MeOD (500 μL). An 1H NMR spectrum was recorded for each 
sample. Then, 20 μL, 40 μL, 80 μL, and 160 μL of D2O were added successively to each 
NMR tube, and 1H NMR spectra were recorded after each addition (see Figure AIII.3). 
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3.5.2. Equilibrium constant determination  
(a) For N-N=biq (Hmte+[2]Cl2  H2O+[6]Cl2): A stock solution A of [10]Cl (17 mg in 5.0 
mL D2O, 5.1 mM) and a stock solution B of Hmte (92 mg Hmte in 2.0 mL D2O, 0.50 M) 
were prepared. Eight NMR tubes containing 0.50 mL of solution A (2.5 μmol [10]Cl) were 
prepared, and to each tube was added 2.5 μL, 5.0 μL, 8.0 μL, 10 μL, 15 μL, 26 μL, 34 μL, 
or 35 μL solution B, resulting in 0.50, 1.0, 1.6, 2.0, 3.0, 5.2, 6.8 or 7.0 equivalents  of Hmte, 
respectively. The NMR tubes were put in a water bath for 30 minutes at 50 °C and left 
standing overnight at room temperature. After equilibration, 1H NMR spectra of all samples 
were measured at room temperature, to determine the relative integral of [6]2+ and [2]2+. 
Then the ratio [RuHmte]/[RuOH2] were determined by integration of the peaks at 6.35 and 
6.75 ppm corresponding to [6]2+ and [2]2+,  respectively, where [RuHmte] represents the 
concentration in [6]2+ and [RuOH2] the concentration in [2]
2+. A plot of [RuHmte]/[RuOH2] 
as a function of equilibrium concentration in Hmte was made. The slope of the plot 
numerically corresponds to K2 (see Figure 3.4 and Equation 3.1). 
(b) For N-N=dmbpy (Hmte+[4]Cl2  H2O+[8]Cl2): A stock solution C of [12]Cl (40 mg in 
5.0 mL D2O, 13 mM) was prepared. NMR samples, each containing 0.50 mL of stock 
solution C (6.4 μmol [12]Cl) were prepared. To each NMR tube was added a known 
amount of pure Hmte (0.60 μL, 1.2 μL, 1.8 μL, 2.4 μL, 3.0 μL, 4.5 μL or 6.0 μL) to give 
1.0, 2.0, 3.0, 4.0, 5.0, 7.5, 10 or 20 equivalents, respectively. Each NMR tube was stirred 
for 5 minutes and then left to stand for more than 10 minutes at room temperature. After 
equilibration, 1H NMR spectra of all samples were measured at room temperature. The ratio 
[RuHmte]/[RuOH2] were determined by integration of the peaks at 6.86 and 6.78 ppm, 
where [RuHmte] represents the concentration in [8]2+ (= 6.86 ppm) and [RuOH2] the 
concentration in [4]2+ (=6.78 ppm). A plot of [RuHmte]/[RuOH2] as a function of 
equilibrium concentration in Hmte was made. The slope of the plot numerically 
corresponds to K4 (see Figure 3.4 and Equation 3.1). 
The values for Gibbs free energy ΔGi at 297 were calculated for both reactions using the 
equation ΔGi=R·T·ln(Ki) 
3.5.3. Kinetics  
A Perkin-Elmer Lambda 900 UV-vis spectrometer equipped with stirring and temperature 
control was used for kinetic experiments. The measurement procedure of the extinction 
coefficients of all aqua and Hmte complexes used in the kinetic study is described in the 
Appendix I, section AI.1. The experimental procedure for calculation of the rate constants 
at 297 K from the slope of a plot of k’i vs. [Hmte] is explained in the section AIII.7.  
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Stock solutions D of complex [1](PF6)2 (2.0 mg in 25 mL H2O, 1.010
–4 M), E of [10]Cl 
(1.6 mg in 25 mL H2O, 1.010
–4 M), F of [11]Cl (3.7 mg in 25 mL H2O, 2.110
–4 M), G of 
[12]Cl (3.5 mg in 25 mL H2O, 2.210
–4 M), and H and I of Hmte (460 mg in 25.0 mL H2O, 
2.0010–1 M (H), and 438 mg in 10.0 mL H2O, 4.7010
–1 M (I)) were prepared. 2.0 mL of 
D, E, F, or G was added to a UV-vis cuvette, which was placed in the UV-vis spectrometer. 
The temperature was set at 50, 60, 70 or 80 °C for D, 24, 28, 35, 42, or 50 °C for E, and 10, 
15, 20, 24 or 28 °C for F and G. After obtaining a constant temperature in each cuvette, 1.0 
mL of H was added to D and E, or 1 mL of I to F, or 0.8 mL H2O plus 0.2 mL of I to G, 
for each experiment at each temperature (final Hmte and Ru concentrations for each 
experiments are given in Tables AIII.1 and AIII.2) In such conditions, Hmte is in large 
excess (pseudo first-order condition). After addition of Hmte, a UV-vis spectrum was taken 
every 60 seconds for D and every 30 seconds for E, F, or G. For each spectrum, the 
concentrations in RuHmte and RuOH2 were determined by deconvolution of the UV-vis 
spectra knowing the extinction coefficients of both RuHmte and RuOH2 species (see 
Appendix I). The pseudo first order rate constants k’i at each temperature for each sample 
D, E, F, or G were determined from the slope of the  plot of ln([RuOH2]/[Ru]tot) vs. time, 
and ki were then calculated knowing the concentration of Hmte in the solution (see Tables 
AIII.1 and AIII.2). By plotting ln(ki/T) as a function of 1/T for each sample, the activation 
enthalpy and entropy were calculated from the slope and y-intercept of the Eyring plot, 
respectively. ΔGi




‡ (see Table 3.3). 
Thermal substitution of Hmte by H2O in [5]
2+
 (k–1). 3 mL of a solution of [5]
2+ (5.6 mg 
of [5](PF6)2  in 25 mL H2O, 2.510
–4 M) was placed in a UV-vis cuvette, which was placed 
at t=0 in the UV-vis spectrometer pre-equilibrated at 70, 75, 80, 85, or 90 °C. UV-vis 
spectra were measured every 60 seconds. The concentrations in [RuHmte] and [RuOH2] 
were determined by deconvolution of the UV-vis spectra knowing the extinction 
coefficients of both RuHmte and RuOH2 species (see Appendix I, Section AI.1). The first-
order rate constant k–1 at each temperature was determined by plotting ln([RuOH2]/[Ru]tot) 
vs. time. The slope and y-intercept of an Eyring plot afforded the activation enthalpy and 
entropy, respectively (see Figure AIII.8). k–1 at 24 C was extracted from extrapolating the 
Eyring Equation down to room temperature; a value of  1.5(4)  10–8 s–1  was found. 






 (k–2, k–3, k–4). At the 
thermodynamic equilibrium between RuOH2, free Hmte, and RuHmte in water, the rates for 
the formation and hydrolysis of RuHmte complex are equal: 
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Thus the first order rate constant k–i for the thermal substitution of Hmte by water is 
numerically given by Equation 3.6. The activation Gibbs energy ΔG‡–i for the thermal 




i– ΔG°i (see 
Table 3.3). 
3.5.4. Photochemistry 
The photochemical quantum yield for [5]2+ was measured using a Varian Cary 50 UV-
visible spectrometer and  a LOT 1000 W Xenon arc lamp, fitted with a water filter and a 
450FS10-50 Andover interference filter (λe=452 nm, Δ1/2=8.9 nm). Irradiation was thus 
performed close to the isosbestic point of the reaction, which was at 449 nm. The 
photochemistry measurements for [6]2+, [7]2+, and  [8]2+ were done using a Perkin-Elmer 
Lambda 900 spectrometer equipped with a custom-made LED lamp fitted to the top of a 1 
cm quartz UV-vis cuvette, using an OSRAM Opto electronics LEDs LB W5KM-EZGY-35 
(λe=465 nm or λe=520 nm, Δ1/2=25 nm). In these cases, UV-vis measurements of a sample 
during irradiation was superimposable with a spectrum of the sample when the LED lamp 
was switched off, which means that the light used to irradiate the sample perpendicularly to 
the optical axis of the spectrophotometer was not detected by the spectrometer.  Photon 
fluxes of the three irradiation setups were measured using the ferrioxalate actinometer; [89] a 
value  = 6.4(6)10–8  Einstein·s–1 was measured at 452 nm for the filtered LOT lamp;  = 
3.9(4)10–9  Einstein·s–1 was found for the LED at 465 nm, and  = 9.8(8)10–10 
Einstein·s–1 was found for the LED at 520 nm. In the latter two cases, the irradiation path 
length was 3 cm, and the volume of the irradiated solution was 3 mL. 
Photosubstitution quantum yield determination for complex [5]
2+ 
(1). 0.75 mL of a 
stock solution of the complex [5](PF6)2 (5.0 mg in 10 mL H2O, 5.710
–4 M) was put in a 
UV-vis cuvette. The volume of the solution was completed to 3 mL with H2O (Final 
concentration: 1.5 10–4 M). The sample was irradiated using the same setup as was used 
for actinometry ( = 6.4(6)10–9 Einstein·s–1). After each irradiation period (1 minute) a 
UV-vis spectrum was measured until a total irradiation time of 10 minutes. The 
concentrations in [5]2+ and [1]2+ were determined by deconvolution knowing the extinction 
coefficients of both species (see Appendix I, section AI.2). The evolution of 
ln([RuHmte]/[Ru]tot) was plotted as a function of irradiation time, and from the slope S of 




Irradiation of an equilibrated sample of the biq system ([2]Cl2[6]Cl2) and 
photosubstitution quantum yield determination for [6]2+ (2). A UV-vis cuvette 
containing 2 mL of a stock solution of [10]Cl (1.5 mg in 10 mL H2O, 2.3  10
–4 M) and 1 
mL of a solution of Hmte (31 mg in 10 mL H2O, 0.030 M)  was prepared and stirred 
overnight to reach equilibrium at 24 C. Then, UV-vis spectra were measured, once in the 
dark, and then during 45 minutes under irradiation using LED lamp at λe= 520 nm. After 45 
minutes the LED lamp was switched off, and UV-vis spectra were measured for 90 minutes 
in the dark (1 minute interval between each spectrum, either under irradiation or in the 
dark). The cycle was repeated 3 more times for a total experimental time of 9 hours (see 
Figure 3.8). For each spectrum [RuHmte] and [RuOH2], i.e., the concentration in [6]
2+ and 
[2]2+, respectively, were determined by deconvolution, knowing the extinction coefficients 
of both species. By calculating the ratio [RuHmte]/[RuOH2] at the equilibrium in the dark 
(Equation 3.8a) and at the photochemical steady state (Equation 3.8b), reporting the second 
order rate constant k2 and the photon flux Ф, the quantum yield 2 was calculated using 
Equations 3.9, to be 0.12(5) (see Table AIII.4 for all numerical values). 
Determination of the photosubstitution quantum yield for [8]2+ (4). 2.0 mL of a stock 
solution of [8]Cl (7.0 mg in 50 mL H2O, 2.210
–4 M) was put in a  UV-vis cuvette and 1 
mL of a solution of Hmte  (277 mg in 5.00 mL H2O, 0.600 M) was added. After 
equilibration at 24 C in the dark, UV-vis spectra of the sample were measured in the dark 
and then 10 times during 10 minutes irradiation with an LED lamp at λe= 465 nm to 
calculate 4 in the same procedure as that for [6]
2+. A value of 0.30(10) was found for 4 
(see Table AIII.4). 
3.5.5. Supporting Information available 
Appendix I: general procedures for extinction coefficient determination, calculation 
concentration of RuHmte and RuOH2 from by deconvolution of the UV-vis data, and 
photosubstitution quantum yield measurements for [1]2+.   
Appendix III: The synthesis of [10]Cl, [12]Cl, proton attribution schemes, NMR spectra of 
[4]2+ and [8]2+ in D2O, procedure for X-ray crystal structure determination, NMR spectra of 
hydrolyzing of [10]Cl and [11]Cl, pKa measurements for [2]2+ and [4]2+, mathematical 
modeling of the fast equilibrium between [4]2+ and [8]2+, numerical values of first-order and 
second-order rate constant for all four systems, determination of the rate law (order of 
Hmte) of the thermal coordination reaction for N-N=bpy, biq, and dmbpy, Eyring plot for 
the thermal hydrolysis of [5]2+, photosubstitution quantum yield measurements for [2]2+, 
[3]2+, and [4]2+.  




[1] A. D. Ryabov, L. G. Kuzmina, N. V. Dvortsova, D. J. Stufkens, R. Van Eldik, Inorg. 
Chem. 1993, 32, 3166-3174. 
[2] H. Nishihara, Coord. Chem. Rev. 2005, 249, 1468-1475. 
[3] O. S. Wenger, L. M. Henling, M. W. Day, J. R. Winkler, H. B. Gray, Polyhedron 
2004, 23, 2955-2958. 
[4] M. Han, T. Hirade, M. Hara, New J. Chem. 2010, 34, 2887-2891. 
[5] P. Pratihar, T. K. Mondal, A. K. Patra, C. Sinha, Inorg. Chem. 2009, 48, 2760-2769. 
[6] T. Mitsuoka, H. Sato, J. Yoshida, A. Yamagishi, Y. Einaga, Chem. Mater. 2006, 18, 
3442-3447. 
[7] R. A. Kopelman, S. M. Snyder, N. L. Frank, J. Am. Chem. Soc. 2003, 125, 13684-
13685. 
[8] A. Bannwarth, S. O. Schmidt, G. Peters, F. D. Sönnichsen, W. Thimm, R. Herges, F. 
Tuczek, Eur. J. Inorg. Chem. 2012, 2012, 2776-2783. 
[9] K. Takahashi, Y. Hasegawa, R. Sakamoto, M. Nishikawa, S. Kume, E. Nishibori, H. 
Nishihara, Inorg. Chem. 2012, 51, 5188-5198. 
[10] M. D. Segarra-Maset, P. W. N. M. van Leeuwen, Z. Freixa, Eur. J. Inorg. Chem. 2010, 
2075-2078. 
[11] M. L. Boillot, J. Zarembowitch, A. Sour, Top. Curr. Chem. 2004, 234, 261-276. 
[12] D. A. Lutterman, A. A. Rachford, J. J. Rack, C. Turro, J. Phys. Chem. Lett. 2010, 1, 
3371-3375. 
[13] A. A. Rachford, J. L. Petersen, J. J. Rack, Inorg. Chem. 2006, 45, 5953-5960. 
[14] J. J. Rack, J. R. Winkler, H. B. Gray, J. Am. Chem. Soc. 2001, 123, 2432-2433. 
[15] J. P. Sauvage, Chem. Commun. 2005, 1507-1510. 
[16] V. Balzani, M. Clemente-Leon, A. Credi, B. Ferrer, M. Venturi, A. H. Flood, J. F. 
Stoddart, Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 1178-1183. 
[17] U. C. Agrawal, H. L. Nigam, J. Indian Chem. Soc. 2008, 85, 677-690. 
[18] S. Campagna, F. Puntoriero, F. Nastasi, G. Bergamini, V. Balzani, Photochemistry and 
Photophysics of Coordination Compounds I 2007, 280, 117-214. 
[19] V. Balzani, A. Credi, M. Venturi, Chem. Soc. Rev. 2009, 38, 1542-1550. 
[20] S. Bonnet, J. P. Collin, M. Koizumi, P. Mobian, J. P. Sauvage, Adv. Mater. 2006, 18, 
1239-1250. 
[21] S. Bonnet, J.-P. Collin, Chem. Soc. Rev. 2008, 37, 1207-1217. 
[22] J. P. Collin, V. Heitz, S. Bonnet, J. P. Sauvage, Inorg. Chem. Commun. 2005, 8, 1063-
1074. 
[23] P. Mobian, J. M. Kern, J. P. Sauvage, Angew. Chem. Int. Ed. 2004, 43, 2392-2395. 
[24] A. C. Laemmel, J. P. Collin, J. P. Sauvage, Eur. J. Inorg. Chem. 1999, 383-386. 
[25] P. J. Bednarski, F. S. Mackay, P. J. Sadler, Anti-Cancer Agents Med. Chem. 2007, 7, 
75-93. 
[26] N. J. Farrer, L. Salassa, P. J. Sadler, Dalton Trans. 2009, 10690-10701. 
[27] B. S. Howerton, D. K. Heidary, E. C. Glazer, J. Am. Chem. Soc. 2012, 134, 8324-8327. 
[28] E. Wachter, D. K. Heidary, B. S. Howerton, S. Parkin, E. C. Glazer, Chem. Commun. 
2012, 48, 9649. 
[29] M. Indelli, C. Chiorboli, Top. Curr. Chem. 2007, 280, 215-255. 
[30] R. E. Mahnken, M. A. Billadeau, E. P. Nikonowicz, H. Morrison, J. Am. Chem. Soc. 
1992, 114, 9253-9265. 
Chapter 3 
98  
[31] U. Schatzschneider, J. Niesel, I. Ott, R. Gust, H. Alborzinia, S. Woelfl, 
ChemMedChem 2008, 3, 1104-1109. 
[32] R. E. Goldbach, I. Rodriguez-Garcia, J. H. van Lenthe, M. A. Siegler, S. Bonnet, 
Chem. Eur. J. 2011, 17, 9924-9929. 
[33] C. Moucheron, A. KirschDeMesmaeker, J. Kelly, J. Photochem. 1997, 40, 91-106. 
[34] S. L. H. Higgins, K. J. Brewer, Angew. Chem., Int. Ed. Engl. 2012, 51, 2-5. 
[35] R. N. Garner, J. C. Gallucci, K. R. Dunbar, C. Turro, Inorg. Chem. 2011, 50, 9213-
9215. 
[36] A. G. De Candia, J. P. Marcolongo, R. Etchenique, L. D. Slep, Inorg. Chem. 2010, 
100625124914047. 
[37] L. Zayat, C. Calero, P. Albores, L. Baraldo, R. Etchenique, J. Am. Chem. Soc. 2003, 
125, 882-883. 
[38] N. L. Fry, P. K. Mascharak, Acc. Chem. Res. 2011, 44, 289-298. 
[39] M. J. Rose, P. K. Mascharak, Coord. Chem. Rev. 2008. 
[40]  . Barrag n, P. L pez-Sen n, L. Salassa, S. Betanzos-Lara, A. Habtemariam,  . 
Moreno, P. J. Sadler,  . March n, J. Am. Chem. Soc. 2011. 
[41] L. Salassa, C. Garino, G. Salassa, R. Gobetto, C. Nervi, J. Am. Chem. Soc. 2008, 130, 
9590-9597. 
[42] B. S. Howerton, D. K. Heidary, E. C. Glazer, J. Am. Chem. Soc. 2012, 134, 8324-8327. 
[43] T. Respondek, R. N. Garner, M. K. Herroon, I. Podgorski, C. Turro, J. J. Kodanko, J. 
Am. Chem. Soc. 2011, 133, 17164-17167. 
[44] D. A. Lutterman, P. K. L. Fu, C. Turro, J. Am. Chem. Soc. 2006, 128, 738-739. 
[45] V. Balzani, G. Bergamini, S. Campagna, F. Puntoriero, Top. Curr. Chem. 2007, 280, 1-
36. 
[46] J. P. Paris, W. W. Brandt, J. Am. Chem. Soc. 1959, 81, 5001-5002. 
[47] C. P. Anderson, D. J. Salmon, T. J. Meyer, R. C. Young, J. Am. Chem. Soc. 1977, 99, 
1980-1982. 
[48] J. Van Houten, R. J. Watts, J. Am. Chem. Soc. 1976, 98, 4853-4858. 
[49] B. Durham, J. V. Caspar, J. K. Nagle, T. J. Meyer, J. Am. Chem. Soc. 1982, 104, 4803-
4810. 
[50] C. R. Hecker, P. E. Fanwick, D. R. McMillin, Inorg. Chem. 1991, 30, 659-666. 
[51] E. Baranoff, J. P. Collin, Y. Furusho, A. C. Laemmel, J. P. Sauvage, Chem. Commun. 
2000, 1935-1936. 
[52] B. Durham, J. L. Walsh, C. L. Carter, T. J. Meyer, Inorg. Chem. 1980, 19, 860-865. 
[53] S. Bonnet, J. P. Collin, N. Gruber, J. P. Sauvage, E. R. Schofield, Dalton Trans. 2003, 
4654-4662. 
[54] P. R. Ashton, R. Ballardini, V. Balzani, A. Credi, K. R. Dress, E. Ishow, C. J. 
Kleverlaan, O. Kocian, J. A. Preece, N. Spencer, J. F. Stoddart, M. Venturi, S. Wenger, 
Chem. Eur. J. 2000, 6, 3558-3574. 
[55] P. R. Ashton, R. Ballardini, V. Balzani, E. C. Constable, A. Credi, O. Kocian, S. J. 
Langford, J. A. Preece, L. Prodi, E. R. Schofield, N. Spencer, J. F. Stoddart, S. 
Wenger, Chem. Eur. J. 1998, 4, 2413-2422. 
[56] E. Baranoff, J. P. Collin, J. Furusho, Y. Furusho, A. C. Laemmel, J. P. Sauvage, Inorg. 
Chem. 2002, 41, 1215-1222. 
[57] P. Mobian, J. M. Kern, J. P. Sauvage, J. Am. Chem. Soc. 2003, 125, 2016-2017. 
[58] T. D. Nguyen, K. C. F. Leung, M. Liong, Y. Liu, J. F. Stoddart, J. I. Zink, Adv. Funct. 
Mater. 2007, 17, 2101-2110. 
[59] J. P. Collin, D. Jouvenot, M. Koizumi, J. P. Sauvage, Inorg. Chem. 2005, 44, 4693-
4698. 
[60] S. Bonnet, J. P. Collin, P. Sauvage, Inorg. Chem. 2006, 45, 4024-4034. 
Photochemistry, thermodynamic, and kinetics of a Ru-S bond in water 
99 
[61] T. Gianferrara, A. Bergamo, I. Bratsos, B. Milani, C. Spagnul, G. Sava, E. Alessio, J. 
Med. Chem. 2010, 53, 4678-4690. 
[62] S. Bonnet, J. P. Collin, J. P. Sauvage, E. Schofield, Inorg. Chem. 2004, 43, 8346-8354. 
[63] C. A. Bessel, J. A. Margarucci, J. H. Acquaye, R. S. Rubino, J. Crandall, A. J. 
Jircitano, K. J. Takeuchi, Inorg. Chem. 1993, 32, 5779-5784. 
[64] R. A. Leising, J. S. Ohman, K. J. Takeuchi, Inorg. Chem. 1988, 27, 3804-3809. 
[65] D. J. Wasylenko, C. Ganesamoorthy, B. D. Koivisto, M. A. Henderson, C. P. 
Berlinguette, Inorg. Chem. 2010, 49, 2202-2209. 
[66] C. M. Che, C. Ho, T. C. Lau, J.Chem.Soc.,Dalton Trans. 1991, 1901-1907. 
[67] K. J. Takeuchi, M. S. Thompson, D. W. Pipes, T. J. Meyer, Inorg. Chem. 1984, 23, 
1845-1851. 
[68] T. W. Swaddle, Coord. Chem. Rev. 1974, 14, 217-268. 
[69] B. Mahanti, G. S. De, Transition Met. Chem. 1994, 19, 201-204. 
[70] N. Aebischer, G. Laurenczy, A. Ludi, A. E. Merbach, Inorg. Chem. 1993, 32, 2810-
2814. 
[71] N. Aebischer, R. Churlaud, L. Dolci, U. Frey, A. E. Merbach, Inorg. Chem. 1998, 37, 
5915-5924. 
[72] F. P. Rotzinger, J. Phys. Chem. A 2000, 104, 8787-8795. 
[73] K. A. Bunten, D. H. Farrar, A. J. Poe, A. J. Lough, Organometallics 2000, 19, 3674-
3682. 
[74] A. Czap, F. W. Heinemann, R. van Eldik, Inorg. Chem. 2004, 43, 7832-7843. 
[75] M. P. Gamasa, J. Gimeno, C. GonzalezBernardo, B. M. MartinVaca, D. Monti, M. 
Bassetti, Organometallics 1996, 15, 302-308. 
[76] T. Kojima, T. Morimoto, T. Sakamoto, S. Miyazaki, S. Fukuzumi, Chem. Eur. J. 2008, 
14, 8904-8915. 
[77] A. Rilak, B. Petrovic, S. Grguric-Sipka, Z. Tesic, Z. D. Bugarcic, Polyhedron 2011, 
30, 2339-2344. 
[78] A. M. Goswami, K. De, Transition Met. Chem. 2007, 32, 419-424. 
[79] M. M. Shoukry, M. R. Shehata, M. S. A. Hamza, R. van Eldik, Dalton Trans. 2005, 
3921-3926. 
[80] R. M. Naik, R. Singh, A. Asthana, Int. J. Chem. Kinet. 2011, 43, 21-30. 
[81] V. Thiel, M. Hendann, K.-J. Wannowius, H. Plenio, J. Am. Chem. Soc. 2012, 134, 
1104-1114. 
[82] R. G. Wilkins, in Kinetics and Mechanism of Reactions of Transition Metal 
Complexes, 2nd ed., Wiley-VCH, Weinheim, 1991, pp. 199-256. 
[83] C. H. Langford, W. R. Muir, J. Am. Chem. Soc. 1967, 89, 3141-3144. 
[84] A. Mukherjee, K. De, Transition Met. Chem. 2005, 30, 677-683. 
[85] R. Krishnan, R. H. Schultz, Organometallics 2001, 20, 3314-3322. 
[86] F. Wang, H. M. Chen, S. Parsons, L. D. H. Oswald, J. E. Davidson, P. J. Sadler, Chem. 
Eur. J. 2003, 9, 5810-5820. 
[87] R. A. Leising, S. A. Kubow, M. R. Churchill, L. A. Buttrey, J. W. Ziller, K. J. 
Takeuchi, Inorg. Chem. 1990, 29, 1306-1312. 
[88] E. C. Constable, K. R. Seddon, Tetrahedron 1983, 39, 291-295. 
[89] J. G. P. Calvert, J. N., Chemical actinometer for the determination of ultraviolet light 










This Chapter has been submitted as a paper; 
Bahreman A.; Rabe M.; Kros A.; Bruylants G.; Bonnet S.; submitted for publication. 
Binding of a ruthenium complex to a thioether 
ligand embedded in a negatively charged lipid 
bilayer: 








The interactions between the ruthenium polypyridyl complex [Ru(terpy)(dcbpy)(H2O)]
2+ 
(terpy=2,2’;6’,2”-terpyridine, dcbpy=6,6’-dichloro-2,2’-bipyridine) and phospholipid 
membranes containing either neutral thioether ligands or cholesterol were investigated 
using UV-visible spectroscopy, Langmuir-Blodgett monolayer surface pressure 
measurements, and Isothermal Titration Calorimety (ITC). The first technique shows that 
when embedded in a membrane a thioether ligand coordinates to the ruthenium complex 
only with negatively charged phospholipids, i.e., in presence of attractive electrostatic 
interaction between the dicationic ruthenium center and the negatively charged 
phospholipid head groups. Lipid monolayer surface pressure and ITC measurements 
revealed that initial adsorption of the ruthenium aqua complex to the surface of negatively 
charged DMPG monolayers and bilayers is faster than coordination of the sulfur ligand to 
the metal. Unexpectedly this adsorption phenomenon is endothermic, thus entropy driven, 
and must result from dehydration of the ruthenium cations and phospholipid head groups. 
In the presence of thioether ligands, initial adsorption to the membrane is followed by two-
dimensional diffusion ultimately leading to the formation of the Ru-S coordination bond. 
This two-step reaction is faster than the coordination of neutral thioether ligands to the 
same complex in homogeneous aqueous solutions. When an uncharged lipid bilayer is used, 
adsorption of the complex to the membrane is negligible and the coordination reaction does 
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4.1. Introduction  
Transition metal complexes, and in particular those involving second- and third-row 
metals like platinum, ruthenium, or gold, have been extensively studied as anticancer 
agents.
[1]
 To explain their cytotoxicity, direct coordination of the metal complexes to 




 has been proposed. 
Next to coordination, non-covalent interactions such as electrostatic force or/and 
intercalation may also play a role.
[5]
 However, interpreting the mode of action of 
metallodrugs is often considered to be a challenge,
[6]
 as cellular environments contain a 
striking diversity of ligands that may bind to metal complexes, such as proteins, 
enzymes, saccharides, or plasma membrane lipids. On the one hand, interactions of 
metallodrugs with non-targeted ligands may be the cause of drug resistance or non-
selective toxicity. Phospholipids, in particular, have been reported as possible targets 
for platinum-based drugs,
[7]
 whereas membrane proteins, which are formally ligands 
embedded in lipid bilayers, often govern influxes and effluxes of metal-based 
anticancer compounds. 
[4, 8-9]
 On the other hand, the metal-lipid affinity may be used as 
a tool to carry metallodrugs to its target using liposomes.
[10-12]
 In this context, 
investigating the interactions of metal complexes with phospholipids or ligands 
embedded in lipid bilayers is crucial for understanding and controlling the therapeutic 
action of inorganic compounds. 
The electrostatic interaction between phospholipids and metal cations, in particular 




, have been extensively investigated.
[13-
25]
 However, to date very few studies report on the interaction of transition metal 
complexes with phospholipid membranes.
[7, 26-32]
 Despite the growing number of 
ruthenium-based anticancer compounds their interaction with phospholipid membranes 
remains essentially unexplored, with the exception of a study on the adsorption of the 
highly charged  ruthenium red cations on phospholipid bilayers.
[33]
 In all published 
studies, the role of electrostatic interaction between metal cations and negative 
phospholipids is only investigated from a thermodynamic point of view, and kinetics 
has been mostly ignored. 
On our way to building artificial molecular machines based on polypyridyl ruthenium 
complexes
[34]
 the reversible binding and light-induced unbinding of the ruthenium aqua 
complex [Ru(terpy)(dcbpy)(H2O)]
2+
 (terpy:2,2’;6’,2”-terpyridine, dcbpy: 6,6’-dichloro-
2,2’-bipyridine) to thioether ligands embedded in negatively charged phospholipid 
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bilayers was demonstrated in Chapter 2 (Figure 4.1). In these studies, it was observed 
that whereas coordination of neutral thioether ligands to ruthenium aqua complexes 
occurred in homogenous aqueous solution, incorporating the thioether ligand in a lipid 
bilayer had strong influence on the coordination reaction, which becomes highly 
dependent on the charge of the membrane. Centrifugation experiments showed that 
positively charged ruthenium aqua complexes interact significantly with negatively 




In the present Chapter UV-vis spectroscopy, Langmuir-Blodgett monolayer surface 
pressure measurements, and calorimetric methods were used to investigate the time 
scale and thermodynamics of the adsorption of the ruthenium complex to the lipid 
membranes, and to see whether adsorption and coordination of the membrane-
embedded ligands to the metal occur simultaneously or sequentially. A two-step 
mechanism for the binding of ruthenium complexes to membrane-embedded thioether 
ligands is proposed. 
 
Figure 4.1. Cartoon representing the thermal binding of the ruthenium aqua complex [2]2+ to a 
DMPG (1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt)) lipid bilayer 
containing ligand 1, to give the thioether complex [3]2+. Not all sodium cations are shown for clarity.  
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4.2. Results  
4.2.1. UV-vis experiments 
UV-vis experiments were performed in order to check the influence of the electrostatic 
interaction between liposomes and ruthenium complexes on the rate of the coordination 
reaction at the membrane surface. The kinetics of the coordination of thioether-
cholesterol ligand 1 inserted in negatively charged DMPG (DMPG=1,2-dimyristoyl-sn-





) was investigated in buffer solutions with 
different ionic strengths at 298 K and in the dark (Figure 4.1). Liposomes decorated 
with 25 mol% ligand 1 with diameter of 140 nm were prepared as characterized by 
dynamic light scattering (DLS). After addition of 5 mol% of the aqua ruthenium 
complex [2]
2+
 the UV-vis spectrum of the liposome solution gradually evolved and an 
equilibrium was obtained after several hours. The liposomes were stable during the 
reaction and did not show any sign of aggregation or fusion at the end of the reaction as 
confirmed by DLS. The absorbance at 500 nm decreased exponentially over time (see 
Figure 4.2b-I, for I=50 mM), which allowed for determining the half reaction time (t1/2) 
for the coordination reaction. The plot of t1/2 vs. the ionic strength I of the buffer 
solution is shown in Figure 4.2a. As expected, the half-reaction time increased almost 
linearly with I, i e., the ligand substitution became slower when the electrostatic 
interaction between the ruthenium dications and the negative liposomes was shielded 
by the other ions present in solution. Interestingly, the coordination reaction at the 
surface of negatively charged membranes is significantly faster than that in 
homogenous aqueous solution using thioether ligands not bound to liposomes. The 
kinetics for the coordination of the water-soluble thioether ligand 2-
(methylthio)ethanol (Hmte) to [2]
2+
 was already reported in Chapter 2 and follows a 






 at 297 K. 
However, with the low concentration used (i.e., 0.3 mM for Hmte and 0.067 mM for 
[2]
2+
) the coordination rate in a I=50 mM buffer solution is very low as t1/2 is over 68 h 
(Figure 4.2a-IV) while the coordination at DMPG membranes showed to have t1/2~2.6 
h (see Figure 4.2a-I). 
To prove that the charge of the liposome is the major factor controlling the kinetics of 
the coordination, two control experiments were performed. In the first experiment, the 
coordination reaction was performed using another negatively charged lipid 1,2-
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dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt (hereafter DOPG)). DOPG 
liposomes containing 25 mol% ligand 1 were mixed with 5 mol% [2]
2+
 in the dark. As 
shown in Figure 4.2b-II, the kinetics of the reaction with DOPG is almost the same as 
that with DMPG liposomes, in a buffer with I=50 mM (t1/2 =154 min and 160 min, 
respectively). Thus, the kinetics of the reaction are almost the same for two different 
negatively charged liposomes. A second control experiment was performed with non-
charged liposomes to check the influence of hydrophobic interactions. Neutral 
liposomes made of DOPC (DOPC=1,2-dioleoyl-sn-glycero-3-phosphocholine) and 
functionalized with the same amount of ligand 1 (25 mol%) were prepared. After 
addition of [2]
2+
 the UV-vis spectrum of the solution remained unchanged at least for 
20 hours in the dark, which is longer than the longest experiment (I~1000 mM) 
realized with DMPG liposomes (Figure 4.2b-III). Overall, These experiments confirm 
that the electrostatic interaction between the ruthenium complex and the surface of the 
lipid bilayer is crucial for the binding of the Ru(II) cations to the sulfur atom of ligand 
1 embedded in a lipid bilayer. 
 
Figure 4.2. a) Plot of the half reaction time t1/2 vs. the total ionic strength I of the buffer for the 
thermal binding of aqua complex [2](PF6)2 to ligand 1 incorporated in DMPG liposomes.  b) Time 
evolution of the absorbance at 500 nm for a solution containing (I) DMPG, (II) DOPG, (III) DOPC 
liposomes containing 25 mol% of ligand 1, or (IV) Hmte (no liposome), after addition of [2](PF6)2 at 
t=0, using a 10 mM phosphate buffer at pH=7 with a total ionic strength of 50 mM.   Conditions for a) 
and b): in the dark, T = 298 K, total concentration of [2]2+=0.067 mM, bulk concentration of ligand 1 
or Hmte=0.3 mM in all samples, lipid concentration= 1.3 mM (as liposomes in plot b-IV lipid 
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In all these experiments however, UV-vis spectroscopy could only probe changes 
occurring in the coordination sphere of the metal center. It does not allow for studying 
changes in the environment of the complex that would not involve ligand exchange, 
such as for example the adsorption of the ruthenium aqua complex at the water-bilayer 
interface. Two other experimental techniques, i.e, surface pressure measurements on 
lipid monolayers, and Isothermal Titration Calorimetry (ITC) were used to gain insight 
into the adsorption step.  
4.2.2. Langmiur-Blodgett monolayer experiments 
Langmuir monolayers are composed of amphiphilic molecules self-assembled at the 
air/water interface. The interaction of these monolayers with molecules dissolved in the 
aqueous subphase can be probed by measuring changes of the surface pressure (∆Π) of 
the monolayer by means of a platinum Wilhelmy plate. Langmuir monolayers are 
recognized as a good model for one leaflet of a lipid bilayer,
[35]
 surface pressure 
measurements were performed to study the interaction of the ruthenium complex [2]
2+ 
with negatively charged and zwitterionic lipid monolayers at the buffer/lipid 
interphase. First, four types of lipid monolayers were prepared at the air/buffer 
interface using DMPG, DMPG containing 25 mol% of ligand 1, DMPC, and DMPC 
containing 25 mol% of ligand 1 lipid mixtures. Stock solutions of the lipids were 
spread onto the phosphate buffer subphase (I=50 mM, pH=7, T=298 K) and the 
monolayer was compressed at a constant rate. Upon compression, the surface pressure 
(Π) was measured as a function of the area of water surface available to each lipid 
molecule (A). The surface pressure-area (Π-A) isotherms that were obtained for each 
sample (see Appendix IV, Figure AIV.1); were in good agreement with previously 
reported data for DMPG and DMPC monolayers.
[36-38]
 Addition of the thioether-
cholesterol ligand 1 to the lipid compositions shifted the Π-A isotherms to lower 
molecular areas compared to pure DMPG or DMPC, which indicates to a slightly 
better packing of the monolayer at the air-buffer subphase in presence of 1. 
In a second series of experiments, lipid monolayers of DMPG containing 25 mol% of 
ligand 1 were prepared on the phosphate subphase at a constant surface pressure, at 298 
K and in the dark. After equilibration a buffered solution of [2]
2+
 was injected into the 
subphase underneath the lipid film, and the resulting change in surface pressure was 





 an increase in the surface pressure takes place within 6-7 min, to reach an 
equilibrium at a slightly higher pressure. The observed evolution time scale is too short 
for ligand coordination to the ruthenium complex to be completed (see Figure 4.2b-I). 
Furthermore, a control experiment was performed using cholesterol as additive instead 
of ligand 1. For such sulfur-deprived DMPG monolayers the surface pressure also 
increased within a couple of minutes after injection of [2]
2+
, and ∆Π was roughly 
identical to that observed for the DMPG sample containing ligand 1 (Figure 4.3a-I). 
Thus, the observed increase of Π cannot be caused by sulfur coordination to the metal. 
 
Figure 4.3. a)Plots of surface pressure vs. time for phospholipid monolayers after injection of [2]2+ 
(final concentration= 0.5 µM) into a buffer subphase. (I) DMPG and 25 mol % cholesterol (I=50 
mM), (II) DMPG and 25 mol% ligand 1 (I=50 mM), (III) DMPG and 25 mol% ligand 1 (I=400 mM), 
(IV) DMPC and 25 mol% ligand 1 (I=50 mM). Each arrow represents an injection of 50 µL of [2]2+, 
Conditions:  concentration of [2]2+ in the stock solution = 0.65 mM, T=298 K, pH=7.0, volume of the 
trough: 65 mL. b) Plot of the surface pressure variation ∆Π as a function of the initial surface pressure 
Π0 for data obtained for DMPG monolayers containing 25 mol% ligand 1 after injection of [2]
2+ (final 
concentration=3.5 µM) in a buffer subphase at different initial surface pressure Π0. Condition: 10 mM 
phosphate buffer, total ionic strength=50 mM, concentration of [2]2+ in the stock solution=2.3 mM, 
T=298 K. 
Consecutive injection of [2]
2+
 to the buffer subphase of DMPG monolayers containing 
either cholesterol or ligand 1 (Π0=14 mN/m ) showed a total surface pressure variation 
(∆Π) of about 6 mN/m at saturation condition (see Figure AIV.2). Such a surface 
pressure variation ∆Π was small compared to those reported for penetrating peptides, 
enzymes, or other lipophilic macromolecules interacting with lipid monolayers, where 
∆Π is usually higher than 10 mN/m.
[39-45]
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insertion of the metal complex into the membrane was limited. Such a conclusion was 
confirmed by another experiment showing that the surface pressure variation ∆Π was 
independent of the initial surface pressure of the monolayer, Π0. When DMPG 
monolayers containing 25 mol% of ligand 1 at various initial surface pressures were 
prepared, in all cases injection of [2]
2+
 (final concentration:3.5 µM) to the subphase led 
to equal surface pressure increase (∆Π=2.6 mN/m, see Figure AIV.4). As shown in 
Figure 4.3b, the slope of the plot of ∆Π vs. Π0 is almost zero, which is differs from the 
behavior of hydrophobic macromolecules that penetrate the hydrophobic core of the 
monolayer. In such cases, ΔΠ typically decreases when the initial surface pressure Π0 
becomes higher,
[39-40, 46-48]
 In fact, the affinity of [2]
2+
 for the DMPG monolayer is not 
high. It can be assumed that the ruthenium complex does not penetrate into the lipid 
monolayer, but rather migrates at the monolayer-water interface and adsorbs to the 
polar head groups of the phospholipids.
[24, 48-49]
 
In order to investigate whether the incidence of the adsorption process is due to 
electrostatic or hydrophobic interactions, two control experiments were performed. In 
the first experiment, a DMPG monolayer containing ligand 1 was formed onto a buffer 
subphase with a high ionic strength (I=400 mM instead of 50 mM). As shown in Figure 
4.3a-III, injections of [2]
2+
 in the subphase did not affect the surface pressure of the 
monolayer. Thus, adsorption of the positively charged ruthenium complex at the 
surface of the DMPG monolayer does not occur when the ionic strength of the 
subphase is high, which is in good agreement with the UV-vis data and highlights the 
role played by electrostatic interaction in the adsorption process. The second control 
consisted in replacing the DMPG lipid by the zwitterionic analogue DMPC. In 
presence of 25 mol% of ligand 1 in a DMPC monolayer no measurable variation of the 
surface pressure was observed after injection of complex [2]
2+
 (Figure 4.3a-IV), which 
proves the low affinity of the ruthenium complex for the zwitterionic monolayer 
surface. In addition, it confirms the low hydrophobicity of the ruthenium complex [2]
2+
 
that does not penetrate into the membrane. Overall, our data support the hypothesis that 
electrostatic forces are crucial for the adsorption of the ruthenium complex at 




4.2.3. ITC experiments 
Surface pressure experiments allow for studying the initial adsorption of ruthenium 
complexes to negatively charged monolayers before the coordination occurs. 
Considering the fast kinetics of the adsorption process on monolayers ITC 
measurements were used to determine the thermodynamic parameters characterizing 
the adsorption of complex [2]
2+
 at the surface of the lipid bilayers. Titrations of DMPG 
liposomes supplemented with 25 mol% cholesterol or ligand 1 by a 0.62 mM solution 
of complex [2]
2+
 were performed at 298 K, pH=7, and I=50 mM. After each ruthenium 
addition, the return to equilibrium took less than 100s, which confirms that the 
adsorption step is characterized by fast kinetics, in accordance with the results obtained 
for the monolayer experiments. As mentioned above, such time scales are significantly 
shorter than that of the coordination of ligand 1 to complex [2]
2+
 at the DMPG 
membrane. In addition the adsorption phenomenon observed by titration of DMPG 
liposomes containing ligand 1 was found to be endothermic (Figure 4.4-II). For DMPG 
membranes containing cholesterol an exothermic process was observed during the 
initial injections of [2]
2+
, but further addition of [2]
2+
 led only to an endothermic 
process similar to that observed with ligand 1 (Figure 4.4-I). The initial exothermic 
evolution may be related to structural changes in the negatively charged lipid bilayer 
due to the interaction of a small amount of divalent cations with the cholesterol and/or 





Two control titrations with [2]
2+
 were made, on the one hand for DMPG liposomes 
containing 25 mol% cholesterol in presence of a high ionic strength buffer (I=400 
mM), and on the other hand of zwitterionic DOPC liposomes containing 25 mol% 
cholesterol using a buffer with I=50 mM. The measured heat exchange was negligible 
in high ionic strength buffer (see plots III and II in Figure 4.4b), and in the case of the 
DOPC liposomes the heat exchange was even comparable with the heat exchange 
observed in absence of liposomes. Overall, the results of the ITC measurements are in 
good agreement with those obtained with UV-vis and surface pressure monolayer 
experiments. They confirm that adsorption of the ruthenium complexes to negatively 
charged membranes is a fast process that does not involve coordination to sulfur. 
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Table 4.1. Thermodynamic data for the adsorption of [2]Cl2 to DMPG liposomes. Conditions: buffer 
with I=50 mM, pH=7 and 298 K, Concentrations:  [lipid]=2.5 mM, [2]Cl2 in titrating solution:5 mM. 
 
Due to the low solubility of [2](PF6)2 in the buffer
 
saturation of the DMPG liposomes 
with ruthenium cations could not be reached (Figure 4.4-II). As a consequence, the fit 
of the model to the experimental data did not give reliable binding parameters. Thus, 
the counter ions of [2]
2+
 were changed to chlorides, which allowed to reach much 
higher ruthenium concentrations (5 mM) and thus for obtaining quantitative 
information on the thermodynamics of the adsorption process. By dissolving 
[Ru(tpy)(dcbpy)(Cl)]Cl in an aqueous solution, the coordinated chloride ligand is 
quickly substituted by an aqua ligand to form [2]Cl2 quantitatively (see Chapter 2 and 




 had a negligible influence on monolayer 
experiments and ITC data at low ruthenium concentrations (0.62 mM, see Appendix 
AIV, Figure AIV.5 and Table AIV.1). Titrations of DMPG liposomes containing 
ligand 25 mol% ligand 1 or cholesterol were undertaken with more concentrated (5 
mM) solutions of [2]
2+
 and more concentrated liposome solutions (lipid concentration: 
2.5 mM). Sigmoidal binding curves were obtained, showing that in such conditions 















Ligand 1 (25 mol%) 1.8(3)×10+4    +9.1 ±0.3 −24 +112 0.28±0.01 




Figure 4.4. Representative binding isotherms obtained upon titration of liposomes with [2]2+ in 
phosphate buffer at pH=7.0 and 298 K. a) Heat pulses per injection of 10 µL [2](PF6)2 (II) or 5 µL of 
[2]Cl2 (V) to a liposome solution containing DMPG and 25 mol% ligand 1. b) and c) corresponding 
integrated areas (points) and best fitted isotherms; x axis shows the molar ratio between total added 
ruthenium concentration [Ru] and the total lipid concentration [lipid] in the solution. Conditions: (I) 
DMPG and 25 mol% cholesterol ([lipid]=1.3 mM, concentration of [2](PF6)2 in titrating solution:0.62 
mM, I=50 mM), (II) DMPG and 25 mol% ligand 1 ([lipid]=1.3 mM, concentration of [2](PF6)2 in 
titrating solution:0.62 mM, I=50 mM), (III) DMPG and 25 mol% cholesterol ([lipid]=1.3 mM, 
concentration of [2](PF6)2 in titrating solution:0.62 mM, I=400 mM), (IV) DMPG and 25 mol% 
cholesterol ([lipid]=2.5 mM, concentration of [2]Cl2 in titrating solution:5 mM, I=50 mM), and (V) 
DMPG and 25 mol% ligand 1 ([lipid]=2.5 mM, concentration of [2]Cl2 in titrating solution:5 mM, 
I=50 mM).   
Unlike at lower concentrations the cholesterol-containing DMPG liposomes were 
found to behave very similarly to DMPG liposomes containing ligand 1, and only an 
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curves to a single set of n identical binding sites provided the adsorption enthalpy 
(ΔH°), affinity constant (Ka), and binding stoichiometry (n), from which the adsorption 
free energy (ΔG°) and entropy (S°) could be derived (Table 4.1). 
For both systems ΔH° and ΔS° were found to be positive, while ΔG° was negative. 
Thus, the adsorption of the ruthenium complex to the DMPG bilayer is endothermic 
and driven by entropy. Presumably, the entropy gain upon adsorption is due to the 
release of water molecules and counter ions (Na
+
 ions) when the ruthenium dications 
come into contact with the phospholipid head groups.
[51-55]
 This interpretation is 
consistent with monolayer surface pressure experiments, as the surface pressure 
increased upon adsorption of the complex. Such an increase advocates for the 
disruption of the hydrogen bonding network between the water molecules and the polar 
heads of the phospholipids, which must significantly contribute to the overall 
unfavorable adsorption enthalpy measured by ITC. In addition, comparison between 
the binding stoichiometry values n obtained for the two systems containing cholesterol 
or ligand 1 revealed that about 5 or 4 lipid molecules, respectively, are bound for each 
ruthenium complex when saturation of the DMPG liposomes is reached. Since only the 
outer leaflet of the lipid bilayer is available for adsorption of the ruthenium complex 
ion, the apparent Ru/lipid ratio at saturation is 2.5 or 2 lipid molecules per ruthenium 
for cholesterol and ligand 1, respectively. This stoichiometry almost fits with two 
monoanionic lipid molecules for one dicationic ruthenium complex, i.e., at saturation 
of the liposome surface all the initial Na
+
 counter cations have been replaced by 
dicationic ruthenium complexes at the membrane surface. Apparent binding constant 
values (see Table 4.1) are very close for both systems and rather low, which highlights 
that sulfur coordination to the ruthenium does not play a significant role at the time 
scale of these experiments, and that it is mostly the electrostatic adsorption onto the 
membrane that is actually monitored. 
4.3. Discussion  
According to our results binding of the ruthenium complex [2]
2+
 to ligand 1 embedded 
in a negatively charged liposome occurs via a two-step mechanism. As proposed in 
Scheme 4.1, the outer leaflet of the negatively charged lipid bilayer can be regarded as 
a “heterogeneous” surface, which first adsorbs ruthenium complexes with fast kinetics 
(minutes). In a second, slower step (hours), the ruthenium complex [2]
2+
 undergoes a 
thermal ligand substitution reaction at the membrane surface, during which the H2O 
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ligand is replaced by ligand 1 to form the Ru-S coordination bond ([3]
2+
). In this model 
coordination of the sulfur ligand to the metal center occurs via two-dimensional 
diffusion of both the ligand and the metal complex at the membrane surface. Metal 
binding to ligands embedded in a negatively charged membrane is faster than in 
homogeneous systems because the fast electrostatic adsorption of the complex to the 
negative surface of the lipid bilayer increases the local ruthenium concentration near 
the thioether ligands, i.e., in the electrostatic double layer.
[50, 56]
 Counter-intuitively, the 
initial adsorption step is not enthalpy driven, because the energy gained by the 
approach of the dicationic ruthenium center to the negatively charged bilayer must be 
paid back by removing two monocationic sodium ions. As a result, the adsorption is 
driven by entropy and occurs via dehydration of the phosphate head groups and of the 
ruthenium dications, and re solvation of the Na
+
 monocations. With neutral lipids, i.e., 
in the absence of electrostatic interaction, hydrophobic interactions are very weak and 
adsorption does not proceed. Thus, the ruthenium concentration in the electrical double 
layer, where most of the sulfur ligands are concentrated, remains low, which hampers 
the coordination reaction. 
 
Scheme 4.1. A two-steps model for the thermal binding of the metal complex [2]2+ to ligand 1 
embedded in a negatively charged membrane. Step (1): adsorption; step (2): ligand substitution at the 
water-membrane interface. 
Although the charge of metal cations is an important parameter for their adsorption to 
lipid bilayers, other parameters such as the type of metal cation, the ligands that may be 
coordinated to it, the number of coordination sites available, and also the surrounding 
environment (ionic force, pH, etc.), all can have a strong influence on the adsorption 
process. The metal-phospholipid interaction differs from case to case, even when 




 are used with the same phospholipid.
[23-24, 
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57-60]
 Furthermore, upon changing the nature of the lipids the adsorption driving force 
for a given metal cation may change as well. In a study by Blume et al. 
[61]
 large 
negative enthalpies were obtained upon addition of CaCl2 to DMPG liposomes, which 





 This interpretation may be relevant to our observations when very low 
concentrations in [2]
2+
 (~0.03 mM) come into contact with DMPG liposomes 
containing cholesterol (1.3 mM, Figure 4.4-I). In contrast, Dimova et al.
[50]
 reported 
the endothermic adsorption of Ca
2+
 ions to mixed neutral/negative liposomes, which is 
similar to the behavior of higher concentrations in [2]
2+
 adsorbing on DMPG 
membranes. Finally, membrane fusion or aggregation does not occur upon addition of 
[2]
2+
 to DOPC, DOPG, DMPG, or DMPC membranes, whereas it is a common 
phenomenon in presence of Ca
2+
 or other divalent cations.
[62-63]
 In spite of their 
identical charge Ca
2+
 and the Ru(II) complex [2]
2+
 are quite different, as the latter is 
surrounded with large, hydrophobic polypyridyl ligands, and has only one potentially 
available coordination site. Overall, the interaction between metal complex ions and 
phospholipid membranes appears to comprise a delicate balance between electrostatics, 
hydrophobic forces, and coordination. In the case of [2]
2+
 and ligand 1 neither phase 
changes, nor vesicle aggregation take place, but simply the fast, entropy-driven 
adsorption of the cation at the water-membrane interface. 
4.4. Conclusion  
Using three different techniques, the present study distinguishes for the first time the 
time scales for the adsorption of a dicationic coordination compound on a negatively 
charged membrane, and the coordination of a membrane-embedded sulfur ligand to the 
metal center. These results have two major consequences. First, a sequential, two-step 
model is proposed for the binding of the metal complex to the membrane-embedded 
ligands. The outer leaflet of a negatively charged lipid bilayer is a surface which 
quickly adsorbs positively charged metal complexes such as [2]
2+
. Any slower 
coordination event will thus take place subsequently, via diffusion of both reagents in 
the two dimensions of the membrane. The relevance of this model for late transition 
metallodrugs binding to membrane proteins will need to be evaluated. 
Secondly, when studying the interaction of metallodrugs with large, negatively charged 
biomolecules such as DNA, proteins, or lipid membranes, electrostatic interaction may 
be strong enough to keep the metal complexes in close proximity to the biomolecules 
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even in absence of coordination to the metal center, which may take place at much 
longer time scales. In other words, studying the interactions between metal complexes 
and biomolecules by precipitation or centrifugation experiments, i e., by experimental 
methods involving short time scales, may conclude to metal-ligand “binding”, whereas, 
formation of the coordination bond between the metal center and the biological ligand 
did, actually, not occur. This fact should be taken into consideration in future studies 
looking at the fate of metallodrugs in a biomimetic or biological environment. 
4.5. Experimental Section  
4.5.1. General 
The thioether-cholesterol ligand 1 and the aqua ruthenium complex [2](PF6)2 were 
synthesized as reported in Chapter 2. 2-Dimyristoyl-sn-glycero-3-phosphoglycerol Sodium 
salt (DMPG), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), and 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-
glycerol) sodium salt (DOPG) were obtained from Avanti Polar Lipids or Lipoid and stored 
at −20 °C. Cholesterol, K2HPO4, K2HPO4, and K2SO4 were obtained from commercial 
sources and used as received. A Perkin-Elmer Lambda 900 UV-vis spectrometer equipped 
with stirring and temperature control was used for UV-vis measurements. Liposomes size 
distributions were determined by dynamic light scattering in a Zetasizer (Malvern 
Instruments Ltd.,U.K.), operated at a wavelength of 633 nm. A KSV Instrument equipped 
with a 230 mL or 60 mL trough was used for Langmuir monolayer measurements. A 
NanoITC-2G  instrument (TA Instruments, Delaware, USA) with a 1 mL titration cell was 
used to perform ITC experiments. 
4.5.2. Phosphate buffer preparation 
Phosphate buffers at pH=7.0 with ionic strengths of 20, 50, 100, 150, 200, 400, 600, 800, 
and 1000 mM were prepared by dissolving  phosphate salts of KH2PO4 and  K2HPO4 (total 
phosphate salt: 0.90 mmol) and 0.0, 0.97, 2.6, 4.6, 5.9, 12.5, 19.2, 26.0, or 32.5 mmol of 
K2SO4 , respectively, in 100 mL Milli-Q water at 298 K. 
4.5.3. Liposome preparation 
The lipid (5.0 µmol) and ligand 1 or cholesterol (1.25 µmol) were mixed from chloroform 
(DOPC, DOPG) or chloroform/methanol 4:1 (DMPG) stock solutions, and dried under 
reduced pressure using rotary evaporation. The lipid films were subsequently placed under 
vacuum for at least 1 h to remove traces of organic solvents, and then hydrated in a 
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phosphate buffer with a desired ionic strength at pH 7.0. The final concentration of the 
lipids was 2.5 mM. The lipid suspensions were freeze-thawed 10 times above the transition 
temperature of the corresponding lipid (from liquid N2 temperature to 323 K), and then 
extruded 11 times above the transition temperature of the lipid by using an Avanti mini-
extruder and polycarbonate membranes with 200 nm pore diameter. The size distribution of 
the liposomes was measured by DLS to give a value centered between 130 and 150 nm. 
The samples were kept at 277 K and used within 10 days. 
4.5.4. UV-vis measurements 
A liposome sample (1.6 mL) containing DMPG, DOPG, or DOPC (2.5 mM) and ligand 1 
(25 mol%, 0.62 mM) in a buffer solution (ionic strength: 20, 50, 100, 150, 200, 400, 600, 
800, or 1000 mM, pH=7.0), or a solution of Hmte in a buffer with I=50 mM (Hmte 
concentration: 0.62 mM) was placed into a UV-vis cell. 1 mL of the corresponding buffer 
solution was added to the cuvette and at t=0 the volume of the cell was completed by 
adding [2]2+ in MilliQ (0.4 mL, 0.5 mM stock solution; ratio [2]2+/ligand 1= 0.5). The final 
concentrations of the lipid, sulfur ligand, and [2]2+ in the cell were 1.3 mM and 0.3 mM, 
and 0.067 mM, respectively. The initial absorbance of the sample at 496 nm after base-line 
correction (subtraction of the absorbance of a liposome sample containing 25 mol% ligand 
1 and without ruthenium) was typically 0.46. The sample was stirred in the dark overnight 
while UV-vis spectra were measured every 3 min, until the thermal equilibrium was 
reached. The final absorption maximum at 473 nm indicates the formation of complex 
[3]2+.  The plot of ln((A0–Ainf)/(At–Ainf)) vs. time was obtained (A0=Absorbance at t=0,  
At=Absorbance at time t, and  Ainf= absorbance at equilibrium time “tinf”, all absorbance 
values measured at λ=500 nm), and the slope of the plot corresponded to the rate constant 
(k). The half reaction time for each reaction was obtained using the equation t1/2=ln(2)/k. 
4.5.5. Langmuir monolayer 
All the measurements were performed at pH=7.0 and 298 K. The Teflon troughs and 
platinum Wilhelmy plate were cleaned properly using cleaning instructions prior to use. 
Hamilton syringes (25 µL, 50 µL, or 100 µL) were used for monolayer spreading and 
ruthenium injections. 
4.5.6. Surface Pressure-Mean Molecular Area Compression Isotherms 
Compression isotherms were carried out on a KSV (U.K.) Langmuir teflon trough (area 
24300 mm2, volume 230 mL). The pure lipid or lipid-ligand spreading solutions were 
prepared by mixing appropriate volumes of chloroform or chloroform/methanol (4:1) stock 
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solutions of phospholipids (1 mg/mL) and of ligand 1 or cholesterol (1 mg/mL). 
Monolayers were formed by depositing small drops of the spreading solutions on the 
phosphate buffer subphase (pH=7.0, T=298 K) with a 25 µL Hamilton microsyringe. For a 
maximum molecular area of 180 Å2/molecule, around 15 µL of each lipid solution was 
spread onto the buffer subphase. The monolayers of the desired composition were 
compressed with 2.4 mm/min and the surface pressure was recorded using a platinum 
Wilhelmy plate.  
4.5.7. Injection of [2]2+ and surface pressure vs. time isotherms 
The experiments were performed on a KSV (U.K.) Langmuir teflon round trough (area 
1963 mm2, volume 65 mL). The pure lipid or lipid-ligand spreading solutions were 
prepared by mixing appropriate volumes of chloroform or chloroform/methanol (4:1) stock 
solutions of phospholipids (0.3 mg/mL) and of ligand 1 or cholesterol (0.30 mg/mL). The 
desired surface pressure for the monolayer corresponded to a specific molecular area 
(Å2/molecule) as shown in Figure AIV.1. Thus, the amount of lipid spreading solution was 
estimated for a desired molecular area (Å2/molecule). The monolayers were spread onto the 
proper subphase (around 8-18 µL of the lipid solution, 3.6 to 8.0 nmol) while recording the 
surface pressure until a desired surface pressure was obtained. After 20-30 min 
equilibration, a stock solution of the ruthenium complex [2](PF6)2 (0.65 mM) (Figure 4.3a) 
or [2]Cl2 (3.5 mM) (Figures 4.3b and AIV.4) in the appropriate buffer was injected into the 
subphase and gently mixed (≤100 rpm) at a slow speed taking care not to disturb the 
monolayer. The surface pressure changes were then recorded until the equilibrium was 
obtained. Control experiments were performed by injection of [2]Cl2 or [2](PF6)2 to the 
subphase without any monolayer or buffer injection under monolayer which did not show 
any changes on the surface pressure of the subphase. 
4.5.8. Isothermal Titration Calorimetry 
The experiments were performed on a TA instruments nano-ITC 2G at 298 K and all the 
solutions were degassed prior to use.  The reaction cell (V=1 mL) was filled with the 
liposome solution containing cholesterol or ligand 1 in the appropriate buffer, and the 
reference cell with the corresponding liposome-free buffer solution. The liposome solution 
was titrated by consecutive injections of 5 µL (49 injections) or 10 µL (24 injections 
preceded by one 5 µl injection) injections of the ruthenium complex [2]2+ solution under 
constant stirring at 300 rpm. The time interval between successive injections was 300 s. 
The dilution heat of the ruthenium complexes were determined by injection of [2]2+ into the 
corresponding buffer and subtracted from the corresponding titrations. Titrations were 
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duplicated to check reproducibility. The data were analyzed using the NanoAnalyze 
software TA Instruments, Delaware, USA) using a 1:n independent binding sites model. 
4.5.9. Supporting Information available 
Surface pressure-mean molecular area compression isotherms (Figure AIV.1); a plot of 
surface pressure variation upon titration of DMPG monolayers containing 25 mol% ligand 
1 with [2]2+ (Figure AIV.2); the surface pressure variation upon injection of [2]2+ to 
zwitterionic monolayers of DOPC and DMPC (Figure AIV.3); the surface pressure 
variation upon injection of [2]2+ to DMPG at different Π0 (Figure AIV.4);ITC and surface 
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Liposomes functionalized with ruthenium 
complexes: towards tumor targeted light- 








Ruthenium complexes [1](PF6)2 to [4](PF6)2 with the general formula [Ru(terpy)(N-
N)(SRR’)]2+ were synthesized, where terpy is 2,2’;6’,2’’-terpyridine, N-N is 2,2’-bipyridine 
(bpy) or phenylpiridin-2-ylmethylene-imine (pymi), and SRR’ is a thioether-cholesterol 
conjugate with a cholesterol tail. Stable DMPC, DMPG, DOPC or DOPG liposomes 
functionalized with these complexes were prepared by extrusion. The ruthenium complexes 
supported on liposomes were photosensitive: substitution of the SRR’ ligand by an aqua 
ligand occurred upon blue light irradiation (λe=452 nm), thus leading to the detachment of 
the complex from the liposome surface. Kinetic studies using UV-vis spectroscopy on 
DOPC and DMPG liposomes decorated with the ruthenium complexes [1](PF6)2 to 
[4](PF6)2 showed that the photoreactivity of these complexes increased at human body 
temperature as compared to room temperature, or when the liposome is composed of 
neutral lipids (DOPC) as compared to negatively charged lipids (DMPG). The Ru-S 
coordination bond of complex [2](PF6)2 supported on a DOPC liposome in a PBS buffer 
was shown to be stable in the dark at 4 °C for at least 7 days. 
Cancer cells were incubated with Ru-functionalized liposomes to study the influence of 
liposome formulation on cellular uptake. For HepG2 cells confocal microscope images 
proved that fluorescently labeled liposomes containing [1](PF6)2 were better taken up when 
the lipid composing the membrane was neutral (DMPC) than when it was negatively 
charged (DMPG). The same effect was observed for the cellular uptake of neutral (DOPC) 
or negatively charged (DOPG) liposomes functionalized with [1](PF6)2 by ovarian cancer 
cells (A2780 and A2780 R). When PEGylated lipids were added in the liposome 
formulation, the effect of the lipid charge was shielded and no difference in cellular uptake 
was observed between DOPC- and DOPG-based formulations functionalized with 
[1](PF6)2, [2](PF6)2, [3](PF6)2, or [4](PF6)2.  
The cytotoxicity of PEGylated liposomes functionalized with complexes [1](PF6)2 – 
[4](PF6)2 in the dark was tested on A2780 and A2780 R ovarian cancer cells. The results 
show that none of the ruthenium-functionalized liposomes is significantly toxic in the dark 
after 6 hours incubation time. Light cytotoxicity tests for non-PEGylated DMPC and 
DMPG liposomes functionalized with [1](PF6)2 showed up to five times  higher 
cytotoxicity after blue light activation, compared to dark toxicity.  
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5.1 Introduction  
Ruthenium-based compounds have attracted much attention as potential anticancer 
agents.
[1-3]
 A significant number of the ruthenium complexes studied in this field exert 
their anticancer activity via initial substitution of a ligand by a water molecule.
[4]
 The 
hydrolyzed ruthenium complex is believed to be cytotoxic by interacting with DNA or 
other biomolecules in the cancer cells.
[5-6]
 The released ligand might also be 
biologically active and bind to nucleic acids or protein active sites.
[7]
 Ruthenium 
complexes often absorb light in the visible region (λmax∼450 nm) and their 
photophysical properties can be tuned. In particular complexes with distorted 
octahedral geometry may undergo photosubstitution reactions upon visible light 
irradiation, which can be used in photoactivated chemotherapy (PACT).
[8]
 The great 
advantage of photoactivation of ruthenium-based prodrugs is to control the time and 
place of complex activation, which results in a greater selectivity of the cytotoxicity.
[9-
10]
 In this case the ground state complex should be thermally stable and not undergo 
spontaneous ligand exchange or hydrolysis.
[11-13]
  
When developing ruthenium-based cytotoxic compounds efficient drug targeting is 
also an important issue. Nano-sized drug delivery systems such as nanoparticles, 
micelles, or liposomes, can be used for specific delivery of the prodrug to cancer 
cells.
[14]
 Provided that these drug delivery systems stay long enough in the blood 
circulation, increased accumulation of the prodrug can be obtained at the tumor 
sites.
[15]
 For example, Sauvage and coworkers
[16]
 recently used mesoporous silica 
nanoparticles (MSNPs) as drug carriers for photosensitive ruthenium 
dipyridophenazine (dppz) complexes. The resulting supramolecular assembly showed 
fast cellular uptake and induced cytotoxic activity upon visible light irradiation.  
Liposomal drug carriers have been extensively used in anticancer therapy since 
1974.
[17-20]
 In tumor tissues the endothelium (blood vessel wall) is distorted and can be 
crossed by liposomes. As a result liposomes penetrate well cancer tissues, and less well 
healthy tissues.
[21]
 It is known that several factors such as liposome size, surface 
charge, and composition, influence their clearance by cells of the immune system and 
thus their circulations lifetime in the blood stream.
[22-25]
 For example liposomes with 
small sizes (<200 nm), with cholesterol in the membrane composition, and a high 
phase transition temperature, show a longer biological half-life.
[26-28]
 In particular, 
adding poly(ethylene glycol) (PEG)-functionalized lipids in the composition of the 
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liposomes was reported to be the most successful method to increase the blood 
circulation lifetime of liposomes. The hydrophobic PEG groups protect the liposome 
surface and prevent its clearance by cells of the immune system.
[29-30]
 Although several 
formulations are now clinically tested with organic drugs, liposomal drug carriers have 
not often been used for metal-based drugs,
[31-33]
 and the first liposomal system for an 
anticancer ruthenium(III) complexes was reported only recently by Paduana and co-
workers.
[34-35]
 To the best of our knowledge liposomes have not yet been used for the 
delivery of light-activatable ruthenium complexes. 
 
Scheme 5.1. Schematic drawing of a liposome functionalized with photosensitive ruthenium 
complexes. Photosubstitution of membrane-embedded sulfur ligands by aqua ligands releases 
ruthenium-aqua complexes, which may be cytotoxic by interacting with DNA, mitochondria, or other 
biomolecules. 
In Chapters 2 and 3 polypyridyl ruthenium complexes of the type [Ru(terpy)(N-
N)(SRR’)]
2+
 were described, where terpy is 2,2′;6′,2′′-terpyridine, N-N is a diimine 
ligand, and SRR’ is a sulfur-containing ligand. These complexes undergo selective 
photosubstitution of the SRR’ ligand by an aqua ligand upon visible light irradiation. In 
addition it was shown in Chapter 3 that for less distorted complexes (e.g., N-N=2,2’-
bipyridine) the Ru-S bond is rather stable in the dark below 50 °C. Thus, these 
complexes are potentially interesting as light-activatable anticancer agents, if the 
corresponding aqua complex is cytotoxic. Moreover, a strategy to decorate liposomes 
with these photosensitive ruthenium complexes was recently published in our group;
[36]
 
such a supramolecular assembly may deliver the ruthenium complex to cancer cells. 
Provided the Ru-functionalized liposomes are taken up by cancer cells, light-induced 
Liposomes functionalized with Ru complexes in drug delivery 
127 
substitution of a membrane-bound sulfur ligand by an aqua ligand would result in the 
dissociation of the ruthenium aqua complex from the liposome carrier, followed by the 
diffusion of the complex into the cell, its interaction with biomolecules, and possibly to 
cell death (see Scheme 5.1). In this Chapter the preparation, characterization, and 
biological activity are described of liposomes functionalized with a photoactive 
ruthenium complex (see Figure 5.1).  
 
 
Figure 5.1. Chemical structures and numbering scheme of polypyridyl ruthenium complexes 
[1](PF6)2 – [4](PF6)2.  
5.2 Results  
5.2.1. Synthesis 
The synthesis of ligands 5
[36]
 and 6 (Chapter 2, Appendix II) is reported elsewhere. 
Ligand 7 was synthesized following a modified literature procedure,
[37]
 consisting in 
the esterification of cholesterol with N-acetylated methionine using DCC 
(dicyclohexylcarboiimide) as coupling reagent and DMAP (N,N-
dimethylaminopyridine) as catalyst. The sulfur-sterol conjugates 6 and 7 were 
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coordinated to ruthenium following the procedure reported for complex [1](PF6)2, by 
the reaction of [Ru(terpy)(bpy)(Cl)]Cl or [Ru(terpy)(pymi)(Cl)]Cl with 6 or 7 in the 
presence of two equiv. of AgBF4 in acetone, followed by column chromatography.
[36]
 
Complexes [Ru(terpy)(bpy)(6)](PF6)2 ([2](PF6)2), [Ru(terpy)(bpy)(7)](PF6)2 
([3](PF6)2), and [Ru(terpy)(pymi)(7)](PF6)2 ([4](PF6)2) were obtained as orange, water-




C NMR, mass 
spectrometry, UV-vis spectroscopy, and elemental analysis.  
5.2.2. Photoreactivity and dark stability of a Ru-S bond at liposomes 
5.2.2.1. Visible light irradiation of Ru-decorated liposome samples 
In order to study the photosubstitution kinetics for complexes [1](PF6)2, [2](PF6)2, 
[3](PF6)2, or [4](PF6)2 at a lipid bilayer surface, liposomes composed of 1,2-dioleoyl-
sn-glycero-3-phosphocholine (hereafter DOPC) or 1,2-dimyristoyl-sn-glycero-3-
phospho-(1'-rac-glycerol)  sodium salt (hereafter DMPG) functionalized with 5 mol% 
of one of the ruthenium complexes were prepared a in phosphate buffer (I=50 mM, 
pH=7.0) (Table 5.1). Each liposome sample was characterized by DLS prior to 
performing other experiments; their average diameter was 130-140 nm. The 
photosubstitution of the sulfur-sterol conjugate 5, 6, or 7 by an aqua ligand upon 
irradiation with blue light (λe=452 nm) was investigated by UV-vis spectroscopy either 
at 25 °C or at 37 °C. For a typical experiment the liposome sample was irradiated from 
the top of the UV-vis cuvette, while UV-vis spectra were measured perpendicular to 
the irradiating light beam (see Appendix I, Figure AI.1). The absorption spectrum of 
the irradiated sample gradually evolved until a photochemical steady state was 
obtained, characterized by an absorption maximum at a longer wavelength. In each 
case an isosbestic point was observed, which indicated that a single photochemical 
reaction was taking place. The UV-vis spectrum at the photochemical steady state 
corresponded with that of the ruthenium-aqua species [Ru(terpy)(N-N)(OH2)]
2+
 (N-
N=bpy or pymi). The concentration of the ruthenium-sulfur complex (RuSRR’) was 
calculated in each experiment as a function of irradiation time (see Appendix I, section 
AI.2.1). As shown in Equation 5.1, the photosubstitution first-order rate constants kφ 
was obtained from the slope of a plot of ln([RuSRR’]/[Ru]tot) vs. irradiation time 
(Figure 5.2a), where [RuSRR’] and [Ru]tot represent the bulk concentration in RuSRR’ 
and the total ruthenium concentration in the sample, respectively. Half-reaction times 
were also calculated using Equation 5.2.  
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 (Equation 5.2) 
The photosubstitution quantum yield φ was obtained from the slope of a plot of the 
number of moles of RuSRR’ remaining in solution, nRuSRR’,
 
vs. the number of moles of 
photons Q absorbed by the RuSRR’ species since t=0 (see Figure 5.2b and Appendix I, 
section AI.3.2). The photosubstitution reactivity (ξ=φ·ε
λe
) of the ruthenium complex, 
where ε
λe
 is the extinction coefficient of RuSRR’ at the irradiation wavelength, better 
represents the photoreactivity of a complex in a given irradiation condition, and was 
calculated as well (see Chapter 6). All photochemical data are reported in Table 5.1. 
Table 5.1. Data for the photosubstitution of the thioether-sterol conjugate 5, 6, or 7 by water for 
liposomes functionalized with ruthenium complexes [1](PF6)2, [2](PF6)2, [3](PF6)2, or [4](PF6)2. 
Irradiation conditions: λe = 452 nm, photon flux Φ452 = 3.0(8)×10
−9 Einstein·s−1, irradiation 
pathlength = 3 cm. Lipid bulk concentration=1.3 mM (as liposomes), total ruthenium concentration 




















[1](PF6)2 DOPC 37 6700 21(2) 5.2(3)×10
−4 0.019(5) 127(8) 455 
[2](PF6)2 DOPC 37 6800 53(3) 2.2(2)×10
−4 0.013(3) 88(6) 455 
[3](PF6)2 DOPC 37 6700 47(3) 2.5(2)×10
−4 0.012(4) 80(5) 453 
[4](PF6)2 DOPC 37 5400 95(5) 1.2(3)×10
−4 0.0080(5) 43(3) 479 
[3](PF6)2 DOPC 25 6700 90(5) 1.3(2)×10
−4 0.0068(5) 46(3) 453 
[3](PF6)2 DMPG 25 5900 156(8) 7.4(5)×10
−5 0.0048(4) 28(2) 464 
[4](PF6)2 DOPC 25 5400 135(8) 8.6(7)×10
−5 0.0049(4) 26(2) 479 
[4](PF6)2 DMPG 25 4600 325(9) 3.6(3)×10
−5 0.0031(6) 14(1) 483 
 
The effect of temperature on the photosubstitution reactivity of complexes [3](PF6)2 
and [4](PF6)2 was investigated first. The photochemical data for these complexes 
(Table 5.1) show that the photosubstitution rate and quantum yield are almost twice 
higher at 37 °C than at 25 °C. Most probably, it is the dependence of the quantum yield 
φ with temperature that explains the faster reaction at human body temperature. The 
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transition from the photochemically generated 
3
MLCT state to the 
3
MC state leading to 
ligand substitution is a thermally activated process, which explains why the elevated 
temperature of the human body is an advantage on the point of view of photoactivation 
of polypyridyl ruthenium complexes. 
 
Figure 5.2. a) Plots of ln(RuSRR’]/[Ru]tot) vs. irradiation time during the blue light irradiation of 
liposomes functionalized with ruthenium complexes [1](PF6)2, [2](PF6)2, [3](PF6)2, or [4](PF6)2. 
[RuSRR’] represents the bulk concentration in RuSRR’, and [Ru]tot the total ruthenium concentration 
in the solution. The slope of each plot is −kφ (s
-1). (b) Plots of the number of moles of RuSRR’ vs. the 
number of moles of photons absorbed by RuSRR’ at time t, since t=0; the slope is the 
photosubstitution quantum yield φ. RuSRR’=[1](PF6)2 (I), [2](PF6)2 (II), [3](PF6)2 (III), [4](PF6)2 (IV). 
Total ruthenium concentration=0.065 mM, bulk lipid concentration=1.3 mM (as liposomes), 
phosphate buffer (pH=7, I=50 mM). Irradiation condition: blue light (e=452 nm), photon flux 
Φ452=3.0(8)10
–9 Einstein.s–1, T=37 °C, irradiation pathlength=3 cm. 
Comparing the photosubstitution reactivity of [1](PF6)2 – [4](PF6)2 on DOPC 
liposomes at 37 °C shows that the highest quantum yield φ and photosubstitution 
reactivity value ξ were obtained for complex [1](PF6)2, and the lowest for complex 
[4](PF6)2. The higher quantum yield of [1](PF6)2 may be due to the higher steric 
hindrance of the thioether ligand 5, as the linker between the sulfur atom and the 
cholesterol moiety is very short. The sulfur ligand is also close to an electron-
withdrawing ester, which might exert reductive effects and modify the ability of the 
ligand to coordinate to the ruthenium. In [2](PF6)2 and [3](PF6)2 the thioether ligands 
are electronically similar, leading to similar quantum yields. For [4](PF6)2 the non-
conjugated imine ligand of the ligand pymi leads to an absorption maximum at higher 
a) b)
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wavelength (475 vs. 460 nm), thus to a more stable 
3
MLCT state and (in the absence of 
steric hindrance) to a lower quantum yield, compared to the bpy-containing complex 
[3](PF6)2. Overall, for a given light intensity the time necessary to activate 50% of the 
complex slightly depends on the chemical structure of the thioether and bidentate 
ligands. 
Another phenomenon was noticed when comparing the photochemical reactivity of 
two of the four complexes on neutral (DOPC) or negatively charged (DMPG) 
liposomes at 25 °C. For complex [3](PF6)2 and [4](PF6)2 the photosubstitution 
reactivity ξ and quantum yield φ were found to be about 1.7 and 1.5 times higher, 
respectively, for DOPC liposomes compared with DMPG liposomes. This observation 
indicates a non-negligible contribution of the electrostatic interaction between the 
positively charged ruthenium complex and the negative surface charge of DMPG 
liposomes, to the strength of the Ru-S bond.  
Overall, changing the temperature, the electronic or steric properties of the ligands, or 
the surface charge of the liposome, all contribute to influencing the photosubstitution 
quantum yield and reaction rate of the ruthenium complexes upon irradiation.  
5.2.2.2. Ruthenium-sulfur bond stability in PBS buffer in the dark  
For phototherapy applications the Ru-S bond of Ru-functionalized liposomes as 
described above is expected to remain stable in the dark and in vitro, i.e., the sulfur 
ligand should not be substituted by water or other ligands (in particular Cl
−
) present in 
biocompatible buffers. Thus, prior to in vitro experiments the thermal stability of the 
Ru-S bond was investigated for complex [2](PF6)2 supported on PEGylated DOPC 
liposomes in a PBS (Phosphate Buffered Saline) buffer containing high chloride 
concentrations (~140 mM). A DOPC:DSPE-PEG2K (98:2) liposome sample (DSPE-
PEG2K=1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene 
glycol)-2000] as the ammonium salt)  containing 5 mol% of [2](PF6)2 was prepared by 
extrusion. The sample was stored in the refrigerator (4 °C) during one week, and 
fractions of the sample were subjected to ultracentrifugation (40,000 rpm; 1 h; T = 25 
°C) at day 0, 1, 3 and 7. In all cases the lipid pellet obtained after centrifugation was 
orange and the supernatant was colorless, which qualitatively meant that most of the 
ruthenium complex was still attached to the lipid bilayer. The ruthenium concentration 
of the samples before and after centrifugation was quantitatively measured using 
inductively coupled plasma optical emission spectroscopy (ICP-OES). In all cases (t=0, 
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1, 3 and 7 days) the total Ru concentration in the supernatant was found to be ~5% 
(~230 ppb) of the ruthenium concentration found before centrifugation (4170(40) ppb, 
at t=0). These results showed that no ruthenium complex dissociated from the liposome 
surface after 7 days in such conditions, and that the 5% already present at t=0, i.e., just 
after preparation, were probably produced during extrusion of the sample, which 
occurs at elevated temperatures (50 °C). Thus, the ruthenium-sulfur bond of complex 
[2](PF6)2 supported on DOPC stealth liposomes was found to be stable in the dark in 
PBS and in the fridge, and the sulfur ligand was not substituted by chloride or water in 
such conditions. 
5.2.3. In vitro experiments 
5.2.3.1. Cellular uptake of fluorescently-labeled, Ru-functionalized liposomes 
The role of a drug delivery system is to deliver the prodrug inside the target cell, hence 
the cellular uptake of Ru-functionalized liposomes was investigated first. Liver 
hepatocellular carcinoma cells (HepG2), non-cisplatin resistant human ovarian cancer 
cells (A2780), and cisplatin-resistant human ovarian cancer cells (A2780 R), were 
chosen for in vitro experiments. The liposome formulation comprised a phospholipid 
(DMPC, DMPG, DOPC, or DOPG), 4 – 5 mol% of the fluorescent lipid 1-acyl-2-{12-
[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphocholine 
(hereafter NBD-PC, λexc=460 nm,  λem=534 nm), 5 mol% of one of the four ruthenium 
complexes [1](PF6)2 – [4](PF6)2, and in some cases 4 mol% of DSPE-PEG2K. All 
liposomes were prepared by extrusion using a 200 nm polycarbonate filter, resulting in 
size distributions around 130-150 nm. The cancer cells were incubated with the 
liposomes for 1 hour, after which the cellular uptake was determined based on the 
fluorescence of the NBD-PC lipid.  
The effect of lipid charge on cellular uptake by HepG2 cells was first investigated for 
complex [1](PF6)2 supported on negatively charged (DMPG) or zwitterionic 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) liposomes. Confocal microscopy 
images were taken after cellular incubation with the liposomes (Figure 5.3). Although 
Ru-free DMPC liposomes were poorly taken up, Ru-functionalization led to an 
increased uptake by HepG2 cells. For DMPG liposomes the reverse effect was 
observed: Ru-free liposomes were well taken up, whereas Ru-functionalized liposomes 
were less taken up. Thus, the surface charge of the liposome has a critical influence on 
liposome uptake for HepG2 cells. Overall, for HepG2 cells using neutral lipids in the 
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liposome formulation seems more beneficial in terms of cellular uptake than using 
negative lipids.  
 
Figure 5.3. Confocal microscope images after cellular uptake of liposomes by HepG2 cells. Intense 
green color represents higher cellular uptake. Liposome compositions: DMPG:NBD-PC (95:5) and 0 
or 5 mol% [1](PF6)2 or DMPC:NBD-PC (95:5) and 0 or 5 mol% [1](PF6)2. [Ru]tot = 0.025 mM, 
[lipid]tot=0.50 mM (as liposomes, diameter~140 nm), detection by fluorescence: λex=460 nm,  
λem=534 nm.  
Confocal microscopy images do not provide quantitative information on the cellular 
uptake of fluorescently-labeled liposomes. As mentioned in section 5.1, liposomes with 
PEGylated lipids (“stealth” liposomes) are known to have higher blood circulation 
lifetime than non-PEGylated ones. Thus, cellular uptake experiments were realized 
using PEGylated Ru-functionalized liposomes and either neutral (DOPC) or negatively 
charged lipids (1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt, 
hereafter DOPG). The lipid formulations consisted in DOPC:DSPE-PEG2K:NBD-PC 
92:4:4 or DOPG:DSPE-PEG2K:NBD-PC 92:4:4 mixtures containing no or an 
additional 5 mol% of one of the four ruthenium complexes [1](PF6)2 – [4](PF6)2. The 
liposomes were prepared by extrusion and characterized by DLS (average diameter 
~140 nm). Their ability to enter cancer cells was measured on A2780 and A2780 R 
cancer cell lines. After 1 hour incubation in the dark the fluorescence of the cell plate 
was measured at 534 nm (λexc=460 nm, λem=534 nm). The fluorescence values F were 
then corrected for the number of cells by dividing F by the protein content Aprot of each 
well (after lysis), as determined by the BCA (bicinchoninic acid) assay. This protein 




 by proteins in an alkaline medium (the 
biuret reaction); the Cu
+
 subsequently reacts with bicinchoninic acid to form a highly 
colored (purple) reaction product.
[38]
 The absorption Aprot of the reaction product was 
measured at 562 nm and correlates linearly to the protein concentration of the sample. 
DMPG DMPG+Ru DMPC DMPC+Ru
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Finally the corrected fluorescence value F/Aprot of each well was compared to that of 
untreated cells ((F/Aprot)ctrl=1 or 100%). The results of these cellular uptake 
experiments are shown in Figure 5.4a.  
In both cell lines PEGylated DOPG liposomes without ruthenium were taken up 
slightly better than PEGylated DOPC liposomes without ruthenium. No significant 
difference was observed between the different cell lines. For liposomes with 
ruthenium, uptake of PEGylated DOPG liposomes was comparable with that of 
PEGylated DOPC liposomes. Although several parameters had changed compared to 
the uptake experiment on HepG2 cells (Figure 5.2), these new data suggest that the 
charge of liposomes may be shielded by the PEG groups. Finally, there were no 
significant differences found for the uptake of PEGylated liposomes functionalized 
with the different ruthenium complexes [1](PF6)2 – [4](PF6)2, which suggests that once 
supported on liposomes, the exact structure of the complex is of minor importance 
regarding cellular uptake.  
According to these data the uptake of liposomes with ruthenium seemed to be lower 
than that of liposomes without ruthenium. However, since uptake data were based on 
the fluorescence intensity of an NBD-PC lipid incorporated in the membrane, the 
presence of the ruthenium complex at the liposome surface might affect the uptake 
data, as it might influence (for example by quenching) the fluorescence of the NBD 
dye. In addition, both the NBD-PC lipid and the ruthenium complex have absorbance 
maxima around 450-460 nm, and the presence of the Ru complex in the sample might 
filter the excitation of the NBD dye, leading to artificially lower emission intensities. 
The effect of the presence of the ruthenium complex at the membrane on NBD-PC 
emission was checked for different concentrations of complex [1](PF6)2 in PEGylated 
DOPC liposomes (DOPC:DSPE-PEG2K:NBD-PC(92:4:4)) (Appendix V, Figure 
AV.1). In PBS buffer the emission of NBD-PC in the liposome membrane indeed was 
found to depend on the amount of ruthenium present in the same membrane. With 5 
mol% ruthenium the fluorescence intensity was decreased by more than 80%, 
compared to the emission of a similar liposome without ruthenium. Thus, based on this 
quenching factor the raw uptake data for DOPC stealth liposomes functionalized with 
[1](PF6)2 were corrected (Figure 5.4b). According to this correction, the uptake of 
liposomes functionalized with complex [1](PF6)2 was found to be much higher, in both 
cell lines, than that of Ru-free DOPC liposomes (22.6 vs. 3.6 for A2780 cells, and 22.5 
vs. 3.1 for A2780 R cells). These results are consistent with the conclusions drawn 
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from confocal microscopy images measured with HepG2 cells, that the presence of Ru 
complexes at the surface of neutral liposomes enhances liposome uptake.  
Because of the fluorescence-quenching problem the uptake results shown in Figure 
5.3a do not provide quantitative information about the amount of ruthenium complex 
taken up by the cells. In an attempt to better quantify ruthenium uptake the cells were 
lysed using NaOH and the ruthenium concentration in the cell lysis was measured by 
ICP-OES (see Appendix V). Unfortunately, the concentration of ruthenium in most of 
the samples was too low to be detected by ICP-OES ([Ru] ≤ 20 ppb). 
 
Figure 5.4. a) Cellular uptake of DOPC (dark grey) and DOPG (light grey) stealth (4% PEG) 
liposomes containing 5 mol% RuSRR’ by A2780 and A2780 R human ovarian cancer cells. (b) 
Uptake data corrected for NBD fluorescence quenching by ruthenium for DOPC stealth liposomes 
containing 5 mol% of complex [1](PF6)2. Incubation conditions: bulk lipid concentration [lipid]tot= 
1.5 mM (as liposomes) in PBS:DMEM (−FCS, +PS, +ph. red) 8:5 medium, total ruthenium 
concentration [Ru]tot = 0.075 mM, incubation time =1 h, T = 310 K, 7% CO2, in the dark. Control 
wells contained untreated cells. 
In order to investigate how cellular uptake was influenced by PEG groups at the 
liposome surface and by the lipid charge, uptake experiments were performed on 




[1](PF6)2. The fluorescent liposomes were composed of neutral (DOPC) or negatively 
charged (DOPG) lipids, 0 or 4 mol% DSPE-PEG2K and also an additional 5 mol% 
[1](PF6)2. All liposomes were prepared by extrusion in PBS buffer and characterized 
by DLS  (diameter~140 nm) prior to incubation with the cells.  
 
Figure 5.5. Effect of PEGylation on cellular uptake by A2780 or A2780 R human ovarian cancer 
cells of DOPC (dark grey) and DOPG (light grey) liposomes containing 5 mol% [1](PF6)2. Liposome 
formulations: DOPC:DSPE-PEG2K:NBD-PC (92:4:4), DOPG:DSPE-PEG2K:NBD-PC (92:4:4), 
DOPC: NBD-PC (96:4),  or DOPG: NBD-PC (96:4).  Incubation conditions: bulk lipid concentration 
= 1.5 mM (as liposomes) in PBS:DMEM (−FCS, +PS, +ph. red) 8:5, bulk ruthenium concentration 
[Ru]tot = 0.075 mM, exposure time = 1 h, T = 310 K, 7% CO2, in the dark. Control wells contained 
untreated cells. 
The uptake data (see Figure 5.5) show that for both cell lines the uptake of non-
PEGylated DOPC liposomes was more than twice higher than that of PEGylated 
liposomes. Assuming that the effect of PEGylation on the fluorescence quenching is 
negligible, PEGylation thus significantly decreases the uptake of neutral liposomes. 
Moreover, the decrease in cellular uptake of PEGylated liposomes was more distinct 
for DOPC liposomes in A2780 cells than in A2780R cells. For negatively charged 
DOPG liposomes, uptake of PEGylated liposomes was only slightly lower than that of 
non-PEGylated liposomes in both cell lines. For non-PEGylated liposomes DOPC 
liposomes were taken up in higher amounts than DOPG liposomes in both cell lines. 
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This observation is in agreement with the results obtained for HepG2 cells; the 
difference in uptake can be assigned to the higher influence of positive charges of the 
ruthenium complexes at the surface of neutral DOPC liposomes, compared to that of 
the same dicationic complexes at the surface of negatively charged DOPG liposomes. 
Overall, cellular uptake decreases upon PEGylation, and positive ruthenium complexes 
at the liposome surface increase the cellular uptake of ruthenium functionalized 
liposomes in absence of PEGylation. 
5.2.3.2. Cytotoxicity 
In photoactivated chemotherapy the aim is to activate the anticancer complex using 
light irradiation. Ideally, liposomes functionalized with ruthenium complexes should be 
non-toxic (or less toxic) in the dark. The dark cytotoxicity of DOPC or DOPG 
PEGylated liposomes functionalized with ruthenium complexes was determined for 
A2780 and A2780 R cell lines. Each formulation consisted of DOPC:DSPE-PEG2K 
(96:4) or DOPG:DSPE-PEG2K (96:4) mixtures containing 0 or 5 mol% of one of the 
ruthenium complexes [1](PF6)2 – [4](PF6)2. Dark cytotoxicity was determined after 6 h 
liposome exposure. After incubation the liposomes were removed and cells were 
incubated in drug-free cell culture medium for 24 h. Then the metabolic activity of the 
cells was determined using the WST-1 cell proliferation reagent.
[39]
 In this protocol a 
known quantity of the WST-1 reagent is added to each well, the cells are incubated, 
and the absorbance W is measured at 450 nm. The formation of a formazan dye is 
correlated to the metabolic activity of the cells, which can be measured and compared 
to reference cells. In order to differentiate a large number of poorly active cells from a 
small number of highly active cells, the metabolic activity obtained by the WST-1 
assay was corrected for the amount of cells in each well by dividing the absorbance 
values W by the protein content Aprot of each well as determined in a BCA assay. In 
order to discuss cell survival, the obtained W/Aprot values (corrected metabolic activity) 
were compared to the corresponding value for untreated cells (W/ Aprot)ctrl =1 or 100%).  
The dark cytotoxicity data (Figure 5.6) show that all PEGylated liposomes, with or 
without ruthenium, exhibited comparably low toxicity against A2780 and A2780 R 
cells, with cell survival of 70% and 100%, respectively. Thus, no difference was 
observed between the four different ruthenium complexes and the liposomes were only 
slightly toxic to A2780 cells and not toxic to A2780 R cells. A low toxicity was 
observed for A2780 cells treated with liposomes without ruthenium, which suggests 
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that the toxicity observed in presence of the Ru complex is not due to the metal 
complexes but to the liposome support. In presence of PEG groups the toxicity of the 
liposomes was not influenced by the lipid charge (DOPC vs. DOPG) in both cell lines.  
 
Figure 5.6. Metabolic activity (W/Apro) of A2780 and A2780 R cells exposed to DOPC (dark grey) 
and DOPG (light grey) stealth liposomes (4 mol% DSPE-PEG2K) with 5 mol% of ruthenium 
complexes. Metabolic activity of untreated cells (control) is 100%. Conditions: bulk lipid 
concentration = 1.5 mM (as liposomes) in PBS:DMEM (−FCS, +PS, −ph. red) (8:5), bulk ruthenium 
concentration [Ru]tot = 0.075 mM, drug exposure time = 6 h, T = 310 K, 7% CO2, in the dark. 
Light cytotoxicity experiments were performed on HepG2 cells exposed to neutral 
(DMPC) or negatively charged (DMPG) liposomes containing 0 or 5 mol% of complex 
[1](PF6)2. Cells were exposed to the liposomes for 30 min, and after removing the 
liposome solutions each well was irradiated with blue light (λe=452 nm, power: 69 
mW) for 15 min at 37 °C. The metabolic activity of the cells was measured after 24 h 
incubation in drug-free medium in the dark using the WST-1 assay as explained above. 
A control cytotoxicity experiment was also performed in the dark to evaluate the effect 
of light irradiation with HepG2 cells. As shown in Figure 5.7 for all liposome samples, 
i.e., with or without ruthenium, cell survival was lower after light exposure compared 
to non-irradiated cells. The best phototoxic activity was obtained for DMPC liposomes 
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higher than dark toxicity. For DMPG liposomes with or without ruthenium light 
cytotoxicity was found to be about 1.6 times higher than dark cytotoxicity. 
After irradiation, the metabolic activity of cells treated with DMPC liposomes 
containing [1](PF6)2 was lower than that of cells treated with DMPC liposomes without 
ruthenium. This might be related to the photoactivation of the ruthenium complex 
[1](PF6)2  and releasing the corresponding ruthenium aqua complex inside the cells. In 
the case of DMPG liposomes the metabolic activity with and without ruthenium was 
almost the same after light exposure. For DMPG liposomes deprived of ruthenium this 
may be explained by the absence of light-sensitive element in the liposomes 
formulation, and the lower metabolic activity might simply be the result of the action 
of blue light on the cells. For Ru-functionalized DMPG liposomes the uptake was low 
(Figure 5.3), explaining the limited effect of Ru on phototoxicity.  
 
Figure 5.7. Metabolic activity W/Aprot (see text) of HepG2 cells exposed to non-PEGylated DMPC or 
DMPG liposomes containing 0 or 5 mol% [1](PF6)2 irradiated with blue light (light grey bars) or kept 
in the dark (dark gray bars); metabolic activity of untreated cells (control) is 100%. DMPG+Ru or 
DMPC+Ru represent DMPC or DMPG liposomes containing 5 mol % [1](PF6)2. Conditions: bulk 
lipid concentration = 2 mM (as liposomes) in phosphate buffer (I=50 mM):PBS: (2:3), bulk 
ruthenium concentration [Ru]tot = 0.1 mM, drug exposure time = 30 min, T = 37 °C, 7% CO2. 
Irradiation parameters: λe=452 nm (blue light), light power=69 mW, incident spot diameter = 2.3 cm, 
light intensity: 17 mW.cm−2. 
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5.3 Discussion  
The uptake data disclosed herein allow for concluding about an optimal liposome 
formulation. Using PEGylated liposomes decreased liposome uptake by A2780 and 
A2780 R cells compared to PEG-free formulations, and lowered the effect of positive 
charge of Ru on cellular uptake. However, PEGylated liposomes are highly beneficial 
for in vivo applications uses as mentioned in the introduction. Actually, finding a 
compromise between uptake and clearance from the blood stream is not easy; based on 
the results reported in this chapter 4 mol% PEG in the liposome formulation seems 
good enough to obtain liposome uptake, in agreement with literature data advocating 
for ~5 mol% of PEG groups for in vivo applications.
[40-41]
 
Cytotoxicity data are not yet complete and suffer from poor statistics. However, initial 
data disclosed in this work are promising, since liposomes functionalized with 
ruthenium, either PEGylated or non-PEGylated, showed low dark cytotoxicity against 
HepG2, A2780 and A2780R cancer cell lines. The poor dark toxicity seems as an 
advantage for photoactivated chemotherapy (PACT); because in PACT it is the 
difference in the dark toxicity and the light cytotoxicity that needs to be maximized. In 
addition high phototoxicity was obtained against HepG2 cells using blue light 
irradiation (452 nm).  Phototoxicity data on A2780 and A2780R cells are not available 
yet due to technical problems in the experimental setup used to irradiate cancer cells. 
Light cytotoxicity was only measured for one ruthenium complex supported on PEG-
free liposomes and one type of cancer cells, and these experiments should be 
performed for the other complexes as well, supported on PEGylated liposomes, and for 
other cancer cell types. Several critical parameters need to be better controlled or 
changed in future experiments. For example, the irradiation condition was not optimal, 
since during irradiation of one well the other wells were not kept in the presence of 
CO2. Although irradiation time was not too long, the absence of CO2 might also cause 
cell death. In addition, the drug exposure time for HepG2 cells was very short (30 min) 
and may not be representative for what happens in vivo. Longer drug exposure times 
should be investigated to see if different cytotoxicities after light irradiation are 
observed.  
As stated by the cellular uptake results, considering the too high detection limit of ICP-
OES ruthenium uptake could not be measured using this technique. In absence of the 
more sensitive ICP-MS apparatus in the laboratory a fluorescent lipid, NBD-PC, was 
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included in the liposomes to measure the uptake of the Ru-functionalized liposomes by 
fluorescence spectroscopy. The fluorescence of the NBD-PC lipid, however, was 
quenched in presence of ruthenium within the same bilayer membrane, as proven for 
complex [1](PF6)2 on DOPC liposomes. The quenching correction for this formulation, 
however, cannot be generalized for other liposome formulations, as it may be 
influenced by the detailed structure of the ruthenium complex, by the nature and charge 
of the lipid, and/or by the presence of PEG groups. Thus, quenching measurements 
should be performed for each liposome formulation to obtain reliable cell uptake data. 
In addition, it may be possible that fluorescence quenching in the cellular environment 
is different from quenching in PBS buffer, as the liposome bilayer might be modified 
upon entering the cell. Finally, uptake results based on the fluorescence of the NBD-PC 
lipid would only be correlated to ruthenium uptake if the Ru-S bond is stable and holds 
the metal complex at the surface of the lipid bilayer in the dark in the cell environment. 
In this ideal case, cellular uptake of the fluorescently labeled, Ru-functionalized 
liposomes would indeed mean that the ruthenium prodrug is also taken up by the cells, 
and that fluorescence data can be interpreted as Ru uptake, after quenching corrections. 
The thermal stability at 4 °C of the Ru-S bond on DOPC liposomes was good for 
complex [3](PF6)2, but such stability cannot be generalized to other complexes, and it 
should also be proven at 37 °C and in the buffer:medium solution used to incubate the 
cells. Overall, uptake data based on the method outlined above are only indicative, and 
a better measurement of ruthenium uptake would be achieved using a more sensitive 
and reliable method such as ICP-MS.  
5.4 Conclusion 
Based on the kinetic, uptake, and cytotoxicity data described in this chapter a number 
of conclusions can be drawn. First, liposomes made of neutral lipids such as DOPC or 
DMPC are better than negatively charged liposomes based on DOPG or DMPG for 
supporting the lipophilic Ru polypyridyl complexes [1](PF6)2 – [4](PF6)2. The 
photosubstitution quantum yields are higher, and the uptake of the slightly positively-
charged liposomes resulting from neutral liposomes and 5 mol% of dicationic 
ruthenium complexes is better. Even though the cytotoxicity in the dark is not different 
from that of liposomes built from negatively charged lipids, their phototoxicity after 
blue light irradiation on HepG2 cells is higher, probably as a result of a higher uptake. 
The presence of PEG groups at the surface of the liposomes levels out the difference in 
Chapter 5 
142  
uptake between Ru-functionalized liposomes built from neutral lipids and those based 
on negatively charged lipids (at least for A2780 and A2780R cells), and also resulted in 
decreased liposome uptake for both DOPC and DOPG liposomes as a result of the 
steric hindrance of the PEG groups.  
The DOPC and DOPG PEGylated liposomes with or without ruthenium were taken up 
by A2780 and A2780 R cells in 1 h treatment. The uptake seemed poorly affected by 
the nature of the ruthenium complexes for both cell lines. However, due to the 
quenching of fluorescence of NBD-PC by the nearby ruthenium complexes, the uptake 
results based on fluorescence data cannot strictly be interpreted quantitatively. Dark 
cytotoxicity results showed that DOPC and DOPG PEGylated liposomes 
functionalized with any of the four ruthenium complexes [1](PF6)2 – [4](PF6)2 were 
poorly toxic against A2780, or A2780 R cells after 6 hour incubation, and that no 
difference in toxicity was observed between formulations. On the other hand, cell 
survival after light irradiation of HepG2 cells treated with non-PEGylated DMPC or 
DMPG liposomes were lower than that of cells kept in the dark, whether ruthenium (as 
complex [1](PF6)2) was present or not.  
Overall, liposomes functionalized with polypyridyl ruthenium complexes such as 
[1](PF6)2 are promising light-activatable anticancer prodrugs as they are stable in the 
dark, taken up by cancer cells, poorly toxic in the dark, and more toxic after visible 
light irradiation. Light toxicity data suggest that light, ruthenium (as complex 
[1](PF6)2), and lipids, may be combined in a cancer cell to lead to cell death. However, 
it is not yet proven that such phototoxicity is related to the photosubstitution reaction 
that can be measured in a UV-vis cell or in an NMR tube. More studies will be needed 
to conclude on that, in particular, more data are needed with better statistics, the 
influence of the structure of the ruthenium complex on the phototoxicity should be 
assessed, as well as the influence of e.g. oxygen concentration, irradiation intensity, or 
irradiation time on phototoxicity must be determined. Finally, in order to conclude on 
the potential interest of Ru-functionalized liposomes in anticancer therapy, IC50 values 
in the dark and after light irradiation are needed, as well as dark and light toxicity data 
on healthy cells and in in vivo models of cancer. 
Liposomes functionalized with Ru complexes in drug delivery 
143 
5.5 Experimental 
5.5.1. Materials and methods 
Pymi,[42] [Ru(terpy)(pymi)Cl]PF6,
[42] [Ru(terpy)(bpy)Cl]Cl,[43] ligand 6,[44] ligand 5,[36] and 
([1](PF6)2)
[45] were synthesized according to literature procedures. Cholesterol, 
dicyclohexylcarboiimide (DCC), 4-N,N-dimethylaminopyridine (DMAP), AgBF4, and 
AgPF6 were bought from Sigma-Aldrich. 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC), 1,2-dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) sodium salt (DMPG), and 
1-acyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-
phosphocholine (NBD-PC), were purchased from Avanti Polar Lipids. 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
sodium salt (DOPG), and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycol)-2000] ammonium  salt (DSPG-2KPEG), were bought from 
Lipoid. All lipids were stored at −20 °C. Syntheses of the metal complexes were performed 
in the absence of light and under argon. PierceTM BCA Protein Assay was purchased as a 
kit from Thermo Scientific (product #23227). Cell Proliferation Reagent WST-1 was 
purchased as a kit from Roche Diagnostics (product #05015944001). All media, buffers and 
sterile plastics used for in vitro experiments were purchased from SPL Life Sciences or 
SARSTEDT AG & Co.  
1H and 13C NMR spectra were recorded on a Bruker 300 DPX spectrometer at 25 °C (The 
notations for proton attribution are shown in Figure 5.1). Chemical shifts are indicated in 
ppm relative to TMS. Characterization of the liposomes (average size and PDI) was done 
using a Dynamic Light Scattering (DLS) Zetasizer instrument (λirr = 632 nm) from 
Malvern. Electrospray mass spectra were recorded on a Finnigan TSQ-quantum instrument 
by using an electrospray ionization technique (ESI-MS). High resolution mass spectrometry 
was performed using a Thermo Finnigan LTQ Orbitrap mass spectrometer equipped with 
an electrospray ion source (ESI) in positive mode (source voltage 3.5 kV, sheath gas flow 
10, capillary temperature 275 ºC) with resolution R = 60.000 at m/z = 400 (mass range = 
150-200) and dioctylphtalate (m/z = 391.28428) as "lock mass". Elemental analysis for C, 
H, N, and S was performed on a Perkin-Elmer 2400 series II analyzer. UV-vis spectra were 
obtained on a Varian Cary 50 UV-vis spectrometer. The irradiation setup was a LOT 1000 
W Xenon arc lamp, fitted with a 400FH90-50 Andover standard cutoff filter and an 
Andover 450FS10-50 (λe=452 nm, Δλ1/2=8.9 nm) interference filter. Photon fluxes of the 
irradiation setup was measured using the ferrioxalate actinometer.[46] Tecan M1000 PRO 
plate reader was used for fluorescence or absorbance measurement of multi-well plates for 
in vitro experiments. The ruthenium concentration after uptake was measured by 
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inductively coupled plasma atomic emission spectroscopy (ICP-OES) on a Varian VISTA-
MPX spectrometer. A Beckman Optima™ L-90K Ultracentrifuge machine was used for 
ultracentrifugation experiments. 
5.5.2. Synthesis   
Compound 7. Cholesterol (200 mg, 0.52 mmol) and N-acetyl-L-methionine (100 mg, 0.52 
mmol) were dissolved in anhydrous benzene (10 mL) under argon atmosphere. DCC (140 
mg, 0.68 mmol) and DMAP (2 mg, 0.02 mmol, 3%) were added and the mixture was stirred 
vigorously for 12 hours, after which the solution was filtered to remove insoluble materials. 
The solvent was evaporated under vacuum by rotary evaporation. The crude product was 
purified by column chromatography on silica gel (petroleum ether/EtOAc 70:30). The 
solvents were evaporated by rotary evaporation at 30 ºC, and compound 7 was obtained as a 
white sticky solid. Yield: 50% (150 mg, 0.26 mmol). 1H NMR (300 MHz, CDCl3) δ 6.13 
(m, J= 8,18  Hz, 1H, δ), 5.38 (m, J= 4,09  Hz, 1H, 6), 4.70-4.64 (m, 3H, 3, γ), 3.44 (m, 1H, 
NH), 2.33 (m, 2H, β), 2.10 (s, 3H, α), 2.03 (s, 2H, 4). 13C NMR (75 MHz, CDCl3) δ 171.70 
(Cθ), 169.96 (Cε), 139.30 (C5), 123.18 (C6), 75.65 (C3), 56.79, 56.24, 51.90 (Cγ), 50.11, 
39.81, 39.62, 38.07 (Cβ), 36.98, 36.68, 36.29, 33.73, 32.22, 32.01, 31.93 (Cα), 30.05, 
28.33, 28.12, 27.82, 27.79, 25.60, 24.93, 23.93, 23.36, 22.93, 21.14 (C4), 19.42, 18.83, 
15.67, 11.96. ES MS m/z (calc): 560.1 (560.4, [M+H]+), 369.2 (369.4, [M-(acetyl-L-
methionine)]+). Elemental analysis (%) for C34H57NO3S.H2O: (calc); C 70.66, H 10.30, N 
2.43, S 5.54; (found); C 70.45, H 9.99, N 2.99, S 5.46. 
General procedure for the synthesis of [2](PF6)2, [3](PF6)2, or [4](PF6)2. [Ru(terpy)(N-
N)(Cl)](Cl) (0.1 mmol), thioether-cholesterol ligand 6 or 7 (0.15 mmol), and AgBF4 (0.2 
mmol) were dissolved in acetone (30 mL). The reaction mixture was refluxed overnight for 
24 h in the dark, then it was filtered hot over celite, and the solvent was removed by rotary 
evaporator under reduced pressure. The product was purified by column chromatography 
on silica gel (acetone/H2O/sat. aq. KPF6 (100:10:1.5) or (80:20:4)). The acetone was 
removed from the collected fractions under vacuum, upon which the product precipitated as 
an orange solid. The product was filtered, washed with water and dried under vacuum for at 
least 4 h. 
[2](PF6)2. Yield: 52%. 
1H NMR (300 MHz, δ in CDCl3)  9.72 (d, J = 5.3 Hz, 1H, A6), 8.55 
(m, J = 8.2 Hz, 3H, A3 + T3’), 8.41 (d, J = 7.9 Hz, 2H, T3), 8.34 (d, J = 8.0 Hz, 1H, B3), 
8.27 – 8.14 (m, 2H, A4 + T4’), 8.03 – 7.85 (m, 3H, A5 + T4), 7.74 (t, 1H, B4), 7.68 (d, J = 
5.0 Hz, 2H, T6), 7.36 (m, 2H, B5 + B6), 7.16 (m, 2H, T5), 5.30 (d, J = 4.8 Hz, 1H, 6), 3.75 
(t, J = 6.6 Hz, 2H, ζ ), 3.64 – 3.37 (m, 10H, α + β + γ + δ + ε), 3.13 (s, 1H, 3), 2.40 – 0.75 
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(m, 47H), 0.67 (s, 3H). 13C NMR (75 MHz, δ in CDCl3) 157.67 + 157.01 + 156.31 + 
156.29 ( B2+ A2 + T2 + T2’), 153.18 (T6), 151.95 (A6), 149.80 (B6) , 140.86 (5),139.09 
(T4), 138.56 +138.37 (B4 + A4), 137.56 (T4’), 128.91 (T5), 128.35 (A5), 127.87 (B5), 
125.16 (T3), 124.85 (A3), 124.48 (T3’), 124.03 (B3), 121.86 (6), 79.56 (3), 70.88 + 70.35 + 
70.30 + 67.52 + 67.30 (α + β + γ + δ + ε), 56.86, 56.28, 50.26, 42.44, 39.88, 39.64, 39.22, 
37.28, 36.97, 36.31, 35.91, 34.47, 32.06, 32.01, 29.82, 28.35, 28.13, 24.42, 23.97, 22.95, 
22.69, 21.19, 19.53, 18.85, 15.04, 12.00. UV-vis: λmax (ε in L·mol
−1·cm−1) in CHCl3: 457 
nm (6100).  ES MS m/z exp (calc): 519.7 (519.4, [M−2PF6]
2+). Elemental analysis for 
C59H79F12N5O3P2RuS: (calc); C, 53.31; H, 5.99; N, 5.27; S, 2.41.  (Found); C, 53.34; H, 
6.22; N, 5.15; S 2.41. 
[3](PF6)2. Yield: 28%. 
1H NMR (300 MHz, acetone-d6) δ 9.98 (d, J= 7.5 Hz, 1H, 6A), 8.95 
(m, 3H, 3T’,3A), 8.78(d, J= 7,5 Hz, 2H, T6), 8.71(d, J= 7,5 Hz, 1H, 6B), 8.56-8.47 (m, 2H, 
T4’,4A), 8.23-8.13 (m, 3H, T5, 5A), 8.04-8.00 (m, 3H, T3, 5B), 7.57-7.54 (m, 3H, 3B, T4), 
7.31 (m, 1H, 4B), 7.17 (d, J= 7,5, 1H, δ), 5.35 (m, 1H, 6), 4.45-4.42 (m, 2H, γ, 3). 13C NMR 
(75 MHz, acetone-d6) δ 171.21 (θ), 170.47 (ε),  159.01, 158.43, 157.79, 157.67, 154.43, 
154.41, 153.35, 151.01, 140.40 (5), 139.99, 139.95, 139.24, 139.19, 138.05, 129.60, 
129.56, 128.90, 128.25, 126.06, 125.68, 125.35, 124.84, 123.46 (6), 75.67 (3), 57.57, 57.06, 
51.32 (γ), 51.01, 43.11, 40.61, 40.26, 38.68 (β), 37.66, 37.33, 36.96, 36.59, 32.70 (α), 
32.59, 31.12, 30.61, 28.69, 28.35, 24.92, 24.53, 23.07, 22.83, 21.74 (4), 19.65, 19.14, 
14.04, 12.23.  UV-vis: λmax in nm (ε in L·mol
−1·cm−1) in CHCl3: 460 nm (8310). ES MS m/z 
(calc): 1195.9 (1195.4, [M−PF6]
+), 525.7 (525.2, [M−2PF6]
2+). HRMS m/z (calc): 
525.23715 (525.23685, [M−2PF6]
2+). 
[4](PF6)2. Yield: 34%.  
1H NMR (300 MHz, acetone-d6) δ 10.04-10.02 (d, J = 7.3 Hz, 1H, 
6Py), δ 9.09 (s, 1H, i), δ 8.69 (d, J=6.8 Hz, 3H, T6 +3Py), 8.59 (d, J = 8.1 Hz, 2H, 
T3’+T5’), 8.53 (t, J = 7.7 Hz, 1H, 4Py), 8.39 – 8.16 (m, 4H, 5T, 5Py, T4’), 8.08 (dd, J = 
11.6, 5.4 Hz, 2H, T3), 7.81 – 7.62 (t, J = 8.1 Hz, 2H, T4), 7.14 (t, J = 8.2, 2H, p-Ph + δ), 
7.00 (t, J = 7.8 Hz, 2H, o-Ph), 6.00 – 5.87 (d, 7.2 Hz, 2H, m-Ph), 5.34 (s, 1H, 6), 4.43 (d, J 
= 8.5 Hz, 2H, γ + 3), 3.62 – 3.44 (m, 1H, ε) 2.24 (s, 2H, β), 1.83 (s, 5H), 1.52 (d, J = 12.3 
Hz, 5H), 1.00 (s, 4H), 0.94 (d, J = 6.5 Hz, 3H), 0.86 (dd, J = 6.6, 1.0 Hz, 6H), 0.71 (s, 3H). 
13C NMR (75 MHz, acetone-d6) δ 205.31 (θ), 170.34 (ε), 170.07 (i), 158.07 (T2 or T2’ or 
2Py), 156.77 (T2 or T2’ or 2Py), 154.18 (T3), 153.02, 147.13 (T2 or T2’ or 2Py), 139.47 
(T5), 138.05 (4Py), 136.77 (T4’), 131.44 (3Py), 129.57 (5Py), 129.23 (o-Ph), 129.06 (4T), 
129.01, 128.01 (p-Ph, 124.85 (6T), 123.73 (3T’), 122.65 (6), 119.95 (m-Ph), 74.82 (ε), 
56.72, 56.21, 50.40 (3), 50.15, 42.26, 39.76, 39.42, 37.84, 36.81, 36.48, 36.12, 35.77, 
33.80, 31.85, 31.75, 30.53, 29.79, 29.53, 29.27, 29.02, 28.76, 28.63, 28.50, 28.25, 28.07, 
27.87, 27.51, 24.09, 23.69, 22.50, 22.25, 22.00, 20.90, 18.81, 18.31, 14.47, 13.46, 11.39. 
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ES MS m/z (calc): 1221.5 (1221.45, [M –PF6]
+), 707.0 (707.1, [M –2PF6–cholesteryl]
+), 
538.3 (538.2, [M–2PF6)]
2+). UV-vis: λmax (ε in L·mol
–1·cm–1) in acetone: 475 nm (10300). 
Elemental analysis for C61H78F12N6O3P2RuS: calc: C 53.62, H 5.75, N 6.15, S 2.35 found: 
C 54.44, H 5.66, N 5.98, S 1.45. 
5.5.3. Liposome preparation 
Stock solutions of phospholipids (5.0×10−3 M in CHCl3 or CHCl3:CH3OH (4:1)) and of 
ruthenium complexes [1](PF6)2 – [4](PF6)2 (5.0×10
−4 M in CHCl3) were prepared and stored 
at −20 °C. The stock solutions were mixed in proportions corresponding to the desired 
liposome formulation. The solvents of the lipid mixture were evaporated to form a lipid 
film at the bottom of a glass tube. Traces of solvent were removed under high vacuum for 
at least 1 h. Each sample was then hydrated with the desired buffer (PBS: Phosphate 
Buffered Saline or chloride-free phosphate buffer: 10 mM of phosphates, I = 50 mM, pH = 
6.97) at 50 °C. The bulk lipid concentration in each sample was 2.50 mM and the 
ruthenium concentration for ruthenium-functionalized liposomes was 0.125 mM. Each 
sample was put through at least 10 freeze/thaw cycles (from liquid nitrogen to 50 °C) until 
a clear solution was obtained. The liposome solution was then extruded at least 11 times at 
50 °C using the Avanti Polar Lipids mini-extruder fitted with a 200 nm pore diameter 
Whatman polycarbonate filter. After extrusion, the samples were characterized by Dynamic 
Light Scattering (DLS) at 25 °C to determine the average diameter (130 – 140 nm in 
general). The samples were stored in the dark at 4 °C if not used right away. 
5.5.4. Light irradiation of liposome samples and UV-vis experiments 
A liposome sample (1.5 mL) containing phospholipids (2.5 mM) and a ruthenium complex 
[1](PF6)2, [2](PF6)2, [3](PF6)2, or [4](PF6)2 (5 mol%, 0.125 mM) in a phosphate buffer 
solution, (I=50 mM, pH=7.0) was placed into a UV-vis cell. 1.5 mL of the phosphate buffer 
solution was added to the cuvette. The final concentrations of the lipid and of the ruthenium 
complex in the cuvette were 1.3 mM and 0.065 mM, respectively. The UV-vis spectrum of 
the sample was first measured in the dark. Then the sample was irradiated at 452 nm using 
the beam of a LOT 1000 W Xenon arc lamp filtered by an Andover bandpath filter, and 
directed into an 2.5 mm diameter optical fiber bundle bringing the light inside the 
spectrophotometer, vertically to the cuvette axis, i.e, perpendicular to the horizontal optical 
axis of the spectrophotometer (see Appendix I, Figure AI.1). The UV-vis spectrum of the 
sample was measured every 3 minutes during irradiation while stirring at 25 °C or 37 °C. 
The irradiation time varied between 2 and 6 h (depending to the kinetics of the reaction) to 
reach the photochemical steady state. The concentrations in [RuSRR’] ([1]2+ to [4]2+) was 
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determined by deconvolution knowing the extinction coefficients of both RuSRR’ and 
RuOH2 species (see Appendix I and V). The evolution of ln([RuSRR’]/[Ru]tot) was plotted 
as a function of irradiation time, and from the slope S of the plot −k at λe=452 nm was 
determined for each sample. Knowing the photon flux and probability of photon absorption 
1−10−3Ae, where Ae is the absorbance of the solution at the excitation wavelength e, the 
number of moles of photons Q absorbed at time t by RuSRR’ since te=0 was calculated. 
Plotting nRuSRR’ vs. Q gave a straight line in each case. The slope of this plot directly 
corresponds to the quantum yield of the photosubstitution reaction (see Appendix I, Section 
AI.3.2). 
5.5.5. Stability of the ruthenium-sulfur bond in PBS in the dark  
7 mL of a DOPC:DSPE-PEG2K (98:2) liposome sample containing 5 mol% of complex 
[3](PF6)2 was prepared in PBS (total lipid bulk concentration: 2.5 mM, [Ru]tot=0.125 mM). 
6.5 mL of this liposome solution was diluted with 6.5 mL of PBS (final lipid concentration: 
1.25 mM, [Ru]tot=0.065 mM). 4 mL fractions of this solution were subjected to 
ultracentrifugation (speed = 40,000 rpm, RCF = 100,000 g, T = 20 °C, time = 2 h) at 
different times (1 day, 3 days, and 7 days) after sample preparation. The ruthenium content 
of the supernatant and of the liposome sample before ultracentrifugation were measured by 
ICP-OES (sample was prepared as described in Appendix V). 
5.5.6. Cell lines and culture conditions 
The human ovarian carcinoma cell line A2780 and its cisplatin resistant analogue A2780R 
were grown as a monolayer at 37 °C in 7% CO2 atmosphere, and were maintained in a 
continuous logarithm culture in Dulbecco’s Modified Eagle Medium (DMEM) containing 
phenol red completed with 10% Fetal Calf Serum (FCS), penicillin/ streptomycin (100 
units/ml, 0.1 mg/ml, respectively), and Glutamax (2 mM). This medium will be further 
referred to as ‘DMEM (+FCS, +P/S, +ph. red). Human liver hepatocellular carcinoma cells 
HepG2 were grown in HepaRG medium at 37 °C in 5% CO2 atmosphere. 
5.5.7. Cellular uptake assay 
For cellular uptake experiments, liposome solutions containing 4% NBD-PC were prepared 
in PBS as described in section 5.5.3. 24-well plates were seeded with A2780 or A2780 R 
cells at 5.0×104 cells/well. Typically, a plate seeded with cells was pre-incubated for 3 days 
(A2780) or 2 days (A2780 R) at 37 °C in 7% CO2 atmosphere until ~100% confluence was 
reached. At the day of cells treatment with the liposome sample, cell culture medium in the 
wells was replaced with fresh medium DMEM (−FCS, + P/S, +ph. red) at 37 °C 1.5 h 
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before treatment. 800 µL of liposome solution in PBS was diluted with 500 µL of DMEM 
(−FCS, + P/S, +ph. red) (total lipid bulk concentration =1.5 mM, ruthenium concentration = 
0.075 mM). Before incubating the cells with liposome solutions, the medium was aspirated 
from each well. Then the cells were exposed to 300 µL of liposome-DMEM solution for 1 
h at 37 °C in 7% CO2 atmosphere in the dark. Control wells were filled with 300 µL of a 
PBS:DMEM (−FCS, +PS, +ph. red) (8:5) mixture. After 1 h liposome exposure, the 
liposome solution was removed and the cells were gently washed once with 1 mL PBS. 
Then 500 µL of PBS was added to each well and the fluorescence of NBD-PC lipids taken 
up by the cells was read with a fluorescence spectrophotometer (λexc = 460 nm, λem = 534 
nm). PBS was then removed, 500 µL of 0.2 M NaOH was added to each well, and the plate 
was rocked at r.t. for 1 hour to lyse the cells. The cell lysis was either used directly in a 
BCA protein determination assay or stored at −20 °C for later use in a BCA protein assay 
(see section5.5.8). To determine the cellular uptake, the fluorescence measurement F for 
each well, due to the NBD-PC lipids, were divided by the absorbance values Aprot obtained 
from the BCA assay. Finally, F/Aprot for each well was divided by (F/Aprot)ctrl of the well 
containing cells that were not treated with liposomes, to obtain the “fold increase of F/A” as 
compared to the control (normalized values for control = 1 or 100%). The obtained value 
represents the cellular uptake of each liposome sample. The ruthenium content of the cell 
lysis was measured by ICP-OES as well (see Appendix AV.2 for the sample preparation 
protocol). 
5.5.8. BCA protein determination assay  
Protein determination was done using the BCA (bicinchoninic acid) protein determination 
assay (PierceTM BCA Protein Assay Kit, Thermo Scientific). For this assay, a working 
reagent was prepared from reagents included in the BCA protein assay kit: Reagent A: 
Bicinchoninic acid and tartrate in an alkaline carbonate buffer solution. Reagent B: 4% 
CuSO4.5H2O (aqueous solution). The working reagent was prepared by mixing reagent A 
and B in a volumetric ratio of 50:1. For the BCA assay, a 96-well plate was filled with 200 
µL of the working reagent in each well. 25 µL of the cell lysis (in 0.2 M NaOH) after 
cytotoxicity or uptake experiment (cells were killed in NaOH 0.2 M) was mixed with the 
working reagent in the corresponding wells of the 96-wells plate. As a control, 25 µL of 
Milli-Q was added to 200 µL working reagent. After addition, the working reagent and the 
cell lysis solutions were properly mixed. The plate was then protected from light and 
incubated at 37 °C and 7% CO2 for 30 minutes, and the absorbance (Aprot) of each well in 
the plate was then measured at 562 nm using a Tecan M1000 PRO plate reader. 
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5.5.9. Confocal microscopy measurements 
Confocal microscopy culture dishes (cover glass bottom dish, 35×10 mm, gamma 
irradiated, SPL Life Sciences) were incubated with fibronectin (0.0005%; 1:200 dilution, 
Sigma-Aldrich, F1141) in 0.9% NaCl for 1-2 h at 37 °C. Typically, 300 µL is used per well 
in an 8-well plate. This volume should be corrected for well surface if wells of other 
dimensions are used. HepG2 cells (3.2×105) were seeded on confocal microscopy culture 
dishes (on the cover glass only) and grown for 24 h in HepaRG medium (volume = 2.5 
mL)at 37 °C in an atmosphere of 5% CO2. Before incubation with liposomes (containing 
5% fluorescent NBD-PC lipid) in order to do fluorescence measurements, the growth 
medium was aspirated and replaced with 1.5 mL of fresh William’s E Medium containing 
penicillin/streptomycin (100 unit/mL and 0.1 mg/mL, respectively) and glutamax (2mM), 
equilibrated at 37 °C. Next, 500 µL of the liposome suspension (lipid concentration = 0.50 
mM in chloride-free phosphate buffer:PBS (1:4), ruthenium 0 or 5 mol%) was added to the 
culture dish. The cells were incubated for 1 h at 37 °C in an atmosphere of 5% CO2 and 
95% air. Before confocal microscopy, cells were washed 3 times with 2 mL PBS 
equilibrated at 37 °C. 2 mL of PBS was added to the culture dish and the cells were imaged 
by confocal microscopy (Leica Microsystems, SP2 confocal microscope, 63 times oil 
immersion objective). 
5.5.10. Dark cytotoxicity assay  
A2780 or A2780 R cells were seeded at 5.0×104 cells/well and grown in 500 µL DMEM 
(+FCS, +PS, + ph. red) in 24 well-plates. No cells were seeded in well F4. The plates were 
pre-incubated for either 2 days (A2780 R) or 3 days (A2780) at 37 °C in 7% CO2 
atmosphere until ~100% confluence was reached. The medium was refreshed 1.5 h before 
exposure of the cells with liposome solutions. Liposome samples (without NBD-PC) were 
prepared in PBS before the start of the experiment as described in section 5.5.3 and diluted 
with DMEM as described in section 5.5.7. Total lipid concentration and ruthenium 
concentration were 1.5 mM and 0.075 mM, respectively. The medium was removed from 
the wells and 300 µL of liposome stock solution at r.t. was added in each well. The cells 
were then incubated for 6 h at 37 °C and 7% CO2 in the dark. After incubation, the 
supernatant was removed from the cell wells. The cells were washed once with 1 mL of 
PBS at r.t and 500 µL of fresh DMEM (+FCS, +PS, −ph. red) was added to each well. The 
cells were then incubated for 24 h at 37 °C and 7% CO2, before measuring cell metabolic 
activity using the WST-1 assay (see section 5.5.11).  
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5.5.11. WST-1 assay  
WST-1 is a colorimetric assay for the quantification of cellular proliferation and 
cytotoxicity. As mentioned in section 5.5.10, the cells were incubated in a drug-free 
medium for 24 h prior to perform WST-1 assay. After 24 h, the medium was replaced with 
250 µL of fresh DMEM (+FCS, +PS, −ph. red). Well F4 was filled with 250 µL of DMEM 
(+FCS, +PS, −ph. red) to be used as a control (no cells in this well). Absorbance of each 
well was read at 450 nm to check for possible absorption of ruthenium in the absorption 
range of WST-1 (420 to 480 nm), but the ruthenium absorption was negligible and almost 
equal to that of wells that contained no ruthenium. The plate was then incubated for 15 
minutes at 37 °C and 7% CO2, after which the cell proliferation reagent WST-1 (1/10 of the 
medium volume: 25 µL) was added to each well. The WST-1 and the medium in the wells 
were properly mixed and the plate was incubated for 60 minutes at 37 °C and 7% CO2. 
After incubation, the absorbance of the solution in each well was read again at 450 nm. The 
supernatant was then removed and cells were washed once with 1 mL of PBS at r.t. Cells 
were then lysed by adding 500 µL of 0.2 M NaOH to each well and the plate was incubated 
for 1 h at r.t. while rocking. The protein content of the cell lysis was then determined by a 
BCA assay (see section 5.5.8). WST-1 cell proliferation results W’ were corrected by 
subtracting the absorbance value found for the control well (F4) W’ctrl. The values 
W=W’−W’ctrl were then divided by the protein absorption data Aprot obtained from a BCA 
assay, to give the metabolic activity of the cells per well W/Aprot. By dividing the metabolic 
activity found for each well, by the metabolic activity of the control wells (W/Aprot)ctrl  (no 
liposomes), the values for metabolic activity (cell survival) were normalized with respect to 
control (no liposomes), which was set to be 100% cell survival. 
5.5.12. Light cytotoxicity assay  
HepG2 cells were seeded at 2.5×104 cells/well and grown in 500 µL HepaRG (+FCS, +PS, 
+ ph. red) in 24 well-plates. Control wells contained no cells. The plate was pre-incubated 
for 2 days at 37 °C in 5% CO2 atmosphere. The medium was refreshed 1.5 h before 
exposure of the cells to the liposomes. Liposome samples (without NBD-PC) in chloride-
free phosphate before (800 µL) were diluted with PBS (1200 µL). Total lipid concentration 
and ruthenium concentration were 2 mM and 0.1 mM, respectively. The medium was 
removed from the wells and 200 µL of liposome stock solution at r.t. was added to each 
well in the dark and the cells were incubated for 30 min at 37 °C and 5% CO2 in the dark. 
After 30 min liposome exposure, the liposome suspension was removed; the cells were 
washed once with 500 µL of PBS (37 °C) in the dark. Subsequently, 300 µL of HepaRG 
was added per well and the plate was incubated in the dark at 37 °C in 5% CO2 atmosphere 
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for 15 min. The plate was placed on a custom-built heated aluminum pad (37 °C, measured 
with a thermocouple, set temp water bath = 58.5 °C) and irradiated at 452 nm for 15 min 
per well (light toxicity) in an otherwise dark room (dark toxicity). The filter was cooled 
with pellets of dry ice (irradiation parameters: incident spot diameter = 2.3 cm; power = 69 
mW, light intensity: 17 mW·cm−2). After irradiation, 200 µL of HepaRG medium was 
added to each well of both plates and the cells were incubated for 1 day prior to perform 
WST-1 assay. The metabolic activity of the cells was determined as described in section 
5.5.11 and compared with the metabolic activity of the HepG2 cells which were exposed to 
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The ruthenium complex [Ru(terpy)(bpy)(Hmte)]2+ ([1]2+), where terpy is 2,2’;6’,2”–
terpyridine, bpy is 2,2’-bipyridine, and Hmte is 2-methylthioethan-1-ol, poorly absorbs 
yellow light, and although its quantum yield for the photosubstitution of Hmte by water is 
comparable at 570 nm and at 452 nm (0.011(4) vs. 0.016(4) at 298 K at neutral pH), the 
photoreaction using yellow photons is very slow. Complex [1]2+ was thus functionalized 
with rhodamine B, an organic dye known for its high extinction coefficient for yellow light. 
Complex [Ru(Rterpy)(bpy)(Hmte)]3+ ([2]3+) was synthesized, where Rterpy is a terpyridine 
ligand covalently bound to rhodamine B via a short saturated linker. [2]Cl3 shows a very 
high extinction coefficient at 570 nm (44000 M−1·cm−1), but its luminescence upon 
irradiation at 570 nm is completely quenched in aqueous solution. The quantum yield for 
the photosubstitution of Hmte by water in [2]3+ was comparable to that in [1]2+ at 570 nm 
(0.0085(6) vs. 0.011(4), respectively), which, in combination with the much higher 
extinction coefficient, resulted in a higher photosubstitution rate constant for [2]3+ than for 
[1]2+. The energy of yellow photons is thus transferred efficiently from the rhodamine 
antenna to the ruthenium center, leading to efficient photosubstitution of Hmte. These 
results bring new opportunities for extending the photoactivation of polypyridyl ruthenium 
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6.1. Introduction  
Ruthenium polypyridyl complexes are known for their rich photochemistry, which 
often requires blue light irradiation.
[1-7]
 In such complexes, photon absorption into a 
Metal-to-Ligand Charge-Transfer band (
1
MLCT) typically situated between 400 and 
500 nm, leads to the corresponding 
3
MLCT state via intersystem crossing. If the 
distortion of the octahedral coordination geometry is sufficient to decrease the ligand 
field splitting energy, further thermal population of the Metal-Centered excited states 
(
3
MC) may result in ligand photosubstitution reactions.
[8-11]
 Recently, this type of 
photoactive metal complexes have been proposed as light-activated drugs in 
phototherapy, as the aqua photoproducts may typically interact with biomolecules and 
lead to significant cytotoxicity, whereas the initial complex may not.
[12-21]
 As has been 
shown in the literature dealing with Photodynamic Therapy (PDT)
[22-24]
 light activation 
allows for controlling the amount of reactive oxygen species produced locally, which 
may contribute to limiting toxicity and side-effects during chemotherapy. On the other 
hand, blue light irradiation in vivo has a rather limited applicability for PDT since its 
tissue penetration is low.
[25-26]
 The fact that the MLCT band of most polypyridyl 
ruthenium complexes is located in the blue region has been restricting, up to now, real 
phototherapeutic applications of these complexes. Thus, it is of great interest to make 
the photoactivation of ruthenium polypyridyl complexes possible with photons of 
longer wavelengths, without sacrificing the complex stability in the dark, which is an 
important requirement in photochemotherapy. 
One strategy, recently reviewed by Brewer et al.,
[27]
 is to design complexes having 
their MLCT band at higher wavelengths. Such strategy sometimes lowers the stability 
of the complexes in the dark, but a few complexes have been published that are 
reasonably stable in the dark and photoactive using red light. A second strategy is the 
coordination of a fluorescent ligand to the ruthenium center in order to sensitize the 
metal complex with photons of higher wavelength. Mascharak and co-workers 
[28-30]
 
have used this strategy to bring the sensitization of ruthenium nitrosyl compounds from 
the UV to the visible region. Typically, direct coordination of the fluorophore to 
ruthenium promotes merging of the absorption band of both fragments, thus shifting 
light activation of the metal center towards higher wavelengths.
[31]
 A third, somewhat 
similar strategy, is to link the fluorophore to the ruthenium complex via a non-
conjugated linker and to use the “reverse” FRET effect. 
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Efficient Förster energy transfer (FRET) from a fluorophore to a ruthenium center is 
typically obtained when the 
1
MLCT absorption band of the ruthenium complex 
overlaps well with the emission band of the fluorophore. The efficiency of FRET is 
also related to the distance between the energy donor and the energy acceptor.
[32-34]
 
When the maximum of the emission spectrum of the dye is at lower wavelength than 
the absorption maximum of the ruthenium complex, forward FRET is obtained.
[35-37]
 
However, for phototherapeutic application, photoactivation of the ruthenium complex 
via forward FRET, i.e., with photons of low wavelength, is not suitable, and “reverse 
FRET” from a fluorophore with an emission maximum at a higher wavelength than 
that of the absorption maximum of the ruthenium moiety, is preferable.
[34]
 Etchenique 
and co-workers recently introduced this strategy by coordinating a green-emitting, 
rhodamine B-functionalized nitrile ligand to a chlorido- bis(bipyridine)ruthenium(II) 
compound. The use of a saturated linker avoided orbital overlap between the dye and 
the complex, and green light irradiation was shown to result in photosubstitution of the 
nitrile ligand, thus releasing the fluorophore from the ruthenium complex.
[38]
 
We report here a new photoactivatable system relying on reverse FRET, in which 
coupling of the rhodamine B dye is realized at the 4’ position of a spectator terpyridine 
ligand that is not released upon light irradiation (Figure 6.1). The photosubstitution of 





, where terpy is 2,2’;6’,2”-terpyridine, bpy is 2,2’-bipyridine, and 
Hmte is 2-methylthioethan-1-ol) is reported in Chapter 3. The absorption spectrum of 
[1]
2+ 
extends up to 610 nm and only slightly overlaps with the emission band of 
rhodamine B (λem=570 nm) (Figure 6.1b). The rhodamine B-functionalized analogue 
complex [2]
3+
 (Figure 6.1c) may thus allow energy transfer from the fluorophore to the 
ruthenium center to occur, thus leading to efficient ligand photosubstitution. The high 
extinction coefficient of the organic dye may allow for more efficient photon collection 
and thus faster photosubstitution of Hmte when excited near 600 nm, compared to 
complex [1]
2+
. In this Chapter, the rate and quantum yield for the photosubstitution of 




 are compared upon both 
yellow (570 nm) and blue (450 nm) light irradiation, in order to investigate the 
efficiency of photosensitization on the Ru-based ligand exchange process. 
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Figure 6.1. a) Chemical structure of [Ru(terpy)(bpy)(Hmte)]2+ ([1]2+). b) Absorption spectrum of 
[1]2+ (left axis) and emission spectrum of rhodamine B (right axis). c) Chemical structure of the 
rhodamine B-functionalized ruthenium complex [2]3+ and photochemical scheme. 
6.2. Results  
6.2.1. Synthesis 
In order to couple a rhodamine B molecule to the 4’ position of the 2,2’;6’,2”-
terpyridine (terpy) ligand an ethanolamine linker may seem at first sight appropriate. 
However, in basic conditions the secondary amide bond resulting from coupling 
between the primary amine of ethanolamine and the carboxylic acid of rhodamine B, 
cyclizes to a spirolactame, which leads to quenching of the fluorescence of the dye.
[39-
40]
 Thus, a secondary amine, 2-methylaminoethanol, was used instead, because the 
resulting tertiary amide cannot be deprotonated and cyclize into the spiro compound. 
The synthetic route towards ligand [4]Cl is shown in Scheme 6.1. In the first step, a 
literature procedure was modified
[41]
 to substitute the chloride substituent of 4’-chloro-
2,2’;6’,2”-terpyridine by 2-methylaminoethanol using KOH as a base, to form 
compound 3. Two structural isomers, compounds 3 (O-bound) and 3’ (N-bound) 








on the reaction time. By using a relatively low amount of KOH (2.8 eq) and short 
reaction times no side product 3’ was detected by 
1
H NMR of the crude product, and 
compound 3 could be further functionalized.  
 
Scheme 6.1. Synthetic procedure towards compound 3 and [4]Cl. (a) KOH, DMSO (dry), heating at 
60 °C for 3 h, overnight at R.T. Yield of 3: 87% (b) POCl3, C2H4Cl2 (dry), reflux, 5 h. (c) I: Et3N, 
CH3CN (dry), reflux, 14h, II: KPF6 in water, III: chloride exchange DOWEX resin, acetone:H2O 
(1:1), 4 h, r.t.  Yield: 31% (from compound 3). 
In the second step, rhodamine B was coupled to 3 following a modified literature 
procedure 
[42]
 involving the acid chloride of rhodamine B and 3 using Et3N as a base in 
acetonitrile. After precipitation from water using PF6
−
 as a counter ion, full water 
solubility was recovered by anion exchange to Cl
−
 using an anion exchange resin. 
Column chromatography on silica gel allowed removing the unreacted rhodamine B to 
afford compound [4]Cl as a purple solid with an overall yield of 31%. The UV-vis 
spectrum of [4]Cl in water (Figure 6.2a and Table 6.1) showed a red shift of the π-π* 
absorption band of about 14 nm (λabs=569 nm), compared to rhodamine B. 
Adapting known synthetic procedures
[43-45]
 the ruthenium complex [2]Cl3 was 
synthesized as shown in Scheme 6.2. Refluxing a mixture of ligand [4]Cl with 
RuCl3·3H2O in methanol resulted in the paramagnetic complex [5]Cl. Product 
formation was followed by TLC and the final product was characterized by 
paramagnetic 
1
H NMR and ESI-MS spectrometry. The unpaired electron of the Ru(III) 




H coupling and thus 
results in broad NMR signals. This effect is significant for hydrogen atoms of the 
terpyridine moiety in [5]Cl that are close to the paramagnetic ruthenium(III) center. 
Highly upfield-shifted signals were observed in methanol-d4 at −1.43 ppm, −10.26 
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ppm, −10.71 ppm and −35.94 ppm for T33’’, T44’’, T55’’, or T66’’. T3’ and T5’ are 
more remote from the paramagnetic center and their signals appear at 10.90 ppm.
[46]
 
The peaks in the 6.90-8.10 ppm region most likely correspond to the rhodamine B 
moiety and traces of the free ligand [4]Cl. In the ESI-MS spectrum a peak at 
m/z=937.7 for [5]
+
 was found that confirmed the formation of compound [5]Cl. 
 
Scheme 6.2. Synthetic route towards ruthenium complexes [5]Cl, [6](PF6)2, and [2]Cl3. (a) MeOH, 
reflux, 7 h, yield: 54%. (b) I: bpy, LiCl, NEt3, EtOH/H2O(3:1), reflux, 6 h. II: KPF6 in water. Yield: 
40%. (c) I: Hmte, AgPF6 (2.6 eq), acetone:H2O (5:3), reflux, 9 h. II: chloride exchange DOWEX 
resin, acetone:H2O (1:1), 4 h, r.t.  Yield: 43%. 
In a second step, the complex [Ru(4)(bpy)(Cl)](PF6)2 ([6](PF6)2) was obtained as a 
purple solid via treatment of [5]Cl with 2,2’-bipyridine in presence of EtN3 and LiCl in 
an ethanol/water mixture, followed by column chromatography and precipitation with 
aqueous KPF6. Finally, the water soluble, potentially photosensitive ruthenium 
complex [Ru(4)(bpy)(Hmte)]Cl3 ([2]Cl3) was synthesized by removal of the chloride 
ligand in [6](PF6)2 using AgPF6 in presence of an excess of Hmte at elevated 
temperatures. The PF6
−
 counter ions were then exchanged using a chloride-loaded 
exchange resin, to form the purple, water-soluble complex [2]Cl3. 
1
H NMR in 
methanol-d4 showed that the protons of the coordinated Hmte ligand (3.46, 1.81, and 
1.36 ppm) are shielded in [2]Cl3 compared to free Hmte (3.75, 2.80, and 2.30 ppm). 
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Moreover, the characteristic aromatic proton for [2]Cl3 at 9.80 ppm (6A) appears at 
different chemical shift compared to that in [6](PF6)2 (10.28 ppm). The high resolution 
mass spectrum showed two peaks for the product at m/z=360.45780 ([2]
3+
) and at 
m/z=540.18289 ([2–H]
2+
). Overall the analogous complexes [2]Cl3 and [1](BF4)2, 
which was synthesized as reported in Chapter 3, are soluble enough in water for 
studying their photophysical properties and the photosensitivity of their Ru-S bond. 
6.2.2. Emission measurements 
The As reported by Etchenique et al. for a similar rhodamine-ruthenium system,
[38]
 
even though the overlap between the emission spectrum of the rhodamine B dye and 
the absorption spectrum of the ruthenium complex [1]
2+
  is rather small (see Figure 
6.1b) the use of a very short linker in [2]
3+
 was expected to allow at least some of the 
energy absorbed by rhodamine B to be donated to the ruthenium center in the covalent 
dyad. The emission and absorption spectra of [2]Cl3 were measured in water and 
compared to that of [4]Cl and rhodamine B (Figure 6.2b). All compounds absorb 
strongly in the yellow region, with extinction coefficient diminished in [4]Cl and 
[2]Cl3, however, compared to rhodamine (Table 6.1). In addition, the emission 
spectrum of [2]Cl3 shows almost complete quenching of the fluorescence of the 
rhodamine B group upon excitation of [2]Cl3 at 570 nm. This effect is not observed in 
the spectrum of ligand [4]Cl, which keeps a significant part of the rhodamine 
fluorescence (Figure 6.2b and Table 6.1). Thus, the energy absorbed by the rhodamine 
B substituent at 570 nm is either transferred to the ruthenium center by energy transfer, 
or wasted via non-radiative decay. If energy transfer to the ruthenium complex is 
efficient, it may lead to the photosubstitution of Hmte by an aqua ligand. (max~450 
nm). 
Table 6.1. Spectroscopic data in MilliQ water for compounds [2]Cl3, [4]Cl, and rhodamine B. 







rhodamine B 120000 555 576 
[4]Cl 74000 569 586 
 [2]Cl3 44000 570 585 
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Figure 6.2. Absorption (a) and emission (b) spectra of rhodamine B, rhodamine B-terpyridine 
conjugate [4]Cl, and rhodamine B-functionalized ruthenium complex [2]Cl3 in MilliQ water at pH=7.  
Excitation: 570 nm, slit width: 3 nm. The concentrations of the solutions used for emission 
measurements were chosen so that their absorbance at 570 nm were identical in the three solutions 
(A570=0.23). 
6.2.3. Photochemistry 
The photoreactivity of [2]
3+
 (hereafter RuHmte) was investigated by looking at whether 
the Hmte ligand could be photosubstituted by an aqua ligand, upon either yellow or 
blue light irradiation in water. The formation of the aqua complex [7]
3+
 (see Scheme 
6.3) was first monitored by 
1
H NMR spectroscopy in D2O. NMR samples containing 
[2]Cl3 in degassed D2O were prepared, and the samples were irradiated with blue (λe = 
452 nm) or yellow light (λe = 570 nm) at room temperature. While the 
1
H NMR 
spectrum of a reference sample in the dark did not change, the spectra of the irradiated 
samples showed the gradual disappearance of the starting compound [2]
3+
 (=9.76 ppm 
for proton 6A (see Scheme 6.2), and =3.48 ppm, 1.83 ppm, and 1.37 ppm for 
coordinated Hmte) and the formation of a single new ruthenium complex (=9.61 ppm 
for proton 6A) and of the free Hmte ligand (at =3.74, 2.66, and 2.01 ppm). Figure 6.3 
shows the evolution of the 
1
H NMR spectra for proton 6A upon irradiation (the 
complete spectra before and after irradiation are shown in Figure AVI.1). Mass spectra 
after irradiation were obtained for both samples, and the peak found at 339.6 is 
characteristic for the formation of [Ru(4)(bpy)(D2O)]
3+









 after about 
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500 min irradiation. The present data show that a substantial amount of Hmte is indeed 
photosubstituted, not only upon blue light irradiation but also upon yellow light 
irradiation, which is absorbed by the rhodamine dye more than by the ruthenium 
fragment (see below). However, these NMR experiments could not provide 
quantitative information on the quantum efficiency of the light-induced substitution 
reaction, as light intensities in the irradiation setup were difficult to determine. 
 
Scheme 6.3. Photosubstitution of Hmte in [2]3+ by an aqua ligand upon blue light (λ=452 nm) or 
yellow light (λ=570 nm) irradiation in aqueous solution. 
 
Figure 6.3. Evolution of the 1H NMR spectra of degassed D2O solution of [2]Cl3 upon irradiation 
with a) blue light (λe=452 nm, Δ1/2=8.9 nm) or b) yellow light (λe=570 nm, Δ1/2=8.9 nm). 
Irradiation times are indicated for each spectrum. Conditions: total ruthenium concentration 
[Ru]tot=5.3×10
−3 M, room temperature. 
In order to get quantitative information about the yellow and blue light-triggered 
release of Hmte from complex [2]
3+
, UV-vis experiments were performed in well-
controlled irradiation conditions. An aqueous solution of [2]Cl3 was exposed to yellow 
light (570 nm) or blue light (452 nm) via a fiber optic bundle  bringing light to the top 
of a UV-vis cuvette, i.e inside the spectrophotometer and perpendicularly to its optical 
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axis (see Appendix I, Figure AI.1). The UV-vis spectra were measured during light 
irradiation (Figure 6.4a). The absorption spectrum of the solution gradually evolved 
until a steady state was obtained after 150 and 320 mintues of irradiation with yellow 
and blue light, respectively. Isosbestic points at 380 nm, 460 nm, and 557 nm indicate 
the occurance of only one photochemical reaction. From the 
1
H NMR and mass 
spectrometry studies it is clear that extensive irradiation of [2]
3+
 leads to the full 
photoconversion into the aqua complex [7]
3+
 (RuOH2) (see Appendix VI, Figure 




 could be 
calculated from the extinction coefficients of both species (see Appendix I, section 
AI.2.1). Using Equation 6.1, the photochemical substitution first-order rate constants 
kφ570 and kφ452  could be obtained from the slope of a plot of ln([RuHmte]/[Ru]tot) vs. 
irradiation time (Figure 6.5a-I and II), where [RuHmte] and [Ru]tot represent the 
concentration in [2]
3+
 and the total ruthenium concentration in the solution, 
respectively. Half-reaction times were calculated using Equation 6.2. The data are 
reported in Table 6.2; they show that the photoconversion rate upon yellow light 
irradiation, kφ570, was twice higher compared to that obtained upon blue light 
irradiation (kφ452). Since the photon flux values at 570 nm and 452 nm (Φ570 and Φ452) 
were not equal, the rate constants kφ570 and kφ452 cannot be directly compared, but the 
photosubstitution quantum yields have to be calculated instead. As expressed in 
Equation 6.3, the photosubstitution rate constant depends on the photon flux Φ, the 
extinction coefficient of RuHmte at the irradiation wavelength ε
λe
, the absorbance 
along the irradiation axis at the irradiation wavelength 3Ae (see Appendix I, Figure 
AI.1), the probability of absorbance of the photon (1−10
−3Ae
), the photosubstitution 
quantum yield φ, the absorption pathlength l, and the irradiated volume V. 
 
        
  
 
       
  
            (Equation 6.1) 
     
   
  
 (Equation 6.2) 
     (    
     )  (
     
    
)    (Equation 6.3) 
The number of moles of RuHmte remaining in solution, nRuHmte,
 
was plotted vs. the 
number of moles of photons Q absorbed at time t since t=0 by RuHmte (Figure 6.5b 
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and Appendix I, section AI.3.2). The photosubstitution quantum yields were obtained 





for yellow and blue light irradiation, respectively (Table 6.2). These values 
are unexpectedly similar, which demonstrates the non-intuitive results that once 
absorbed, a yellow photon has almost the same probability to lead to ligand 
photosubstitution as a blue photon. 
However, the quantity of RuOH2 formed in a given irradiation time depends on the 
amount of light absorbed by the complex at the irradiation wavelength as well. In this 
regard, the extinction coefficients of compound [2]
3+













, respectively). Thus, in order 
to compare the photosubstitution rates the extinction coefficients must be considered as 
well. Multiplying the extinction coefficient by the photosubstitution quantum yield 
gives a value called the photosubstitution reactivity (ξ),
[38]
 which  best represents how 
fast a photoreaction will occur under a given photon flux. Actually, Equation 6.3 
simplifies into Equation 6.4 when the absorbance Ae is small compared to 1. 
   (     
 
 
)          (     
 
 
)      (Equation 6.4) 
The calculated values of ξ are reported in Table 6.2. These values show that for 
complex [2]
3+
 Hmte substitution is one order of magnitude faster with yellow light than 
with blue light. In fact, ten times more moles of photoproduct ([7]
2+
) were produced 
upon yellow light irradiation compared to blue light irradiation at short reaction times. 
Quantitatively, the higher molar absorptivity of the complex [2]
3+
 at 570 nm due to the 
allowed character of the intraligand π-π* transition of the rhodamine B moiety, 
promotes intensive absorption of yellow photons compared to blue ones. 
In order to evaluate the influence of the rhodamine B antenna on the photosubstitution 
of Hmte, similar irradiation experiments were performed on complex [1]
2+
, which does 
not have the fluorophore antenna. Upon yellow light irradiation (570 nm) the 
absorption band of [1]
2+
 at 450 nm gradually disappeared to give rise to a new 





, see Figure 6.4b). The first-order photosubstitution rate constant was obtained 
from the slope of the plots of ln([RuHmte]/[Ru]tot) vs. irradiation time (Figure 6.5a-III), 
and the photosubstitution quantum yield was obtained as described above (Figure 6.5b-
III). The photosubstitution quantum yield of compound [1]
2+
 upon blue light irradiation 
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was reported in Chapter 3 different irradiation conditions.
[45]
 For better comparison 
with [2]
3+
 we repeated the measurement in the same irradiation conditions as for [2]
3+
 
(Figure 6.5-IV). All photochemical data, including half-reaction times, are reported in 
Table 6.2. Like for [2]
3+
 the photosubstitution quantum yields for [1]
2+
 upon blue light 
and yellow light irradiation were found to be very close to each other, i.e., 0.016(4) vs. 
0.011(4), respectively. This counter-intuitive result confirms our observations on [2]
3+
, 
that once absorbed by [1]
2+
 yellow photons are able to lead to ligand photosubstitution 
as efficiently as blue photons. 
In order to compare the photoreactivity of different compounds one should compare 
their ξ values, which depends on both the extinction coefficient (ελ) and the 
photosubstitution quantum yield (φλ). Although the photosubstitution quantum yields at 




, the extinction 
coefficient at 570 nm (ε570) is two orders of magnitudes higher for [2]
3+
 than for [1]
2+
 
due to the presence of the yellow-absorbing dye, while the values of ε452 are of the 
same order of magnitude for both complexes. As a result, under yellow light irradiation 
ξ is about two orders of magnitude higher for [2]
3+
 than for [1]
2+
, and it is still four 
times higher than that of [1]
2+
 under blue light irradiation. Overall, at constant photon 
flux the different extinction coefficients (ελ) most strongly influence the 




 at 450 or 570 nm, whereas the 
quantum yields poorly depend on irradiation wavelength. 
This result is similar to Kasha’s rule, which states that the fluorescence quantum yield 
of a fluorophore is independent on the irradiation wavelength.
[47]
 Indeed, like for 
fluorophores where emission always occurs from the lowest singlet excited state, for 




 photosubstitution is expected to occur from 
a ruthenium-based 
3
MLCT state via thermal promotion to a nearby dissociative 
3
MC 
state. Reaching the 
3
MLCT state can be done either by direct excitation of the 
1
MLCT 
band of the ruthenium complex, or by excitation of the rhodamine dye followed by 
energy transfer to the ruthenium fragment. In the case of a direct excitation of the metal 
complex ([1]
2+
) yellow photons need to be absorbed by vibrationally excited ground-
state complexes, to be able to lead to the 
3
MLCT excited state. Once there, non-
radiative decay will occur with almost the same probability as when the 
3
MLCT state is 
obtained by absorption of blue photons by a non-vibrationally excited ground state 
complex. In the case of indirect excitation of [2]
3+
 with yellow photon the 
3
MLCT state 
is probably reached efficiently via absorption by the rhodamine group, followed by 
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energy transfer. While from Etchenique’s work energy transfer was expected to occur 
in [2]
3+
, it was not expected to be that efficient. 
 
Figure 6.4. a) Time evolution of the UV-vis spectrum of an aqueous solution of a) [2]3+ and b) [1]2+ 
irradiated with yellow light (λe=570 nm). Condition: photon flux Φ=5.310
–9  Einstein·s–1, irradiation 
pathlength l’=3 cm, T=298 K. Total ruthenium concentrations: a) [Ru]tot =3.410
–5 M b) [Ru]tot 
=1.210–4 M. 
 
Figure 6.5. a) Plots of ln([RuHmte]/[Ru]tot) vs. irradiation time; [RuHmte] represents the 
concentration in [2]3+ or [1]2+, and [Ru]tot the total ruthenium concentration in the solution. The slope 
of each plot is kφ (s
-1). b) Plots of the number of moles of RuHmte vs. the number of moles of photons 
Q absorbed by RuHmte at time t, since t=0; the slope is the photosubstitution quantum yield φ. I) 
RuHmte=[2]3+, [Ru]tot=3.410
–5 M, yellow light (e=570 nm). II) RuHmte=[2]
3+, [Ru]tot=3.410
–5 M, 
blue light (e=452 nm). III) RuHmte=[1]
2+, [Ru]tot=1.210
–4 M, yellow light (e=570 nm). IV) 
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RuHmte=[1]2+, [Ru]tot=1.210
–4 M, blue light (e=452 nm). Photon fluxes:  Φ570=5.3(8)10
–9 
Einstein.s–1 and Φ452=3.0(6)10
–9  Einstein·s–1. 
Table 6.2. Photochemical data for the photosubstitution of Hmte by H2O in [2]
3+ and [1]2+ in MilliQ 
water. Condition: T=298 K, irradiation pathlength l’=3 cm, concentration in [2]3+: 3.410–5 M, 





















φ ξ  
(φ·ελe) 
[2]3+ 570 44000 5.3(8)×10−9 4.4(3)×10−4 26(2) 8.5(6)×10−3 370(15) 
[2]3+ 452 4800 3.0(6)×10−9 1.9(3)×10−4 59(2) 9.2(7)×10−3 44(8) 
[1]2+ 570 450 5.3(8)×10−9 5.2(2)×10−5 220(5) 1.1(4)×10−2 4.8(5) 
[1]2+ 452 6600 3.0(6)×10−9 1.3(4)×10−4 89(3) 1.6(4)×10−2 100(10) 
 
6.3. Discussion  
 The covalent binding of a rhodamine B dye to the terpy ligand of the ruthenium 
complex in [2]
3+
 leads to rather efficient photosensitization, as photosubstitution upon 
yellow light irradiation became faster even compared to blue light irradiation of the 
parent complex [1]
2+
. Sensitization seems occur via energy transfer from the rhodamine 
B sensitizer to the 
1
MLCT excited state of the ruthenium complex, which is consistent 
with the work reported by Etchenique.
[38]
 By using a short saturated linker, the 
attachment of rhodamine B to the ruthenium complex occurs without mixing the 
orbitals of the dye and that of the ruthenium complex. Thus, we assume that the 
spectrum of [1]
2+
 is a good model for the contribution of the ruthenium moiety to the 
spectrum of [2]
3+
, i.e., that the excited states of the rhodamine B part and of the 
ruthenium part in [2]
3+
 are not too much affected by each other. By comparing the 
extinction coefficient of [2]
3+
 with that of [1]
2+
 in Table 6.2, it appears that only 1% of 
the yellow photons are absorbed by the ruthenium-centered 
1
MLCT band in [2]
3+
, 
while this fraction goes up to 73% for blue photons. In fact, the presence of rhodamine 
B is not significantly interfering with the MLCT-based blue photon absorption in [2]
3+
, 
whereas, it contributes largely to yellow photon absorption. 
Considering on the one hand the emission quenching of the rhodamine B moiety in 
[2]
3+
, and on the other hand the very similar photosubstitution quantum yields upon 
blue and yellow light irradiation, non-radiative decay in [2]
3+





MLCT state of the ruthenium moiety, rather than from the S1 excited state of 
the rhodamine B moiety. According to Etchenique’s work the energy transfer in [2]
3+
 is 
expected to occur via reverse FRET mechanism, i.e., the rather small spectral overlap 
between the emission of the FRET donor and the absorption of the ruthenium acceptor 
must be compensated by the very short distance between both components in the dyad. 
However, other types of energy transfer mechanisms, such as Dexter’s,
[32]
 cannot be 
fully ruled out at that stage. Deeper photophysical and theoretical studies would be 
needed to assess whether direct orbital overlap between the rhodamine antenna and the 
ruthenium center in [2]
3+
 plays a role in the energy transfer process. 
From a pure photochemical point of view, such sensitization might find application in 
photoactivated chemotherapy (PACT), for which the practical efficiency of a given 
compound will depend on the amount of photoproduct generated in a given irradiation 
time. Thus, at a given light intensity the photosubstitution quantum yield does not 
matter too much, but it is the photosubstitution reactivity ξ, which also takes the 
extinction coefficient into account, that should be considered. On the other hand, it 
cannot be forgotten that functionalization of a light-activatable metallodrug with large, 
flat aromatic dye is expected to change many biological properties of the complex such 
as its lipophilicity, uptake mechanism, and/or mechanism of cytotoxicity. In the end, 
only compounds that combine good uptake, a low toxicity in the dark, a high toxicity 
after ligand substitution, and a high photosubstitution reactivity, might be interesting 
for medicinal purposes. 
6.4. Conclusions  
Our data show that yellow photons that do not seem to have enough energy to populate 
the 
1




 lead, once absorbed, lead to photosubstitution of 
Hmte with almost the same quantum efficiency as that achieved with blue photons. 
Thus, for this family of ruthenium compounds Kasha’s rule remains valid, i.e., the 
quantum efficiency of photosubstitution reactions does not depend on the energy of the 
incoming photons. However, irradiating photosensitive complexes such as [1]
2+
 far 
down their absorption band does render photon collection less efficient. Upon covalent 
attachment of an organic dye with high molar absorptivity (here rhodamine B for 
yellow photons) the absorption problem was solved, and for complex [2]
3+
 efficient 
energy transfer from the dye to the ruthenium center was observed. The resulting 
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photosubstitution reactivity under yellow light irradiation became even higher than that 
of compound [1]
2+
 under blue light irradiation. 
To conclude, it may be noted that sensitizing the ruthenium complex with dyes 
absorbing at still higher wavelengths, i.e., up in the red region, might become 
increasingly difficult. The efficiency of energy transfer is expected to decrease when 
the spectrum overlap between the emission of the dye and the MLCT band of the 
ruthenium complex becomes smaller, as a result of which sensitization might not 
remain possible with dyes that absorb too far in the red region. In the extreme case of 
negligible spectral overlap, the photoreactivity of the metal center and the emission of 
the fluorophore are expected to decouple. In such a case, the absorbed photons are 
expected to lead either to ligand photosubstitution or to fluorescence, depending on the 
irradiation wavelength. Such systems might find potential application in molecular 
imaging, for example to probe the position of a ruthenium complex and follow its fate, 
either in biological or in artificial systems.
[18, 48]
 
6.5. Experimental section  
6.5.1. General 
1H and 13C NMR spectra were recorded using a Bruker DPX-300 spectrometer; chemical 
shifts are indicated in ppm relative to TMS. Electrospray mass spectra were recorded on a 
Finnigan TSQ-quantum instrument by using an electrospray ionization technique (ESI-
MS). High resolution mass spectrometry was performed using a Thermo Finnigan LTQ 
Orbitrap mass spectrometer equipped with an electrospray ion source (ESI) in positive 
mode (source voltage 3.5 kV, sheath gas flow 10, capillary temperature 275 ºC) with 
resolution R = 60.000 at m/z = 400 (mass range = 150-200) and dioctylphtalate (m/z = 
391.28428) as "lock mass". UV-vis spectra were obtained on a Varian Cary 50 UV-vis 
spectrometer. Emission spectra were obtained using Shimadzu RF-5301 spectrofluorimeter. 
The irradiation setup was a LOT 1000 W Xenon arc lamp, fitted with a 400FH90-50 
Andover standard cutoff filter and a Andover 450FS10-50 (λe=452 nm, Δλ1/2=8.9 nm) or a 
570FS10-50 (λe=570 nm, Δλ1/2=8.9 nm) interference filter. DMSO and dichloroethane were 
dried over CaSO4 and distilled before use. CH3CN was dried using a solvent dispenser 
PureSolve 400. 4’-Chloro-2,2’;6’,2”-terpyridine[49] and [Ru(terpy)(bpy)(Hmte)](BF4)2 
[1](BF4)2 (Chapter 3) were synthesized following literature procedures. AgPF6, LiCl, KPF6 
and the anionic exchange resin DOWEX 22 were purchased from Sigma-Aldrich. 
Triethylamine was purchased from Acros; KOH and POCl3 were purchased from Merck; 
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and rhodamine B was purchased from Lambda Physik. The eluent for column 
chromatography purification of compound [6](PF6)2 was prepared by mixing MeCN, 
MeOH, and H2O 66:17:17 ratio, followed by addition of solid NaCl until saturation was 
reached. 
6.5.2. Synthesis 
Compound 3. 2-methylaminoethanol (45 mg, 0.60 mmol) was added to a suspension of 
powdered KOH (94 mg, 1.7 mmol) in dry DMSO (2 mL). The mixture was stirred for 30 
min at 333 K. 4’-chloro-2,2’:6’,2”-terpyridine (160 mg, 0.600 mmol) was added and the 
mixture was stirred at 333 K for 3 h and then overnight at r.t. Then, the mixture was poured 
onto water (60 mL). The aqueous phase was extracted with DCM (3×30 mL) and the 
organic phases were combined and dried over MgSO4. DCM was evaporated under reduced 
pressure and the product was left 24 h under high vacuum at 40 ºC to remove trace amounts 
of DMSO. Compound 3 was obtained as pale yellow oil (160 mg, 0.520 mmol, 87% yield). 
1H NMR (300 MHz, CD3OD, 298 K, see Scheme 6.2  for proton attribution) δ (ppm) 8.61 
(d, J = 4.8 Hz, 2H, T66’’), 8.54 (d, J = 8.0 Hz, 2H, T33’’), 7.96 – 7.87 (m, 4H, T44’’+ T3’ 
+ T5’), 7.41 (ddd, J = 7.5, 4.8, 1.1 Hz, 2H, T44’’), 4.29 (t, J = 5.2 Hz, 2H, α), 3.00 (t, J = 
5.2 Hz, 2H, β), 2.46 (s, 3H, γ). 13C NMR (75 MHz, CD3OD, 298 K) δ (ppm) 168.39 (T4’), 
158.32 (T1), 157.03 (T1’), 150.09 (T66’’), 138.68 (T3’,T5’), 125.43 (T44’’), 122.91 
(T33’’), 108.35 (T44’’), 68.18 (α), 50.84 (β), 35.85 (γ). High resolution ES-MS m/z (calc): 
307.15589 (307.15516, [M+H]+). 
Compound [4]Cl. Following a literature procedure[42] phosphorus oxychloride (60.0 µL, 
0.657 mmol) was added to a solution of rhodamine B (150 mg, 0.313 mmol) in dry 1,2-
dichloroethane (5 mL). The mixture was refluxed for 5 h. The solvent was evaporated 
under reduced pressure and the crude mixture was immediately re-dissolved in dry CH3CN 
(10 mL). Et3N (131 µL, 0.939 mmol) and compound 3 (96 mg, 0.31 mmol) were added and 
the mixture was refluxed for 14 h. The solvent was evaporated under reduced pressure at 30 
ºC and the crude product was dissolved in water and filtered to remove any solid. The 
product was precipitated by addition of KPF6, filtered, washed with H2O, and dried in a 
desiccator at ambient pressure over silica gel blue for 4 h. Exchange of the PF6
− counter 
anions with Cl− was achieved by stirring an acetone/water solution (1:1) of the product with 
the Cl− exchange resin DOWEX 22 (2.0 g) for 4 h. The resin was filtered, acetone was 
evaporated under reduced pressure at 22 ºC, and water was removed using a freeze drier. 
The product was purified by column chromatography on silica gel (CHCl3/MeOH, 10% to 
20% of MeOH). Solvents were evaporated under reduced pressure and compound [4]Cl 
was obtained as a purple solid (75 mg, 0.097 mmol, 31%). 1H NMR (300 MHz, CD3OD, 
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298 K, see Scheme 6.2  for proton attribution) δ (ppm) 8.77 – 8.70 (m, 4H, T33’’, T66’’), 
8.06 (td, J = 7.7, 1.8 Hz, 2H, T44’’), 7.84 – 7.72 (m, 3H,5R,4R,3R), 7.70 (s, 2H, T3’,T5’), 
7.54 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, T44’’), 7.47 (dd, J = 6.5, 1.0 Hz, 1H, 5R), 7.34 (d, J = 
9.6 Hz, 2H, 10R’,1R’), 7.01 (dd, J = 9.6, 2.5 Hz, 2H, 2R’,9R’), 6.44 (d, J = 2.4 Hz, 2H, 
4R’,7R’), 3.84 (t, J = 4.3 Hz, 2H, α), 3.74 (t, J = 4.3 Hz, 2H, β), 3.41 (dd, J = 13.4, 6.6 Hz, 
8H, δ), 2.96 (s, 3H, γ), 1.14 (t, J = 7.1 Hz, 12H, ε). 13C NMR (75 MHz, CD3OD, 298 K) δ 
(ppm) 171.10 (C=O), 167.99 (3R,8R), 158.80, 158.25, 157.00, 156.87, 156.30, 150.30 
(T66’’), 138.82 (T55’’), 137.59, 133.31 (2R’+9R’), 131.73+131.65 (3R+2R+4R), 131.17, 
130.99 (5R), 128.75 (T5’), 125.78 (T44’’), 122.89 (T33’’), 115.19 (1R’+10R’), 114.43, 
108.06 (T’3), 97.19 (4R’+7R’), 68.13 (α+β), 46.80 (δ), 40.53 (γ), 12.78 (ε). High resolution 
ES-MS m/z (calc): 731.37096 (731.37041 [M]+). UV-vis: λmax (ε in L·mol
−1·cm−1) in pure 
H2O: 569 nm (74000). Anal. Calcd for C46H47ClN6O3·CHCl3·H2O: C, 62.39; H, 5.57; N, 
9.29. Found: C, 61.77; H, 5.75; N, 9.68. 
Compound [5]Cl. Compound [4]Cl (120 mg, 0.156 mmol) and RuCl3·3H2O (41 mg, 0.16 
mmol) were dissolved in MeOH (20 mL) and refluxed for 7 h under argon. The mixture 
was first cooled down to room temperature, and then cooled in an ice bath for 30 min and 
overnight in the fridge. The precipitate was filtered off and air dried to yield [5]Cl as a dark 
purple powder (83 mg, 0.075 mmol, 54%).  1H NMR (300 MHz, CD3OD, 298 K, see 
Scheme 6.2  for proton attribution) δ (ppm) 10.90 (s, T3’,T5’), 8.07 – 7.88 (m, 3H), 7.69 
(d, J = 6.9 Hz, 2H), 7.55 (d, J = 9.4 Hz, 2H), 7.01 (d, J = 9.7 Hz, 3H), −1.43 (s, 
T33’’/T44’’/T55’’), −10.26 (s, T33’’/T44’’/T55’’), −10.71 (s, T33’’/T44’’/T55’’), −35.94 
(s, T66’’). ES-MS m/z (calc): 938.2 (937.7 [M−Cl]+). 
Compound [6](PF6)2. [5]Cl (78 mg, 0.080 mmol), 2,2’-bipyridine (13 mg, 0.083 mmol), 
and LiCl (5.0 mg, 0.12 mmol) were mixed in a 3:1 EtOH/H2O mixture (15 mL) and the 
solution was degassed with argon for 5 min, after which Et3N (15 µL, 0.10 mmol) was 
added. The reaction mixture was refluxed under argon for 6 h, and then it was filtered hot 
over celite. The filtrate was evaporated under reduced pressure. Column chromatography 
purification was performed over silica gel (eluent: MeCN / MeOH / H2O, 66:17:17 
saturated in NaCl, Rf=0.5). The solvent was evaporated, then the crude product was 
dissolved in water (50 mL), and precipitated by adding KPF6 (~1 g). After filtration, 
washing with water and drying in a desiccator at ambient pressure over silica gel blue for 5 
h compound [6](PF6)2 was obtained in 40% yield as a dark purple powder (41 mg, 0.031 
mmol). 1H NMR (300 MHz, CD3OD, 298 K, see Scheme 6.2 for proton notation) δ (ppm) 
10.28 (d, J = 5.6 Hz, 1H, 6A), 8.79 (d, J = 8.2 Hz, 1H, 3A), 8.51 (d, J = 8.1 Hz, 3H, 10R’ + 
1R’+ 3B), 8.32 (t, J = 8.1 Hz, 1H, 4A), 8.07 – 7.91 (m, 5H, 2R’+ 9R’+ 7R’+ 5R+ 5A), 7.89 
– 7.68 (m, 6H, T3’+ T5’+ 3R + 4B + T33’’), 7.47 (d, J = 7.6 Hz, 1H, 2R), 7.44 – 7.31 (m, 
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5H, 4R’+ 4R + 5B+ T44’’), 7.13 – 7.01 (m, 3H, 6B + T55’’), 6.71 (d, J = 2.4 Hz, 2H, 
T66’’), 4.02 (t, J = 4.5 Hz, 2H, α), 3.88 (d, J = 4.5 Hz, 2H, β), 3.45 (m, 8H, δ), 3.05 (s, 3H, 
γ), 1.31 (t, J = 12.9 Hz, 12H, ε). 13C NMR (75 MHz, CD3OD, 298 K) δ (ppm) 
13C NMR (75 
MHz, CD3OD, 298 K) δ 171.25 (C=O), 166.26 (3R,8R), 160.55, 160.48, 159.89, 159.07, 
159.03, 158.19, 157.10, 153.86 (6A), 153.78, 152.85 (4R’), 138.42 (4R’+ 5R), 137.72 (4A), 
137.64, 136.70 (T33’’), 133.46 (T44’’), 132.43 (2R), 131.99 (T3’), 131.89 (T5’), 130.98 
(4B), 129.85 (3R), 128.74 (4R), 128.57 (5B), 127.96 (5A), 127.43 (6B), 125.09 (10R’+1R), 
124.85 (3B), 124.58 (3A), 115.40 (T55’’), 114.40, 110.89 (2R’+ 9R’), 97.76 (6T +6’’T), 
69.91(α+ β), 48.15 (δ) , 46.98 (γ), 13.04 (ε). High resolution ESI-MS m/z (calc): 512.15646 
(512.15650 [M−2PF6]
2+). UV-vis: λmax (ε in L·mol
–1·cm–1) in 9:1 acetone/H2O:570 nm 
(58000). 
Compound [2]Cl3. [6](PF6)2 (30 mg, 0.023 mmol) and AgPF6 (15 mg, 0.060 mmol) were 
dissolved in a 3:5 acetone/H2O mixture (8 mL). To this solution was added Hmte (156 μL, 
1.80 mmol). The mixture was refluxed under argon for 9 h in the dark, after which it was 
filtered hot over celite. Acetone was removed under reduced pressure upon which the crude 
product with PF6
− counter ions precipitated in water. It was filtered, washed and dried. PF6
− 
ions were exchanged by Cl− by stirring a 1:1 acetone/water solution (20 mL) of the crude 
product [2](PF6)3 with ion-exchange resin DOWEX 22 (30 mg) for 4 h. After filtration of 
the resin, acetone was evaporated under reduced pressure, and water was removed using a 
freeze drier machine to afford [2]Cl3 as a reddish purple powder (12 mg, 0.011 mmol,  
43%). 1H NMR (300 MHz, CD3OD, 298 K, see Scheme 6.2  for proton attribution) δ (ppm) 
9.80 (d, J = 6.1 Hz, 1H, 6A), 8.81 (d, J = 8.1 Hz, 1H, 3A), 8.57 (t, J = 8.7 Hz, 2H, 1R’ + 
3B), 8.39 (m, 2H, 10R’ + 4A), 8.0-8.05 (m, 4H, 5R + 9R’+ 7R’ + 5A), 7.93 (t, 2H, 4B + 
2R’), 7.86 – 7.73 (m, 5H, 3R + T33’’+ T3’+ T5’), 7.56 (m, 1H, 2R), 7.48 – 7.32 (m, 4H, 
4R’+ 4R + T4 + T4’’), 7.27 (d, J = 7.2 Hz, 1H, 5B), 7.20 – 7.07 (m, 3H, 6B + T55’’), 6.92 
(d, J = 4.1 Hz, 2H, T6 + T6’’), 4.46 (d, J = 5.5 Hz, 2H, α), 3.80 (t, 2H, β), 3.69 (q, 8H, δ), 
3.46(d, J = 5.7 Hz, 2H, HO-CH2), 3.25 (s, 3H, γ), 1.81 (t, J = 5.8 Hz, 2H, CH2-S), 1.43 – 
1.36 (s, 3H, S-CH3), 1.28 (t, J = 6.9 Hz, 12H, ε). 
13C NMR (75 MHz, CD3OD, 298 K) δ 
(ppm) 173.90 (C=O), 168.19 (3R,8R), 159.51, 159.34, 159.30, 159.12, 158.99, 158.96, 
157.22, 154.52 (6A), 153.41, 140.05, 139.95, 139.09, 137.18, 135.81, 135.50, 133.83, 
133.34, 133.24, 131.33, 131.16, 129.59, 128.90, 127.22, 126.20, 125.81, 124.98, 115.35, 
114.86, 112.95, 97.32, 60.46 (α), 47.05 (β), 46.10 (δ), 46.08 (S-CH3), 39.53 (γ), 38.51 (OH-
CH2), 38.08(CH2-S), 12.83 (ε). High resolution ES MS m/z (calc): 360.45788 (360.45780 
[M–3Cl]3+), 540.18291 (540.18289 [M–3Cl–H]2+). UV-vis: λmax (ε in L·mol
−1·cm–1) in pure 
H2O: 570 nm (44000). 
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6.5.3. Emission measurements 
Three stock solutions of rhodamine B (solution A, 2.4 mg in 50 mL H2O, 1.010
–4 M), of 
compound [4]Cl (solution B, 3.8 mg in 50 mL H2O, 1.010
–4 M) and of compound [2]Cl3 
(solution C, 1.2 mg in 10 mL H2O, 1.010
–4 M) were prepared. 150 µL of stock solution A, 
100 µL of solution B, or 120 µL of solution C was transferred into a quartz cuvette and was 
diluted to 3 mL by adding H2O using a micropipette (final concentrations: of A’: 5.010
–6 
M, B’: 3.310–6 M, C’: 4.010–6 M). The absorbance of each solution was measured 
(A570=0.23 for all solutions). Emission spectra were recorded with the same excitation 
parameters (λe=570 nm). 
6.5.4. Irradiation experiments 
NMR measurements. [2]Cl3 (3.8 mg, 3.2 μmol) was weighed into an NMR tube and 
degassed D2O (0.60 mL) was added to the tube in the dark under argon. The 
1H NMR of 
the sample was measured as a reference, and irradiation at 452 nm or 570 nm was started at 
T=298 K using the beam of a LOT 1000 W Xenon arc lamp filtered with an Andover filter 
at the appropriate wavelength, and arriving on the side of the NMR tube. The temperature 
of the tube was kept constant by thermostat set at 298 K.  After 220 minutes, 310 minutes, 
and 480 minutes of irradiation at 452 nm, or 170 minutes, 320 minutes, and 530 minutes at 
570 nm, 1H NMR spectra were measured. A reference sample was also prepared at the 
same concentration, and kept in the dark for comparison of their 1H NMR spectra. Neither 
of these reference samples showed any observable conversion in the dark. 
UV-vis experiments. 1 mL of a stock solution D of compound [2]Cl3 (1.2 mg in 10 mL 
H2O, 1.010
–4 M) or 0.8 mL of a stock solution E of [1](BF4)2 (1.7 mg in 5 mL H2O, 4.5 
×10−4 M) was transferred into a UV-vis cuvette. The volume of the solution was completed 
to 3 mL with H2O (using a micropipette) in the dark (final concentration: D’: 3.410
–5 M, 
E’: 1.210–4 M). The UV-vis spectrum of each sample was measured and afterwards the 
sample was irradiated at 452 nm or 570 nm using the beam of a LOT 1000 W Xenon arc 
lamp filtered by an Andover bandpath filter, and directed into an 2.5 mm diameter optical 
fiber bundle bringing the light vertically into the cuvette, i.e, perpendicular to the horizontal 
optical axis of the spectrophotometer (see Appendix I). After each irradiation period 
(varying from 1 min to 3 min depending on the samples) a UV-vis spectrum was measured 
until a total irradiation time of 350 minutes and 82 minutes was reached, for D’ and E’, 
respectively. The concentrations in [RuHmte] ([2]3+ or [1]2+) and [RuOH2] ([7]
3+ or [8]2+) 
were determined by deconvolution knowing the extinction coefficients of both species (see 
Appendix I). The evolution of ln([RuHmte]/[Ru]tot) was plotted as a function of irradiation 
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time, and from the slope S of these plot k at λe=452 nm or λe=570 nm were determined to 
be 1.9(3)10–4 s-1 and 4.4(3)10–4 s-1, for [2]3+, respectively, and 1.3(4)10–4 and 5.2(2)10–
5 s-1 for [1]2+, respectively. Knowing the photon flux and probability of photon absorption 
1−10−3Ae, where 3Ae is the absorbance of the solution at the excitation wavelength e, the 
number of moles of photons Q absorbed at time t by RuHmte since tirr=0 was calculated. 
Plotting nRuHmte (the number of moles of RuHmte complex [1]
2+ or [2]3+) vs. Q gave a 
straight line in each case. The slope of this plot directly corresponds to the quantum yield of 
the photosubstitution reaction. The values for the photosubstitution quantum yields were 
9.2(3)×10−3 and 8.5(3)×10−3, respectively, for [2]3+ and 1.6(4)×10−2 and 1.1(4)×10−2, 
respectively, for [1]2+ , at λe=452 nm or λe=570 nm, respectively (see Appendix I, Section 
AI.3.2). 
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7.1.1. General Introduction (Ch 1) 
Polypyridyl ruthenium complexes are classical tools in photochemistry.
[1-2]
 Their 
photophysical properties can be tuned in order to get the desired behavior under light 
irradiation. In particular, ruthenium complexes with distorted octahedral geometry are 




Two potential applications of this kind of complexes are discussed, being the design of 
light-controlled molecular machines, and light-activatable anticancer prodrugs. In this 
thesis, a link between these two applications using lipid bilayers was made. 
Photosubstitution reactions are first studied at the surface of lipid bilayers in order to 
mimic natural molecular machines. By anchoring monodentate ligands at the 
membrane, the ruthenium complex can bind thermally to the membrane, and be 
cleaved by visible light irradiation to realize a model of molecular carrier controlled by 
light. In the second part the same liposomes functionalized with photosensitive 
ruthenium complexes are considered for photochemotherapy as the ruthenium aqua 
complex liberated by light irradiation may be cytotoxic. The ruthenium-functionalized 
liposomes, which act as pro-drugs, may be delivered to cancer cells. Once taken up 
they can be activated by light irradiation, resulting in a photosubstitution reaction that 
releases the active ruthenium aqua complex from the membrane into the cell. Thus, by 
combining the photochemistry of ruthenium complexes and the biological properties of 
liposomes we moved from a very fundamental, biomimetic topic dealing with 
molecular motion, to the second, more applied field of drug delivery.  
7.1.2. Ruthenium polypyridyl complexes hopping at anionic lipid bilayer 
surface through a supramolecular bond sensitive to visible light 
(Ch 2) 
In Chapter 2 the new ruthenium complex [Ru(terpy)(dcbpy)(Hmte)]
2+
 (RuHmte) is  
introduced, where terpy is 2,2’;6’,2”-terpyridine, dcbpy is 6,6’-dichloro-2,2’-
bipyridine, and Hmte is 2-methylthioethan-1-ol. Based on kinetics and thermodynamic 
data it is shown that steric hindrance of the dcbpy ligand induces destabilization of 
both the ruthenium thioether complex RuHmte and the aqua analogue 
[Ru(terpy)(dcbpy)(H2O)]
2+
 (RuOH2). These two species are in fact in thermal 
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equilibrium at room temperature and in the dark. However, shining blue light allows 
for selective substitution of the thioether ligand by an aqua ligand, thus shifting the 
equilibrium towards the formation of the RuOH2 complex (see Scheme 7.1a). Such 
light-induced equilibrium shift is shown to be repeatable at least four times in 
homogenous aqueous solution. 
Thermal binding and light-induced unbinding of a thioether ligand to the ruthenium 
center was also achieved at the surface of negatively charged liposomes (see Figure 
7.1b). UV-vis measurements show that the ruthenium aqua complex efficiently 
coordinates to a membrane-embedded thioether ligand in the dark, and that upon 
exposure to visible light the Ru-S coordination bond is selectively cleaved to release 
the ruthenium aqua complex into the solution. This cycle is shown to be repeatable four 
times by switching on and off the source of visible light. Thus, light-triggered hopping 
of a ruthenium complex is achieved at a lipid bilayer membrane surface.  
 
Scheme 7.1. a) Thermal equilibrium between [Ru(terpy)(N-N)(H2O)]
2+ and [Ru(terpy)(N-
N)(SRR’)]2+ and the photosubstitution of SRR’ ligand by H2O. SRR’ is a thioether ligand such as 2-
methylthioethan-1-ol and N-N is a diimine ligand such as dcbpy. b) Light-induced ruthenium binding 




The light-controlled hopping of a ruthenium complex at the membrane has two 
requirements: first, the steric hindrance of the ruthenium complex should be high 
enough to allow for fast thermal binding and photo-induced unbinding. Secondly, the 
liposomes should be negatively charged so that the ruthenium aqua complexes actually 
bind to the membrane-embedded sulfur ligands. These two issues are discussed in 
Chapters 3 and 4, respectively.  
7.1.3. Spontaneous formation in the dark, and visible light-induced 
cleavage, of a Ru-S bond in water: a thermodynamic and kinetic 
study (Ch 3) 
In Chapter 3 the thermal and photochemical reactivity in water of four related 
ruthenium polypyridyl complexes with the general formula [Ru(terpy)(N-N)(Hmte)]
2+
 
is described, where N-N are the four diimine ligands bpy, biq, dcbpy, or dmbpy (see 
Scheme 3.1a). For each of these complexes photo cleavage of the Ru-S bond occurs, 
resulting in the formation of the aqua complex [Ru(terpy)(N-N)(H2O)]
2+
 (RuOH2). In 
this chapter it is described how the steric hindrance of the N-N ligand influences both 
the thermodynamic stability and kinetic lability of the RuHmte and RuOH2 complexes 
in the dark. The kinetics of the photosubstitution reactions are reported as well.  
Upon increasing the steric hindrance of the N-N ligand, the rates of thermal binding to 
and thermal cleavage of the Hmte ligand from the ruthenium center increase. A shift 
was observed along the series bpy, biq, dcbpy, and dmbpy, from a very slow thermal 
equilibrium between RuOH2 and RuHmte with N-N=bpy, to a very fast one with N-
N=dmbpy. The increased lability of the hindered complexes in water is not due to the 
change of the enthalpy of activation of the substitution reaction (∆H
‡
). Instead, it is due 
to the variation of the entropy of activation ∆S
‡
, which from being negative for bpy and 
biq, becomes positive for dcbpy and dmbpy. Such change in activation entropy 
indicates a change in the mechanism of the substitution reaction, from an interchange 
associative mechanism with bpy and biq (∆S
‡
<0) to an interchange dissociative 
mechanism for dcbpy and dmbpy (∆S
‡
>0).  
On the other hand, the quantum efficiency of the photocleavage of the Ru-S bond upon 
light irradiation also increases along the series N-N= bpy, biq, dcbpy, and dmbpy. 
Overall, two requirements were found for shifting with light the equilibrium between 
the RuHmte and RuOH2 species in water. First, the thermodynamic stability of the 
RuHmte complex in water and in the dark must be higher than that of the RuOH2 
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complex (k−i<ki) to lead to the spontaneous formation of the thioether complex. If the 
establishment of thermal equilibrium is too slow however, such as for the least 
hindered complex with N-N=bpy, RuHmte formation does not occur at room 
temperature because there is not enough thermal energy to cross the activation barrier 
of the coordination reaction. Secondly, the rate of the photosubstitution of the Hmte 
ligand by water must be higher than that of its thermal dissociation (k−i<kφ, see Figure 
7.1a). For the most hindered ruthenium complex with N-N=dmbpy this condition is not 
met, and the thermal lability of RuHmte is so high that light cannot induce a significant 
shift of the thermal equilibrium between RuHmte and RuOH2. To conclude, only the 
moderately hindered complexes, i.e., those with N-N=biq and dcbpy, are suitable for 
shifting with light the equilibrium between RuHmte and RuOH2.   
7.1.4. Binding of a ruthenium complex to a thioether ligand embedded in 
a negatively charged lipid bilayer: a two-step mechanism (Ch 4) 
As mentioned in section 7.1.2., negatively charged membranes are required for the 
binding of ruthenium aqua complexes to membrane-embedded thioether ligands. In 
Chapter 4, the role of the negative charge of the membranes on the coordination 
reaction occurring at the water-membrane interface is reported. The interaction of the 
complex [Ru(terpy)(dcbpy)(H2O)]
2+
 with phospholipid membranes containing either 
neutral thioether ligands or cholesterol was studied using three different techniques: 
UV-visible spectroscopy, Langmuir-Blodgett monolayer surface pressure 
measurements, and Isothermal Titration Calorimety (ITC). The first technique proved 
that ruthenium binding to the thioether ligands becomes slower when the electrostatic 
interaction between the ruthenium cations and the negative liposomes is shielded by 
higher ionic strengths. Thus, adsorption of the dicationic ruthenium complex at the 
surface of the negative membranes plays a prominent role in the formation of the Ru-S 
coordination bond. 
Information about the time scale of such adsorption phenomenon and about its 
thermodynamics was obtained from lipid monolayer surface pressure and ITC 
measurements. It was shown that the adsorption of the ruthenium aqua complex to the 
surface of negatively charged monolayers and bilayers is much faster (minutes) than 
coordination, i.e., ligand exchange (hours). In addition, the adsorption phenomenon 
was found to be endothermic, i.e., entropy driven. Based on these results a two-step 
model is proposed for the binding of the dicationic metal complex to the thioether 
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ligands embedded in negative liposomes. In the first step, the outer leaflet of a 
negatively charged lipid bilayer quickly adsorbs the positively charged metal 
complexes, whereas in the second step the Ru-S bond formation occurs via two-
dimensional diffusion of both reagents at the membrane (see Scheme 4.2). Such two-
step reaction at negative membranes is faster, all other conditions being the same, than 
the corresponding Ru-S bond formation in homogenous solutions.  
7.1.5. Liposomes functionalized with ruthenium: towards a tumor-
targeted, light-controlled anticancer prodrugs (Ch 5) 
In Chapter 5, the potential application of liposomes decorated with photosensitive 
polypyridyl ruthenium complexes in drug delivery is discussed. Four non-labile 
ruthenium complexes with the general formula [Ru(terpy)(N-N)(SRR’)]
2+
 (N-N = bpy 
(2,2’-bipyridine) or pymi (phenylpyridin-2-ylmethylene-imine), and SRR’ = thioether 
ligands with a cholesterol tail, were prepared and were supported on neutral and 
negatively charged liposomes. All ruthenium-functionalized liposomes are 
photoreactive; shining blue light on them results in the photocleavage of the ruthenium 
complex from the liposome surface. The photosubstitution reactions are shown to be 
faster at human body temperature (37 °C) than at room temperature, and slightly faster 
at neutral bilayer surfaces than at negatively charged ones.  
Cellular uptake experiments on human carcinoma cell lines showed that in the absence 
of PEGylation, ruthenium-functionalized liposomes built from neutral lipids are better 
taken up by HepG2, A2780, and A2780R cancer cells than their analogues built from 
negatively charged lipids. When PEGylated lipids are introduced in the liposome 
formulation, the charge of the resulting ruthenium-functionalized stealth liposomes is 
shielded, which results in a decreased cellular uptake compared to PEG-free liposomes. 
Moreover, almost equal cellular uptakes were obtained when neutral and negatively 
charged lipids are used for PEGylated liposomes containing Ru. Overall, the structure 
of the ruthenium complexes did not affect significantly these uptake results.  
Dark cytoxicity tests with DOPC and DOPG stealth liposomes functionalized with any 
of the four ruthenium complexes showed that these liposomes are poorly toxic against 
A2780 and A2780R cell lines, with no significant variation between the different 
ruthenium complexes. Light cytotoxicity results were obtained on HepG2 cells for one 
of the ruthenium complexes supported on non-PEGylated liposomes with different 
surface charges. The results showed up to five times higher cytotoxicity after light 
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irradiation than in the dark. Thus, liposomes decorated with ruthenium complexes are 
promising in drug delivery.    
7.1.6. Yellow-light sensitization of a ligand photosubstitution reaction in a 
ruthenium polypyridyl complex covalently bound to a rhodamine 
dye (Ch 6) 
In Chapter 6 the possibility of extending the photoactivation of polypyridyl ruthenium 
complexes towards longer wavelengths by photosensitization, is discussed. As 
mentioned in section 7.1.1. some of these metal complexes have been proposed as 
light-activatable drugs in phototherapy. However, their potential application in vivo is 
limited since they mostly show high molar absorptivities near 450 nm, i.e., for blue 
light, which is known to poorly penetrate human tissues.
[4-5]
 
The photosubstitution of a thioether ligand by a water molecule was studied with 570 
nm photons (i.e., yellow light). A rhodamine B dye, which has a high molar 
absorptivity for yellow light, was covalently bound via a short saturated linker to the 
terpyridine ligand Rtpy in the complex [Ru(Rterpy)(bpy)(Hmte)]
2+
. The excellent 
antenna effect of the rhodamine B dye, coupled to efficient energy transfer to the 
ruthenium center, resulted in faster photosubstitution of the Hmte ligand with yellow 
photons, than with blue photons.  
In this chapter also the rate of photosubstitution reactions is discussed when photons of 
insufficient energy, compared to that of the 
1
MLCT state, are used. Both for the 
rhodamine B-functionalized ruthenium complex and for its antenna-free analogue 
[Ru(terpy)(bpy)(Hmte)]
2+
 the quantum yields upon yellow light or blue light irradiation 
were found to be comparable. In fact, at constant photon flux it is the extinction 
coefficient that mostly influences the photosubstitution rate for these complexes, 
whereas the photosubstitution quantum yield hardly depends on the irradiation 
wavelength.  
7.2. Conclusions and Outlook 
7.2.1. General conclusions 
In this thesis the thermal- and photo-substitution behavior of polypyridyl ruthenium 
complexes with the general formula of [Ru(terpy)(N-N)(SRR’)]
2+ 
is described, either at 
the surface of lipid bilayers, or in homogeneous solutions. It is shown that the 
successive thermal binding and light-induced unbinding of the cationic ruthenium 
complex at the surface of the lipid bilayer requires negatively charged liposomes and 
ruthenium complexes containing moderately hindered N-N bidentate ligands such as 
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biq or dcbpy. Our results in homogeneous solution show that changing the steric 
hindrance of the bidentate ligand influences both the photo- and thermal reactivities of 
these complexes, by altering the mechanism of the Ru-S bond formation. It is also 
shown that the Ru-S bond formation at the surface of negative lipid bilayers is faster 
than the same reaction in homogenous aqueous solutions, and a two-steps mechanism 
is proposed for the thermal coordination of ruthenium aqua complexes at membrane-
embedded ligands. 
The application of ruthenium-functionalized liposomes in drug delivery is discussed in 
Chapter 5. In vitro tests on cancer cell lines show that neutral liposomes functionalized 
with ruthenium compounds are more readily taken up by cancer cells than ruthenium-
free liposomes. The liposome samples with ruthenium compounds are shown to be 
poorly cytotoxic in the dark. After light irradiation, the cytotoxicity increased at least 
up to five times for ruthenium complexes supported on non-PEGylated liposomes. 
Finally, the photoactivation of polypyridyl complexes with low-energy photons was 
studied using a photosensitization approach. A photosubstitution reaction was made 
faster upon yellow light irradiation than upon blue light irradiation by covalently 
linking a rhodamine B dye to the ruthenium complex.  
7.2.2. Outlook 
7.2.2.1. Molecular motion at the surface of a lipid bilayer 
In this research it was shown that a ruthenium complex can hop at the surface of a lipid 
bilayer in a light-controlled manner. The ultimate goal of this research is to achieve 
unidirectional motion at the lipid bilayer surface, such as reported linear organic 
molecular machines.
[6-7]
 For this aim the thioether ligands at the membrane should be 
organized in a way to produce a dissymmetric track. The first issue to solve for 
extending this research is to modify the ruthenium complex in order to detect its lateral 
position, and possibly to probe binding and unbinding events by single-molecule 
techniques. One approach is to use fluorescent imaging techniques, which have shown 
their potential at the single-molecule level. Since ruthenium complexes of the type 
[Ru(terpy)(N-N)(SRR’)]
2+ 
photosubstitute a ligand under light irradiation their 
luminescence is very poor. Thus, a fluorophore would need to be covalently linked to 
the ruthenium complex. As discussed in Chapter 6, however, the emission spectrum of 
the fluorophore overlapped with the 
1
MLCT absorption band of the ruthenium 
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complex, and the fluorescence of the dye was quenched by Förster energy transfer. To 
avoid such quenching a fluorophore absorbing in the red region of the spectrum, i.e., at 
wavelengths higher than 630 nm, should be used. It is expected that in this case the 
photoreactivity of the metal center and the emission of the fluorophore may be 
decoupled, which would allow for probing the position of the ruthenium complex via 
excitation of the fluorophore.  
7.2.2.2. Liposomes functionalized with ruthenium in photoactivated 
chemotherapy 
Liposomal drug delivery for ruthenium-based anticancer compounds has not been 
investigated extensively, except for two recent studies in 2012.
[8-9]
 In Chapter 5, it was 
shown that liposomes functionalized with polypyridyl complexes are potential 
candidates for drug delivery. However, our results are only preliminary, and more 
investigations need to be done in this area. The first important point is to modify the 
uptake detection method. Our uptake results are currently based on the fluorescence of 
NBD-PC lipids included in the formulation of the liposomes. However, the excitation 
wavelength of NBD-PC overlaps with the 
1
MLCT absorption band of the ruthenium 
complex, as a result of which the fluorescence of NBD is partially quenched by the 
ruthenium complex. As explained in Chapter 5, the extent of fluorescence quenching in 
the cell culture can be estimated based on the data obtained in absence of cells. 
However, this estimation remains rather qualitative since the cell environment is 
different from that of an aqueous buffer. Ideally the amount of ruthenium in cells 
should be quantified by metal trace analysis methods after uptake experiments. 
Unfortunately valid ruthenium concentrations in cell lysis solutions could not be 
obtained using ICP-OES. A more sensitive detection method, such as ICP-MS, should 
be used in the future. 
The dark and light cytotoxicity investigations need to be extended in the future in an 
optimal condition for different drug exposure times using stealth liposomes.  
Irradiation of the cells after drug exposure should be performed in at least 5% CO2 
atmosphere and 37 °C. Light intensity and photon flux also should be measured 
precisely and correctly. Finally, after finding the optimal conditions, all of the in vitro 
tests, i.e., uptake, dark toxicity and light cytotoxicity, should be performed on healthy 
cells as well to determine the toxicity of such liposomes to these healthy cells and 
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AI.1. Determination of the extinction coefficients 
AI.1.1. Extinction coefficients of kinetically stable compounds in an 
aqueous solution  
For a non-labile compound RuL (where L is a monodentate ligand, typically L=H2O, or 
SRR’) at room temperature the extinction coefficient was determined as follows: 
A stock solution α of compound RuL was prepared (typical concentration:10−4 M) in water 
and by successive dilution of solution α, five or six solutions with different concentrations 
(typically between 10−4 and 10−5 M) were prepared. The UV-vis spectra of all samples were 
measured, typically between 350-700 nm. The extinction coefficient at each wavelength 
was then determined from the slope of the plot of absorbance vs. concentration according to 
Beer-Lambert Equation AI.1. In this equation l is the UV-vis absorbance pathlength, εRuL is 
the extinction coefficient of RuL, and [RuL] is the concentration of RuL. 
                 (Equation AI.1) 
AI.1.2. Extinction coefficients of kinetically labile compounds involved in a 
fast thermodynamic equilibrium 
When the ruthenium thioether complex RuSRR’ is in a thermal equilibrium with the 
corresponding ruthenium aqua complex RuOH2 (taking into account that none of H2O or 
thioether ligands absorb light) determination of the extinction coefficient of RuSRR’ 
requires a different method than of kinetically stable compounds. A stock solution  of  
thioether compound SRR’ in water and a stock solution  of RuSRR’ in solution , were 
prepared. Four solutions containing 3–x mL of solution  and x mL of solution  were 
prepared, where x = 0.5, 1.0, 1.5 or 2 mL. UV-vis spectra were measured for all samples. In 
such conditions, the concentration in thioether SRR’ compound is the same for all samples, 
so that the ratio [RuSRR’]/[RuOH2] remains constant (Equation AI.2). However, due to 
dilution of the ruthenium complex (solution ) with the SRR’ solution (solution ), the total 
concentration in ruthenium [Ru]tot increases from x=0.5 to x=2. At constant 
[RuSRR’]/[RuOH2] ratio, [RuSRR’] is proportional to [Ru]tot and can be calculated 
according to Equation AI.3. 
   
        
       
            (Equation AI.2) 
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 (Equation AI.3) 
From the value of r in Equation AI.3 and the extinction coefficient of RuOH2 which was 
determined using the method in section AI.1.1, the extinction coefficient of RuSRR’ was 
calculated using Equation AI.4. In this equation εeq is the extinction coefficient obtained 
from the slope of the plot of the absorbance versus [RuSRR’] at the equilibrium. 
        
    ((   )        )
 
 (Equation AI.4) 
 
AI.2. Calculation of the concentration of the compounds from the 
UV-vis measurements 
AI.2.1. One-wavelength method 
There are two distinct methods for calculating the concentrations of two photochemically 
interconverting compounds in the solution by deconvolution of the UV-vis spectra. The 
first method needs one wavelength, at which the change in absorbance is large during the 
experiment. Another requirement for this method is that the reaction goes to completion. If 
we consider a substitution reaction RuSRR’+H2O RuOH2+SRR’, after a given amount of 
time, all of RuSRR’ is expected to be converted into RuOH2 (assuming that H2O and RSS’ 
do not absorb light). The contribution of each compound to the absorbance of the solution 
(for each absorption measurement at tj during the reaction) is a function of its 
concentration, the length of the cell, and the extinction coefficient of the compound, 
according to Beer-Lambert’s law (see Equation AI.5).  
   
           
                    
          (Equation AI.5) 
If at t, RuSRR’ is fully converted into RuOH2, thus the equation becomes: 
  
          
              (Equation AI.6) 
 
 [Ru]tot is the total Ru concentration. If we replace [RuOH2] by [Ru]tot−[RuSRR’]  in 
Equation AI.5, [RuSRR’] can be obtained from Equation AI.7. 
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    
 
  (       
        
 )
 (Equation AI.7) 
AI.2.2. Two-wavelength method 
If the reaction does not go to completion, the absorbance at two different wavelengths 1 
and 2 can be expressed as: 
   
            
                     
           (Equation AI.8.a) 
   
            
                     
           (Equation AI.8b) 
Thus, [RuSRR’] can be expressed as:  
         
   
   (         
          )
         
  
   (Equation AI.9) 
Equation AI.9 can be substituted in the Equation AI.8b, and [RuOH2] can thus be expressed 
as a function of A1 and A2 to yield Equation AI.10 (with l= 1 cm). 
        
   
          
      
          
  
       
         
           




Calculation of concentrations and kinetic studies using the two-wavelength method depends 
on the accuracy of four extinction coefficients at two different wavelengths, whereas in the 
one-wavelength method only two extinction coefficients are needed. However, in the one-
wavelength method the rate constant is highly sensitive to the accuracy of the absorbance at 
  . In fact, if the reaction does not go to completion a wrong value is taken for 
  
        the accuracy of the calculated concentrations are slightly lower than the 
concentrations calculated with two-wavelength method.  
AI.3. Photosubstitution quantum yield measurements  
A.I.3.1. Irradiation close to an isosbestic point  
For a photosubstitution reaction, where SRR’ in RuSRR’ is substituted by H2O, assuming 
that the aqua complex RuOH2 is not thermally reactive or photoreactive and that RuSRR’ is 
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thermally stable in water and in the dark at room temperature, the photosubstitution 
quantum yield can be measured as follows: 
The expression of the rate of the photosubstitution reaction is given by Equations AI.11 and 
AI.12, where kφi is a first-order photosubstitution rate constant, nRuSRR’ the number of moles 
of the RuSRR’ complex at time t, i the photosubstitution quantum yield, and qRuSRR’ the 
number of moles of photons absorbed by the RuSRR’ complex per unit time. qRuSRR’ can be 
calculated using Equation AI.13, where Φ is the photon flux determined by standard 
ferrioxalate actinometry,[1] 1–10–Ae is the probability of photon absorption, Ae is the 
absorbance of the solution at the irradiation wavelength, and (ARuSRR’/ARu(tot)) the relative 
contribution of the RuSRR’ complex to the total absorbance of the solution at the 
irradiation wavelength.  
       
        
  
              (Equation AI.11) 
                   (Equation AI.12) 
          (    
   )  (
       
  
) (Equation AI.13) 
If the irradiation wavelength λe is chosen close to the wavelength of the isosbestic point the 
probability of photon absorption remains constant during irradiation because ARuSRR’ and Ae 
do not vary in time and at λe, εe =εRuSRR’=εRu(tot).  Equations AI.12 and AI.13 rearrange to 
Equation AI.14, where nRu(tot) is the total number of moles of ruthenium complexes in the 
UV-vis cuvette. 
       
        
  
    (       )  (
       
   (   )
)     (Equation AI.14) 
 
By comparison between equation AI.11 and AI.14, quantum yield φi can be obtained from 
Equation AI.15.  
   
       (   )
  (       )




Note 1: kφi in Equation AI.15 can be obtained from the slope of a plot of 
ln([RuSRR’]/[Ru]tot) vs. irradiation time (see Equation AI.11). For kinetically unstable 
RuSRR’ complex in water, where RuSRR’ and RuOH2 are in a thermal equilibrium, 
another method is used to calculate kφi  (see Appendix III, section AIII.9). 
AI.3.2.     Irradiation at the wavelength that is not an isosbestic point  
When the irradiation wavelength is not close to an isosbestic point, the absorbance at the 
irradiation wavelength is not constant throughout the irradiation, which must be taken into 
account. Thus the procedure below was applied to calculate the photosubstitution quantum 
yields.[2] 
The average absorbance between two consecutive UV-vis measurements at tj and tj+1, at the 
irradiation wavelength λe, was calculated according to Equation AI.16. 
(  )    
(  )    (  )   
 
 (Equation AI.16) 
The number of moles of photons qj absorbed by the ruthenium complex RuSRR’ between 
two consecutive UV-vis measurements (∆t= tj+1−tj), was calculated according to Equation 
AI.17. In this Equation Φ is the photon flux at irradiation wavelength λe and  (  
  (  )   ) is the probability of photon absorption. If the sample was irradiated from the top 
of the cuvette (l’=3 cm), while the absorbance was measured perpendicular to the light 
irradiation direction (absorbance pathlength l=1 cm), Ae must be multiplied by 3 (see Figure 
AI.1).  
   (
       
(  )   
)
 
 (     (  )   )       (Equation AI.17) 
The total number of moles of absorbed photons since t0 (t0tj), Qj, can then be calculated at 
each irradiation time according to Equation AI.18.  
 ( )  ∑  
 
 (Equation AI.18) 
Finally, the quantum yield φi can be obtained from the slope of a plot of the number of 
moles of RuSRR’(nRuSRR’) vs. Qj.  
Note 2: probability of absorbance depends on the irradiation pathlength (l’). If the sample is 
irradiated from the top of the UV-vis cuvette l’=3 cm (see Figure AI.1), Ae, which is 
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measured by a spectrometer over a pathlength of l cm, must be multiplied by 3. Thus in 
Equation AI.15 and AI.17 probability of absorbance is: (1−10−(Ae×3)).  
 
Figure AI.1. Irradiation of a solution in a UV-vis cuvette is done in situ, perpendicular to the optical 
axis of the spectrophotometer. Irradiation pathlength=l’, UV-vis absorption pathlength=l, Iλe: light 
power at irradiation wavelength λe. I’: UV-vis light beam intensity measured by the 
spectrophotometer. 
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AII.1. Synthesis  
Dcbpy: 6,6-dibromo-2,2’-bipyridine (800 mg, 2.56 mmol) and PCl5 (2.64 g, 12.68 mmol) 
were dissolved in POCl3 (26 mL). To this solution was added KI (0.26 g, 1.57 mmol). The 
solution was heated to reflux for 48 hours after which POCl3 was distilled under vacuum. 
Water was slowly added to the residue after which the suspension was basified using 
concentrated aqueous ammonia. The suspension was extracted twice with DCM, the 
organic phase dried with MgSO4, filtered and the filtrate evaporated under reduced 
pressure. The white solid was recrystallized twice from toluene to yield 6,6-dichloro-2,2’-
bipyridine (393 mg, 68%). Characterization was identical to the reference.[1] 
[Ru(terpy)(dcbpy)Cl]Cl ([3]Cl): [Ru(tpy)Cl3] (67.1 mg, 0.15 mmol) and dcbpy (58.7 mg, 
0.26 mmol) were dissolved in ethylene glycol (1 mL). The mixture was heated to 180 °C 
for 4 hours, after which EtOH (2 mL) was added. The mixture was filtered to remove 
insoluble material and the filtrate was put under reduced pressure to remove EtOH. The 
purple solution was purified over neutral alumina (eluent: 95:5 DCM/MeOH); excess 
ethylene glygol was removed by coevaporation with toluene. The product was finally 
reprecipitated from MeOH/Et2O to yield [3]Cl as a violet powder (47.5 mg, 50%). 
1H NMR 
(300 MHz, MeOD, see Scheme 2.1 for proton notation) δ 8.75 (d, J = 8.1 Hz, 1H, B3), 8.54 
(d, J = 8.1 Hz, 2H, T3’5’), 8.51 – 8.41 (m, 3H, T33”+A3), 8.32 (t, J = 8.0 Hz, 1H, B4), 8.18 
– 8.03 (m, 4H, T66”+T4’+B5), 8.00 (td, J = 7.9, 1.4 Hz, 2H, T44”), 7.72 (t, J = 8.0 Hz, 1H, 
A4), 7.45 (dd, J = 9.6, 3.6 Hz, 2H, T55”), 7.17 (d, J = 7.9 Hz, 1H, A5). 13C NMR (75 MHz, 
CDCl3) δ 166.17+160.93+160.27+ 160.21+159.75+159.22 (B6+B2+A2+A6+T22”+T2’6’), 
153.86 (T66”), 139.76 (B4), 138.39 (A4), 137.82 (T44”), 135.54 (T4’), 128.77 (B5), 
127.44 (A5), 127.15 (T55”), 123.47 (T33”), 122.81 (A3), 122.55 (B3), 122.28 (T3’5’). ES 
MS m/z (calc): 595.9 (534.86  [M – Cl−]+), 295.7 (295.7 [M – 2 Cl + MeOH]2+). Anal. 
Calcd for C25H17Cl4N5Ru·4H2O: C, 42.75; H, 3.59; N, 9.97. Found: C, 42.90; H, 3.01; N, 
10.05. 
[Ru(terpy)(dcbpy)(H2O)](PF6)2 ([1](PF6)2): [3]Cl (50 mg, 85 μmol) and AgPF6 (65 mg, 
0.26 mmol) were dissolved in 4:1 acetone/H2O (5 mL). The solution was shortly heated to 
boiling point and allowed to cool down. The solution was filtered over celite, concentrated 
under reduced pressure to 1 mL, after which it was put in the fridge overnight. The 
suspension was filtered to yield [1](PF6)2 as a brown powder (42.7 mg, 58%). 
1H NMR 
(300 MHz, D2O, 298 K) δ 8.66 (d, J = 8.2 Hz, 1H, B3), 8.51 (d, J = 8.1 Hz, 2H, T3’5’), 
8.43 (d, J = 8.0 Hz, 2H, T33”), 8.38 – 8.27 (m, 2H, B4+A3), 8.21 (t, J = 8.1 Hz, 1H, T4’), 
8.13 (d, J = 5.5 Hz, 2H, T66”), 8.10 – 7.93 (m, 3H, B5+T44”), 7.66 (t, J = 8.0 Hz, 1H, A4), 
7.45 (ddd, J = 7.0, 5.7, 1.1 Hz, 2H, T55”), 7.12 (d, J = 8.0 Hz, 1H, A5). UV-vis: λmax (ε in 
L·mol-1·cm-1) in H2O: 488 nm (7550). ES MS m/z (calc): 590.0 (590.45  [M – 2 PF6
 – H2O 
+ MeO]+). 13C NMR was impossible due to the poor solubility of [1](PF6)2 in D2O. 
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Scheme AII.1. Synthesis of ligand 4 and atom numbering scheme for NMR athribution. 
6: A suspension of NaSMe (6.40 g, 91.3 mmol) in dry tetrahydrofuran (200 mL) was 
prepared under argon. While stirring 2-[2-(2-chloroethoxy)ethoxy]ethanol (9.62 g, 57.1 
mmol) was added to the flask. The reaction mixture was refluxed under argon overnight 
and the solvent was evaporated under reduced pressure. The crude light yellow oil was 
dissolved in dichloromethane (130 mL) and washed with water (80 mL) and brine (2  80 
mL). The organic layer was dried with MgSO4 and concentrated under reduced pressur to 
give 6 as a colorless oil (8.80 g, 85%). 1H NMR (300 MHz, δ in CDCl3):
  3.76-3.62 (m, 
10H, α + β + γ + δ + ε), 2.71 (t, 2H, ζ), 2.46 (s, 1H, OH), 2.15 (s, 3H, η). 13C NMR (75 
MHz, δ in CDCl3):  72.39 + 70.39 + 70.29 + 70.22 (α + β + γ + δ), 61.67 (ε), 33.35 (ζ), 
15.94 (η). ES MS m/z (calc): 180.1 (180.3, [M +Li]+). 
7: To a solution of 6 (2.20 g, 12.2 mmol) in pyridine (10 ml) at 0 °C was added 4-
toluenesulfonyl chloride (2.60 g, 13.6 mmol). The reaction mixture was left to stir at 0 °C 
for 3 h and at 10 °C for an additional 3.5 h. Toluene (30 ml) and HCl 10% (30 ml) were 
added. After drying the organic layer with MgSO4, the solvent was evaporated to yield 7 as 
light yellow oil (2.7 g, 66%). 1H NMR (300 MHz, δ in CDCl3):
  7.80 (d, J = 8.2 Hz, 1H, 
CH-tosylate), 7.34 (d, J = 8.0 Hz, 1H, CH-tosylate), 4.16 (t, 2H, α), 3.76 – 3.50 (m, 8H, α + 
β + γ + δ), 2.67 (t, J = 6.8 Hz, 2H, ζ), 2.44 (s, 1H, η), 2.13 (s, 1H, CH3-tosylate). 
13C NMR 
(75 MHz, δ in CDCl3):   144.93, 133.17, 129.95, 128.12, 70.91 + 70.74 + 70.38 + 69.35 + 
68.89 (α + β + γ + δ + ε),  33.59 (ζ), 21.68, 16.07 (η). ES MS m/z (calc): 357.1 (357.0, [M 
+Na]+), 373.2 (373.2, [M+K]+). 
4: A suspension of sodium hydride (0.22 g, 9.2 mmol) in dry tetrahydrofuran (40 mL) was 
prepared under argon. While stirring, cholesterol (1.20 g, 3.10 mmol) was added to the 
flask. After 30 min, compound 7 (1.32 g, 3.95 mmol) in dry tetrahydrofuran (5 mL) was 
added to the mixture. It was then heated to reflux under argon for 48 h. The flask was 
cooled to room temperature and 60 mL of a (1:1) mixture of water and HCl 1 M was added. 
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The product was extracted three times with diethylether: petroleum ether 1:15 (v/v) (40 
mL). The combined organic layers were washed once with HCl 1 M (30 mL), mixtures 
dried with MgSO4 and finally evaporated off to give compound 4 as a sticky white solid 
(1.31 g, 76%). 1H NMR (300 MHz, , δ in CDCl3): 5.34 (d, J = 5.1 Hz, 1H, 6), 3.74 – 3.57 
(m, 10H, α + β + γ + δ + ε), 3.17 (m, 1H, 3), 2.69 (t, J = 6.9 Hz, 2H, ζ), 2.42 – 2.19 (m, 2H), 
2.14 (s, 3H, η), 2.05 – 0.81 (m, 42H), 0.67 (s, 3H). 13C NMR (75 MHz, δ in CDCl3): 141.17 
(C5), 121.70 (C6), 79.67 (C3),  71.58 + 71.13 + 70.81 + 70.51 (α + β + γ + δ), 67.48 (ε), 
56.96, 56.34, 50.37, 42.49, 39.97, 39.68, 39.25, 37.42, 37.04, 36.36, 35.94, 33.61, 32.12 (ζ), 
32.07, 28.54, 28.39, 28.17, 24.45, 23.99, 22.96, 22.71, 21.24, 19.54, 18.88, 16.20 (η), 
12.02. High resolution ES MS m/z exp (calc):  549.43413 (549.43413, [M + H] +), 
566.46068 (566.45998, [M + NH4]
+), 571.41608 (571.41482, [M + Na] +). Anal. Calcd for 
C34H60O3S: calculated: C, 74.39; H, 11.02; N, 0.00; S, 5.84. Found: C, 74.39;  H, 11.16; N, 
0.0; S, 5.85. 
AII.2. X-ray crystallography for [2](PF6)2  
All reflection intensities were measured at 110(2) K using a KM4/Xcalibur (detector: 
Sapphire3) with enhance graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) under 
the program CrysAlisPro (Version 1.171.34.36, Oxford Diffraction Ltd., 2010). The 
program CrysAlisPro was used to refine the cell dimensions. Data reduction was done 
using the program CrysAlisPro (Version 1.171.34.36, Oxford Diffraction Ltd., 2010). The 
structure was solved with the program SHELXS-97[2] and was refined on F2 with 
SHELXL-97.[2] Analytical numeric absorption corrections based on a multifaceted crystal 
model were applied using CrysAlisPro. The temperature of the data collection was 
controlled using the system Cryojet (manufactured by Oxford Instruments). The H atoms 
were placed at calculated positions using the instructions AFIX 23, AFIX 43, AFIX 137 
with isotropic displacement parameters having values 1.2 or 1.5 times Ueq of the attached 
C atoms. The H atom located on O1 was found from difference Fourier maps, and its 
position was restrained so that d(OH) is 0.84(2) Å. The structure of [2](PF6)2 is mostly 
ordered. One of the two independent PF6
 counterions is found to be disordered over two 
orientations, and the occupancy factor of the major component refines to 0.60(3). 
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Figure AII.1. Time evolution of the UV-vis spectrum of a solution containing 
[Ru(terpy)(dcbpy)(H2O)]
2+ ([1]2+) and Hmte in pseudo-first order conditions.  
 
Figure AII.2. a) Plot of ln([RuOH2]/[Ru]tot) vs. time for 200, 400, 600 and 800 eq. of Hmte (pseudo-
first order conditions). b) Plot of k’1 vs. [Hmte] in pseudo-first order conditions. Conditions: T = 297 
K; [Ru]tot = 1.410
−4 M. 
 
Figure AII.3. a) UV-vis spectra of a solution of [2](PF6)2 in water irradiated at 465 nm. b) Plot of 
ln([RuHmte]/[Ru]tot) as a function of irradiation time. Conditions: λe = 465 nm, photon flux :3.910
−9 
Einstein·s−1, sample temperature 297 K, concentration [Ru]tot = 1.510





Figure AII.4. Left: Time evolution of the absorbance at 500 nm, for a sample containing DMPG 
vesicles with 25 mol % ligand 4, and 5 mol % complex [1]2+  after equilibration at room temperature 
in the dark, spectra measured every 3 minutes. Right: Plot of ln([RuSRR’]/[Ru]tot) vs. irradiation time 
for the measurement of the photosubstitution quantum yield at the membrane interface; [RuSRR’] 
represents the concentration in [5]2+ in mol·L−1. Conditions: [lipid] = 1.3 mM, 25 mol% of ligand 4, 
vesicle average diameter 140 nm, 5 mol% of complex [1]2+ (6.710−5 M), irradiation wavelength 465 
nm, photon flux :3.910−9 Einstein·s−1. 
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AIII.1. Synthesis  
[Ru(terpy)(biq)(Cl)]Cl ([10]Cl).
[1] [Ru(tpy)Cl3]  (200 mg, 0.453 mmol) and 2,2’-
biquinoline (116 mg, 0.452 mmol) were mixed in  3:1 EtOH/H2O mixture (20 mL) and the 
solution was degassed with argon for 5 min, after which Et3N (0.094 mL, 0.68 mmol) was 
added. The reaction mixture was refluxed   under argon for 7 h in the dark, after which it 
was filtered hot over celite. The filtrate was evaporated under reduced pressure. Column 
chromatography purification was then performed over silica gel (eluent: 15:85 MeOH / 
DCM, Rf=0.4). The solvent was evaporated and the product was finally reprecipitated from 
ethanol and toluene to yield [10]Cl as a violet powder (95 mg, 32% yield). 1H NMR (300 
MHz, MeOD, 298 K, see Figure AIII.1 for proton notation) 1H δ (ppm) 9.64 (d, J = 8.4 Hz, 
1H, B8), 8.95 (dd, J = 20.5, 8.9 Hz, 2H, B3+B4), 8.66 (t, m, 3H, A3+T3’), 8.48 (d, J = 8.0 
Hz, 2H, 3T), 8.25 (m, 3H, B5+A4+T4’), 8.00 – 7.75 (m, 7H, T4+B6+B7+A5+T6), 7.44 (t, 
J = 7.5 Hz, 1H, A6), 7.33 (m, 2H, T5), 7.20 (t, J = 8.0, 6.4 Hz, 1H, A7), 6.80 (d, J = 8.8 Hz, 
1H, A8). 13C NMR (75 MHz, CDCl3) δ (ppm) 163.24+160.70+ 160.37+ 159.96 
(T2+T2’+A2+B2), 153.87 (T6), 153.18+152.51 (A8a+B8b), 139.77(B4), 138.86 (T4), 
137.74+136.84 (A4+B5), 132.05 (A7), 131.84+131.77 (6B+7B), 130.75+129.96 
(A4a+B4a), 130.45+130.55 (A5+B8), 129.75 (T4’), 129.65 (A6), 128.37 (T5), 124.92 (T3), 
124.86 (A8), 123.95 (T3’), 121.76+121.69 (A3+B3). ES MS m/z (calc): 626.0 (625.8 [M - 
Cl]+). UV-vis: λmax (ε in L·mol
–1·cm–1) in MeOH: 571 nm (7400). Anal. Calcd for 
C33H23Cl2N5Ru: C, 59.91; H, 3.50; N, 10.59. Found: C, 60.15; H, 3.45; N, 10.54. 
[Ru(terpy)(dmbpy)Cl]Cl ([12]Cl). [Ru(tpy)Cl3] (500 mg, 1.13 mmol), dmbpy (209 mg, 
1.13 mmol) and LiCl (50 mg, 1.2 mmol) were mixed in 3:1 EtOH/H2O mixture (100 mL). 
The suspension was put under argon. Et3N (0.25 mL, 1.8 mmol) was added and the reaction 
was refluxed for 20 hours. Then it was filtered hot over celite to remove insoluble 
byproducts. The filtrate was rotary evaporated, then purified over alumina in the dark 
(eluent: 1% MeOH / DCM). The product eluted from the column as the initial violet band 
(Rf=0.3). The solvent was evaporated and the solid was reprecipitated from 1% MeOH / 
DCM and Et2O to yield [12]Cl as a dark violet powder (337 mg, 51 %). 
1H NMR (400 
MHz, MeOD, 298 K, see Figure AIII.1 for proton assignment) δ (ppm) 8.58 (m, 3H, B5 + 
T3’), 8.50 (d, J = 8.1 Hz, 2H, T3), 8.29 (d, J = 8.1 Hz, 1H, A3), 8.20 (t, J = 7.9 Hz, 1H, 
B4), 8.11 – 8.02 (m, 3H, T6 + T4’), 7.97 (t, J = 7.4 Hz, 2H, T4), 7.81 (d, J = 7.8 Hz, 1H, 
T5), 7.58 (t, J = 7.9 Hz, 1H, A4), 7.48 – 7.40 (m, 2H, T5), 6.89 (d, J = 7.7 Hz, 1H, A5), 
3.30 (s, 3H, B7), 1.52 (s, 3H, A7). 13C NMR (300 MHz, MeOD, 298 K) δ (ppm) 168.91 
(B6), 167.09 (A6), 161.57+161.54+161.40 (A2+T2+T2’), 159.36 (B2), 154.47 (T6), 138.72 
(B4), 138.63 (T4), 137.66 (A4), 135.85 (T4’), 128.59 (B5), 128.53 (T5), 127.45 (A5), 
124.83 (T3), 123.77 (T’3), 122.59 (C5), 122.33 (A3), 28.77 (B7), 23.74 (A7). ES MS m/z 
(calc): 553.81 (554.03 [M - Cl]+), 259.33 (259.28 [M – 2 Cl]2+). UV-vis: λmax (ε in L·mol
–




–1) in MeOH: 504 nm (6400). Anal. Calcd for C27H23Cl2N5Ru·2.5H2O: C, 51.11; H, 
4.45; N, 11.04. Found: C, 51.98; H, 4.44; N, 11.05. 
[Ru(terpy)(dcbpy)(Cl)]Cl ([11]Cl): See Chapter 2 and Appendix II.  
AIII.2. 
1H NMR and proton attribution  
 
Figure AIII.1. Notations for the attribution of the 1H and 13C NMR spectra for compounds [2]2+, 
[6]2+, [4]2+, and [8]2+.  
 
Figure AIII.2. 1H NMR of [4]Cl2 (top) and [8]Cl2 (down)  in pure D2O (aromatic region, N-
N=dmbpy). Conditions:[Ru]tot=13.6 mM, [Hmte]=0 (top) or 0.53 M (bottom), pH ~ 7, 298 K.  
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AIII.3. X-ray crystallography for [5](PF6)2  
All reflection intensities were measured at 110(2) K using a KM4/Xcalibur (detector: 
Sapphire3) with enhance graphite-monochromated Mo Kα radiation (λ = 0.71073 Å) under 
the program CrysAlisPro (Version 1.171.34.36, Oxford Diffraction Ltd., 2010). The 
program CrysAlisPro (Version 1.171.34.36, Oxford Diffraction Ltd., 2010) was used to 
refine the cuvette dimensions. Data reduction was done using the program CrysAlisPro 
(Version 1.171.34.36, Oxford Diffraction Ltd., 2010). The structure was solved with the 
program SHELXS-97 (Sheldrick, 2008) and was refined on F2 with SHELXL-97 
(Sheldrick, 2008). Analytical numeric absorption corrections based on a multifaceted 
crystal model were applied using CrysAlisPro (Version 1.171.34.36, Oxford Diffraction 
Ltd., 2010). The temperature of the data collection was controlled using the system Cryojet 
(manufactured by Oxford Instruments). The H atoms were placed at calculated positions 
using the instructions AFIX 23, AFIX 43, AFIX 137 or AFIX 147 with isotropic 
displacement parameters having values 1.2 or 1.5 times Ueq of the attached C or O atoms. 
The structure of [5](PF6)2 is mostly ordered. One of the two independent PF6
 counter ions 
is found to be disordered over two orientations, and the occupancy factor of the major 
component refines to 0.906(4). 
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AIII.4. Aquation of hindered chlorido complexes in CD3OD/D2O 
mixtures 
 
Figure AIII.3. 1H NMR spectra showing the hydrolysis of [Ru(terpy)(N-N)(Cl)]Cl ([10]Cl, [11]Cl, 
and [12]Cl) upon addition of increasing amount of D2O in MeOD. Conditions: a) initial 
[Ru]tot=6.610
–3 M, b) initial [Ru]tot=9.210
–3 M, and c) initial [Ru]tot=9.610
–3 M, T= 297K.  
AIII.5. Determination of pKa of [2]2+ and [4]2+ 
pH titration: 3 mL of a 67 µM solution of [10]Cl or [12]Cl in perchloric acid (33 mM) was 
added to a UV-vis cell. A pH measurement electrode was added to the top and aliquots of 
aqueous NaOH (0.1 – 1 M) were added to give a range of pH values. After each addition of 
NaOH, the solution was stirred until a stable pH was observed, then a UV-vis spectrum was 
obtained. By deconvolution, the relative amounts of [2]2+ and [4]2+ were plotted vs. pH 
(Figure AIII.4). The data points were fitted to Equation AIII.1, which gave the pKa of both 
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aqua complexes. The pKa values were determined to be 9.5(1) and 10.5(1) for [10]
2+ and 
[12]2+, respectively. 
[     ]  
 
      (      )
 (Equation AIII.1) 
 
 
Figure AIII.4. tOP: Evolution of the UV-vis spectrum of [2]2+ and [4]2+ (67 µM) upon increasing pH 
using NaOH. Bottom: Composition (expressed in percent of the non-deprotonated species RuOH2) 
during titration with NaOH. Squares: [10]2+, circles: [12]2+. Black lines: fit curves for the data points 
using Equation AIII.1. 
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AIII.6. Calculating the rate constants at different temperatures for 
the fast equilibrium between [4]2+ and [8]2+  
If we consider the interconversion between [4]2+ and [8]2+ the rate law of this reaction can 
be expressed as Equation AIII.2. 
 [      ]
  
   [     ]  [    ]     [      ] (Equation AIII.2) 
 
If pseudo first-order conditions are used (large excess of Hmte), since the concentration of 
Hmte is constant k4[Hmte] can be replaced by the pseudo first-order rate constants k’4 (see 
Equation 3.2 in the article). 
Since k–4 is significant, [RuOH2] is substituted by [Ru]tot – [RuHmte] in Equation 3.2 (see 
Chapter 3), which simplified to Equation 3.3, where k’4 +k–4 =kobs is usually called the 
“observed” rate constant (unit: s−1). 
Integration of this differential Equation 3.3 leads to Equation 3.4 (see Chapter 3), where c is 
a constant derived from integration. 
Since there is no linear form of this formula, data had to be fitted with Equation AIII.3, 
using a non-linear least-squares minimization procedure as described by Lagarias et al.[2] 
(simplex search method). The program MATLAB was used for the optimization. 






       (Equation AIII.3) 
Figure AIII.5 shows a plot of the experimental data points, compared to the fitted model. 
The modeled curve closely matches the experimental data and thus k’4=k4[Hmte] and k–4 
could be calculated from the constants A=k’4[Ru]tot and B=kobs=k’4+k–4  determined 






Table AIII.1. The values of A, B, and C used as a model for Equation 3.4 and the kinetic data of the 
dmbpy system (equilibrium between [4]2+ and [8]2+) at different temperatures. Conditions: [Ru]tot = 
1.5 10–4 M, [Hmte] = 3.2 10–2 M, MilliQ water, pH ~ 7. 
T (K) A B C k–4  (s
–1) k4  (M
–1·s–1) 
283 7.6 10–8 1.1 10–3 2.7 10–8 6.3 10–4 1.610–2 
288 1.5 10–7 2.3 10–3 1.5 10–7 1.4 10–3 3.010–2 
293 2.7 10–7 4.2 10–3 2.6 10–7 2.410–3 5.410–2 
297 4.3 10–7 6.9 10–3 4.1 10–7 4.1 10–3 8.810–2 
301 7.4 10–7 1.2 10–2 6.5 10–7 7.410–3 1.510–2 
 
 
Figure AIII.5. Plot of [RuHmte] (concentration in [8]2+) vs. time during thermal substitution of H2O 
by Hmte in complex [Ru(terpy)(dmbpy)(H2O)]
2+ ([4]2+). Conditions: [Hmte] = 0.032 M, [Ru]tot= 
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Table AIII.2. Experimental pseudo first-order and second-order rate constants (k’i=ki[Hmte] and ki) 
at different temperatures for N-N=bpy, biq, and dcbpy. Condition: [Ru]tot=6.710
–5 M and [Hmte]= 
6.710–2 M for N-N=bpy and biq , [Ru]tot=1.410












AIII.7. Order of Hmte and second-order rate constant determination 
at 297 K in the thermal coordination reaction for N-N=bpy, 
biq, and dmbpy 
Stock solutions θ of complex [1](PF6)2 (4.0 mg in 25 mL H2O, 2.010
–4 M), ι of [10]Cl (2.2 
mg in 25 mL H2O, 1.310
–4 M), κ of [12]Cl (3.5 mg in 25 mL H2O, 2.210
–4 M), and ξ and 
χ of Hmte (600 mg in 25.0 mL H2O, 2.6010
–1 M (ξ), and 1090 mg in 25.0 mL H2O, 
4.7310–1 M (χ)) were prepared. 2.0 mL of θ, ι, or κ was added to a UV-vis cuvette, which 
was placed in the UV-vis spectrometer. The temperature was set at 50 °C for θ, and at 24°C 
for ι, or κ. After obtaining a constant temperature in each cuvette, to each solution was 
added x mL of H2O, and 1-x mL of ξ or χ, where x is 0.2, 0.6, 0.8 or 1.0 mL of ξ to θ, and 
0.2, 0.4, 0.8 or 1.0 mL of χ to ι, and 0.05, 0.10, 0.15 or 0.20 mL of ξ to κ . After addition of 
Hmte, a UV-vis spectrum was taken every 30 seconds. For each spectrum, the 
concentrations in [RuHmte] and [RuOH2] were determined by deconvolution of the UV-vis 
spectra knowing the extinction coefficients of both RuHmte and RuOH2 species. For N-
N=bpy and biq ([1]2+ and [2]2+) thermal back coordination (k-i) is negligible and for each 
Hmte concentration the pseudo first order rate constants kobs=ki[Hmte] were determined 
from the slope of the (linear) plot of ln([RuOH2]/[Ru]tot) vs. time (Figure AIII.6). For N-
N-N T (K) k’i (s
–1) ki  (M
–1·s–1) 
bpy 323 5.4 10–5 8.210–4 
333 1.4 10–4 2.110–3 
343 3.710–4 5.610–3 
353 7.910–4 1.210–2 
biq 297 4.310–4 6.510–3 
301 7.510–4 1.110–2 
308 1.710–3 2.610–2 
315 3.410–3 5.210–2 
323 6.210–3 9.310–2 
327 8.810–3 1.310–1 
dcbpy 283 5.710–4 3.610–3 
288 1.110–3 7.010–3 
293 2.110–3 1.310–2 
297 3.610–3 2.310–2 
301 6.410–3 4.010–2 
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N=dmbpy ([4]2+), thermal back coordination is not negligible and as shown in Figure 
AIII.6c linear trend lines are not best fits for the data points. In such conditions kobs= 
ki[Hmte]+k-i, and a plot of [RuHmte] vs. time was obtained for each Hmte concentration. 
All the data were modeled to Equation AIII.3, and A=k’4[Ru]tot and B=kobs=k’4+k–4 were 
directly obtained from the model (see Equation 3.4). The plot of kobs  vs. [Hmte] was 
obtained for each N-N ligand (see Figure AIII.7). Finally, the second-order rate constant ki 
were obtained from the slope of these plots for i=1 (bpy), 2 (biq), and 4 (dmbpy). 
Half reaction times are calculated according to the Equation AIII.4. 
    ( )  
   




Figure AIII.6. Plot of ln([RuOH2]/[Ru]tot) vs. time for the coordination of Hmte to a) [1]
2+, b) [2]2+, 
and c) [4]2+ upon adding  different equivalents of Hmte to the solution. Conditions: in water, pH~7, a) 
T=323 K, [Ru]tot=1.3×10
−4 M, b) T=297 K, [Ru]tot=8.4×10
−5 M , c) T=297 K, [Ru]tot=1.5×10
−4 M. 
 
Figure AIII.7. Plot of k’i vs. [Hmte] in pseudo-first order conditions. a) N-N=bpy, slope= 
k1=8.8×10
−4 M−1·s−1, T=323 K, pH~7, [Ru]tot=1.3×10
−4 M, b) N-N=biq, slope=k2=6.4×10
−3 M−1·s−1, 
T=297 K, [Ru]tot=8.4×10
−5 M , c) N-N=dmbpy, slope k4=0.12 M
−1·s−1, T=297 K, [Ru]tot=1.5×10
−4 M. 
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AIII.8. Kinetics of the thermal hydrolysis of [5]2+ (N-N=bpy) in MilliQ 
water at different temperatures 
Table AIII.3. Experimental first-order rate constants (k–1) at different temperatures for the thermal 
hydrolysis of [5]2+ in MilliQ water. Condition: [Ru]tot=2.510
–4 M. 
T (K) k–1 (s
–1) 
343 7.0 10–6 
348 1.2 10–5 
353 2.1 10–5 
358 4.3 10–5 
363 5.8 10–5 
 
Figure AIII.8. Eyring plot for the thermal substitution of Hmte by an aqua ligand in [5]2+. The slope 







and ΔG‡–1 (at 297K) were found to be 110(6) kJ·mol
–1, –22(10) J·mol–1·K–1, and 117(10) kJ·mol–1, 
respectively. 
AIII.9. Quantum yield measurements for  [6](PF6)2 and [8](PF6)2 
Compound [5]2+ is kinetically stable and the photosubstitution quantum yield for this 




Figure AIII.9. a) Evolution of the UV-vis spectra of an aqueous solution of [5](PF6)2 irradiated with 
blue light. Full conversion to [1](PF6)2 is achieved within 30 minutes. Spectra were taken at 1, 2, 3, 
…, 10, and 30 minutes. b) Plot of ln([RuHmte]/[Ru]tot) vs. irradiation time. Condition: water, T=297 
K, [Ru]tot=1.010
–4 M, e=452 nm, photon flux Φ=6.410
–9  Einstein·s–1, slope ki= 2.810
–3 s–1, 
e=6000 L·mol
–1·cm–1, Ae=0.88, and irradiation pathlength l’= 1 cm. 
Compound  [6]2+ or [8]2+ (RuHmte) are not kinetically stable and the equilibrium between 
RuHmte and RuOH2 is fast, and the quantum yield cannot be measured for these 
compounds  in a general way as reported in AI.3. In addition, isolation of [6](PF6)2 or 
[8](PF6)2 as pure solids was impossible. In order to perform quantum yield measurements a 
LED lamp was mounted on top of the UV-vis cuvette to irradiate the sample inside the UV-
vis spectrometer. In such conditions, temperature stabilization issues during sample transfer 
are eliminated, and back-coordination of Hmte to RuOH2 is minimized. 
To measure i, an aqueous solution of each complex [10]Cl or [12]Cl was prepared that 
contained a large excess of Hmte. After equilibration in the dark, the ratio 
[RuHmte]/[RuOH2] was measured by UV-vis spectroscopy; a value of 1.6 was found for 
the biq system and of 0.50 for the dmbpy system. The equilibrated samples were then 
subjected to visible light irradiation at room temperature at λe= 520 nm or λe=465 nm, 
respectively. In such conditions, three reactions take place simultaneously: 1) the 
photochemical cleavage of the Ru-S bond, 2) the thermal cleavage of the Ru-S bond, and 3) 
the thermal binding of Hmte back to the aqua complex (see Scheme 3.1). In such 
conditions, the variation of [RuHmte] is given by Equation AIII.5, which can be rewritten 
for the thermal equilibrium in the dark (eq) into Equation 3.8a, and for the photochemical 
steady state (ss) into Equation 3.8b. 
 [      ]
  
   [     ]  [    ]     [      ]     [      ] 
(Equation   
AIII.5) 
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The plot of the ratio [RuHmte]/[RuOH2] as a function of irradiation time was obtained by 
deconvolution of the UV-vis spectra using the extinction coefficients of RuHmte and 
RuOH2. Since [8]
2+ (N-N=dmbpy) is involved in a very fast thermal equilibrium with [4]2+, 
visible light irradiation did not change significantly the ratio [RuHmte]/[RuOH2]
 during 
irradiation (see Figure AIII.10a), whereas for the biq system the thermal kinetics are lower 
and light irradiation leads to a photochemical steady state after about 1800 s irradiation. 
This steady state was characterized by a [RuHmte]/[RuOH2] ratio of 0.10,
 which is very 
different from the ratio at the equilibrium in the dark (1.6, see Figure AIII.10b). Since ki is 
known, k–i could be calculated using Equation 3.8a. In a second stage, kφi was obtained by 
using the values of ki and k–i in Equation 3.8b. The photochemical quantum yields were 
calculated using Equation 3.9, to give values of 0.12(5) and 0.30(6) for 2 and 4, 
respectively, at 297 K. 
For comparison purposes 3 was also determined by the same method as for biq and 
dmbpy: an equilibrated solution of [3]2+ and [7]2+ was characterized by a 
[RuHmte]/[RuOH2] ratio of 2.0, and in the steady state at λe= 465 nm a value of 0.13(5) 
was obtained for 3 (see Figure AIII.10c), which is consistent with the reported value in 
Chapter 2. All numerical parameters used to perform this calculation are indicated in Table 
AIII.4.   
 
Figure AIII.10. Plots of the ratio [RuHmte]/[RuOH2] vs. irradiation time for a) N-N=dmbpy  ([8]
2+ 
 [4]2+), Conditions:  T= 297 K, blue light (e=465 nm, photon flux Φ=4.0(4)10
–9 Einstein·s–1), 
[Ru]tot = 1.910
–4 M , [Hmte] = 0.20 M. b) N-N=biq ([6]2+  [2]2+), Conditions: T= 297 K, green  
light (e=520nm, photon flux Φ=9.8(5)10
–9 Einstein·s–1), [Ru]tot =  8.610
–5 M , [Hmte] = 0.011. c) 
N-N=dcbpy ([7]2+  [3]2+), Conditions:  T= 297 K, blue light (e=465 nm, photon flux Φ=4.0(4)10
–9 
Einstein·s–1), [Ru]tot = 1.610





Table AIII.4. Photochemical data for the calculation of the photosubstitution quantum yield for 
RuHmte complexes [5]2+, [6]2+and [8]2+. Conditions: T=297 K, MilliQ water, pH ~ 7. 
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[RuHmte]/[RuOH2]light  0.14 0.18 0.375 
[Hmte] (mol·L–1)  0.011 0.010 0.20 
k’i  (s
–1)  7.310–5 2.210–4 1.810–2 
k–i  (s
–1)  4.410–5 1.110–4 4.510–2 
kφi   (s
–1) 2.810–3 4.210–4 1.110–3 2.010–3 
Ae 0.88 0.57 1.0 0.66 
[Ru]tot (M) 1.510
–4 9.010–5 1.510–4 2.010–4 
e (nm) 450  520 465 465 
Photon flux  (Einstein·s−1) 6.410–8 9.810–10 3.910–9 3.910–9 
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Binding of a ruthenium complex to a thioether ligand 
embedded in a negatively charged lipid bilayer:  
























Figure AIV.1. Surface pressure vs. mean molecular area isotherms for the compression of lipid 
monolayers made of DMPG, DMPG with 25 mol% ligand 1, DMPC, and DMPC containing 25 mol 
% ligand 1, at the air/buffer interface. Compression rate: 2.4 mm/min, T=298 K, 10 mM phosphate 
buffer with I=50 mM, pH=7.0. 
 
Figure AIV.2. Plot of surface pressure variation after each injection of [2]2+ vs. total concentration of 
[2]2+ in the trough upon titration of DMPG monolayers containing 25 mol% ligand 1. Conditions:  
concentration of titrating [2](PF6)2solution = 0.65 mM, T=298 K, lipid contents: 4.0 to 8.0 nmol. 
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Figure AIV.3. Plots of surface pressure vs. time for zwitterionic monolayers after injection of [2]2+ 
(0.5 µM) into the buffer subphase: (I) DMPC and 25 mol % cholesterol, and (II) DOPC and 25 mol% 
ligand 1. Each arrow represents the injection of 50 µL [2]2+. Conditions:  concentration of titrating 
[2](PF6)2 solution=0.65 mM, T=298 K, phosphate buffer: I=50 mM, pH=7.0, volume of the trough: 
65 mL. 
 
Figure AIV.4. Plots of surface pressure vs. time for DMPG monolayers containing 25 mol% of 
ligand 1 after injection of [2]2+ (3.5 µM) in a buffer subphase at different initial surface pressure Π0. 
Condition: 10 mM phosphate buffer, total ionic strength=50 mM, concentration of [2]2+ in the stock 
solution=2.3 mM, T=298 K. At Π0=0, there is no monolayer. Each arrow in the Figure shows an 





Figure AIV.5. Plots of surface pressure vs. time for a DMPG monolayer containing 25 mol% ligand 
1 after injection of [2](PF6)2 (1.0 µM) or [2](Cl)2 (1.1 µM) into a buffer subphase  at an initial surface 
pressure Π0~35.5 mN/m. Conditions: I=50 mM, concentrations of ruthenium stock solutions: 0.65 
mM for [2](PF6)2, 3.5 mM for [2]Cl2. T=298 K.  
 
Table AIV.1. Thermodynamic data for the adsorption of [2](PF6)2 or [2]Cl2 to DMPG liposomes 
functionalized with 25 mol% thioether-cholesterol ligand 1. Conditions: ruthenium concentration = 
















+4    58 ±9 −23 +275 0.18 ±0.01 
[2]Cl2 2.3(5)×10




Supporting Information of Chapter 5:  
Liposomes functionalized with ruthenium complexes: 
























AV.1. Quantification of the quenching of NBD-PC fluorescence by 
ruthenium complex [1](PF6)2 supported on a liposome  
 
In order to determine the amount of quenching of NBD-PC by the ruthenium complex 
[1](PF6)2 incorporated in PEGylated DOPC liposomes (DOPC:DSPE-PEG2K:NBD-PC 
(92:4:4) in PBS, the following procedure was performed. Liposomes that contained 
different amounts (0.5 to 5 mol%) of complex [1](PF6)2 were prepared as explained in 
section 5.5.3. A 24-well plate was prepared with liposome solutions in each well and the 
plate was read with a fluorescence spectrophotometer set at the excitation wavelength: 460 
± 5 nm and emission wavelength: 534 ± 5 nm. A plot of the fluorescent values vs. 
concentration of the ruthenium in each sample (mol%) was obtained (Figure AIV.1). The 
emission intensity of NBD-PC was found to be dependent on the amount of ruthenium 
present in the liposome membrane (expressed in mol% of the complex in the lipid 
formulation). The ruthenium concentration dependence was modeled as a second order 
polynomial (for ≤5 mol% Ru) as shown in Equation AV.1. 
                                  (R2 = 0.9968)      (Equation AV.1) 
In this equation, F is the fluorescence at λem. = 534 nm (F(0 mol% Ru) = 100%) and [RuSRR’] is 
the amount of [1](PF6)2 in mol% in the membrane.  
 
Figure AIV.1. Quenching of NBD-PC by different amounts of ruthenium complex [1](PF6)2 in mol% 
supported on DOPC:DSPE-PEG2K:NBD-PC(92:4:4) liposomes. Bulk total lipid concentration: = 2.5 
mM (as liposomes), in PBS, T = 25 °C. 
Supporting information of chapter 5 
221 
AV.2. Sample preparation protocol for ruthenium concentration 
measurement by ICP-OES 
After cellular uptake of each liposome sample containing Ru, the cell lysis (in NaOH 0.2 
M) was collected from each well and mixed together.  2.0 mL of the cell lysis was put in a 
glass reaction tube and 1000 µL of HNO3 (65%) was added. The tube was closed by a glass 
marble. It was then put in an oven at 90 °C for 3 h, after which the digested sample was 
transferred to a volumetric flask and completed to 5.0 mL with Milli-Q. The clear solution 
was put in a corning tube and the ruthenium concentration was measured by ICP-OES. For 
all samples, the measured value for ruthenium concentration was lower than the sensitivity 
of the ICP-OES machine ([Ru]<20 ppb), while the concentration of the ruthenium in the 
liposome stock solution (before exposure to the cells) was measured to be about 3820(40) 
ppb in 5 mL digested solution  (5 mol% Ru complex (e.g., [1](PF6)2) functionalized on 
liposomes, [Ru]tot = 0.075 mM, [lipid]tot= 1.5 mM) . The expected concentration for 100% 
cellular uptake was 3870(40) ppb in 5 mL solution. 
Table AV.1. Extinction coefficients of the ruthenium complexes at one wavelength. The values were 












RuSRR’ RuOH2 RuSRR’ RuOH2 RuSRR’ RuOH2 RuSRR’ RuOH2 
  
(L·mol–1·cm–1) 
4700 1000 4600 2400 5000 2100 5000 3100 
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Yellow-light sensitization of a ligand photosubstitution 
reaction in a ruthenium polypyridyl complex covalently 























AVI.1. 1H NMR Spectra of the irradiated compounds  
 
 
Figure AVI.1. 1H NMR spectra of [2]Cl3 (region 10–1.0 ppm) in D2O before (a) and after (b) 
irradiation with yellow light for 530 min. The arrows show the peaks of coordinated Hmte and 6A in 
[2]3+, and the stars indicate free Hmte (aliphatic part) and 6A in [Ru(4)(bpy)(D2O)]
3+ (aromatic part). 
Conditions: Yellow light irradiation (λe=570 nm, Δ1/2=8.9 nm, t=530 min, photon flux: 5.3×10
−9 
Einstein·s-1), [Ru]tot=5.3×10
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Figure AVI.2. 1H NMR spectra of [2](PF6)3 (region 10–6.6 ppm) in acetone-d6/D2O (90:10) (a) 
before irradiation and in the dark; (b) after 4 h irradiation with yellow light (λe=570 nm, Δ1/2=8.9 
nm); the solution contains a mixture of [2]3+ and [Ru(4)(bpy)(D2O)]
3+; and (c) after leaving the 
sample under sun light for 2 days; full photoconversion to the aqua compound [7]3+ was reached. 
Conditions: [Ru]tot=2.0×10
−3 M, T=298 K. 
AVI.2. Photon flux determination   
The photon flux for the irradiation setup at 452 nm was measured using the ferrioxalate 
actinometer.[1]  However, the ferrioxalate actinometer is not suited for 570 nm photons, so 
that an indirect method was used. The light power (in mW·cm−2) at 452 nm (I452) and 570 
nm (I570) was measured using an OPHIR Nova power meter. Knowing the photon flux at 
452 nm (Φ452), the photon flux at 570 nm (Φ570) was calculated using Equation AVI.1. In 
this equation Eλ is the photon energy at 452 nm (E452=4.4×10
−19 J) and at 570 nm 
(E570=3.5×10
−19 J). The photon flux at 570 nm was found to be 5.3×10−9 Einstein·s−1.  
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Samenvatting (Summary in Dutch) 
Algemene inleiding (H 1) 
Polypyridyl-rutheniumcomplexen worden veel gebruikt in fotochemie.
[1-2]
 Hun 
fotofysische eigenschappen kunnen worden verfijnd om de gewenste reactie te krijgen 
als ze met licht worden beschenen met licht. Rutheniumcomplexen, in het bijzonder die 
met een verstoord-octaëdrische geometrie, kunnen een ligand vervangen voor een 




Twee mogelijke toepassingen van dit soort verbindingen worden besproken: allereerst 
als lichtgestuurde moleculaire machines en ten tweede als antikankermedicijn dat door 
licht geactiveerd kan worden. In dit proefschrift wordt er verbinding gelegd tussen deze 
twee toepassingen door gebruik te maken van een membraan van een dubbele laag van 
vetten. In het eerste deel van het in dit proefschrift beschreven werk zijn 
fotosubstitutiereacties van rutheniumverbindingen bestudeerd op het oppervlak van 
membranen, om natuurlijke moleculaire machines na te bootsen. Door 
monodentaatliganden in het membraan te binden kan het rutheniumcomplex thermisch 
aan het membraan binden terwijl het weer worden losgemaakt door bestraling met 
licht; op deze manier kan een model van een lichtbestuurde moleculaire transporteur 
worden gerealiseerd. In het tweede deel van het beschreven werk worden dezelfde 
membranen met daarop verankerde, lichtgevoelige rutheniumcomplexen beschouwd 
als mogelijke fotochemotherapeutica, omdat het ruthenium-watercomplex dat vrijkomt 
bij de bestraling met licht mogelijk cytotoxisch is. De membranen met daarop de 
rutheniumverbinding, die als prodrug fungeren, zouden naar kankercellen gebracht 
kunnen worden. Eenmaal opgenomen kunnen ze worden geactiveerd met licht, wat 
resulteert in een fotosubstitutiereactie waarbij het actieve ruthenium-watercomplex 
vrijkomt in de cel. Door de fotochemie van rutheniumverbindingen en de biologische 
eigenschappen van liposomen te combineren, zijn we van een fundamenteel 
biomimetisch onderwerp, moleculaire beweging, naar het tweede onderwerp gekomen, 




Ruthenium-polypyridylcomplexen die springen op het oppervlak van 
anionische dubbellagen van vetten door middel van een lichtgevoelige 
supramoleculaire verbinding (H 2) 
In hoofdstuk 2 is de nieuwe rutheniumverbinding [Ru(terpy)(dcbpy)(Hmte)]
2+
 
(RuHmte) geïntroduceerd (terpy = 2,2’;6’,2”-terpyridine, dcbpy = 6,6’-dichloro-2,2’-
bipyridine, Hmte = 2-methylthioethan-1-ol). Met behulp van kinetiekmetingen en 
thermodynamische gegevens is aangetoond dat de sterische hindering van de 
methylgroepen in dcbpy destabilisatie veroorzaakt van zowel het ruthenium-
thioethercomplex (afgekort als RuHmte) als ook de waterbevattende verbinding 
[Ru(terpy)(dcbpy)(H2O)]
2+
 (afgekort als RuOH2). Bij kamertemperatuur en in het 
donker zijn deze twee verbindingen in thermisch evenwicht. Echter, bestraling van de 
oplossing met blauw licht resulteert in selectieve substitutie van het thioetherligand 
door een waterligand, wat het evenwicht verschuift richting de vorming van RuOH2 
(zie schema 7.1a). Het is aangetoond dat deze evenwichtsverschuiving veroorzaakt 
door licht ten minste vier keer herhaald kan worden in een homogene, waterige 
oplossing. 
Thermisch binden en lichtgeïnduceerde dissociatie van een thioetherligand aan het 
rutheniumcentrum is ook uitgevoerd op het oppervlak van negatief geladen liposomen 
(zie schema 7.1b). UV-vis metingen laten zien dat het ruthenium-watercomplex 
efficiënt coördineert aan een membraangebonden thioetherligand in het donker, en dat 
tijdens beschijnen met zichtbaar licht de Ru-S-binding selectief wordt verbroken zodat 
het ruthenium-watercomplex wordt losgelaten. Het is aangetoond dat deze reacties vier 
keer herhaald kunnen worden door de lichtbron aan en weer uit te schakelen. Hiermee 
is dus lichtgeïnduceerd ‘springen’ van een rutheniumcomplex op een membraan van 
vetten bereikt. 
Efficiënt, lichtgestuurde springen van een rutheniumcomplex op het membraan heeft 
twee vereisten. Allereerst moet de sterische hindering van het rutheniumcomplex hoog 
genoeg zijn om snelle thermische coördinatie en lichtgeïnduceerde dissociatie mogelijk 
te maken. Ten tweede moeten de liposomen negatief geladen zijn zodat de 
rutheniumcomplexen in de buurt van het membraan blijven en weer kunnen binden aan 
de membraangebonden zwavelliganden. Deze twee zaken worden verder besproken in 





Schema 7.1. a) Thermisch evenwicht tussen Ru(terpy)(N-N)(H2O)]
2+ en [Ru(terpy)(N-N)(SRR’)]2+ 
en de fotosubstitutie van SRR´ door H2O. SRR’is een thioetherligand zoals 2-methylthioethan-1-ol  
en N-N is een diimineligand zoals dcbpy. b) Lichtgeïnduceerde rutheniumbinding en dissociatie op 
een negatief geladen membraan. 
Spontane vorming in het donker en lichtgeïnduceerde verbreking van 
een Ru-S-binding in water: een thermodynamische en kinetische studie 
(H 3) 
In hoofdstuk 3 wordt de thermische en fotochemische reactiviteit in water beschreven 
van vier verwante ruthenium-polypyridylcomplexen met de algemene formule 
[Ru(terpy)(N-N)(Hmte)]
2+
 (N-N = bpy, biq, dcbpy, of dmbpy, zie schema 3.1a). Bij elk 
van deze complexen wordt de Ru-S-binding verbroken door bestraling met licht, wat 
resulteert in de vorming van het ruthenium-watercomplex [Ru(terpy)(N-N)(H2O)]
2+
 
(RuOH2). In dit hoofdstuk is beschreven hoe de sterische hindering van het N-N ligand 
de thermodynamische stabiliteit en kinetische labiliteit van de RuHmte- en RuOH2-
complexen in het donker beïnvloedt. De kinetiek van de van fotosubstitutiereacties is 
ook gerapporteerd.  
Met toenemende sterische hindering van het N-N ligand, wordt de snelheid van 
thermische binding aan en thermische dissociatie van het Hmte-ligand van het 
rutheniumcentrum vergroot. Een verschuiving is waargenomen langs de serie van bpy, 
biq, dcbpy, en dmbpy, van een zeer langzaam thermisch evenwicht tussen RuOH2 en 
RuHmte met N-N=bpy, tot een zeer snel evenwicht met N-N=dmbpy. 
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De grotere labiliteit van de gehinderde complexen in water wordt niet veroorzaakt door 
een verandering van de activeringsenthalpie van de substitutiereactie (∆H
‡
), maar door 
een verandering van de activeringsentropie ∆S
‡
, die negatief is voor bpy en biq en 
positief is voor dcbpy en dmbpy. Deze verandering in de activeringsentropie geeft aan 
dat er een verandering is in het mechanisme van de substitutiereactie, van een 
associatief mechanisme voor de verbindingen met bpy en biq (∆S
‡
<0) naar een 
dissociatief mechanisme voor de complexen met dcbpy en dmbpy (∆S
‡
>0).  
De kwantumefficiëntie van de fotoverbreking van de Ru-S-binding neemt ook toe 
langs de serie van N-N = bpy, biq, dcbpy, en dmbpy. In het algemeen zijn er twee 
voorwaarden gevonden om het evenwicht tussen RuHmte en RuOH2 in water met licht 
te verschuiven. Allereerst moet de thermodynamische stabiliteit van het RuHmte-
complex in het donker in water groter zijn dan dat van RuOH2 (k−i<ki) om te leiden tot 
de spontane vorming van de ruthenium-thioetherverbinding. Echter, RuHmte wordt 
niet gevormd als de instelling van het thermische evenwicht te langzaam is, zoals in het 
geval van het complex met het minst-gehinderde ligand bpy, omdat er niet genoeg 
thermische energie is om de activeringsbarrière van de coördinatiereactie te 
overwinnen. Ten tweede moet de snelheid van de fotosubstitutie van het Hmte-ligand 
voor een waterligand hoger zijn die van de analoge thermische substitutiereactie 
(k−i<kφ, zie schema 7.1a). Voor het complex met het meest sterisch-gehinderde ligand 
dmbpy geldt dit niet; de thermische labiliteit van het RuHmte-complex is zo hoog dat 
licht geen significante verschuiving kan veroorzaken in het evenwicht tussen RuHmte 
en RuOH2. De conclusie is dat alleen de complexen die niet al te zeer gehinderd zijn, 
namelijk die met N-N=biq en dcbpy, geschikt zijn voor de verschuiving van het 
evenwicht tussen RuHmte en RuOH2 met licht. 
Het binden van een rutheniumcomplex aan een thioetherligand dat 
gebonden is aan een negatief geladen dubbellaag van vetten: een 
tweestapsmechanisme (H 4) 
Negatief geladen membranen zijn nodig voor de binding van ruthenium-
watercomplexen aan membraangebonden thioetherliganden, zoals besproken in 
hoofdstuk 2. In hoofdstuk 4 wordt de rol gerapporteerd van de negatieve lading van de 
membranen in de coördinatiereactie die plaatsvindt op het water-membraan grensvlak. 
De interactie van het complex [Ru(terpy)(dcbpy)(H2O)]
2+
 met fosfolipidemembranen 
die neutrale thioetherliganden óf cholesterol bevatten, is bestudeerd door gebruik te 
maken van drie verschillende technieken: UV-visible spectroscopie, oppervlaktedruk-





De resultaten van de eerste techniek toonden aan dat de reactie van de 
rutheniumverbinding met de thioetherliganden langzamer wordt wanneer de 
elektrostatische interactie tussen de rutheniumkationen en de negatief geladen 
liposomen wordt afgeschermd door een grotere ionsterkte van de oplossing. Adsorptie 
van het dikationische rutheniumcomplex op het oppervlak van de negatieve 
membranen speelt dus een prominente rol in de vorming van de Ru-S 
coördinatieverbinding.  
Informatie over de tijdsschaal van dit adsorptiefenomeen en over de thermodynamica is 
verkregen uit de metingen van de oppervlaktedruk van een monolaag van vetten en uit 
ITC metingen. Het is aangetoond dat de adsorptie van het ruthenium-watercomplex aan 
het oppervlak van de negatief-geladen monolagen en dubbellagen veel sneller is 
(minuten) dan coördinatie aan de thioetherverbinding (liganduitwisseling) (uren). 
Bovendien bleek het adsorptiefenomeen endotherm te zijn, oftewel gedreven door 
entropie. Gebaseerd op deze resultaten is een tweestapsmechanisme voorgesteld voor 
de binding van het dikationische metaalcomplex aan thioetherliganden die verankerd 
zijn in negatief-geladen liposomen. In de eerste stap adsorbeert de buitenste laag van 
een negatief geladen dubbellaag van vetten de positief geladen metaalcomplexen, en in 
de tweede stap wordt de Ru-S verbinding gevormd via tweedimensionale diffusie van 
beide reagentia op het membraan (zie Schema 4.2). Deze tweestapsreactie op negatief 
geladen membranen is sneller dan de corresponderende Ru-S vorming in een 
homogene oplossing.  
Ruthenium-gefunctionaliseerde liposomen: naar een tumor-gerichte, 
licht-gecontroleerde antikanker geneesmiddel (H 5) 
In hoofdstuk 5 is de potentiële toepassing beschreven van liposomen die 
gefunctionaliseerd zijn met lichtgevoelige polypyridyl-rutheniumcomplexen. Vier niet-
labiele rutheniumcomplexen zijn gemaakt met de algemene formule [Ru(terpy)(N-
N)(SRR’)]
2+
 (N-N = bpy of pymi (fenylpyridin-2-ylmethylene-imine), en SRR’ = 
thioetherliganden met een cholesterolstaart). Deze verbindingen zijn allemaal geplaatst 
op neutrale en negatief geladen liposomen. Alle vier de ruthenium-gefunctionaliseerde 
liposomen zijn fotoreactief; als oplossingen met deze liposomen worden beschenen 
met blauw licht, wordt de ruthenium-zwavelbinding verbroken. De 
fotosubstitutiereacties bleken sneller te zijn bij menselijke lichaamstemperatuur (37 °C) 
dan bij kamertemperatuur (25 °C), en iets sneller op het oppervlak van neutrale 




Celopname-experimenten op menselijke kankercellen lieten zien dat, in afwezigheid 
van PEG, het verhogen van de netto oppervlaktespanning van de liposomen resulteert 
in hogere celopname voor HepG2, A2780 en A2780R kankercellijnen. 
Rutheniumgefunctionaliseerde liposomen bestaande uit neutrale vetten worden beter 
opgenomen dan de analoge liposomen van negatief geladen lipiden. Echter, wanneer 
gePEGyleerde vetten geïntroduceerd worden in het membraan, wordt de netto 
oppervlaktespanning van de resulterende rutheniumgefunctionaliseerde 
“stealthliposomen” afgeschermd, wat resulteert in een verlaagde celopname vergeleken 
met PEG-vrije liposomen. In het algemeen heeft de exacte structuur van de 
rutheniumcomplexen geen significant effect op de celopnameresultaten. 
De giftigheidtesten van de neutrale en negatief-geladen “stealthliposomen” 
gefunctionaliseerd met een van de vier rutheniumcomplexen onder uitsluiting van licht, 
lieten zien dat deze liposomen in lage mate toxisch zijn voor A2780 en A2780R 
cellijnen, zonder significante verschillen tussen de vier rutheniumcomplexen. De 
cytotoxiciteit op HepG2 cellen is ook bepaald na bestraling met licht van één van de 
rutheniumcomplexen gebonden aan niet-gePEGyleerde liposomen. Het resultaat is dat 
bestraling met licht leidt tot een minimaal 40% hogere cytotoxiciteit ten opzichte van 
de cytotoxiciteit in het donker. Bij neutrale liposomen is dit effect het sterkst en is de 
cytotoxiciteit na bestraling met licht zelfs 80% hoger. Op basis van deze resultaten kan 
geconcludeerd worden dat het gebruik van ruthenium-gefunctionaliseerde liposomen 
veelbelovend is voor gecontroleerde afgifte van antikankermedicijnen.  
Sensitizatie met geel licht van een ligand-fotosubstitutiereactie in een 
ruthenium-polypyridylcomplex dat covalent gebonden is aan een 
rhodaminekleurstof (H 6) 
In hoofdstuk 6 wordt de mogelijkheid besproken om de fotoactivering van polypyridyl-
rutheniumcomplexen uit te bereiken met langere golflengtes. Zoals vermeld in 
hoofdstuk 1 zijn verscheidene polypyridyl-rutheniumcomplexen voorgesteld als 
lichtactiveerbare medicijnen voor fototherapie. Echter, hun potentiële toepassing in 
vivo is gelimiteerd, omdat ze voornamelijk blauw licht (450 nm) absorberen, waarvan 
bekend is dat het zeer slecht doordringt in menselijk weefsel.  
De fotosubstitutie van een thioetherligand op een rutheniumcomplex door een 
watermolecuul is bestudeerd met geel licht (570 nm). Een rhodamine-B kleurstof met 
een hoge molaire absorptie voor geel licht is covalent gebonden via een korte 
verzadigde linker aan het terpyridineligand Rtepy in het complex 
[Ru(Rterpy)(bpy)(Hmte)]
2+
. Het uitstekende antenne-effect van de rhodamine-B 
kleurstof, gekoppeld aan efficiënte energieoverdracht naar het rutheniumcentrum via 
Samenvatting 
233 
het omgekeerde Förstermechanisme, resulteerde onverwacht in snellere fotosubstitutie 
van het thioetherligand door bestraling met geel licht dan met blauw licht. 
In hoofdstuk 6 is de snelheid van fotosubstitutiereacties besproken wanneer fotonen 
met onvoldoende energie, vergeleken met dat van de 
1
MLCT toestand, zijn gebruikt. 
Voor zowel het rhodamine-B-gefunctionaliseerde rutheniumcomplex en voor zijn 
antenneloze equivalent [Ru(terpy)(bpy)(Hmte)]
2+
 zijn de kwantumopbrengsten 
vergelijkbaar voor blauw of geel licht. Sterker nog, bij een constante fotonflux is het de 
extinctiecoëfficient die de snelheidsconstante van fotosubstitutie het meest beïnvloedt 
voor deze complexen, terwijl de kwantumopbrengst van fotosubstitutie nauwelijks 
afhangt van de gebruikte golflengte. 
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